data_2kmm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kmm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.2 mp0 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.65 131.26 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.711 0.767 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.6 ttm -94.89 131.7 40.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.232 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.03 164.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -123.78 144.47 49.68 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.412 0.625 . . . . 0.0 109.51 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.8 176.27 1.98 Allowed Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -34.53 84.54 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -81.35 -3.68 53.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.575 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.32 9.34 85.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -69.91 150.81 46.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.286 . . . . 0.0 110.299 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.3 mm -90.06 124.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -131.5 112.4 12.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -94.02 136.19 34.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.501 -0.75 . . . . 0.0 109.219 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.3 mt -122.31 148.18 51.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.493 2.129 . . . . 0.0 112.717 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -56.01 139.31 47.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.62 12.63 77.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.06 154.8 41.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.7 p -127.49 174.57 8.92 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.55 0.69 . . . . 0.0 109.984 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.62 71.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.507 -0.746 . . . . 0.0 109.444 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.76 -42.45 99.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -61.49 -43.02 99.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.79 . . . . 0.0 110.088 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.54 80.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.178 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -64.96 -36.54 84.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.336 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.5 m -58.49 -41.56 85.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 78.0 mt -68.16 -73.77 0.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.32 -179.8 6.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.924 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 73.5 m -100.11 -59.57 1.69 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.568 -0.708 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.425 ' OD1' ' CD2' ' A' ' 451' ' ' HIS . 49.2 t0 -60.17 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.867 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.6 -43.41 97.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.227 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.49 -37.46 94.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.05 -16.41 63.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.054 -1.263 . . . . 0.0 109.381 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.425 ' CD2' ' OD1' ' A' ' 447' ' ' ASP . 45.3 m-70 -95.79 17.26 15.48 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 25.6 p -74.29 116.77 15.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.388 -0.82 . . . . 0.0 109.539 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.2 pt -99.44 -2.79 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -0.766 . . . . 0.0 109.247 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.26 -171.6 39.41 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.022 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -148.71 148.02 29.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -1.178 . . . . 0.0 109.126 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -135.63 120.86 18.99 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.01 133.14 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.557 0.694 . . . . 0.0 109.92 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 460' ' ' LYS . 19.4 t-20 56.51 43.27 26.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.681 -0.637 . . . . 0.0 109.671 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 55.33 10.38 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.625 -0.672 . . . . 0.0 109.957 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 458' ' ' ASN . 88.4 tttt -115.24 145.25 42.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.564 -0.71 . . . . 0.0 109.652 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 461' ' ' LEU . 4.3 mm? -72.93 141.37 47.84 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.38 148.38 22.19 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.02 162.6 37.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.274 1.982 . . . . 0.0 112.68 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.7 mp -62.71 -40.3 96.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.443 -0.785 . . . . 0.0 109.624 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 93.1 p -75.75 10.38 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.039 -1.038 . . . . 0.0 109.434 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.401 ' H ' ' C ' ' A' ' 464' ' ' LEU . 92.1 t80 -68.33 135.35 51.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 110.347 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.43 131.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.31 144.09 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.675 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -115.2 150.56 35.93 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.42 0.629 . . . . 0.0 109.421 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 472' ' ' ASP . 15.6 p -70.78 155.34 40.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.0 -36.57 1.47 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 470' ' ' SER . 99.0 m-20 -68.6 145.14 54.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.246 . . . . 0.0 111.002 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -86.29 140.23 30.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.763 . . . . 0.0 109.175 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.08 132.1 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.543 -0.723 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -136.82 116.02 12.55 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.35 138.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.92 130.89 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.275 -179.859 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.54 129.97 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.82 142.9 31.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.0 109.648 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.84 164.5 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.54 137.1 54.56 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.603 0.716 . . . . 0.0 109.479 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.05 165.55 14.7 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.85 -14.42 44.52 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.548 2.165 . . . . 0.0 111.232 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -85.22 -5.11 59.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.576 -0.702 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.34 9.3 82.1 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 427' ' ' GLU . 4.5 mp0 -84.19 162.04 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.288 -1.125 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.92 129.22 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -127.99 132.04 49.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -109.6 139.39 44.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 109.527 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 97.4 mt -136.4 147.9 61.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.488 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.46 158.65 56.58 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.486 2.124 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -56.63 146.34 25.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.55 77.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.57 154.42 41.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.687 -0.89 . . . . 0.0 110.142 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 69.5 p -127.57 170.47 12.59 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.595 0.712 . . . . 0.0 109.693 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.73 74.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 109.321 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.68 -42.09 99.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.44 -43.68 98.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -61.29 -44.68 96.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 109.523 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.74 -36.51 83.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.191 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.4 t -61.57 -39.54 91.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.578 -0.701 . . . . 0.0 110.132 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 89.2 mt -48.44 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 447' ' ' ASP . 99.3 m-70 -151.24 20.46 0.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 m 68.52 -37.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.624 . . . . 0.0 109.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 445' ' ' HIS . 99.7 m-20 -62.15 -44.23 97.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 448' ' ' LEU . 3.5 mm? -63.72 -43.06 97.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.825 . . . . 0.0 108.983 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -71.25 -29.65 68.24 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -76.44 -9.77 58.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -1.072 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -138.83 28.47 2.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.19 109.23 13.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.5 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.4 pt -100.65 -2.52 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.511 -0.743 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.32 176.51 45.99 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.066 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.6 149.99 29.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -1.083 . . . . 0.0 109.106 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -135.56 124.59 24.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 0.0 108.89 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.0 t -122.16 133.02 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.565 -0.709 . . . . 0.0 109.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 55.79 42.97 28.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.603 -0.686 . . . . 0.0 109.687 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m80 54.86 13.82 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.864 -0.523 . . . . 0.0 110.264 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -117.91 137.4 52.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 109.133 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.57 135.22 54.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.13 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.32 150.82 56.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.74 160.77 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.253 1.969 . . . . 0.0 112.547 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.2 mp -62.72 -40.33 96.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 465' ' ' SER . 3.4 t -77.7 15.06 0.89 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.507 -0.745 . . . . 0.0 109.167 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.435 ' H ' ' C ' ' A' ' 464' ' ' LEU . 86.8 t80 -67.54 134.11 50.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.907 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.96 131.39 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.785 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.95 145.66 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.806 . . . . 0.0 110.243 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -119.58 146.18 45.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.537 0.684 . . . . 0.0 109.175 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.1 t -64.93 141.24 58.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 110.68 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.7 -32.83 4.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -72.73 147.04 46.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.251 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.34 144.16 28.22 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.81 132.95 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-O 121.668 0.747 . . . . 0.0 109.786 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -139.62 128.62 23.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.94 128.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.007 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.22 100.0 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.025 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 110.025 -179.744 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.3 mp0 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.05 131.07 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.684 0.754 . . . . 0.0 109.486 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.7 ttp -98.22 129.97 44.96 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.723 0.773 . . . . 0.0 110.458 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.33 164.47 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.33 137.35 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.856 0.836 . . . . 0.0 109.96 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.39 159.66 30.67 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.93 -16.22 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.251 1.967 . . . . 0.0 111.413 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -83.27 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.03 6.42 88.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 429' ' ' LYS . 82.7 tt0 -86.6 152.48 22.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.943 . . . . 0.0 110.705 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 428' ' ' ILE . 29.9 mm -84.18 129.2 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.492 0.663 . . . . 0.0 109.804 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 427' ' ' GLU . 34.9 mmtm -132.76 109.4 9.64 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.597 0.713 . . . . 0.0 110.13 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -102.37 128.67 48.86 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.6 mt -122.47 152.69 61.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.14 145.94 24.51 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.459 2.106 . . . . 0.0 112.745 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -58.39 137.01 57.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.847 0.832 . . . . 0.0 110.634 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.23 13.93 72.84 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -72.61 166.54 22.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.913 . . . . 0.0 110.209 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 p -127.13 172.34 10.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.992 0.901 . . . . 0.0 110.581 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.61 -26.6 61.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.09 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.72 -45.4 92.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.418 -0.801 . . . . 0.0 109.719 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -64.82 -38.39 90.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.691 -0.631 . . . . 0.0 109.421 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -61.23 -45.34 94.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.786 -0.571 . . . . 0.0 109.974 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.51 91.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.646 -0.659 . . . . 0.0 109.515 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -68.64 -34.09 75.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.494 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 30.8 m -58.08 -42.07 84.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.81 -0.556 . . . . 0.0 109.706 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.08 -70.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.714 -0.616 . . . . 0.0 109.603 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -149.2 -176.17 5.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.559 -0.713 . . . . 0.0 109.904 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 37.6 t -92.45 -71.01 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.498 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 27.2 t70 -55.78 -48.63 75.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.793 -0.567 . . . . 0.0 110.231 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -44.5 95.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.531 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.07 -38.73 92.66 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.75 -10.7 59.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.874 . . . . 0.0 109.501 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 16.0 m80 -99.66 20.8 13.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.97 117.9 22.55 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.585 0.707 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.6 pt -101.16 -3.46 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.49 176.94 46.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.71 146.34 37.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.797 -0.825 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -134.75 122.27 21.9 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.394 0.616 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -122.44 132.76 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.702 0.763 . . . . 0.0 109.8 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 54.42 45.69 26.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.653 0.739 . . . . 0.0 109.796 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 459' ' ' HIS . 58.1 t-80 56.41 14.04 1.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.055 0.455 . . . . 0.0 109.969 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.44 141.15 47.44 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.725 0.774 . . . . 0.0 110.159 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.404 ' C ' ' CD1' ' A' ' 461' ' ' LEU . 0.3 OUTLIER -79.58 112.31 16.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.544 0.688 . . . . 0.0 109.522 -179.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -120.95 151.02 54.35 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.85 163.3 36.01 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.604 2.202 . . . . 0.0 112.648 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.62 -39.93 95.36 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 109.786 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.6 m -75.45 8.35 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.773 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 91.1 t80 -67.54 135.01 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.698 0.761 . . . . 0.0 110.406 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.426 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 79.8 t -78.53 131.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.828 0.823 . . . . 0.0 109.757 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.4 mt -74.41 143.39 44.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.654 0.74 . . . . 0.0 110.407 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -116.26 144.6 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.767 0.794 . . . . 0.0 109.801 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.5 t -66.76 139.81 57.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.756 0.789 . . . . 0.0 110.564 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.28 -34.99 4.18 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.05 144.21 48.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.732 -0.864 . . . . 0.0 110.872 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -87.44 144.22 26.85 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.499 0.666 . . . . 0.0 109.562 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.42 131.31 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.575 0.703 . . . . 0.0 109.969 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -133.07 137.98 46.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.03 130.94 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.64 0.734 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.01 131.74 42.09 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.536 0.684 . . . . 0.0 109.676 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.694 0.759 . . . . 0.0 109.721 -179.8 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.1 mp0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.387 0.613 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.45 131.03 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.55 0.69 . . . . 0.0 109.301 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 50.8 ttp -97.88 136.54 38.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.523 -0.735 . . . . 0.0 109.768 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.11 161.55 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -115.33 134.59 54.97 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.659 0.742 . . . . 0.0 109.787 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 166.27 13.63 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.71 -15.05 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.531 2.154 . . . . 0.0 111.471 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -85.91 -6.2 59.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.196 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.72 11.9 78.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -85.84 161.77 18.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.143 . . . . 0.0 110.206 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 1.3 mp -107.78 129.03 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.92 123.35 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -102.08 127.87 48.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 14.1 mt -118.49 158.21 47.56 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.53 149.17 83.7 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.33 2.02 . . . . 0.0 112.873 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -57.48 134.21 55.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.458 -0.777 . . . . 0.0 110.418 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.73 76.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -63.54 167.87 5.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -1.148 . . . . 0.0 110.246 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 70.0 p -127.52 172.33 10.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.666 0.746 . . . . 0.0 110.002 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -30.07 68.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.477 -0.764 . . . . 0.0 109.219 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.05 -43.12 99.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 0.0 109.309 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.68 -41.35 99.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.43 -43.65 98.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 109.939 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.96 -44.8 87.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -65.49 -35.73 81.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.404 -0.81 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 26.2 m -58.64 -41.47 86.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.753 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 76.5 mt -68.96 -77.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.651 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 445' ' ' HIS . 6.1 m80 -124.29 -151.18 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.604 -0.685 . . . . 0.0 109.2 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 26.5 m -128.54 -70.49 0.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.59 -0.694 . . . . 0.0 109.251 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.446 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.6 m-20 -64.19 -39.5 94.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.08 -44.95 95.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.059 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.14 93.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 452' ' ' CYS . 35.4 t70 -64.43 -38.36 90.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -1.09 . . . . 0.0 109.605 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.446 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 60.9 m80 -78.6 28.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 8.8 t -79.21 123.97 27.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 453' ' ' ILE . 36.0 pt -97.6 -5.01 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.214 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . 175.88 179.74 46.55 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.75 149.54 43.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.995 . . . . 0.0 109.122 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -132.41 122.6 25.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.33 132.88 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.692 -0.63 . . . . 0.0 109.643 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . 0.528 HD22 ' CG ' ' A' ' 472' ' ' ASP . 98.0 m-20 55.9 42.37 28.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.721 -0.612 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.8 m80 57.15 12.03 1.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.739 -0.6 . . . . 0.0 109.879 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.96 136.25 53.21 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.632 0.73 . . . . 0.0 109.653 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.92 134.63 52.4 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.577 -0.702 . . . . 0.0 109.863 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.09 150.9 57.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.795 . . . . 0.0 109.294 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.5 161.6 42.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.558 2.172 . . . . 0.0 113.01 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 464' ' ' LEU . 10.5 mp -63.27 -40.16 96.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.699 -0.626 . . . . 0.0 109.451 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 8.4 t -76.43 8.19 3.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.207 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 90.1 t80 -61.26 134.91 57.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.512 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.411 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 76.1 t -76.9 130.09 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.478 -0.764 . . . . 0.0 109.98 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.8 147.71 33.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 110.409 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -125.7 145.19 50.29 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.621 0.724 . . . . 0.0 109.518 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 97.6 p -65.4 145.17 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.658 0.742 . . . . 0.0 110.846 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.43 -32.53 4.69 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . 0.528 ' CG ' HD22 ' A' ' 458' ' ' ASN . 88.7 m-20 -72.73 145.77 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.88 139.67 30.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.17 131.93 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.569 0.7 . . . . 0.0 109.992 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.91 114.01 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.61 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.88 114.24 26.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 109.594 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.535 -0.728 . . . . 0.0 110.224 -179.561 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.9 mp0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.317 0.58 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.0 131.73 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.737 0.78 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.6 ttm -90.33 132.9 35.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.758 0.79 . . . . 0.0 110.084 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.63 163.46 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.404 0.621 . . . . 0.0 109.425 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -123.57 138.68 54.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.013 0.911 . . . . 0.0 109.929 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 159.39 29.87 Favored Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.41 -34.81 33.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.331 2.021 . . . . 0.0 112.221 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.81 -4.13 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.818 -0.551 . . . . 0.0 109.696 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.36 7.45 82.62 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -74.09 153.21 39.71 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.676 0.75 . . . . 0.0 110.682 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.97 122.5 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.406 0.622 . . . . 0.0 109.629 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -127.31 135.91 51.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.846 0.831 . . . . 0.0 110.235 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -108.11 132.86 53.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 31.5 mt -122.14 152.45 60.25 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 147.84 28.91 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.262 1.975 . . . . 0.0 112.86 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.21 129.32 41.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.646 0.736 . . . . 0.0 110.58 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 13.95 76.19 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.36 173.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.671 0.748 . . . . 0.0 110.604 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 33.0 p -127.97 172.01 11.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.874 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.71 65.8 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.09 -42.47 99.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.97 -42.05 98.7 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -62.1 -42.87 99.66 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.98 92.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.0 -36.6 83.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.3 m -58.95 -42.87 90.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.565 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 77.6 mt -66.61 -59.93 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.734 -0.604 . . . . 0.0 109.789 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.4 m-70 -158.85 -176.06 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.441 0.638 . . . . 0.0 109.858 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 39.9 t -101.58 -61.72 1.34 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.09 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.51 -44.96 95.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.742 -0.599 . . . . 0.0 109.935 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -45.11 93.53 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.15 89.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.98 -34.35 78.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.885 -0.773 . . . . 0.0 109.406 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -85.12 16.5 3.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 49.7 t -72.79 116.67 13.56 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.597 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.2 pt -102.53 -0.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . 0.449 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -173.03 170.86 44.01 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.745 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.12 149.51 31.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.069 -0.665 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -138.82 130.59 27.7 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 64.7 t -119.97 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.663 0.744 . . . . 0.0 109.677 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 58.49 41.64 22.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 56.94 12.99 1.33 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -113.05 115.36 28.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.896 0.855 . . . . 0.0 109.792 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.1 tp -51.32 133.92 28.5 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.556 0.694 . . . . 0.0 110.229 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.1 152.34 39.6 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.13 161.57 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.595 2.196 . . . . 0.0 112.651 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 464' ' ' LEU . 10.8 mp -62.79 -38.2 89.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.1 m -75.05 7.45 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.847 -0.533 . . . . 0.0 109.663 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -69.58 134.08 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.564 0.697 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 82.8 t -78.61 131.04 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.596 0.713 . . . . 0.0 109.865 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.71 146.24 42.43 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.629 0.728 . . . . 0.0 110.631 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -121.11 144.54 48.51 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.866 0.841 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 140.75 58.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.659 0.743 . . . . 0.0 111.121 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.57 -25.89 18.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.32 163.29 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.666 -0.903 . . . . 0.0 110.946 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -109.31 120.72 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 20.9 t -93.09 132.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.841 0.829 . . . . 0.0 110.622 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.5 0.667 . . . . 0.0 109.316 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.23 130.82 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.805 0.812 . . . . 0.0 110.455 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.65 106.35 18.61 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.588 0.709 . . . . 0.0 109.213 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.588 0.708 . . . . 0.0 110.171 179.845 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.3 mp0 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 18.2 m -119.32 130.94 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.592 -0.692 . . . . 0.0 109.215 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 49.5 ttp -96.66 137.94 34.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.74 165.18 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -113.32 138.51 49.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.515 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' THR . . . . . 0.492 ' HG1' ' H ' ' A' ' 425' ' ' LYS . 0.9 OUTLIER -98.6 162.49 21.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 108.784 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.27 -32.29 40.52 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.191 1.928 . . . . 0.0 111.998 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . 0.492 ' H ' ' HG1' ' A' ' 423' ' ' THR . 99.4 mttt -78.53 -1.64 34.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.05 -1.031 . . . . 0.0 109.323 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.22 12.09 81.29 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.24 158.83 32.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -1.163 . . . . 0.0 110.55 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.6 mm -106.24 124.41 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.463 -0.773 . . . . 0.0 109.077 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -128.67 132.94 48.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -0.758 . . . . 0.0 109.016 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -106.74 138.41 42.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.1 mt -131.64 147.6 66.69 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.92 157.31 62.36 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.375 2.05 . . . . 0.0 112.705 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.41 143.01 25.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.64 12.62 74.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.06 42.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 110.364 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.2 p -127.45 172.03 11.04 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.588 0.709 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.28 69.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.49 -0.756 . . . . 0.0 109.593 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.58 -42.26 99.45 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 109.197 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.59 -44.71 93.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -61.5 -43.65 98.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.11 85.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.152 -0.968 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -64.31 -36.87 85.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.0 m -59.01 -42.29 89.75 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.96 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.71 -57.36 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.991 -1.068 . . . . 0.0 109.658 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.649 ' CG ' ' H ' ' A' ' 446' ' ' SER . 65.6 t60 -161.48 -173.48 3.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.144 -0.972 . . . . 0.0 109.333 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' SER . . . . . 0.649 ' H ' ' CG ' ' A' ' 445' ' ' HIS . 8.7 m -103.41 -60.53 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.74 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 451' ' ' HIS . 43.5 t0 -62.16 -45.7 92.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -43.89 97.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 108.816 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.67 -35.51 92.02 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -73.41 -10.77 60.08 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.28 -1.13 . . . . 0.0 109.36 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 59.5 m-70 -97.36 7.85 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 108.841 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 452' ' ' CYS . 29.9 p -73.55 116.44 14.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.392 -0.818 . . . . 0.0 109.822 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.08 -2.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.05 177.54 43.95 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.55 142.79 41.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -1.074 . . . . 0.0 108.958 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.74 121.9 21.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.5 133.85 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 57.38 43.95 22.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.764 0.792 . . . . 0.0 109.356 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 54.17 13.27 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.747 . . . . 0.0 110.224 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -114.71 136.65 52.83 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.54 -0.725 . . . . 0.0 109.418 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.1 tp -67.83 134.46 50.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.89 151.2 48.65 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 108.861 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.55 162.08 38.47 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.598 2.199 . . . . 0.0 112.746 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.6 mp -62.92 -39.34 94.25 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.717 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.3 m -75.19 7.85 3.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.115 -0.991 . . . . 0.0 109.181 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -66.21 134.95 53.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.242 -0.911 . . . . 0.0 110.255 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.71 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.43 144.63 44.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.234 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 100.0 m-20 -117.18 151.68 36.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.686 -0.634 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.3 p -68.92 154.12 42.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.522 -0.736 . . . . 0.0 110.848 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.45 -37.2 1.59 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.94 145.4 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.398 . . . . 0.0 110.964 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -87.43 149.79 24.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.51 -0.743 . . . . 0.0 109.508 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 61.9 t -118.62 132.8 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.521 -0.737 . . . . 0.0 109.749 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -138.08 113.78 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.0 139.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 110.011 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.4 111.7 23.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.418 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.2 mp0 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.03 130.86 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.692 0.758 . . . . 0.0 109.071 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.2 ttp -100.2 140.62 34.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.856 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 166.3 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.82 138.74 50.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.804 0.811 . . . . 0.0 109.837 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' THR . . . . . 0.607 ' HG1' ' H ' ' A' ' 425' ' ' LYS . 0.2 OUTLIER -99.52 165.79 14.08 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.568 ' N ' ' HG1' ' A' ' 423' ' ' THR . 31.8 Cg_endo -64.96 -16.01 53.31 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.569 2.179 . . . . 0.0 111.446 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . 0.607 ' H ' ' HG1' ' A' ' 423' ' ' THR . 14.3 mptt -86.27 -3.68 59.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 108.914 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.42 84.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.94 167.36 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 110.419 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.0 mm -108.09 128.71 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.592 -0.692 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.01 131.47 53.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.525 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -107.82 132.67 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.9 mt -126.57 147.87 62.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.673 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.54 158.14 56.82 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -56.42 139.58 48.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.32 76.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.67 154.89 41.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -1.086 . . . . 0.0 110.104 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.5 p -127.05 172.72 10.26 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.829 0.823 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -30.6 66.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.707 -0.621 . . . . 0.0 110.053 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.33 -43.01 98.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.56 -40.72 97.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 109.725 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . 0.408 ' O ' ' OG ' ' A' ' 443' ' ' SER . 77.8 t80 -61.08 -42.88 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.451 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.16 93.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.809 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.43 -37.37 80.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 440' ' ' PHE . 91.1 p -61.56 -35.96 79.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.49 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.574 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 92.4 mt -63.95 -43.58 95.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.174 -0.954 . . . . 0.0 109.63 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.2 m-70 -162.12 -120.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.739 . . . . 0.0 109.384 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 5.7 p -158.83 -68.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.17 -39.04 92.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -43.26 99.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.238 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.2 89.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.6 -34.27 77.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -82.41 21.34 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 42.1 t -76.67 122.92 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -0.843 . . . . 0.0 109.664 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -105.48 -4.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.85 -177.32 46.54 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.32 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.19 148.94 30.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -1.144 . . . . 0.0 109.209 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -132.01 126.54 34.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.76 130.56 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.645 0.736 . . . . 0.0 109.72 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . 0.452 HD22 ' CB ' ' A' ' 472' ' ' ASP . 11.2 m120 55.55 41.79 30.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 109.81 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 57.55 16.27 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -118.51 138.76 52.29 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.703 0.763 . . . . 0.0 109.86 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.87 139.04 53.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.2 m -151.06 149.8 25.86 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.43 162.08 42.2 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.339 2.026 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.11 -39.31 94.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.0 m -75.3 8.14 2.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.274 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.3 t80 -65.64 135.4 54.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.42 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 77.5 t -77.09 130.72 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.673 0.749 . . . . 0.0 110.019 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.74 145.23 38.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.0 110.175 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -118.5 147.64 43.44 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.677 0.751 . . . . 0.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 94.1 p -65.24 151.43 46.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 80.2 -38.35 2.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . 0.452 ' CB ' HD22 ' A' ' 458' ' ' ASN . 99.4 m-20 -68.42 144.27 54.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -1.037 . . . . 0.0 110.796 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -89.23 145.47 25.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.486 -0.759 . . . . 0.0 109.172 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.98 133.24 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.551 -0.718 . . . . 0.0 109.75 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -132.73 142.22 48.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.75 131.2 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.6 0.714 . . . . 0.0 109.74 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.0 mt -92.67 137.38 32.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.773 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 109.528 -179.777 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.146 0.498 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.45 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 31.5 ttm -99.96 144.48 28.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.721 -0.612 . . . . 0.0 109.703 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.51 163.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.24 137.63 53.53 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.676 0.75 . . . . 0.0 109.734 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.67 177.67 1.57 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -29.99 85.65 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.453 2.102 . . . . 0.0 111.595 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.9 -4.52 59.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.16 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.04 13.99 80.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.41 147.17 46.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 428' ' ' ILE . 1.4 mp -90.92 127.58 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -131.23 110.07 10.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -90.24 137.41 32.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.759 -0.588 . . . . 0.0 109.718 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.77 148.45 69.98 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.52 155.01 72.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.466 2.11 . . . . 0.0 112.464 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.23 145.84 10.14 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.668 0.746 . . . . 0.0 110.434 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.63 13.02 79.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.0 150.93 47.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.976 . . . . 0.0 110.267 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.5 p -127.46 172.72 10.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.645 0.736 . . . . 0.0 109.799 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.24 -30.47 66.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.673 -0.642 . . . . 0.0 109.643 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.62 -43.23 97.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.57 -42.05 99.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -61.37 -43.68 98.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.558 -0.714 . . . . 0.0 109.841 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.42 83.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 0.0 109.804 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.87 -36.16 83.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.8 m -59.66 -39.31 83.99 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.603 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 93.3 mt -63.1 -44.31 96.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.762 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.5 m-70 -161.97 -120.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.644 . . . . 0.0 109.521 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 6.0 p -152.93 -76.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.562 -0.712 . . . . 0.0 109.079 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.67 -42.34 98.07 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.441 0.638 . . . . 0.0 109.574 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -44.6 95.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.331 -0.856 . . . . 0.0 108.924 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -65.87 -43.83 93.09 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 452' ' ' CYS . 57.1 t0 -68.83 -29.28 67.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.993 . . . . 0.0 109.607 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -80.62 18.49 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.376 -0.828 . . . . 0.0 108.825 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' A' ' 450' ' ' ASP . 63.8 m -79.79 133.04 36.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.588 -0.695 . . . . 0.0 109.951 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.21 -4.24 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.614 -0.678 . . . . 0.0 109.476 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.89 47.4 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.18 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.05 151.99 48.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.509 -0.995 . . . . 0.0 109.703 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . 0.511 ' HZ3' ' C ' ' A' ' 459' ' ' HIS . 39.9 tttm -133.23 119.98 20.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.652 -0.655 . . . . 0.0 109.308 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.89 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . 0.558 HD22 ' CB ' ' A' ' 472' ' ' ASP . 14.4 m120 57.45 37.8 27.96 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.511 ' C ' ' HZ3' ' A' ' 456' ' ' LYS . 29.1 m170 58.83 13.64 2.84 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.78 156.42 26.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.548 0.69 . . . . 0.0 109.816 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.02 113.43 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.482 -0.762 . . . . 0.0 109.703 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.99 150.69 46.38 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.74 162.28 38.07 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.636 2.224 . . . . 0.0 112.697 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.8 mp -62.86 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.653 -0.655 . . . . 0.0 109.517 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.9 m -75.33 4.35 7.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.326 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -62.72 135.68 57.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.799 . . . . 0.0 110.44 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.22 132.3 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.576 0.703 . . . . 0.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.79 148.07 46.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.631 -0.668 . . . . 0.0 110.509 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.23 142.21 51.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.646 0.736 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.8 t -66.84 141.09 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.619 0.724 . . . . 0.0 110.801 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 91.02 -36.44 3.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . 0.558 ' CB ' HD22 ' A' ' 458' ' ' ASN . 91.8 m-20 -70.27 144.01 51.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.438 -1.037 . . . . 0.0 110.454 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.2 143.01 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.556 -0.715 . . . . 0.0 109.391 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.08 132.35 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.42 0.629 . . . . 0.0 109.803 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -140.5 126.1 19.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 34.9 m -94.4 132.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.499 -0.75 . . . . 0.0 109.843 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.87 111.9 23.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.639 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.586 0.708 . . . . 0.0 110.016 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 9.7 m -109.92 130.5 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' MET . . . . . 0.412 ' CE ' ' NH2' ' A' ' 430' ' ' ARG . 39.0 ttm -91.03 134.21 34.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.807 . . . . 0.0 109.308 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.23 162.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.14 138.77 52.69 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.488 0.661 . . . . 0.0 109.596 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 165.62 14.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.09 -14.74 45.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.179 1.919 . . . . 0.0 111.129 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.98 -4.27 59.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.467 -0.77 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.65 85.36 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.08 165.9 18.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 110.069 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.3 mm -110.91 128.4 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.52 -0.737 . . . . 0.0 109.022 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -126.85 140.22 52.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.412 ' NH2' ' CE ' ' A' ' 420' ' ' MET . 95.9 mtt-85 -113.35 136.79 52.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.632 -0.668 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.25 147.33 63.27 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.15 159.78 51.1 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.257 1.972 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -57.05 148.89 20.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.468 -0.77 . . . . 0.0 110.302 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 10.46 81.64 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.03 44.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -1.046 . . . . 0.0 109.759 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.1 p -127.57 173.58 9.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.631 -0.668 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.98 -34.36 69.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.93 -43.03 99.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 109.638 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.87 -41.8 98.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . 0.409 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 79.7 t80 -60.78 -44.58 96.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.055 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.75 86.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.04 -1.038 . . . . 0.0 109.939 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -64.04 -37.89 89.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.08 . . . . 0.0 109.673 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 60.6 p -59.77 -37.12 78.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 89.2 mt -63.46 -54.19 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.987 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 99.6 m-70 -161.93 -126.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 19.4 m -146.63 -64.7 0.29 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.011 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.93 -45.36 92.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.0 109.98 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -44.83 95.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.9 90.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.09 -18.47 63.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -1.196 . . . . 0.0 110.011 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -103.29 42.35 1.17 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.392 -0.818 . . . . 0.0 109.321 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.32 127.43 44.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.446 -0.784 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 453' ' ' ILE . 42.1 pt -101.57 -5.2 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.12 178.55 48.22 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.56 149.31 48.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.645 -0.915 . . . . 0.0 108.704 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . 0.465 ' NZ ' ' C ' ' A' ' 459' ' ' HIS . 44.8 tttm -132.88 120.83 22.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 94.1 t -123.57 133.83 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.542 -0.724 . . . . 0.0 109.705 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.33 43.59 19.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.465 ' C ' ' NZ ' ' A' ' 456' ' ' LYS . 79.5 m80 53.13 13.16 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 110.653 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -118.09 137.04 53.2 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.378 -0.826 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.3 134.83 54.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.628 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.29 150.93 53.64 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.34 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.636 2.224 . . . . 0.0 112.716 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.7 mp -62.45 -39.09 92.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.216 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -74.64 7.74 2.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.338 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 464' ' ' LEU . 92.0 t80 -65.45 133.78 52.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.949 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 78.2 t -79.56 132.18 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.49 149.23 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.378 -0.826 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -124.1 145.37 49.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.616 -0.677 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.7 t -65.69 142.44 58.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -0.799 . . . . 0.0 110.495 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.89 -32.46 5.1 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -73.08 149.37 43.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.349 -1.089 . . . . 0.0 109.716 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -95.53 130.14 42.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 22.1 t -103.55 131.66 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.455 -0.778 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -134.51 143.14 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.46 132.46 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.479 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.81 128.65 46.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.327 -0.858 . . . . 0.0 109.248 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.498 1.937 0 O-C-N 121.547 -0.721 . . . . 0.0 109.567 -179.832 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.365 0.602 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.1 131.58 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.631 0.729 . . . . 0.0 109.519 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 54.6 ttm -96.99 133.69 41.33 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.687 0.756 . . . . 0.0 110.405 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.08 163.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -115.69 142.35 46.86 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.902 0.858 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.71 176.71 1.78 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.33 -29.92 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.071 1.847 . . . . 0.0 111.429 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.11 -4.91 59.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.173 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.5 79.95 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.59 157.55 37.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.52 -0.988 . . . . 0.0 110.485 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.3 mm -99.68 123.98 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.646 -0.659 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -127.43 126.33 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -106.62 133.86 50.65 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.26 0.552 . . . . 0.0 109.646 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.76 152.96 77.82 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.54 147.82 22.11 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.36 2.04 . . . . 0.0 112.492 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.14 132.37 52.74 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.914 0.864 . . . . 0.0 110.632 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.6 13.59 75.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.3 170.9 0.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.986 . . . . 0.0 110.677 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.9 p -127.54 171.08 11.93 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.143 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.77 67.96 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.327 0.584 . . . . 0.0 109.968 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.39 -42.56 98.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.69 -39.85 95.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.712 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.27 -43.68 98.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.792 . . . . 0.0 109.156 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.3 95.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.627 -0.671 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -65.03 -36.68 85.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 38.9 m -58.81 -41.57 87.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.04 -76.71 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -138.42 179.05 6.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.419 -0.801 . . . . 0.0 109.897 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 33.6 t -103.95 -55.06 2.44 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.378 0.609 . . . . 0.0 109.612 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.58 -49.68 74.31 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.512 0.673 . . . . 0.0 109.659 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.95 -44.71 88.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.739 0.78 . . . . 0.0 109.611 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . 0.472 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.73 -42.19 93.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 450' ' ' ASP . 65.8 t0 -66.63 -35.46 80.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.942 . . . . 0.0 109.864 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 451' ' ' HIS . 11.1 t-160 -81.74 20.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.197 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 28.7 p -74.53 129.98 38.75 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.498 0.666 . . . . 0.0 109.947 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 453' ' ' ILE . 25.4 pt -104.43 -4.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.37 48.48 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 147.04 40.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.58 -0.953 . . . . 0.0 109.709 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -131.66 124.04 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.08 131.84 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.614 0.721 . . . . 0.0 109.998 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 54.7 44.06 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 109.937 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.436 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 54.0 t-80 58.49 13.39 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.281 0.562 . . . . 0.0 109.68 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.02 144.53 43.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.751 . . . . 0.0 109.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.13 113.53 20.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.423 0.63 . . . . 0.0 109.589 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.75 151.69 54.85 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.07 162.78 36.68 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.497 2.131 . . . . 0.0 112.375 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 466' ' ' TYR . 10.6 mp -63.32 -39.42 94.52 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.402 0.62 . . . . 0.0 109.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.6 t -75.56 10.52 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.286 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.437 ' H ' ' C ' ' A' ' 464' ' ' LEU . 93.0 t80 -69.1 135.48 50.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.788 0.804 . . . . 0.0 110.518 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.433 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 81.7 t -81.2 131.48 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 121.721 0.772 . . . . 0.0 109.778 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.61 145.08 45.67 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.617 0.722 . . . . 0.0 110.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.02 144.18 44.9 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.67 0.747 . . . . 0.0 109.877 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 42.6 t -68.62 140.18 55.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.947 0.879 . . . . 0.0 111.143 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.11 -26.19 16.28 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.95 163.31 25.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.986 . . . . 0.0 111.359 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -103.43 134.51 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 51.3 t -114.48 132.2 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.699 0.761 . . . . 0.0 110.301 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.79 146.23 39.2 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.29 131.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.727 0.775 . . . . 0.0 110.188 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.5 131.91 34.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.573 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 121.68 0.752 . . . . 0.0 110.235 -179.447 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.8 130.88 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.429 -0.794 . . . . 0.0 108.964 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.6 ttm -92.5 138.43 31.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.786 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.48 164.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.03 137.39 53.57 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' THR . . . . . 0.611 ' HG1' ' H ' ' A' ' 425' ' ' LYS . 0.1 OUTLIER -98.98 171.51 5.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.94 -29.5 82.49 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.939 1.759 . . . . 0.0 111.113 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . 0.611 ' H ' ' HG1' ' A' ' 423' ' ' THR . 19.3 mmmt -81.24 -4.35 55.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.626 . . . . 0.0 109.623 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.0 83.46 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -73.87 156.65 37.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -1.171 . . . . 0.0 110.198 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.7 mm -103.12 125.14 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.08 132.9 47.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.565 -0.709 . . . . 0.0 109.262 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -107.25 134.99 49.52 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 49.2 mt -131.0 153.07 81.68 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.6 147.17 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.985 1.79 . . . . 0.0 112.707 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -54.87 130.34 40.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.673 -0.642 . . . . 0.0 110.092 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.03 76.36 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -52.09 172.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 109.864 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.7 p -128.22 171.42 11.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.551 -0.718 . . . . 0.0 109.958 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.73 71.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.06 -43.55 98.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.432 -0.793 . . . . 0.0 109.532 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -61.12 -43.85 98.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.01 -45.53 79.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.439 -0.788 . . . . 0.0 109.842 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -62.16 -37.95 87.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.832 . . . . 0.0 109.744 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.2 m -58.87 -41.55 87.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.81 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.97 -43.93 97.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.308 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.689 ' CD2' ' H ' ' A' ' 446' ' ' SER . 73.5 t60 -173.68 -130.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.421 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' SER . . . . . 0.689 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 8.1 t -145.42 -64.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.65 -44.95 94.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.449 -0.782 . . . . 0.0 109.731 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -46.0 89.76 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -68.74 -39.11 86.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -37.88 89.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.511 -0.993 . . . . 0.0 109.839 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -83.17 20.06 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 109.498 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 27.7 p -71.09 122.47 20.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.675 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.9 pt -99.64 -2.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.793 . . . . 0.0 109.777 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.54 179.66 45.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.24 146.29 36.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 109.053 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -134.01 122.06 22.48 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.263 -0.898 . . . . 0.0 108.951 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.06 134.46 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.678 -0.639 . . . . 0.0 109.607 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 58.09 41.94 23.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 55.2 18.45 2.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.627 . . . . 0.0 110.141 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -122.75 144.09 49.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.628 -0.67 . . . . 0.0 109.213 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 41.9 tp -70.17 134.28 47.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.33 149.87 53.01 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.05 162.18 41.1 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.486 2.124 . . . . 0.0 112.617 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.8 mp -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.71 -0.619 . . . . 0.0 109.65 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 96.6 p -75.96 10.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.749 . . . . 0.0 109.627 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.5 t80 -65.09 135.94 56.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 110.226 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.434 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 22.3 t -79.29 131.26 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.89 149.32 39.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.395 -0.816 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -124.14 141.97 51.61 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.537 0.684 . . . . 0.0 109.396 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.9 t -66.19 142.45 57.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.69 . . . . 0.0 110.781 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.33 10.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -78.87 161.14 26.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -1.043 . . . . 0.0 109.998 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -105.56 122.82 46.81 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.5 t -97.4 132.24 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.458 -0.776 . . . . 0.0 110.244 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.0 141.72 47.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.16 130.8 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.447 -0.783 . . . . 0.0 109.64 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.17 137.92 31.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 97.4 p . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.446 -0.784 . . . . 0.0 109.676 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 121.378 0.608 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.1 m -114.31 131.25 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.651 0.739 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' MET . . . . . 0.424 ' H ' ' HG ' ' A' ' 470' ' ' SER . 63.8 ttp -95.02 135.4 36.61 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.525 0.679 . . . . 0.0 110.003 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.18 164.68 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.09 141.24 48.69 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.678 0.751 . . . . 0.0 109.73 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.52 176.25 2.04 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.28 -33.48 85.07 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.896 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.94 -4.21 54.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 80.91 10.68 84.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.85 155.73 40.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.636 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.22 124.33 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -127.19 131.88 50.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -105.71 135.52 46.98 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.451 0.643 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 23.1 mt -138.69 150.77 66.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.69 156.13 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.429 2.086 . . . . 0.0 112.719 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.16 154.49 7.78 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.291 1.043 . . . . 0.0 111.101 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 78.71 7.03 88.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.58 153.35 43.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.356 -1.085 . . . . 0.0 110.443 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 47.8 p -127.04 171.21 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.772 0.796 . . . . 0.0 110.159 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.3 -28.52 63.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.564 0.697 . . . . 0.0 109.829 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -46.67 86.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 109.578 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.68 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -61.13 -44.33 97.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.677 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.1 -47.37 83.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.0 -34.73 78.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.539 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 34.4 m -59.23 -41.2 88.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.579 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.38 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.95 -151.19 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.373 -0.83 . . . . 0.0 109.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 82.1 p -127.32 -73.99 0.6 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.583 0.706 . . . . 0.0 110.034 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.525 ' N ' ' OG ' ' A' ' 446' ' ' SER . 99.6 m-20 -64.13 -43.28 95.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -46.58 87.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.007 0.908 . . . . 0.0 109.295 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.25 -40.21 94.68 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 452' ' ' CYS . 65.3 t0 -65.62 -37.92 87.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -1.066 . . . . 0.0 109.946 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 73.6 m-70 -76.77 26.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.196 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.509 ' H ' ' C ' ' A' ' 450' ' ' ASP . 21.6 p -79.7 121.11 24.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.65 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 38.6 pt -101.38 -3.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.48 179.51 47.47 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.244 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.05 152.8 32.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -1.072 . . . . 0.0 109.364 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -131.01 131.31 44.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.742 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.15 132.56 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.44 0.638 . . . . 0.0 109.511 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 56.43 39.38 30.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.518 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 78.1 m80 58.94 13.13 2.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.453 0.644 . . . . 0.0 109.69 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.77 136.83 49.25 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.778 0.799 . . . . 0.0 109.62 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.0 tp -66.44 131.74 46.73 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.707 0.765 . . . . 0.0 110.473 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 7.0 m -146.87 149.93 37.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.8 158.6 55.47 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.423 2.082 . . . . 0.0 112.421 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.52 -38.45 90.0 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.668 0.747 . . . . 0.0 109.761 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.8 m -75.27 8.34 2.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 109.41 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.471 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 94.3 t80 -66.21 137.36 56.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.899 . . . . 0.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.471 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 82.1 t -75.88 130.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.067 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.8 mt -78.77 142.99 36.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.547 0.689 . . . . 0.0 110.624 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 99.7 m-20 -116.16 148.03 40.78 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.57 0.7 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' SER . . . . . 0.424 ' HG ' ' H ' ' A' ' 420' ' ' MET . 16.5 m -74.26 140.66 45.13 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.793 0.806 . . . . 0.0 110.947 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.16 -23.13 37.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 42.3 p-10 -84.48 171.8 12.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.291 -1.123 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -110.94 129.03 56.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.1 131.61 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.584 -0.697 . . . . 0.0 109.747 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -130.44 138.22 50.2 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.33 130.54 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.727 0.775 . . . . 0.0 110.221 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.74 141.4 30.02 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.468 0.652 . . . . 0.0 109.409 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.604 0.716 . . . . 0.0 109.694 -179.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.17 130.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' MET . . . . . 0.492 ' SD ' ' CG2' ' A' ' 428' ' ' ILE . 49.2 ttp -100.31 143.87 29.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.631 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.27 161.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.73 125.86 54.78 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.547 0.689 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' THR . . . . . 0.475 ' HG1' ' H ' ' A' ' 425' ' ' LYS . 0.2 OUTLIER -89.19 156.23 48.89 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.97 -15.96 42.26 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.148 1.899 . . . . 0.0 111.238 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . 0.475 ' H ' ' HG1' ' A' ' 423' ' ' THR . 71.0 mmtt -81.9 -3.18 53.59 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.449 -0.782 . . . . 0.0 109.178 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.07 161.22 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -1.133 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.492 ' CG2' ' SD ' ' A' ' 420' ' ' MET . 35.0 mm -110.14 129.2 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.511 -0.743 . . . . 0.0 109.068 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -125.91 134.54 51.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -106.3 133.27 51.26 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.639 -0.663 . . . . 0.0 109.513 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.72 147.18 52.63 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.05 158.19 55.84 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.318 2.012 . . . . 0.0 111.97 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -56.09 143.05 34.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.281 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 11.54 81.12 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.61 152.46 44.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.569 -0.959 . . . . 0.0 109.791 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.7 p -127.57 172.9 10.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.6 -0.687 . . . . 0.0 109.686 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.65 65.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.461 -0.774 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.82 -42.44 99.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.319 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -61.15 -43.6 98.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 109.956 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . 0.406 ' O ' ' OG ' ' A' ' 443' ' ' SER . 66.3 t80 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.11 -42.63 81.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.619 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -67.36 -38.02 84.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.148 -0.97 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 440' ' ' PHE . 91.1 p -59.8 -37.02 77.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 109.664 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.32 -42.8 99.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 109.231 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.677 ' CD2' ' H ' ' A' ' 446' ' ' SER . 85.8 t60 -173.49 -119.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' SER . . . . . 0.677 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 37.3 p -155.62 -64.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 451' ' ' HIS . 64.0 t0 -61.82 -48.78 79.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.492 -0.755 . . . . 0.0 109.803 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -45.45 92.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.275 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -67.18 -40.8 92.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 452' ' ' CYS . 64.6 t0 -63.72 -37.26 86.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.099 . . . . 0.0 109.522 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' A' ' 447' ' ' ASP . 51.5 m80 -81.15 27.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 109.2 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 13.2 p -77.35 129.78 36.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 24.6 pt -102.92 -5.26 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 0.0 109.313 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 175.68 -175.12 47.23 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.15 150.57 42.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 108.836 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -132.82 121.6 23.2 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.3 t -122.73 134.34 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.692 . . . . 0.0 109.289 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.2 m120 55.59 39.52 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.526 0.679 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 57.1 t-80 57.86 8.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 110.232 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -111.47 146.68 36.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.452 -0.78 . . . . 0.0 109.285 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.43 142.06 48.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.5 -0.75 . . . . 0.0 109.704 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.84 148.87 34.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.19 159.94 49.8 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.06 1.84 . . . . 0.0 112.368 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.5 mp -62.35 -40.16 95.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.578 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -75.85 7.44 3.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.21 136.6 58.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.86 130.17 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 109.641 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.55 146.55 36.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.468 -0.77 . . . . 0.0 109.79 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 94.6 m-20 -123.98 151.7 43.36 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.547 -0.721 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 11.6 p -75.24 145.39 41.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.822 . . . . 0.0 110.458 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.81 -21.45 41.44 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 49.4 p-10 -84.18 172.05 12.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -1.145 . . . . 0.0 109.893 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -115.1 131.93 56.77 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.92 131.64 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.815 . . . . 0.0 110.014 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -135.72 113.3 10.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.53 137.34 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.807 . . . . 0.0 110.27 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.5 mt -96.6 135.0 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 109.255 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.53 -0.732 . . . . 0.0 109.77 -179.672 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.16 129.63 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.419 0.628 . . . . 0.0 109.61 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.3 ttm -102.91 132.87 48.83 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.49 163.54 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -117.66 144.09 45.55 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.905 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.27 174.3 3.17 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.49 -31.85 87.44 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.226 1.95 . . . . 0.0 111.289 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.99 -3.99 55.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.51 -0.744 . . . . 0.0 109.215 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.11 11.68 83.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.79 154.96 41.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -1.199 . . . . 0.0 110.517 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 36.3 mm -94.3 124.25 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -129.95 106.99 9.03 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -97.45 127.86 43.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.464 -0.773 . . . . 0.0 109.415 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 40.0 mt -120.09 148.88 47.96 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 154.29 74.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.15 1.9 . . . . 0.0 112.193 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -52.62 146.59 9.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.875 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.13 7.38 80.37 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.0 151.47 47.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.747 -0.855 . . . . 0.0 110.159 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -127.38 171.55 11.43 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.494 0.664 . . . . 0.0 109.544 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.36 65.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.19 -46.06 88.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.84 -42.99 99.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -61.8 -44.94 95.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.77 . . . . 0.0 109.613 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.89 84.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 0.0 109.611 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.84 -34.03 77.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.1 m -58.63 -43.02 89.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 62.4 mt -63.3 -47.97 80.03 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 109.759 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 78.7 m-70 -166.01 -166.1 0.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 71.7 p -109.45 -37.24 5.78 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.42 -48.31 73.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 109.64 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.8 mm? -63.76 -41.07 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.579 -0.701 . . . . 0.0 109.295 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.09 -33.06 86.22 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -87.49 -24.2 24.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.393 -1.063 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -100.01 14.53 30.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 109.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 7.9 t -80.35 110.41 15.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.179 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.78 0.73 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.651 -0.656 . . . . 0.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -172.96 173.17 45.52 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.194 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.92 29.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -1.052 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -133.15 122.44 24.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.23 131.56 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.569 0.699 . . . . 0.0 109.943 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 56.18 45.05 24.03 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.308 0.575 . . . . 0.0 109.861 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.7 12.24 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.666 -0.646 . . . . 0.0 109.814 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.21 132.54 56.58 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.547 0.689 . . . . 0.0 109.384 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.03 135.1 51.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.24 151.57 44.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.0 109.45 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.49 161.63 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.442 2.095 . . . . 0.0 112.336 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 464' ' ' LEU . 10.7 mp -62.8 -38.63 91.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.591 -0.693 . . . . 0.0 109.605 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.9 m -74.85 7.92 2.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.2 -0.938 . . . . 0.0 109.335 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.2 t80 -69.47 134.63 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.421 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 25.3 t -77.21 131.26 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.843 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 71.8 mt -75.15 144.74 42.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.293 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -115.96 147.92 40.64 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.422 0.63 . . . . 0.0 109.367 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.1 p -65.52 153.14 42.3 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.658 0.742 . . . . 0.0 111.214 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 81.36 -40.07 2.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.0 144.24 54.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.12 . . . . 0.0 111.016 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 474' ' ' VAL . 21.5 tm0? -85.81 143.35 28.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . 0.518 ' O ' ' NE2' ' A' ' 473' ' ' GLN . 66.7 t -116.42 132.14 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.571 -0.705 . . . . 0.0 109.935 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 12.4 m -109.85 133.83 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.64 -0.662 . . . . 0.0 110.046 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -89.84 108.33 19.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.726 . . . . 0.0 109.267 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.792 -179.777 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.507 0.67 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.0 130.84 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.695 0.759 . . . . 0.0 109.051 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.2 ttp -99.36 139.59 34.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.616 0.722 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.79 165.08 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.58 139.4 53.57 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.779 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 165.71 14.71 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.85 -9.74 26.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.707 2.271 . . . . 0.0 111.632 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -90.9 -5.32 55.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.115 -0.991 . . . . 0.0 109.492 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.47 6.23 77.81 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -83.44 160.75 21.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -1.221 . . . . 0.0 110.318 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 32.0 mm -105.83 128.01 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -127.07 134.41 50.28 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -110.42 136.28 49.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.72 -0.613 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 85.1 mt -135.83 147.97 63.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.91 154.2 71.32 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.284 1.989 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.693 ' H ' ' NE2' ' A' ' 433' ' ' GLN . 0.0 OUTLIER -55.1 147.42 16.09 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.723 0.773 . . . . 0.0 110.991 -179.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.2 81.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.33 157.45 35.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.522 -0.987 . . . . 0.0 110.17 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 58.1 p -126.54 167.63 15.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.859 0.838 . . . . 0.0 109.928 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.35 68.28 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.522 0.677 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.01 -43.59 98.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.587 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.45 -42.87 99.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.669 0.747 . . . . 0.0 109.656 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -61.77 -44.79 96.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.502 -0.749 . . . . 0.0 110.157 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.15 84.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.75 -36.28 83.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.76 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 444' ' ' LEU . 39.1 t -63.49 -36.6 84.31 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 443' ' ' SER . 96.3 mt -52.59 -105.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.23 -2.24 37.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 t 70.81 -55.8 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.597 0.713 . . . . 0.0 109.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.1 t0 -65.46 -38.79 90.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 450' ' ' ASP . 7.3 tt -62.8 -41.6 99.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.692 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -49.19 -9.4 0.12 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 451' ' ' HIS . 8.2 p-10 -91.28 -22.68 20.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.046 -1.267 . . . . 0.0 109.434 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.578 ' N ' ' OD1' ' A' ' 450' ' ' ASP . 40.2 m80 -100.91 -1.18 35.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.361 -0.837 . . . . 0.0 109.053 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 26.1 p -61.98 118.1 6.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 41.1 pt -105.84 -5.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.806 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.33 176.44 46.01 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.11 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.0 151.96 38.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -1.162 . . . . 0.0 109.515 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -132.5 123.8 27.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.551 -0.718 . . . . 0.0 109.194 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -123.1 133.25 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.724 0.773 . . . . 0.0 109.812 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . 0.579 HD22 ' CB ' ' A' ' 472' ' ' ASP . 12.3 m120 55.69 40.89 30.9 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.516 0.675 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m80 56.21 13.01 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.426 0.631 . . . . 0.0 109.364 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.13 135.35 54.01 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.743 0.783 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.9 tp -66.74 134.98 53.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 0.0 109.813 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.32 150.68 49.07 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.357 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.37 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.505 2.136 . . . . 0.0 112.444 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.55 -37.09 86.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.7 m -75.02 3.92 7.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 109.33 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -62.87 135.46 57.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.368 -0.832 . . . . 0.0 110.426 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.31 130.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.625 0.726 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.89 147.52 38.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.61 -0.681 . . . . 0.0 110.494 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -124.26 148.06 47.65 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.815 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 41.6 t -64.19 140.01 58.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.913 0.863 . . . . 0.0 111.123 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.15 -31.16 6.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . 0.579 ' CB ' HD22 ' A' ' 458' ' ' ASN . 98.8 m-20 -73.2 147.7 44.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -1.101 . . . . 0.0 111.026 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -95.53 141.93 28.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.72 . . . . 0.0 109.786 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.2 132.22 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.647 0.737 . . . . 0.0 109.787 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -138.12 113.58 9.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 109.046 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.0 134.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.77 96.19 8.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.452 -0.78 . . . . 0.0 109.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.739 0.781 . . . . 0.0 110.381 -179.511 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.6 mp0 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.2 m -112.52 131.4 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.3 ttm -98.36 136.09 39.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.19 164.61 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.92 140.74 49.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.103 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 176.66 1.89 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.09 -34.22 97.29 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 111.912 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -81.43 -3.87 54.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 109.143 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.57 82.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -71.82 153.11 42.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.317 . . . . 0.0 110.371 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.25 127.17 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -129.15 113.71 15.42 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.69 127.62 45.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.9 mt -131.83 156.12 80.52 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.07 144.79 56.27 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.904 1.736 . . . . 0.0 112.677 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -62.4 141.08 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.545 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.48 84.41 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -66.05 179.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -1.071 . . . . 0.0 110.136 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.0 p -127.67 169.5 13.72 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.96 -26.33 64.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.03 -43.01 99.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.353 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.73 -40.16 96.34 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.845 . . . . 0.0 109.116 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 83.1 t80 -61.46 -43.93 97.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.603 -0.686 . . . . 0.0 109.365 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.51 87.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.81 -33.85 76.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.355 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 7.1 t -59.92 -44.2 94.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.798 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.564 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 70.1 mt -65.16 -55.87 16.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.179 -0.95 . . . . 0.0 109.847 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.8 m-70 -160.02 -167.34 1.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.546 -0.721 . . . . 0.0 109.776 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 69.6 m -110.37 -62.42 1.52 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.613 -0.68 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.46 -48.44 79.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -43.66 94.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.486 -0.759 . . . . 0.0 109.032 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.37 -43.19 95.43 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 450' ' ' ASP . 59.9 t0 -73.64 -10.34 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -100.94 22.75 11.67 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 84.4 m -81.95 130.74 35.16 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.47 -4.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.9 45.59 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -150.38 152.17 33.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -1.176 . . . . 0.0 109.123 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -133.15 127.11 33.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 109.191 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.89 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 14.8 m120 53.0 57.56 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.787 -0.571 . . . . 0.0 110.342 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 458' ' ' ASN . 35.1 p80 41.67 30.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.233 0.54 . . . . 0.0 110.182 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.75 135.48 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.89 134.46 52.1 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.522 -0.736 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.76 150.57 63.36 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.67 160.43 49.49 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.393 2.062 . . . . 0.0 112.256 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 466' ' ' TYR . 10.4 mp -63.07 -39.0 93.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.484 -0.76 . . . . 0.0 109.229 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 94.8 p -74.98 10.3 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.244 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 464' ' ' LEU . 94.0 t80 -67.02 133.34 49.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.101 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.96 131.02 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.86 145.75 42.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 110.129 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -121.83 134.63 54.89 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.533 0.682 . . . . 0.0 109.427 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -55.68 135.9 51.04 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 96.31 -12.53 66.55 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -83.69 171.35 13.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -1.163 . . . . 0.0 110.47 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -122.19 114.26 20.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 18.9 t -93.16 131.79 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -133.0 113.84 13.28 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.9 m -83.73 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.3 mt -99.97 131.95 45.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.514 -0.741 . . . . 0.0 109.038 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.698 . . . . 0.0 109.752 -179.297 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.6 m -112.29 130.53 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.4 ttm -97.11 135.98 38.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 109.765 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.53 165.24 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.564 -0.71 . . . . 0.0 109.238 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' A' ' 428' ' ' ILE . 78.8 m-85 -111.07 141.44 44.56 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.995 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 427' ' ' GLU . 82.1 p -96.39 151.44 38.07 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.7 -17.68 51.05 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.563 1.509 . . . . 0.0 110.685 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.431 -0.793 . . . . 0.0 109.176 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.77 1.17 65.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 427' ' ' GLU . 23.2 mp0 -88.19 155.81 19.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.034 -1.274 . . . . 0.0 109.177 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' A' ' 422' ' ' PHE . 2.7 tp -106.91 140.26 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.46 132.77 53.49 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -103.81 133.45 48.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.275 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.8 mt -132.83 148.05 67.93 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.49 157.8 59.6 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.214 1.943 . . . . 0.0 112.157 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.81 148.66 12.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.391 -0.818 . . . . 0.0 110.085 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.9 81.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.84 41.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -127.21 174.44 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.509 -0.744 . . . . 0.0 109.663 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.77 71.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.951 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.97 -42.18 98.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.029 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.96 -43.27 95.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.925 . . . . 0.0 109.703 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.44 -45.06 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.06 85.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.983 . . . . 0.0 109.801 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -63.93 -36.94 85.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.02 . . . . 0.0 109.643 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.6 m -58.02 -41.84 83.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.887 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.92 -75.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -141.89 -178.46 5.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 109.589 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 78.2 p -101.29 -54.01 2.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.407 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.1 m-20 -62.33 -45.95 90.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -43.49 96.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.003 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.44 -38.81 93.83 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.91 -11.8 61.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 109.202 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -105.01 13.43 30.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 30.3 p -74.75 120.8 20.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.935 . . . . 0.0 109.816 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.9 pt -101.81 -3.1 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 109.439 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.54 45.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -153.05 150.3 29.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.265 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -135.5 133.03 38.06 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.419 -0.801 . . . . 0.0 109.391 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.33 131.24 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 56.47 44.55 24.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.317 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 54.21 15.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.75 . . . . 0.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -113.85 137.1 52.12 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.471 -0.768 . . . . 0.0 109.241 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.25 135.25 53.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.859 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.13 151.28 33.92 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.918 . . . . 0.0 108.984 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.31 162.08 42.0 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.473 2.115 . . . . 0.0 112.615 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.6 mp -61.88 -40.35 95.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.739 . . . . 0.0 109.546 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 92.7 p -75.29 10.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -67.23 135.66 53.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.684 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 72.7 t -78.46 132.58 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -0.872 . . . . 0.0 109.681 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -74.97 148.97 39.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 109.77 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -123.19 145.59 48.5 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 36.9 t -65.37 144.22 57.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.55 -40.67 3.03 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.37 145.4 51.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -1.107 . . . . 0.0 109.799 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -87.62 149.95 23.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.153 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.91 131.29 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -131.66 138.76 48.88 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.87 130.12 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 109.384 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.72 136.18 33.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 109.434 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.601 -0.687 . . . . 0.0 109.426 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.599 0.714 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.89 130.46 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.834 0.825 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.0 ttp -99.97 136.34 40.03 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.736 0.779 . . . . 0.0 110.043 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.79 164.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.26 138.58 54.45 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.07 0.938 . . . . 0.0 110.229 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.04 164.96 15.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.69 -13.55 40.36 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.487 2.125 . . . . 0.0 111.671 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.78 -5.52 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.376 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.35 8.13 83.88 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -84.69 159.45 20.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.624 -0.927 . . . . 0.0 110.566 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 428' ' ' ILE . 31.6 mm -105.43 128.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.739 0.78 . . . . 0.0 109.493 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -127.88 144.88 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.525 0.679 . . . . 0.0 109.636 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -124.71 136.0 53.51 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.694 . . . . 0.0 110.072 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 35.6 mt -127.47 147.81 63.89 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.88 158.27 58.55 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.429 2.086 . . . . 0.0 112.593 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.31 141.42 24.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.973 0.892 . . . . 0.0 110.661 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.4 84.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.28 150.78 46.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.686 -0.89 . . . . 0.0 110.278 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.1 p -127.24 173.5 9.69 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.929 0.871 . . . . 0.0 110.227 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.64 62.32 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . 0.417 ' CD1' ' CE1' ' A' ' 442' ' ' TYR . 0.2 OUTLIER -62.92 -45.88 90.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.589 -0.695 . . . . 0.0 109.363 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . 0.407 ' O ' ' OG ' ' A' ' 443' ' ' SER . 85.1 t80 -60.76 -44.35 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.765 -0.584 . . . . 0.0 109.8 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.43 90.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . 0.417 ' CE1' ' CD1' ' A' ' 438' ' ' LEU . 5.5 m-85 -68.37 -36.73 79.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' SER . . . . . 0.595 ' HG ' ' N ' ' A' ' 444' ' ' LEU . 70.3 p -60.27 -38.28 83.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.72 -0.612 . . . . 0.0 109.478 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.595 ' N ' ' HG ' ' A' ' 443' ' ' SER . 85.1 mt -71.88 -75.37 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.491 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -140.48 -179.38 5.98 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 13.0 m -102.42 -59.05 1.77 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.469 -0.77 . . . . 0.0 110.293 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 37.8 p-10 -63.21 -44.04 96.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.026 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.529 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -63.96 -45.12 90.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.511 -0.743 . . . . 0.0 109.065 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.33 92.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.08 -36.15 83.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.737 -0.86 . . . . 0.0 109.557 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.22 20.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.794 -0.566 . . . . 0.0 109.673 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 10.4 t -77.73 120.71 23.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.2 -4.94 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.46 178.3 48.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.49 148.19 39.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.977 . . . . 0.0 109.958 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -129.54 121.41 27.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.65 0.738 . . . . 0.0 109.694 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.13 132.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.776 0.798 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 54.84 43.9 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.599 0.714 . . . . 0.0 109.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.86 15.07 2.09 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -118.2 134.58 54.89 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.829 0.823 . . . . 0.0 109.815 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.27 134.37 50.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.673 0.749 . . . . 0.0 110.061 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.06 150.35 41.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.725 -0.609 . . . . 0.0 109.787 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.62 163.17 33.91 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.598 2.199 . . . . 0.0 112.826 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.73 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.149 0.5 . . . . 0.0 109.693 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 5.6 t -75.53 8.15 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.645 -0.659 . . . . 0.0 109.668 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -68.22 134.37 50.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 109.676 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.12 130.21 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.777 0.798 . . . . 0.0 109.922 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.9 mt -75.97 144.24 41.08 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.564 0.697 . . . . 0.0 110.243 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -115.24 145.55 42.32 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.892 0.853 . . . . 0.0 110.118 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.4 t -66.01 139.99 58.25 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.461 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.44 -32.78 5.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -74.73 145.32 43.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.895 . . . . 0.0 110.904 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -86.85 144.76 26.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.519 0.676 . . . . 0.0 109.268 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.69 132.53 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.937 0.875 . . . . 0.0 110.127 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -135.74 141.51 44.86 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.455 0.645 . . . . 0.0 109.305 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.93 131.73 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.859 0.838 . . . . 0.0 110.005 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.12 131.21 45.32 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.469 0.652 . . . . 0.0 109.668 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.628 0.728 . . . . 0.0 109.507 179.627 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.295 0.569 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.1 130.75 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' MET . . . . . 0.41 ' H ' ' HG ' ' A' ' 470' ' ' SER . 51.1 ttm -95.53 133.77 39.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.646 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.76 163.52 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.53 140.48 52.96 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.615 0.722 . . . . 0.0 109.613 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.1 175.82 2.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.4 -30.04 90.15 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.372 2.048 . . . . 0.0 111.561 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -81.22 -4.09 54.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 109.204 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.69 9.18 85.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.77 151.88 45.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -1.078 . . . . 0.0 110.414 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.77 122.67 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.462 -0.774 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -128.05 131.36 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -108.04 134.82 50.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.656 -0.653 . . . . 0.0 109.36 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.99 157.43 69.42 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.697 -0.627 . . . . 0.0 109.393 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.94 150.25 79.24 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.208 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -54.34 137.26 42.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -0.838 . . . . 0.0 110.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.09 13.3 74.73 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -65.45 159.35 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -1.08 . . . . 0.0 110.057 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.3 p -126.93 171.97 10.84 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.691 0.758 . . . . 0.0 110.014 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.6 62.88 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.664 -0.647 . . . . 0.0 109.953 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -46.59 87.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.091 -1.006 . . . . 0.0 109.383 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.47 -39.24 93.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.421 -0.799 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -60.83 -44.96 96.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.58 92.99 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -67.59 -36.35 80.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 11.7 t -59.82 -43.6 94.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.775 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.21 -74.91 0.09 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.758 ' HD1' ' H ' ' A' ' 446' ' ' SER . 1.2 t-80 -135.7 -179.73 5.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.467 -0.77 . . . . 0.0 109.673 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' SER . . . . . 0.758 ' H ' ' HD1' ' A' ' 445' ' ' HIS . 29.9 p -103.09 -56.11 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.694 -0.629 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 36.9 p-10 -66.85 -41.66 86.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -64.37 -44.54 91.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.329 -0.857 . . . . 0.0 109.025 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.32 93.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -70.9 -11.31 60.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -1.095 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -104.55 14.87 29.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 11.2 t -77.7 123.53 26.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 109.756 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 453' ' ' ILE . 37.8 pt -102.64 -4.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -174.42 176.46 46.75 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.537 -1.315 . . . . 0.0 109.898 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.16 147.05 45.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -1.056 . . . . 0.0 109.049 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -133.01 121.49 22.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.82 133.78 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.425 0.631 . . . . 0.0 109.543 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 57.28 44.1 22.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.495 0.664 . . . . 0.0 109.708 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 55.77 17.56 2.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.028 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -122.02 142.21 50.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.489 -0.757 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.51 132.81 45.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.69 -0.631 . . . . 0.0 109.896 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.43 150.22 50.55 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.079 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.63 162.05 40.96 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.567 2.178 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 466' ' ' TYR . 10.7 mp -63.35 -38.5 91.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.9 m -75.02 8.8 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.125 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 464' ' ' LEU . 93.0 t80 -67.58 134.21 50.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.01 132.04 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.852 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.88 148.09 40.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.634 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -123.8 145.09 49.3 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.545 0.688 . . . . 0.0 109.454 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' SER . . . . . 0.41 ' HG ' ' H ' ' A' ' 420' ' ' MET . 18.8 m -66.45 144.72 56.33 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.589 0.709 . . . . 0.0 111.224 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.12 -30.32 5.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -74.9 153.47 38.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -1.09 . . . . 0.0 110.783 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -98.17 128.97 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.34 131.34 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.97 144.39 45.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.2 m -109.88 132.18 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.556 0.693 . . . . 0.0 109.722 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.18 129.63 42.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.47 -0.769 . . . . 0.0 109.212 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.593 -0.692 . . . . 0.0 109.528 -179.779 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.016 0.436 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.4 131.31 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.485 0.66 . . . . 0.0 109.449 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 12.3 ptm -97.3 147.51 24.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.646 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.51 161.78 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.03 120.59 42.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.55 0.69 . . . . 0.0 109.646 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.6 p -88.48 154.13 50.96 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.18 -13.13 14.89 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.279 1.986 . . . . 0.0 111.284 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -85.02 -3.68 58.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.28 3.67 88.59 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.88 159.49 19.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.959 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 428' ' ' ILE . 35.2 mm -113.1 129.6 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.478 -0.763 . . . . 0.0 109.542 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -121.87 137.57 54.73 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -105.01 131.19 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 109.91 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.95 147.43 46.29 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.06 154.44 74.06 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.86 137.96 37.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.581 0.705 . . . . 0.0 110.573 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.0 13.24 75.12 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.94 155.58 40.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -1.047 . . . . 0.0 110.207 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.4 p -127.09 175.33 8.2 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.664 0.745 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.2 -33.36 67.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.693 -0.629 . . . . 0.0 110.125 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.03 -41.97 99.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.117 -0.989 . . . . 0.0 109.794 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -60.44 -43.31 96.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.33 -0.856 . . . . 0.0 109.814 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . 0.415 ' O ' ' OG ' ' A' ' 443' ' ' SER . 70.3 t80 -61.52 -43.45 98.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.429 -0.795 . . . . 0.0 109.98 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.45 -44.6 80.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.89 -36.34 84.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 440' ' ' PHE . 50.7 p -58.98 -34.36 71.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.78 -76.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.686 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -143.49 -173.8 4.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.265 -0.897 . . . . 0.0 110.101 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 29.7 t -104.17 -55.22 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.412 0.625 . . . . 0.0 109.512 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.485 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 25.7 p-10 -63.01 -48.83 77.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.817 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.457 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -63.97 -43.15 96.63 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.471 -0.768 . . . . 0.0 109.198 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -64.35 -41.13 98.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 66.3 t0 -69.42 -27.41 65.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -1.066 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . 0.485 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 34.5 m80 -87.72 18.11 4.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.277 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 42.6 m -80.23 117.04 20.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -0.875 . . . . 0.0 109.663 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.94 -2.54 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.751 . . . . 0.0 109.377 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.16 178.03 43.78 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.402 -1.38 . . . . 0.0 110.288 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.89 150.5 29.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -1.024 . . . . 0.0 109.067 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -135.79 131.9 36.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.571 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.47 130.83 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.567 0.699 . . . . 0.0 109.538 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 55.84 43.35 27.76 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.45 0.643 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.481 ' O ' ' ND1' ' A' ' 459' ' ' HIS . 59.0 t-80 57.9 12.98 1.91 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 109.965 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -113.83 135.34 54.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 47.8 tp -66.68 135.08 53.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 110.109 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.04 151.2 37.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.099 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.17 161.89 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.483 2.122 . . . . 0.0 112.344 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.6 mp -63.05 -38.31 90.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.646 -0.659 . . . . 0.0 109.504 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.5 p -75.07 9.43 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.977 . . . . 0.0 109.3 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.419 ' H ' ' C ' ' A' ' 464' ' ' LEU . 92.6 t80 -68.88 135.26 50.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.404 -0.81 . . . . 0.0 110.206 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.35 130.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.306 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.63 147.51 37.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 110.174 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -125.46 146.61 49.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.607 -0.683 . . . . 0.0 109.909 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 68.2 m -70.49 141.43 51.98 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.565 0.698 . . . . 0.0 110.865 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.48 -22.72 39.31 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.32 171.04 13.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.198 -1.178 . . . . 0.0 110.529 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.69 127.38 56.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.82 131.7 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.371 -0.831 . . . . 0.0 109.911 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.54 116.05 14.6 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 3.6 m -85.05 130.93 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.35 143.67 26.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.558 -0.714 . . . . 0.0 109.652 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.989 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.1 ptm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.452 0.644 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.2 mp0 -83.35 165.54 19.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.406 -0.809 . . . . 0.0 109.518 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.65 131.26 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.711 0.767 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.6 ttm -94.89 131.7 40.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.232 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.03 164.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -123.78 144.47 49.68 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.412 0.625 . . . . 0.0 109.51 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.8 176.27 1.98 Allowed Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -34.53 84.54 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -81.35 -3.68 53.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.575 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.32 9.34 85.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -69.91 150.81 46.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.286 . . . . 0.0 110.299 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.3 mm -90.06 124.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -131.5 112.4 12.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -94.02 136.19 34.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.501 -0.75 . . . . 0.0 109.219 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.3 mt -122.31 148.18 51.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.493 2.129 . . . . 0.0 112.717 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -56.01 139.31 47.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.62 12.63 77.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.06 154.8 41.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.7 p -127.49 174.57 8.92 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.55 0.69 . . . . 0.0 109.984 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.62 71.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.507 -0.746 . . . . 0.0 109.444 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.76 -42.45 99.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -61.49 -43.02 99.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.79 . . . . 0.0 110.088 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.54 80.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.178 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -64.96 -36.54 84.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.336 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.5 m -58.49 -41.56 85.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 78.0 mt -68.16 -73.77 0.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.32 -179.8 6.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.924 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 73.5 m -100.11 -59.57 1.69 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.568 -0.708 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.425 ' OD1' ' CD2' ' A' ' 451' ' ' HIS . 49.2 t0 -60.17 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.867 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.6 -43.41 97.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.227 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.49 -37.46 94.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.05 -16.41 63.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.054 -1.263 . . . . 0.0 109.381 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.425 ' CD2' ' OD1' ' A' ' 447' ' ' ASP . 45.3 m-70 -95.79 17.26 15.48 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 25.6 p -74.29 116.77 15.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.388 -0.82 . . . . 0.0 109.539 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.2 pt -99.44 -2.79 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -0.766 . . . . 0.0 109.247 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.26 -171.6 39.41 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.022 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -148.71 148.02 29.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -1.178 . . . . 0.0 109.126 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -135.63 120.86 18.99 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.01 133.14 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.557 0.694 . . . . 0.0 109.92 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 460' ' ' LYS . 19.4 t-20 56.51 43.27 26.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.681 -0.637 . . . . 0.0 109.671 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 55.33 10.38 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.625 -0.672 . . . . 0.0 109.957 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 458' ' ' ASN . 88.4 tttt -115.24 145.25 42.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.564 -0.71 . . . . 0.0 109.652 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 461' ' ' LEU . 4.3 mm? -72.93 141.37 47.84 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.38 148.38 22.19 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.02 162.6 37.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.274 1.982 . . . . 0.0 112.68 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.7 mp -62.71 -40.3 96.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.443 -0.785 . . . . 0.0 109.624 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 93.1 p -75.75 10.38 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.039 -1.038 . . . . 0.0 109.434 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.401 ' H ' ' C ' ' A' ' 464' ' ' LEU . 92.1 t80 -68.33 135.35 51.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 110.347 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.43 131.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.31 144.09 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.675 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -115.2 150.56 35.93 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.42 0.629 . . . . 0.0 109.421 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 472' ' ' ASP . 15.6 p -70.78 155.34 40.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.0 -36.57 1.47 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 470' ' ' SER . 99.0 m-20 -68.6 145.14 54.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.246 . . . . 0.0 111.002 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -86.29 140.23 30.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.763 . . . . 0.0 109.175 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.08 132.1 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.543 -0.723 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -136.82 116.02 12.55 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.35 138.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.92 130.89 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.7 t -139.95 146.24 38.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.275 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 480' ' ' LYS . 88.3 p -81.74 -8.24 59.68 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.808 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 479' ' ' SER . 53.1 mtmt 39.14 34.63 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.732 0.777 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 18.1 m -62.84 142.32 58.28 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 110.26 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.49 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 88.9 mt -95.58 2.9 54.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.92 143.72 57.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.939 . . . . 0.0 110.208 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 69.3 m80 -141.14 160.07 40.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.0 m80 55.67 19.11 3.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.559 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.8 -44.7 96.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.356 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -89.34 153.97 20.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.059 -1.025 . . . . 0.0 110.027 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -74.2 130.9 40.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 110.535 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 16.6 p80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.058 -0.973 . . . . 0.0 109.63 179.844 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.5 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -132.38 148.44 52.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.233 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.54 129.97 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.82 142.9 31.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.0 109.648 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.84 164.5 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.54 137.1 54.56 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.603 0.716 . . . . 0.0 109.479 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.05 165.55 14.7 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.85 -14.42 44.52 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.548 2.165 . . . . 0.0 111.232 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -85.22 -5.11 59.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.576 -0.702 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.34 9.3 82.1 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 427' ' ' GLU . 4.5 mp0 -84.19 162.04 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.288 -1.125 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.92 129.22 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -127.99 132.04 49.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -109.6 139.39 44.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 109.527 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 97.4 mt -136.4 147.9 61.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.488 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.46 158.65 56.58 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.486 2.124 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -56.63 146.34 25.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.55 77.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.57 154.42 41.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.687 -0.89 . . . . 0.0 110.142 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 69.5 p -127.57 170.47 12.59 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.595 0.712 . . . . 0.0 109.693 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.73 74.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 109.321 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.68 -42.09 99.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.44 -43.68 98.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -61.29 -44.68 96.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 109.523 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.74 -36.51 83.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.191 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.4 t -61.57 -39.54 91.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.578 -0.701 . . . . 0.0 110.132 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 89.2 mt -48.44 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 447' ' ' ASP . 99.3 m-70 -151.24 20.46 0.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 m 68.52 -37.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.624 . . . . 0.0 109.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 445' ' ' HIS . 99.7 m-20 -62.15 -44.23 97.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 448' ' ' LEU . 3.5 mm? -63.72 -43.06 97.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.825 . . . . 0.0 108.983 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -71.25 -29.65 68.24 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -76.44 -9.77 58.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -1.072 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -138.83 28.47 2.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.19 109.23 13.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.5 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.4 pt -100.65 -2.52 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.511 -0.743 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.32 176.51 45.99 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.066 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.6 149.99 29.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -1.083 . . . . 0.0 109.106 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -135.56 124.59 24.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 0.0 108.89 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.0 t -122.16 133.02 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.565 -0.709 . . . . 0.0 109.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 55.79 42.97 28.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.603 -0.686 . . . . 0.0 109.687 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m80 54.86 13.82 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.864 -0.523 . . . . 0.0 110.264 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -117.91 137.4 52.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 109.133 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.57 135.22 54.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.13 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.32 150.82 56.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.74 160.77 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.253 1.969 . . . . 0.0 112.547 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.2 mp -62.72 -40.33 96.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 465' ' ' SER . 3.4 t -77.7 15.06 0.89 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.507 -0.745 . . . . 0.0 109.167 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.435 ' H ' ' C ' ' A' ' 464' ' ' LEU . 86.8 t80 -67.54 134.11 50.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.907 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.96 131.39 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.785 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.95 145.66 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.806 . . . . 0.0 110.243 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -119.58 146.18 45.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.537 0.684 . . . . 0.0 109.175 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.1 t -64.93 141.24 58.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 110.68 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.7 -32.83 4.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -72.73 147.04 46.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.251 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.34 144.16 28.22 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.81 132.95 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-O 121.668 0.747 . . . . 0.0 109.786 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -139.62 128.62 23.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.94 128.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.007 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.22 100.0 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.025 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.0 p -84.26 166.4 17.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 110.025 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 38.5 t -80.38 -2.54 46.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.54 -0.725 . . . . 0.0 109.193 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 481' ' ' SER . 19.2 mmmt -53.57 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 110.244 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 480' ' ' LYS . 12.6 m -173.28 70.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 85.9 mt -91.82 -1.97 57.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -77.32 118.01 19.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.537 -0.727 . . . . 0.0 109.943 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 80.9 m80 41.36 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.453 0.644 . . . . 0.0 110.315 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.59 -8.48 59.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.077 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 78.4 m80 51.14 179.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.701 . . . . 0.0 110.688 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . 0.53 ' CG ' ' N ' ' A' ' 488' ' ' HIS . 86.3 t60 55.06 166.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.434 0.635 . . . . 0.0 110.396 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.53 ' N ' ' CG ' ' A' ' 487' ' ' HIS . 79.7 m80 -102.65 129.83 49.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.532 -0.73 . . . . 0.0 110.267 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.915 -1.041 . . . . 0.0 109.955 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' MET . . . . . 0.488 ' SD ' ' OE1' ' A' ' 433' ' ' GLN . 55.8 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 121.669 0.747 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.3 mp0 -135.83 166.23 23.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.05 131.07 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.684 0.754 . . . . 0.0 109.486 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.7 ttp -98.22 129.97 44.96 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.723 0.773 . . . . 0.0 110.458 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.33 164.47 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.33 137.35 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.856 0.836 . . . . 0.0 109.96 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.39 159.66 30.67 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.93 -16.22 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.251 1.967 . . . . 0.0 111.413 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -83.27 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.03 6.42 88.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 429' ' ' LYS . 82.7 tt0 -86.6 152.48 22.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.943 . . . . 0.0 110.705 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 428' ' ' ILE . 29.9 mm -84.18 129.2 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.492 0.663 . . . . 0.0 109.804 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 427' ' ' GLU . 34.9 mmtm -132.76 109.4 9.64 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.597 0.713 . . . . 0.0 110.13 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -102.37 128.67 48.86 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.6 mt -122.47 152.69 61.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.14 145.94 24.51 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.459 2.106 . . . . 0.0 112.745 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.488 ' OE1' ' SD ' ' A' ' 417' ' ' MET . 59.1 tt0 -58.39 137.01 57.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.847 0.832 . . . . 0.0 110.634 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.23 13.93 72.84 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -72.61 166.54 22.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.913 . . . . 0.0 110.209 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 p -127.13 172.34 10.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.992 0.901 . . . . 0.0 110.581 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.61 -26.6 61.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.09 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.72 -45.4 92.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.418 -0.801 . . . . 0.0 109.719 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -64.82 -38.39 90.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.691 -0.631 . . . . 0.0 109.421 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -61.23 -45.34 94.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.786 -0.571 . . . . 0.0 109.974 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.51 91.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.646 -0.659 . . . . 0.0 109.515 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -68.64 -34.09 75.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.494 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 30.8 m -58.08 -42.07 84.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.81 -0.556 . . . . 0.0 109.706 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.08 -70.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.714 -0.616 . . . . 0.0 109.603 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -149.2 -176.17 5.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.559 -0.713 . . . . 0.0 109.904 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 37.6 t -92.45 -71.01 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.498 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 27.2 t70 -55.78 -48.63 75.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.793 -0.567 . . . . 0.0 110.231 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -44.5 95.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.531 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.07 -38.73 92.66 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.75 -10.7 59.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.874 . . . . 0.0 109.501 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 16.0 m80 -99.66 20.8 13.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.97 117.9 22.55 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.585 0.707 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.6 pt -101.16 -3.46 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.49 176.94 46.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.71 146.34 37.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.797 -0.825 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -134.75 122.27 21.9 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.394 0.616 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -122.44 132.76 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.702 0.763 . . . . 0.0 109.8 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 54.42 45.69 26.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.653 0.739 . . . . 0.0 109.796 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 459' ' ' HIS . 58.1 t-80 56.41 14.04 1.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.055 0.455 . . . . 0.0 109.969 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.44 141.15 47.44 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.725 0.774 . . . . 0.0 110.159 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.404 ' C ' ' CD1' ' A' ' 461' ' ' LEU . 0.3 OUTLIER -79.58 112.31 16.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.544 0.688 . . . . 0.0 109.522 -179.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -120.95 151.02 54.35 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.85 163.3 36.01 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.604 2.202 . . . . 0.0 112.648 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.62 -39.93 95.36 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 109.786 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.6 m -75.45 8.35 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.773 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 91.1 t80 -67.54 135.01 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.698 0.761 . . . . 0.0 110.406 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.426 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 79.8 t -78.53 131.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.828 0.823 . . . . 0.0 109.757 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.4 mt -74.41 143.39 44.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.654 0.74 . . . . 0.0 110.407 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -116.26 144.6 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.767 0.794 . . . . 0.0 109.801 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.5 t -66.76 139.81 57.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.756 0.789 . . . . 0.0 110.564 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.28 -34.99 4.18 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.05 144.21 48.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.732 -0.864 . . . . 0.0 110.872 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -87.44 144.22 26.85 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.499 0.666 . . . . 0.0 109.562 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.42 131.31 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.575 0.703 . . . . 0.0 109.969 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -133.07 137.98 46.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.03 130.94 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.64 0.734 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.01 131.74 42.09 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.536 0.684 . . . . 0.0 109.676 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 55.9 m -126.78 152.19 47.24 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.694 0.759 . . . . 0.0 109.721 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 93.6 p -73.13 68.39 0.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.794 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -95.14 -7.11 40.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 482' ' ' LEU . 51.9 p -146.31 -124.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.631 -0.668 . . . . 0.0 110.014 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.547 ' N ' ' OG ' ' A' ' 481' ' ' SER . 58.0 mt 59.2 1.3 0.22 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 481' ' ' SER . 79.2 mm-40 -51.55 111.14 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.927 0.87 . . . . 0.0 109.996 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.01 -35.89 77.17 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.737 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.598 ' CE1' ' CD2' ' A' ' 486' ' ' HIS . 13.4 t-80 69.42 127.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.801 0.81 . . . . 0.0 110.556 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . 0.598 ' CD2' ' CE1' ' A' ' 485' ' ' HIS . 72.6 m-70 52.12 92.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.644 0.735 . . . . 0.0 110.203 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -69.01 135.52 51.02 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.749 0.785 . . . . 0.0 109.907 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -151.9 -1.77 0.3 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.276 179.793 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' MET . . . . . 0.597 ' N ' ' SD ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.1 mp0 -80.56 164.11 23.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 110.279 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.45 131.03 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.55 0.69 . . . . 0.0 109.301 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 50.8 ttp -97.88 136.54 38.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.523 -0.735 . . . . 0.0 109.768 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.11 161.55 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -115.33 134.59 54.97 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.659 0.742 . . . . 0.0 109.787 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 166.27 13.63 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.71 -15.05 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.531 2.154 . . . . 0.0 111.471 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -85.91 -6.2 59.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.196 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.72 11.9 78.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -85.84 161.77 18.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.143 . . . . 0.0 110.206 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 1.3 mp -107.78 129.03 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.92 123.35 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -102.08 127.87 48.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 14.1 mt -118.49 158.21 47.56 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.53 149.17 83.7 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.33 2.02 . . . . 0.0 112.873 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -57.48 134.21 55.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.458 -0.777 . . . . 0.0 110.418 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.73 76.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -63.54 167.87 5.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -1.148 . . . . 0.0 110.246 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 70.0 p -127.52 172.33 10.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.666 0.746 . . . . 0.0 110.002 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -30.07 68.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.477 -0.764 . . . . 0.0 109.219 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.05 -43.12 99.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 0.0 109.309 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.68 -41.35 99.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.43 -43.65 98.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 109.939 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.96 -44.8 87.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -65.49 -35.73 81.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.404 -0.81 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 26.2 m -58.64 -41.47 86.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.753 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 76.5 mt -68.96 -77.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.651 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 445' ' ' HIS . 6.1 m80 -124.29 -151.18 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.604 -0.685 . . . . 0.0 109.2 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 26.5 m -128.54 -70.49 0.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.59 -0.694 . . . . 0.0 109.251 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.446 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.6 m-20 -64.19 -39.5 94.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.08 -44.95 95.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.059 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.14 93.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 452' ' ' CYS . 35.4 t70 -64.43 -38.36 90.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -1.09 . . . . 0.0 109.605 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.446 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 60.9 m80 -78.6 28.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 8.8 t -79.21 123.97 27.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 453' ' ' ILE . 36.0 pt -97.6 -5.01 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.214 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . 175.88 179.74 46.55 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.75 149.54 43.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.995 . . . . 0.0 109.122 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -132.41 122.6 25.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.33 132.88 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.692 -0.63 . . . . 0.0 109.643 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . 0.528 HD22 ' CG ' ' A' ' 472' ' ' ASP . 98.0 m-20 55.9 42.37 28.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.721 -0.612 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.8 m80 57.15 12.03 1.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.739 -0.6 . . . . 0.0 109.879 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.96 136.25 53.21 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.632 0.73 . . . . 0.0 109.653 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.92 134.63 52.4 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.577 -0.702 . . . . 0.0 109.863 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.09 150.9 57.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.795 . . . . 0.0 109.294 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.5 161.6 42.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.558 2.172 . . . . 0.0 113.01 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 464' ' ' LEU . 10.5 mp -63.27 -40.16 96.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.699 -0.626 . . . . 0.0 109.451 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 8.4 t -76.43 8.19 3.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.207 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 90.1 t80 -61.26 134.91 57.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.512 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.411 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 76.1 t -76.9 130.09 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.478 -0.764 . . . . 0.0 109.98 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.8 147.71 33.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 110.409 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -125.7 145.19 50.29 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.621 0.724 . . . . 0.0 109.518 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 97.6 p -65.4 145.17 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.658 0.742 . . . . 0.0 110.846 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.43 -32.53 4.69 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . 0.528 ' CG ' HD22 ' A' ' 458' ' ' ASN . 88.7 m-20 -72.73 145.77 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.88 139.67 30.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.17 131.93 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.569 0.7 . . . . 0.0 109.992 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.91 114.01 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.61 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.88 114.24 26.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 109.594 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 95.2 p -85.57 172.83 10.63 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.535 -0.728 . . . . 0.0 110.224 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 94.1 p -84.79 -3.51 58.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.447 -0.783 . . . . 0.0 109.624 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.9 135.91 56.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.157 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 88.9 p -66.29 149.06 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 0.0 110.612 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.5 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 87.4 mt -98.47 3.93 48.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.0 109.117 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.99 139.31 58.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 70.9 m80 -146.18 157.76 43.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -96.69 102.2 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.808 . . . . 0.0 109.896 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -91.16 -8.89 47.4 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 86.2 t60 52.71 72.94 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.468 -0.77 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -152.9 139.7 18.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.62 -179.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 47.3 ttp . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.9 mp0 -80.9 168.2 19.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.317 0.58 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.0 131.73 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.737 0.78 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.6 ttm -90.33 132.9 35.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.758 0.79 . . . . 0.0 110.084 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.63 163.46 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.404 0.621 . . . . 0.0 109.425 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -123.57 138.68 54.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.013 0.911 . . . . 0.0 109.929 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 159.39 29.87 Favored Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.41 -34.81 33.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.331 2.021 . . . . 0.0 112.221 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.81 -4.13 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.818 -0.551 . . . . 0.0 109.696 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.36 7.45 82.62 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -74.09 153.21 39.71 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.676 0.75 . . . . 0.0 110.682 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.97 122.5 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.406 0.622 . . . . 0.0 109.629 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -127.31 135.91 51.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.846 0.831 . . . . 0.0 110.235 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -108.11 132.86 53.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 31.5 mt -122.14 152.45 60.25 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 147.84 28.91 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.262 1.975 . . . . 0.0 112.86 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.21 129.32 41.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.646 0.736 . . . . 0.0 110.58 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 13.95 76.19 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.36 173.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.671 0.748 . . . . 0.0 110.604 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 33.0 p -127.97 172.01 11.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.874 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.71 65.8 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.09 -42.47 99.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.97 -42.05 98.7 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -62.1 -42.87 99.66 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.98 92.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.0 -36.6 83.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.3 m -58.95 -42.87 90.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.565 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 77.6 mt -66.61 -59.93 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.734 -0.604 . . . . 0.0 109.789 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.4 m-70 -158.85 -176.06 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.441 0.638 . . . . 0.0 109.858 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 39.9 t -101.58 -61.72 1.34 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.09 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.51 -44.96 95.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.742 -0.599 . . . . 0.0 109.935 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -45.11 93.53 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.15 89.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.98 -34.35 78.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.885 -0.773 . . . . 0.0 109.406 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -85.12 16.5 3.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 49.7 t -72.79 116.67 13.56 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.597 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.2 pt -102.53 -0.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . 0.449 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -173.03 170.86 44.01 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.745 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.12 149.51 31.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.069 -0.665 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -138.82 130.59 27.7 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 64.7 t -119.97 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.663 0.744 . . . . 0.0 109.677 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 58.49 41.64 22.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 56.94 12.99 1.33 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -113.05 115.36 28.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.896 0.855 . . . . 0.0 109.792 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.1 tp -51.32 133.92 28.5 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.556 0.694 . . . . 0.0 110.229 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.1 152.34 39.6 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.13 161.57 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.595 2.196 . . . . 0.0 112.651 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 464' ' ' LEU . 10.8 mp -62.79 -38.2 89.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.1 m -75.05 7.45 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.847 -0.533 . . . . 0.0 109.663 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -69.58 134.08 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.564 0.697 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 82.8 t -78.61 131.04 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.596 0.713 . . . . 0.0 109.865 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.71 146.24 42.43 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.629 0.728 . . . . 0.0 110.631 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -121.11 144.54 48.51 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.866 0.841 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 140.75 58.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.659 0.743 . . . . 0.0 111.121 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.57 -25.89 18.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.32 163.29 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.666 -0.903 . . . . 0.0 110.946 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -109.31 120.72 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 20.9 t -93.09 132.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.841 0.829 . . . . 0.0 110.622 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.5 0.667 . . . . 0.0 109.316 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.23 130.82 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.805 0.812 . . . . 0.0 110.455 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.65 106.35 18.61 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.588 0.709 . . . . 0.0 109.213 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 480' ' ' LYS . 18.7 p -87.57 169.31 12.29 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.588 0.708 . . . . 0.0 110.171 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.7 m -77.27 32.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.25 0.548 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 478' ' ' SER . 9.9 mtpm? -81.45 -4.65 56.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 483' ' ' GLU . 10.3 p -46.09 107.88 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.563 0.697 . . . . 0.0 109.894 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 482' ' ' LEU . 3.3 mm? 56.29 6.12 0.23 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 481' ' ' SER . 48.5 mt-10 46.81 -168.51 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.49 0.662 . . . . 0.0 110.379 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -149.58 163.88 36.66 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.764 0.792 . . . . 0.0 110.12 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -68.99 129.59 40.36 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.626 0.727 . . . . 0.0 110.557 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -82.75 128.14 34.1 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.591 0.71 . . . . 0.0 110.257 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -109.29 124.6 51.19 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.404 0.621 . . . . 0.0 109.972 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.55 126.57 52.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.786 0.803 . . . . 0.0 110.383 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.777 -1.106 . . . . 0.0 109.85 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.3 mp0 -135.87 145.06 45.96 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 18.2 m -119.32 130.94 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.592 -0.692 . . . . 0.0 109.215 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 49.5 ttp -96.66 137.94 34.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.74 165.18 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -113.32 138.51 49.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.515 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' THR . . . . . 0.492 ' HG1' ' H ' ' A' ' 425' ' ' LYS . 0.9 OUTLIER -98.6 162.49 21.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 108.784 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.27 -32.29 40.52 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.191 1.928 . . . . 0.0 111.998 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . 0.492 ' H ' ' HG1' ' A' ' 423' ' ' THR . 99.4 mttt -78.53 -1.64 34.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.05 -1.031 . . . . 0.0 109.323 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.22 12.09 81.29 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.24 158.83 32.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -1.163 . . . . 0.0 110.55 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.6 mm -106.24 124.41 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.463 -0.773 . . . . 0.0 109.077 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -128.67 132.94 48.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -0.758 . . . . 0.0 109.016 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -106.74 138.41 42.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.1 mt -131.64 147.6 66.69 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.92 157.31 62.36 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.375 2.05 . . . . 0.0 112.705 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.41 143.01 25.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.64 12.62 74.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.06 42.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 110.364 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.2 p -127.45 172.03 11.04 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.588 0.709 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.28 69.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.49 -0.756 . . . . 0.0 109.593 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.58 -42.26 99.45 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 109.197 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.59 -44.71 93.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -61.5 -43.65 98.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.11 85.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.152 -0.968 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -64.31 -36.87 85.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.0 m -59.01 -42.29 89.75 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.96 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.71 -57.36 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.991 -1.068 . . . . 0.0 109.658 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.649 ' CG ' ' H ' ' A' ' 446' ' ' SER . 65.6 t60 -161.48 -173.48 3.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.144 -0.972 . . . . 0.0 109.333 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' SER . . . . . 0.649 ' H ' ' CG ' ' A' ' 445' ' ' HIS . 8.7 m -103.41 -60.53 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.74 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 451' ' ' HIS . 43.5 t0 -62.16 -45.7 92.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -43.89 97.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 108.816 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.67 -35.51 92.02 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -73.41 -10.77 60.08 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.28 -1.13 . . . . 0.0 109.36 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 59.5 m-70 -97.36 7.85 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 108.841 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 452' ' ' CYS . 29.9 p -73.55 116.44 14.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.392 -0.818 . . . . 0.0 109.822 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.08 -2.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.05 177.54 43.95 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.55 142.79 41.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -1.074 . . . . 0.0 108.958 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.74 121.9 21.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.5 133.85 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 57.38 43.95 22.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.764 0.792 . . . . 0.0 109.356 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 54.17 13.27 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.747 . . . . 0.0 110.224 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -114.71 136.65 52.83 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.54 -0.725 . . . . 0.0 109.418 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.1 tp -67.83 134.46 50.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.89 151.2 48.65 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 108.861 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.55 162.08 38.47 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.598 2.199 . . . . 0.0 112.746 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.6 mp -62.92 -39.34 94.25 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.717 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.3 m -75.19 7.85 3.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.115 -0.991 . . . . 0.0 109.181 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -66.21 134.95 53.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.242 -0.911 . . . . 0.0 110.255 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.71 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.43 144.63 44.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.234 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 100.0 m-20 -117.18 151.68 36.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.686 -0.634 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.3 p -68.92 154.12 42.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.522 -0.736 . . . . 0.0 110.848 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.45 -37.2 1.59 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.94 145.4 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.398 . . . . 0.0 110.964 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -87.43 149.79 24.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.51 -0.743 . . . . 0.0 109.508 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 61.9 t -118.62 132.8 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.521 -0.737 . . . . 0.0 109.749 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -138.08 113.78 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.0 139.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 110.011 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.4 111.7 23.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.418 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 5.8 t -107.59 35.62 3.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 1.3 p 54.45 17.8 1.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.777 . . . . 0.0 109.731 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -67.9 138.45 56.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.184 -0.948 . . . . 0.0 110.277 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 9.1 p -75.31 139.42 42.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.772 . . . . 0.0 109.705 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.79 -22.87 10.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.03 131.93 47.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.227 -0.92 . . . . 0.0 110.2 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -91.14 130.27 37.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.779 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -78.6 155.53 29.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 110.93 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . 0.453 ' O ' ' ND1' ' A' ' 486' ' ' HIS . 57.3 t-80 57.46 41.91 25.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . 0.439 ' CG ' ' N ' ' A' ' 488' ' ' HIS . 86.2 t60 -79.86 162.0 25.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.466 -0.771 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.439 ' N ' ' CG ' ' A' ' 487' ' ' HIS . 39.7 p-80 -150.65 153.6 35.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.135 -0.936 . . . . 0.0 109.877 -179.712 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 19.7 tpp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.404 0.621 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.2 mp0 -135.67 149.86 49.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.336 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.03 130.86 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.692 0.758 . . . . 0.0 109.071 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.2 ttp -100.2 140.62 34.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.856 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 166.3 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.82 138.74 50.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.804 0.811 . . . . 0.0 109.837 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' THR . . . . . 0.607 ' HG1' ' H ' ' A' ' 425' ' ' LYS . 0.2 OUTLIER -99.52 165.79 14.08 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.568 ' N ' ' HG1' ' A' ' 423' ' ' THR . 31.8 Cg_endo -64.96 -16.01 53.31 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.569 2.179 . . . . 0.0 111.446 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . 0.607 ' H ' ' HG1' ' A' ' 423' ' ' THR . 14.3 mptt -86.27 -3.68 59.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 108.914 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.42 84.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.94 167.36 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 110.419 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.0 mm -108.09 128.71 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.592 -0.692 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.01 131.47 53.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.525 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -107.82 132.67 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.9 mt -126.57 147.87 62.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.673 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.54 158.14 56.82 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -56.42 139.58 48.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.32 76.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.67 154.89 41.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -1.086 . . . . 0.0 110.104 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.5 p -127.05 172.72 10.26 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.829 0.823 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -30.6 66.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.707 -0.621 . . . . 0.0 110.053 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.33 -43.01 98.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.56 -40.72 97.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 109.725 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . 0.408 ' O ' ' OG ' ' A' ' 443' ' ' SER . 77.8 t80 -61.08 -42.88 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.451 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.16 93.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.809 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.43 -37.37 80.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 440' ' ' PHE . 91.1 p -61.56 -35.96 79.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.49 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.574 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 92.4 mt -63.95 -43.58 95.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.174 -0.954 . . . . 0.0 109.63 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.2 m-70 -162.12 -120.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.739 . . . . 0.0 109.384 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 5.7 p -158.83 -68.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.17 -39.04 92.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -43.26 99.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.238 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.2 89.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.6 -34.27 77.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -82.41 21.34 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 42.1 t -76.67 122.92 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -0.843 . . . . 0.0 109.664 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -105.48 -4.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.85 -177.32 46.54 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.32 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.19 148.94 30.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -1.144 . . . . 0.0 109.209 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -132.01 126.54 34.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.76 130.56 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.645 0.736 . . . . 0.0 109.72 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . 0.452 HD22 ' CB ' ' A' ' 472' ' ' ASP . 11.2 m120 55.55 41.79 30.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 109.81 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 57.55 16.27 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -118.51 138.76 52.29 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.703 0.763 . . . . 0.0 109.86 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.87 139.04 53.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.2 m -151.06 149.8 25.86 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.43 162.08 42.2 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.339 2.026 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.11 -39.31 94.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.0 m -75.3 8.14 2.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.274 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.3 t80 -65.64 135.4 54.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.42 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 77.5 t -77.09 130.72 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.673 0.749 . . . . 0.0 110.019 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.74 145.23 38.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.0 110.175 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -118.5 147.64 43.44 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.677 0.751 . . . . 0.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 94.1 p -65.24 151.43 46.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 80.2 -38.35 2.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . 0.452 ' CB ' HD22 ' A' ' 458' ' ' ASN . 99.4 m-20 -68.42 144.27 54.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -1.037 . . . . 0.0 110.796 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -89.23 145.47 25.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.486 -0.759 . . . . 0.0 109.172 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.98 133.24 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.551 -0.718 . . . . 0.0 109.75 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -132.73 142.22 48.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.75 131.2 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.6 0.714 . . . . 0.0 109.74 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.0 mt -92.67 137.38 32.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.773 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 57.3 m -127.3 154.15 45.28 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 109.528 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 71.3 p -88.92 85.8 6.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -87.35 -8.62 56.44 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 97.0 p -77.24 168.05 20.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.847 . . . . 0.0 110.756 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 482' ' ' LEU . 3.3 mm? -83.76 -2.56 56.56 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 55.14 166.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.712 0.767 . . . . 0.0 110.979 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -80.03 164.76 23.18 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.786 0.803 . . . . 0.0 110.4 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.44 ' H ' ' CD2' ' A' ' 485' ' ' HIS . 7.3 p80 -58.59 -41.43 85.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.811 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -72.44 129.82 39.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -82.5 134.5 35.21 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.744 0.783 . . . . 0.0 110.398 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 85.4 t60 45.71 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.627 0.727 . . . . 0.0 110.314 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 75.6 m80 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.969 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' MET . . . . . 0.425 ' SD ' ' OE1' ' A' ' 433' ' ' GLN . 11.9 ptt? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 -82.37 157.74 23.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.438 -0.789 . . . . 0.0 110.012 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.45 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 31.5 ttm -99.96 144.48 28.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.721 -0.612 . . . . 0.0 109.703 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.51 163.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.24 137.63 53.53 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.676 0.75 . . . . 0.0 109.734 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.67 177.67 1.57 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -29.99 85.65 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.453 2.102 . . . . 0.0 111.595 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.9 -4.52 59.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.16 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.04 13.99 80.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.41 147.17 46.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 428' ' ' ILE . 1.4 mp -90.92 127.58 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -131.23 110.07 10.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -90.24 137.41 32.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.759 -0.588 . . . . 0.0 109.718 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.77 148.45 69.98 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.52 155.01 72.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.466 2.11 . . . . 0.0 112.464 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.425 ' OE1' ' SD ' ' A' ' 417' ' ' MET . 51.1 tt0 -52.23 145.84 10.14 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.668 0.746 . . . . 0.0 110.434 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.63 13.02 79.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.0 150.93 47.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.976 . . . . 0.0 110.267 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.5 p -127.46 172.72 10.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.645 0.736 . . . . 0.0 109.799 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.24 -30.47 66.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.673 -0.642 . . . . 0.0 109.643 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.62 -43.23 97.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.57 -42.05 99.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -61.37 -43.68 98.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.558 -0.714 . . . . 0.0 109.841 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.42 83.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 0.0 109.804 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.87 -36.16 83.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.8 m -59.66 -39.31 83.99 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.603 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 93.3 mt -63.1 -44.31 96.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.762 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.5 m-70 -161.97 -120.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.644 . . . . 0.0 109.521 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 6.0 p -152.93 -76.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.562 -0.712 . . . . 0.0 109.079 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.67 -42.34 98.07 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.441 0.638 . . . . 0.0 109.574 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -44.6 95.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.331 -0.856 . . . . 0.0 108.924 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -65.87 -43.83 93.09 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 452' ' ' CYS . 57.1 t0 -68.83 -29.28 67.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.993 . . . . 0.0 109.607 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -80.62 18.49 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.376 -0.828 . . . . 0.0 108.825 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' A' ' 450' ' ' ASP . 63.8 m -79.79 133.04 36.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.588 -0.695 . . . . 0.0 109.951 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.21 -4.24 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.614 -0.678 . . . . 0.0 109.476 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.89 47.4 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.18 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.05 151.99 48.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.509 -0.995 . . . . 0.0 109.703 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . 0.511 ' HZ3' ' C ' ' A' ' 459' ' ' HIS . 39.9 tttm -133.23 119.98 20.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.652 -0.655 . . . . 0.0 109.308 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.89 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . 0.558 HD22 ' CB ' ' A' ' 472' ' ' ASP . 14.4 m120 57.45 37.8 27.96 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.511 ' C ' ' HZ3' ' A' ' 456' ' ' LYS . 29.1 m170 58.83 13.64 2.84 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.78 156.42 26.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.548 0.69 . . . . 0.0 109.816 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.02 113.43 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.482 -0.762 . . . . 0.0 109.703 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.99 150.69 46.38 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.74 162.28 38.07 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.636 2.224 . . . . 0.0 112.697 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.8 mp -62.86 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.653 -0.655 . . . . 0.0 109.517 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.9 m -75.33 4.35 7.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.326 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -62.72 135.68 57.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.799 . . . . 0.0 110.44 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.22 132.3 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.576 0.703 . . . . 0.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.79 148.07 46.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.631 -0.668 . . . . 0.0 110.509 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.23 142.21 51.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.646 0.736 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.8 t -66.84 141.09 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.619 0.724 . . . . 0.0 110.801 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 91.02 -36.44 3.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . 0.558 ' CB ' HD22 ' A' ' 458' ' ' ASN . 91.8 m-20 -70.27 144.01 51.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.438 -1.037 . . . . 0.0 110.454 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.2 143.01 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.556 -0.715 . . . . 0.0 109.391 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.08 132.35 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.42 0.629 . . . . 0.0 109.803 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -140.5 126.1 19.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 34.9 m -94.4 132.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.499 -0.75 . . . . 0.0 109.843 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.87 111.9 23.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.639 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.528 ' HG ' ' HZ1' ' A' ' 480' ' ' LYS . 8.2 t -89.66 172.75 8.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.586 0.708 . . . . 0.0 110.016 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 30.19 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 0.0 109.68 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.528 ' HZ1' ' HG ' ' A' ' 478' ' ' SER . 43.7 mmtm -71.75 145.11 48.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 110.689 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 96.2 p -71.71 107.36 4.5 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.753 0.787 . . . . 0.0 110.151 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.56 9.66 42.73 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 57.54 104.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.613 0.721 . . . . 0.0 110.331 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -61.47 -39.99 92.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.706 -0.621 . . . . 0.0 109.887 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -75.82 66.88 2.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -61.67 -40.9 96.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.548 -0.72 . . . . 0.0 109.279 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -151.3 164.39 36.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -84.87 122.65 29.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 109.971 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.734 -179.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 418' ' ' GLU . 11.4 tmm? . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.496 ' O ' ' SD ' ' A' ' 417' ' ' MET . 97.3 mt-10 -114.1 145.73 41.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 9.7 m -109.92 130.5 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' MET . . . . . 0.412 ' CE ' ' NH2' ' A' ' 430' ' ' ARG . 39.0 ttm -91.03 134.21 34.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.807 . . . . 0.0 109.308 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.23 162.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.14 138.77 52.69 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.488 0.661 . . . . 0.0 109.596 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 165.62 14.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.09 -14.74 45.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.179 1.919 . . . . 0.0 111.129 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.98 -4.27 59.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.467 -0.77 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.65 85.36 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.08 165.9 18.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 110.069 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.3 mm -110.91 128.4 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.52 -0.737 . . . . 0.0 109.022 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -126.85 140.22 52.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.412 ' NH2' ' CE ' ' A' ' 420' ' ' MET . 95.9 mtt-85 -113.35 136.79 52.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.632 -0.668 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.25 147.33 63.27 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.15 159.78 51.1 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.257 1.972 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -57.05 148.89 20.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.468 -0.77 . . . . 0.0 110.302 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 10.46 81.64 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.03 44.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -1.046 . . . . 0.0 109.759 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.1 p -127.57 173.58 9.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.631 -0.668 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.98 -34.36 69.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.93 -43.03 99.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 109.638 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.87 -41.8 98.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . 0.409 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 79.7 t80 -60.78 -44.58 96.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.055 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.75 86.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.04 -1.038 . . . . 0.0 109.939 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -64.04 -37.89 89.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.08 . . . . 0.0 109.673 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 60.6 p -59.77 -37.12 78.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 89.2 mt -63.46 -54.19 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.987 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 99.6 m-70 -161.93 -126.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 19.4 m -146.63 -64.7 0.29 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.011 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.93 -45.36 92.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.0 109.98 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -44.83 95.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.9 90.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.09 -18.47 63.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -1.196 . . . . 0.0 110.011 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -103.29 42.35 1.17 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.392 -0.818 . . . . 0.0 109.321 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.32 127.43 44.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.446 -0.784 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 453' ' ' ILE . 42.1 pt -101.57 -5.2 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.12 178.55 48.22 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.56 149.31 48.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.645 -0.915 . . . . 0.0 108.704 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . 0.465 ' NZ ' ' C ' ' A' ' 459' ' ' HIS . 44.8 tttm -132.88 120.83 22.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 94.1 t -123.57 133.83 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.542 -0.724 . . . . 0.0 109.705 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.33 43.59 19.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.465 ' C ' ' NZ ' ' A' ' 456' ' ' LYS . 79.5 m80 53.13 13.16 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 110.653 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -118.09 137.04 53.2 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.378 -0.826 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.3 134.83 54.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.628 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.29 150.93 53.64 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.34 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.636 2.224 . . . . 0.0 112.716 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.7 mp -62.45 -39.09 92.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.216 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -74.64 7.74 2.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.338 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 464' ' ' LEU . 92.0 t80 -65.45 133.78 52.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.949 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 78.2 t -79.56 132.18 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.49 149.23 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.378 -0.826 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -124.1 145.37 49.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.616 -0.677 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.7 t -65.69 142.44 58.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -0.799 . . . . 0.0 110.495 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.89 -32.46 5.1 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -73.08 149.37 43.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.349 -1.089 . . . . 0.0 109.716 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -95.53 130.14 42.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 22.1 t -103.55 131.66 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.455 -0.778 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -134.51 143.14 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.46 132.46 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.479 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.81 128.65 46.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.327 -0.858 . . . . 0.0 109.248 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 73.0 m -130.8 119.19 21.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.547 -0.721 . . . . 0.0 109.567 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 83.7 p -91.22 -4.9 55.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 109.001 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 46.4 90.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.444 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 27.9 m -79.57 105.86 11.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.637 -0.664 . . . . 0.0 109.739 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.444 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 84.5 mt -96.01 -0.58 50.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.07 139.98 57.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 110.395 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 75.1 m80 -141.35 23.72 2.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.665 ' CG ' ' H ' ' A' ' 486' ' ' HIS . 86.4 t60 -139.61 176.85 8.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.448 -0.783 . . . . 0.0 109.78 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . 0.665 ' H ' ' CG ' ' A' ' 485' ' ' HIS . 56.2 t-80 55.58 84.29 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.713 -0.617 . . . . 0.0 109.939 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -133.59 19.62 3.91 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -151.13 162.67 40.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.195 -0.941 . . . . 0.0 110.145 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.756 -179.759 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 55.5 ttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.746 0.784 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.4 167.97 20.9 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.365 0.602 . . . . 0.0 110.178 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.1 131.58 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.631 0.729 . . . . 0.0 109.519 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 54.6 ttm -96.99 133.69 41.33 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.687 0.756 . . . . 0.0 110.405 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.08 163.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -115.69 142.35 46.86 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.902 0.858 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.71 176.71 1.78 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.33 -29.92 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.071 1.847 . . . . 0.0 111.429 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.11 -4.91 59.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.173 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.5 79.95 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.59 157.55 37.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.52 -0.988 . . . . 0.0 110.485 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.3 mm -99.68 123.98 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.646 -0.659 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -127.43 126.33 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -106.62 133.86 50.65 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.26 0.552 . . . . 0.0 109.646 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.76 152.96 77.82 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.54 147.82 22.11 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.36 2.04 . . . . 0.0 112.492 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.14 132.37 52.74 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.914 0.864 . . . . 0.0 110.632 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.6 13.59 75.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.3 170.9 0.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.986 . . . . 0.0 110.677 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.9 p -127.54 171.08 11.93 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.143 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.77 67.96 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.327 0.584 . . . . 0.0 109.968 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.39 -42.56 98.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.69 -39.85 95.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.712 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.27 -43.68 98.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.792 . . . . 0.0 109.156 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.3 95.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.627 -0.671 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -65.03 -36.68 85.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 38.9 m -58.81 -41.57 87.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.04 -76.71 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -138.42 179.05 6.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.419 -0.801 . . . . 0.0 109.897 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 33.6 t -103.95 -55.06 2.44 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.378 0.609 . . . . 0.0 109.612 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.58 -49.68 74.31 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.512 0.673 . . . . 0.0 109.659 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.95 -44.71 88.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.739 0.78 . . . . 0.0 109.611 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . 0.472 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.73 -42.19 93.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 450' ' ' ASP . 65.8 t0 -66.63 -35.46 80.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.942 . . . . 0.0 109.864 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 451' ' ' HIS . 11.1 t-160 -81.74 20.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.197 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 28.7 p -74.53 129.98 38.75 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.498 0.666 . . . . 0.0 109.947 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 453' ' ' ILE . 25.4 pt -104.43 -4.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.37 48.48 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 147.04 40.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.58 -0.953 . . . . 0.0 109.709 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -131.66 124.04 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.08 131.84 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.614 0.721 . . . . 0.0 109.998 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 54.7 44.06 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 109.937 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.436 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 54.0 t-80 58.49 13.39 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.281 0.562 . . . . 0.0 109.68 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.02 144.53 43.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.751 . . . . 0.0 109.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.13 113.53 20.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.423 0.63 . . . . 0.0 109.589 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.75 151.69 54.85 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.07 162.78 36.68 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.497 2.131 . . . . 0.0 112.375 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 466' ' ' TYR . 10.6 mp -63.32 -39.42 94.52 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.402 0.62 . . . . 0.0 109.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.6 t -75.56 10.52 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.286 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.437 ' H ' ' C ' ' A' ' 464' ' ' LEU . 93.0 t80 -69.1 135.48 50.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.788 0.804 . . . . 0.0 110.518 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.433 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 81.7 t -81.2 131.48 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 121.721 0.772 . . . . 0.0 109.778 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.61 145.08 45.67 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.617 0.722 . . . . 0.0 110.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.02 144.18 44.9 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.67 0.747 . . . . 0.0 109.877 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 42.6 t -68.62 140.18 55.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.947 0.879 . . . . 0.0 111.143 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.11 -26.19 16.28 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.95 163.31 25.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.986 . . . . 0.0 111.359 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -103.43 134.51 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 51.3 t -114.48 132.2 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.699 0.761 . . . . 0.0 110.301 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.79 146.23 39.2 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.29 131.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.727 0.775 . . . . 0.0 110.188 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.5 131.91 34.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.573 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.7 m -130.32 153.97 48.13 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.68 0.752 . . . . 0.0 110.235 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.4 p -90.41 83.64 5.93 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.499 0.666 . . . . 0.0 109.491 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -113.64 5.58 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 87.5 p -85.14 -1.37 56.8 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.606 0.717 . . . . 0.0 109.267 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 482' ' ' LEU . 8.3 mp -80.78 -5.79 57.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -73.3 147.07 44.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.626 -0.671 . . . . 0.0 110.177 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -146.78 139.46 25.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -0.816 . . . . 0.0 109.881 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.425 ' CG ' ' O ' ' A' ' 485' ' ' HIS . 86.5 t60 -81.78 57.12 3.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.79 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . 0.564 ' HD1' ' H ' ' A' ' 488' ' ' HIS . 55.0 t-80 -73.84 147.47 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -59.91 -42.98 95.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.773 -0.579 . . . . 0.0 109.929 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.564 ' H ' ' HD1' ' A' ' 486' ' ' HIS . 81.7 t60 -119.84 118.37 30.62 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.619 0.723 . . . . 0.0 109.512 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.745 -179.795 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.5 159.19 42.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.471 -0.768 . . . . 0.0 109.076 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.8 130.88 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.429 -0.794 . . . . 0.0 108.964 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.6 ttm -92.5 138.43 31.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.786 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.48 164.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.03 137.39 53.57 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' THR . . . . . 0.611 ' HG1' ' H ' ' A' ' 425' ' ' LYS . 0.1 OUTLIER -98.98 171.51 5.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.94 -29.5 82.49 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.939 1.759 . . . . 0.0 111.113 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . 0.611 ' H ' ' HG1' ' A' ' 423' ' ' THR . 19.3 mmmt -81.24 -4.35 55.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.626 . . . . 0.0 109.623 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.0 83.46 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -73.87 156.65 37.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -1.171 . . . . 0.0 110.198 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.7 mm -103.12 125.14 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.08 132.9 47.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.565 -0.709 . . . . 0.0 109.262 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -107.25 134.99 49.52 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 49.2 mt -131.0 153.07 81.68 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.6 147.17 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.985 1.79 . . . . 0.0 112.707 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -54.87 130.34 40.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.673 -0.642 . . . . 0.0 110.092 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.03 76.36 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -52.09 172.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 109.864 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.7 p -128.22 171.42 11.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.551 -0.718 . . . . 0.0 109.958 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.73 71.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.06 -43.55 98.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.432 -0.793 . . . . 0.0 109.532 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -61.12 -43.85 98.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.01 -45.53 79.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.439 -0.788 . . . . 0.0 109.842 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -62.16 -37.95 87.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.832 . . . . 0.0 109.744 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.2 m -58.87 -41.55 87.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.81 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.97 -43.93 97.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.308 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.689 ' CD2' ' H ' ' A' ' 446' ' ' SER . 73.5 t60 -173.68 -130.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.421 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' SER . . . . . 0.689 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 8.1 t -145.42 -64.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.65 -44.95 94.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.449 -0.782 . . . . 0.0 109.731 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -46.0 89.76 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -68.74 -39.11 86.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -37.88 89.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.511 -0.993 . . . . 0.0 109.839 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -83.17 20.06 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 109.498 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 27.7 p -71.09 122.47 20.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.675 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.9 pt -99.64 -2.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.793 . . . . 0.0 109.777 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.54 179.66 45.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.24 146.29 36.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 109.053 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -134.01 122.06 22.48 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.263 -0.898 . . . . 0.0 108.951 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.06 134.46 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.678 -0.639 . . . . 0.0 109.607 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 58.09 41.94 23.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 55.2 18.45 2.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.627 . . . . 0.0 110.141 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -122.75 144.09 49.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.628 -0.67 . . . . 0.0 109.213 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 41.9 tp -70.17 134.28 47.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.33 149.87 53.01 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.05 162.18 41.1 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.486 2.124 . . . . 0.0 112.617 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.8 mp -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.71 -0.619 . . . . 0.0 109.65 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 96.6 p -75.96 10.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.749 . . . . 0.0 109.627 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.5 t80 -65.09 135.94 56.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 110.226 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.434 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 22.3 t -79.29 131.26 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.89 149.32 39.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.395 -0.816 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -124.14 141.97 51.61 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.537 0.684 . . . . 0.0 109.396 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.9 t -66.19 142.45 57.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.69 . . . . 0.0 110.781 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.33 10.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -78.87 161.14 26.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -1.043 . . . . 0.0 109.998 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -105.56 122.82 46.81 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.5 t -97.4 132.24 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.458 -0.776 . . . . 0.0 110.244 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.0 141.72 47.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.16 130.8 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.447 -0.783 . . . . 0.0 109.64 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.17 137.92 31.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 97.4 p -137.02 157.64 46.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.446 -0.784 . . . . 0.0 109.676 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 92.0 p -85.36 -3.69 58.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.497 -0.752 . . . . 0.0 109.847 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.32 -144.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.775 . . . . 0.0 110.266 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 481' ' ' SER . 10.4 t 56.53 26.15 10.64 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.403 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 88.6 mt -92.67 11.4 26.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.749 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 56.95 160.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.539 0.685 . . . . 0.0 110.543 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -80.66 108.18 14.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.69 -0.631 . . . . 0.0 109.809 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -67.36 -39.54 85.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.68 -0.637 . . . . 0.0 110.043 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -50.93 144.96 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -150.47 165.77 32.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.522 -0.737 . . . . 0.0 109.478 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -150.7 151.71 32.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 109.136 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 489' ' ' HIS . 85.9 t60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 -115.64 165.67 12.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.601 -0.687 . . . . 0.0 109.643 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.1 m -114.31 131.25 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.651 0.739 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' MET . . . . . 0.424 ' H ' ' HG ' ' A' ' 470' ' ' SER . 63.8 ttp -95.02 135.4 36.61 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.525 0.679 . . . . 0.0 110.003 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.18 164.68 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.09 141.24 48.69 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.678 0.751 . . . . 0.0 109.73 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.52 176.25 2.04 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.28 -33.48 85.07 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.896 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.94 -4.21 54.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 80.91 10.68 84.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.85 155.73 40.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.636 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.22 124.33 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -127.19 131.88 50.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -105.71 135.52 46.98 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.451 0.643 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 23.1 mt -138.69 150.77 66.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.69 156.13 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.429 2.086 . . . . 0.0 112.719 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.16 154.49 7.78 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.291 1.043 . . . . 0.0 111.101 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 78.71 7.03 88.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.58 153.35 43.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.356 -1.085 . . . . 0.0 110.443 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 47.8 p -127.04 171.21 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.772 0.796 . . . . 0.0 110.159 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.3 -28.52 63.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.564 0.697 . . . . 0.0 109.829 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -46.67 86.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 109.578 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.68 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -61.13 -44.33 97.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.677 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.1 -47.37 83.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.0 -34.73 78.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.539 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 34.4 m -59.23 -41.2 88.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.579 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.38 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.95 -151.19 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.373 -0.83 . . . . 0.0 109.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 82.1 p -127.32 -73.99 0.6 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.583 0.706 . . . . 0.0 110.034 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.525 ' N ' ' OG ' ' A' ' 446' ' ' SER . 99.6 m-20 -64.13 -43.28 95.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -46.58 87.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.007 0.908 . . . . 0.0 109.295 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.25 -40.21 94.68 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 452' ' ' CYS . 65.3 t0 -65.62 -37.92 87.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -1.066 . . . . 0.0 109.946 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 73.6 m-70 -76.77 26.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.196 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.509 ' H ' ' C ' ' A' ' 450' ' ' ASP . 21.6 p -79.7 121.11 24.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.65 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 38.6 pt -101.38 -3.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.48 179.51 47.47 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.244 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.05 152.8 32.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -1.072 . . . . 0.0 109.364 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -131.01 131.31 44.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.742 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.15 132.56 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.44 0.638 . . . . 0.0 109.511 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 56.43 39.38 30.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.518 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 78.1 m80 58.94 13.13 2.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.453 0.644 . . . . 0.0 109.69 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.77 136.83 49.25 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.778 0.799 . . . . 0.0 109.62 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.0 tp -66.44 131.74 46.73 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.707 0.765 . . . . 0.0 110.473 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 7.0 m -146.87 149.93 37.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.8 158.6 55.47 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.423 2.082 . . . . 0.0 112.421 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.52 -38.45 90.0 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.668 0.747 . . . . 0.0 109.761 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.8 m -75.27 8.34 2.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 109.41 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.471 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 94.3 t80 -66.21 137.36 56.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.899 . . . . 0.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.471 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 82.1 t -75.88 130.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.067 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.8 mt -78.77 142.99 36.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.547 0.689 . . . . 0.0 110.624 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 99.7 m-20 -116.16 148.03 40.78 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.57 0.7 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' SER . . . . . 0.424 ' HG ' ' H ' ' A' ' 420' ' ' MET . 16.5 m -74.26 140.66 45.13 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.793 0.806 . . . . 0.0 110.947 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.16 -23.13 37.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 42.3 p-10 -84.48 171.8 12.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.291 -1.123 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -110.94 129.03 56.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.1 131.61 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.584 -0.697 . . . . 0.0 109.747 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -130.44 138.22 50.2 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.33 130.54 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.727 0.775 . . . . 0.0 110.221 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.74 141.4 30.02 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.468 0.652 . . . . 0.0 109.409 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.5 p -137.25 158.28 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.604 0.716 . . . . 0.0 109.694 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 480' ' ' LYS . 92.9 p -82.49 -6.08 59.1 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 479' ' ' SER . 68.4 mttm 40.66 34.09 0.23 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.897 0.856 . . . . 0.0 110.085 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 67.6 m -80.66 -3.51 50.85 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.492 -0.755 . . . . 0.0 109.153 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.11 75.29 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.04 121.41 27.37 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 485' ' ' HIS . 84.3 t60 -173.24 124.8 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 109.331 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 484' ' ' HIS . 78.0 m80 -154.93 21.67 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -61.91 -43.23 99.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.394 -0.817 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -74.42 138.27 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.805 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 488' ' ' HIS . 58.6 t-80 56.17 10.93 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.408 0.623 . . . . 0.0 110.122 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 75.9 m80 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.119 179.445 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 44.3 tpp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.11 158.68 22.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.654 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.17 130.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' MET . . . . . 0.492 ' SD ' ' CG2' ' A' ' 428' ' ' ILE . 49.2 ttp -100.31 143.87 29.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.631 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.27 161.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.73 125.86 54.78 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.547 0.689 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' THR . . . . . 0.475 ' HG1' ' H ' ' A' ' 425' ' ' LYS . 0.2 OUTLIER -89.19 156.23 48.89 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.97 -15.96 42.26 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.148 1.899 . . . . 0.0 111.238 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . 0.475 ' H ' ' HG1' ' A' ' 423' ' ' THR . 71.0 mmtt -81.9 -3.18 53.59 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.449 -0.782 . . . . 0.0 109.178 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.07 161.22 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -1.133 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.492 ' CG2' ' SD ' ' A' ' 420' ' ' MET . 35.0 mm -110.14 129.2 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.511 -0.743 . . . . 0.0 109.068 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -125.91 134.54 51.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -106.3 133.27 51.26 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.639 -0.663 . . . . 0.0 109.513 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.72 147.18 52.63 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.05 158.19 55.84 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.318 2.012 . . . . 0.0 111.97 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -56.09 143.05 34.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.281 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 11.54 81.12 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.61 152.46 44.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.569 -0.959 . . . . 0.0 109.791 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.7 p -127.57 172.9 10.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.6 -0.687 . . . . 0.0 109.686 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.65 65.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.461 -0.774 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.82 -42.44 99.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.319 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -61.15 -43.6 98.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 109.956 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . 0.406 ' O ' ' OG ' ' A' ' 443' ' ' SER . 66.3 t80 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.11 -42.63 81.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.619 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -67.36 -38.02 84.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.148 -0.97 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 440' ' ' PHE . 91.1 p -59.8 -37.02 77.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 109.664 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.32 -42.8 99.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 109.231 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.677 ' CD2' ' H ' ' A' ' 446' ' ' SER . 85.8 t60 -173.49 -119.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' SER . . . . . 0.677 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 37.3 p -155.62 -64.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 451' ' ' HIS . 64.0 t0 -61.82 -48.78 79.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.492 -0.755 . . . . 0.0 109.803 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -45.45 92.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.275 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -67.18 -40.8 92.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 452' ' ' CYS . 64.6 t0 -63.72 -37.26 86.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.099 . . . . 0.0 109.522 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' A' ' 447' ' ' ASP . 51.5 m80 -81.15 27.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 109.2 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 13.2 p -77.35 129.78 36.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 24.6 pt -102.92 -5.26 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 0.0 109.313 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 175.68 -175.12 47.23 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.15 150.57 42.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 108.836 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -132.82 121.6 23.2 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.3 t -122.73 134.34 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.692 . . . . 0.0 109.289 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.2 m120 55.59 39.52 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.526 0.679 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 57.1 t-80 57.86 8.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 110.232 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -111.47 146.68 36.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.452 -0.78 . . . . 0.0 109.285 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.43 142.06 48.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.5 -0.75 . . . . 0.0 109.704 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.84 148.87 34.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.19 159.94 49.8 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.06 1.84 . . . . 0.0 112.368 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 464' ' ' LEU . 10.5 mp -62.35 -40.16 95.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.578 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -75.85 7.44 3.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.21 136.6 58.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.86 130.17 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 109.641 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.55 146.55 36.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.468 -0.77 . . . . 0.0 109.79 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 94.6 m-20 -123.98 151.7 43.36 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.547 -0.721 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 11.6 p -75.24 145.39 41.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.822 . . . . 0.0 110.458 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.81 -21.45 41.44 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 49.4 p-10 -84.18 172.05 12.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -1.145 . . . . 0.0 109.893 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -115.1 131.93 56.77 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.92 131.64 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.815 . . . . 0.0 110.014 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -135.72 113.3 10.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.53 137.34 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.807 . . . . 0.0 110.27 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.5 mt -96.6 135.0 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 109.255 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.5 m -127.79 154.48 45.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.53 -0.732 . . . . 0.0 109.77 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.2 p -90.62 87.27 6.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.18 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.38 -168.66 0.34 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 110.309 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 14.7 m -87.03 93.82 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 109.783 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 482' ' ' LEU . 9.0 mp -95.45 -9.8 31.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . 0.607 ' N ' ' HD1' ' A' ' 485' ' ' HIS . 97.4 mt-10 56.15 153.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.63 0.729 . . . . 0.0 110.899 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 484' ' ' HIS . 29.9 t-80 48.78 12.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.38 -0.825 . . . . 0.0 109.548 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.607 ' HD1' ' N ' ' A' ' 483' ' ' GLU . 36.3 p-80 -87.36 146.62 25.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.324 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 45.37 -165.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.484 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -148.21 168.62 22.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.858 . . . . 0.0 109.856 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 58.16 50.02 10.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.883 -1.056 . . . . 0.0 109.918 179.657 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' MET . . . . . 0.606 ' N ' ' SD ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 -83.68 167.28 17.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 109.659 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.16 129.63 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.419 0.628 . . . . 0.0 109.61 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.3 ttm -102.91 132.87 48.83 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.49 163.54 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -117.66 144.09 45.55 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.905 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.27 174.3 3.17 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.49 -31.85 87.44 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.226 1.95 . . . . 0.0 111.289 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.99 -3.99 55.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.51 -0.744 . . . . 0.0 109.215 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.11 11.68 83.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.79 154.96 41.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -1.199 . . . . 0.0 110.517 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 36.3 mm -94.3 124.25 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -129.95 106.99 9.03 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -97.45 127.86 43.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.464 -0.773 . . . . 0.0 109.415 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 40.0 mt -120.09 148.88 47.96 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 154.29 74.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.15 1.9 . . . . 0.0 112.193 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -52.62 146.59 9.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.875 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.13 7.38 80.37 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.0 151.47 47.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.747 -0.855 . . . . 0.0 110.159 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -127.38 171.55 11.43 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.494 0.664 . . . . 0.0 109.544 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.36 65.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.19 -46.06 88.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.84 -42.99 99.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -61.8 -44.94 95.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.77 . . . . 0.0 109.613 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.89 84.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 0.0 109.611 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.84 -34.03 77.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.1 m -58.63 -43.02 89.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 62.4 mt -63.3 -47.97 80.03 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 109.759 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 78.7 m-70 -166.01 -166.1 0.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 71.7 p -109.45 -37.24 5.78 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.42 -48.31 73.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 109.64 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.8 mm? -63.76 -41.07 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.579 -0.701 . . . . 0.0 109.295 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.09 -33.06 86.22 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -87.49 -24.2 24.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.393 -1.063 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -100.01 14.53 30.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 109.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 7.9 t -80.35 110.41 15.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.179 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.78 0.73 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.651 -0.656 . . . . 0.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -172.96 173.17 45.52 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.194 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.92 29.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -1.052 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -133.15 122.44 24.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.23 131.56 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.569 0.699 . . . . 0.0 109.943 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 56.18 45.05 24.03 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.308 0.575 . . . . 0.0 109.861 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.7 12.24 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.666 -0.646 . . . . 0.0 109.814 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.21 132.54 56.58 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.547 0.689 . . . . 0.0 109.384 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.03 135.1 51.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.24 151.57 44.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.0 109.45 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.49 161.63 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.442 2.095 . . . . 0.0 112.336 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 464' ' ' LEU . 10.7 mp -62.8 -38.63 91.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.591 -0.693 . . . . 0.0 109.605 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.9 m -74.85 7.92 2.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.2 -0.938 . . . . 0.0 109.335 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.2 t80 -69.47 134.63 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.421 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 25.3 t -77.21 131.26 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.843 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 71.8 mt -75.15 144.74 42.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.293 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -115.96 147.92 40.64 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.422 0.63 . . . . 0.0 109.367 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.1 p -65.52 153.14 42.3 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.658 0.742 . . . . 0.0 111.214 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 81.36 -40.07 2.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.0 144.24 54.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.12 . . . . 0.0 111.016 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 474' ' ' VAL . 21.5 tm0? -85.81 143.35 28.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . 0.518 ' O ' ' NE2' ' A' ' 473' ' ' GLN . 66.7 t -116.42 132.14 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.571 -0.705 . . . . 0.0 109.935 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 12.4 m -109.85 133.83 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.64 -0.662 . . . . 0.0 110.046 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -89.84 108.33 19.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.726 . . . . 0.0 109.267 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.517 ' HG ' ' HZ2' ' A' ' 480' ' ' LYS . 19.6 p -84.44 169.35 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.792 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.7 t -98.43 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 0.0 109.085 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.517 ' HZ2' ' HG ' ' A' ' 478' ' ' SER . 63.3 mttp -60.41 139.43 57.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.784 . . . . 0.0 110.173 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 69.0 m -62.53 147.42 49.05 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.71 0.767 . . . . 0.0 110.501 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 482' ' ' LEU . 3.7 mm? -86.81 -3.13 59.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 484' ' ' HIS . 80.0 mm-40 -60.44 -112.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.66 -0.65 . . . . 0.0 110.079 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 483' ' ' GLU . 57.0 t-80 57.62 120.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.642 0.734 . . . . 0.0 110.003 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -154.47 152.48 30.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -111.43 106.47 15.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.717 -0.614 . . . . 0.0 109.573 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 489' ' ' HIS . 84.2 t60 -171.25 130.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 488' ' ' HIS . 55.0 t-80 52.06 8.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 487' ' ' HIS . 86.0 t60 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.101 -0.952 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' MET . . . . . 0.608 ' N ' ' SD ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.723 0.773 . . . . 0.0 109.012 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 -81.11 161.43 24.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.507 -0.746 . . . . 0.0 110.094 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.0 130.84 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.695 0.759 . . . . 0.0 109.051 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.2 ttp -99.36 139.59 34.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.616 0.722 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.79 165.08 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.58 139.4 53.57 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.779 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 165.71 14.71 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.85 -9.74 26.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.707 2.271 . . . . 0.0 111.632 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -90.9 -5.32 55.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.115 -0.991 . . . . 0.0 109.492 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.47 6.23 77.81 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -83.44 160.75 21.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -1.221 . . . . 0.0 110.318 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 32.0 mm -105.83 128.01 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -127.07 134.41 50.28 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -110.42 136.28 49.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.72 -0.613 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 85.1 mt -135.83 147.97 63.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.91 154.2 71.32 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.284 1.989 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.693 ' H ' ' NE2' ' A' ' 433' ' ' GLN . 0.0 OUTLIER -55.1 147.42 16.09 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.723 0.773 . . . . 0.0 110.991 -179.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.2 81.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.33 157.45 35.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.522 -0.987 . . . . 0.0 110.17 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 58.1 p -126.54 167.63 15.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.859 0.838 . . . . 0.0 109.928 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.35 68.28 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.522 0.677 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.01 -43.59 98.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.587 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.45 -42.87 99.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.669 0.747 . . . . 0.0 109.656 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -61.77 -44.79 96.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.502 -0.749 . . . . 0.0 110.157 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.15 84.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.75 -36.28 83.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.76 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 444' ' ' LEU . 39.1 t -63.49 -36.6 84.31 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 443' ' ' SER . 96.3 mt -52.59 -105.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.23 -2.24 37.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 t 70.81 -55.8 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.597 0.713 . . . . 0.0 109.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.1 t0 -65.46 -38.79 90.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 450' ' ' ASP . 7.3 tt -62.8 -41.6 99.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.692 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -49.19 -9.4 0.12 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 451' ' ' HIS . 8.2 p-10 -91.28 -22.68 20.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.046 -1.267 . . . . 0.0 109.434 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.578 ' N ' ' OD1' ' A' ' 450' ' ' ASP . 40.2 m80 -100.91 -1.18 35.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.361 -0.837 . . . . 0.0 109.053 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 26.1 p -61.98 118.1 6.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 41.1 pt -105.84 -5.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.806 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.33 176.44 46.01 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.11 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.0 151.96 38.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -1.162 . . . . 0.0 109.515 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -132.5 123.8 27.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.551 -0.718 . . . . 0.0 109.194 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -123.1 133.25 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.724 0.773 . . . . 0.0 109.812 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . 0.579 HD22 ' CB ' ' A' ' 472' ' ' ASP . 12.3 m120 55.69 40.89 30.9 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.516 0.675 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m80 56.21 13.01 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.426 0.631 . . . . 0.0 109.364 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.13 135.35 54.01 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.743 0.783 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.9 tp -66.74 134.98 53.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 0.0 109.813 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.32 150.68 49.07 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.357 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.37 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.505 2.136 . . . . 0.0 112.444 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.55 -37.09 86.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.7 m -75.02 3.92 7.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 109.33 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -62.87 135.46 57.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.368 -0.832 . . . . 0.0 110.426 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.31 130.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.625 0.726 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.89 147.52 38.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.61 -0.681 . . . . 0.0 110.494 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -124.26 148.06 47.65 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.815 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 41.6 t -64.19 140.01 58.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.913 0.863 . . . . 0.0 111.123 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.15 -31.16 6.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . 0.579 ' CB ' HD22 ' A' ' 458' ' ' ASN . 98.8 m-20 -73.2 147.7 44.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -1.101 . . . . 0.0 111.026 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -95.53 141.93 28.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.72 . . . . 0.0 109.786 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.2 132.22 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.647 0.737 . . . . 0.0 109.787 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -138.12 113.58 9.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 109.046 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.0 134.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.77 96.19 8.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.452 -0.78 . . . . 0.0 109.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 96.0 p -85.29 166.37 16.54 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.739 0.781 . . . . 0.0 110.381 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.2 m -87.6 -4.61 58.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.077 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.83 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 5.0 m -76.43 101.7 5.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.68 -1.09 47.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.9 96.57 7.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.397 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -95.13 -14.65 23.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -101.81 13.42 34.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.228 -0.92 . . . . 0.0 109.096 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 75.7 m80 54.89 -92.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.675 -0.64 . . . . 0.0 110.023 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.52 141.23 46.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -152.12 164.12 37.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.635 -0.666 . . . . 0.0 109.383 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.893 -1.051 . . . . 0.0 108.914 179.875 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.6 mp0 -110.64 167.07 10.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.547 -0.721 . . . . 0.0 109.534 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.2 m -112.52 131.4 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.3 ttm -98.36 136.09 39.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.19 164.61 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.92 140.74 49.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.103 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 176.66 1.89 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.09 -34.22 97.29 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 111.912 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -81.43 -3.87 54.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 109.143 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.57 82.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -71.82 153.11 42.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.317 . . . . 0.0 110.371 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.25 127.17 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -129.15 113.71 15.42 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.69 127.62 45.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.9 mt -131.83 156.12 80.52 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.07 144.79 56.27 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.904 1.736 . . . . 0.0 112.677 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -62.4 141.08 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.545 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.48 84.41 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -66.05 179.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -1.071 . . . . 0.0 110.136 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.0 p -127.67 169.5 13.72 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.96 -26.33 64.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.03 -43.01 99.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.353 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.73 -40.16 96.34 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.845 . . . . 0.0 109.116 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 83.1 t80 -61.46 -43.93 97.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.603 -0.686 . . . . 0.0 109.365 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.51 87.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.81 -33.85 76.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.355 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 7.1 t -59.92 -44.2 94.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.798 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.564 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 70.1 mt -65.16 -55.87 16.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.179 -0.95 . . . . 0.0 109.847 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.8 m-70 -160.02 -167.34 1.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.546 -0.721 . . . . 0.0 109.776 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 69.6 m -110.37 -62.42 1.52 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.613 -0.68 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.46 -48.44 79.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -43.66 94.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.486 -0.759 . . . . 0.0 109.032 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.37 -43.19 95.43 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 450' ' ' ASP . 59.9 t0 -73.64 -10.34 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -100.94 22.75 11.67 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 84.4 m -81.95 130.74 35.16 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.47 -4.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.9 45.59 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -150.38 152.17 33.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -1.176 . . . . 0.0 109.123 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -133.15 127.11 33.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 109.191 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.89 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 14.8 m120 53.0 57.56 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.787 -0.571 . . . . 0.0 110.342 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 458' ' ' ASN . 35.1 p80 41.67 30.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.233 0.54 . . . . 0.0 110.182 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.75 135.48 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.89 134.46 52.1 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.522 -0.736 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.76 150.57 63.36 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.67 160.43 49.49 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.393 2.062 . . . . 0.0 112.256 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 466' ' ' TYR . 10.4 mp -63.07 -39.0 93.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.484 -0.76 . . . . 0.0 109.229 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 94.8 p -74.98 10.3 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.244 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 464' ' ' LEU . 94.0 t80 -67.02 133.34 49.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.101 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.96 131.02 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.86 145.75 42.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 110.129 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -121.83 134.63 54.89 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.533 0.682 . . . . 0.0 109.427 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -55.68 135.9 51.04 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 96.31 -12.53 66.55 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -83.69 171.35 13.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -1.163 . . . . 0.0 110.47 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -122.19 114.26 20.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 18.9 t -93.16 131.79 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -133.0 113.84 13.28 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.9 m -83.73 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.3 mt -99.97 131.95 45.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.514 -0.741 . . . . 0.0 109.038 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 45.2 t -136.37 145.91 45.91 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.698 . . . . 0.0 109.752 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 480' ' ' LYS . 94.9 p -85.53 -4.04 59.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.76 . . . . 0.0 108.959 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 479' ' ' SER . 99.0 mttt 52.66 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.725 0.774 . . . . 0.0 110.618 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.447 ' HG ' ' CG ' ' A' ' 483' ' ' GLU . 11.4 p -64.22 -36.94 85.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.466 -0.771 . . . . 0.0 109.495 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 79.5 mt 56.37 42.27 27.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.628 -0.67 . . . . 0.0 109.895 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . 0.447 ' CG ' ' HG ' ' A' ' 481' ' ' SER . 7.3 pt-20 -147.05 71.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.137 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -66.79 -39.21 87.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 109.529 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -59.42 131.4 50.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.299 -0.875 . . . . 0.0 109.694 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -111.05 143.59 41.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.612 -0.68 . . . . 0.0 109.835 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 487' ' ' HIS . 86.3 t60 -141.7 44.96 1.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -152.26 164.07 38.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.411 -0.806 . . . . 0.0 109.653 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.933 179.898 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 39.9 tpp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.2 149.07 41.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.617 -0.677 . . . . 0.0 109.292 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.6 m -112.29 130.53 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.4 ttm -97.11 135.98 38.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 109.765 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.53 165.24 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.564 -0.71 . . . . 0.0 109.238 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' A' ' 428' ' ' ILE . 78.8 m-85 -111.07 141.44 44.56 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.995 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 427' ' ' GLU . 82.1 p -96.39 151.44 38.07 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.7 -17.68 51.05 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.563 1.509 . . . . 0.0 110.685 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.431 -0.793 . . . . 0.0 109.176 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.77 1.17 65.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 427' ' ' GLU . 23.2 mp0 -88.19 155.81 19.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.034 -1.274 . . . . 0.0 109.177 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' A' ' 422' ' ' PHE . 2.7 tp -106.91 140.26 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.46 132.77 53.49 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -103.81 133.45 48.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.275 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.8 mt -132.83 148.05 67.93 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.49 157.8 59.6 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.214 1.943 . . . . 0.0 112.157 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.81 148.66 12.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.391 -0.818 . . . . 0.0 110.085 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.9 81.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.84 41.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -127.21 174.44 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.509 -0.744 . . . . 0.0 109.663 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.77 71.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.951 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.97 -42.18 98.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.029 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.96 -43.27 95.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.925 . . . . 0.0 109.703 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.44 -45.06 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.06 85.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.983 . . . . 0.0 109.801 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -63.93 -36.94 85.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.02 . . . . 0.0 109.643 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.6 m -58.02 -41.84 83.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.887 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.92 -75.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -141.89 -178.46 5.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 109.589 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 78.2 p -101.29 -54.01 2.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.407 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.1 m-20 -62.33 -45.95 90.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -43.49 96.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.003 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.44 -38.81 93.83 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.91 -11.8 61.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 109.202 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -105.01 13.43 30.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 30.3 p -74.75 120.8 20.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.935 . . . . 0.0 109.816 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.9 pt -101.81 -3.1 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 109.439 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.54 45.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -153.05 150.3 29.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.265 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -135.5 133.03 38.06 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.419 -0.801 . . . . 0.0 109.391 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.33 131.24 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 56.47 44.55 24.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.317 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 54.21 15.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.75 . . . . 0.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -113.85 137.1 52.12 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.471 -0.768 . . . . 0.0 109.241 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.25 135.25 53.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.859 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.13 151.28 33.92 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.918 . . . . 0.0 108.984 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.31 162.08 42.0 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.473 2.115 . . . . 0.0 112.615 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.6 mp -61.88 -40.35 95.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.739 . . . . 0.0 109.546 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 92.7 p -75.29 10.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -67.23 135.66 53.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.684 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 72.7 t -78.46 132.58 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -0.872 . . . . 0.0 109.681 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -74.97 148.97 39.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 109.77 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -123.19 145.59 48.5 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 36.9 t -65.37 144.22 57.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.55 -40.67 3.03 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.37 145.4 51.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -1.107 . . . . 0.0 109.799 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -87.62 149.95 23.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.153 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.91 131.29 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -131.66 138.76 48.88 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.87 130.12 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 109.384 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.72 136.18 33.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 109.434 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.6 m -129.68 156.9 43.51 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.601 -0.687 . . . . 0.0 109.426 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 93.9 p -78.48 -2.41 38.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 482' ' ' LEU . 45.7 mmtm -76.26 144.96 40.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.308 -0.87 . . . . 0.0 109.956 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 71.0 m -64.03 71.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.673 -0.642 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 480' ' ' LYS . 2.3 pp -89.66 -1.88 58.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.233 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.27 -5.03 59.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 0.0 109.586 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -108.35 117.91 35.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.469 -0.769 . . . . 0.0 109.703 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.455 ' O ' ' N ' ' A' ' 487' ' ' HIS . 98.8 m-70 -58.38 -77.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 488' ' ' HIS . 73.2 m80 47.0 18.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 485' ' ' HIS . 69.4 t60 59.64 -70.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.439 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.555 ' N ' ' O ' ' A' ' 486' ' ' HIS . 75.0 m80 -70.62 136.44 49.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.981 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.447 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -90.14 162.11 15.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.599 0.714 . . . . 0.0 110.086 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.89 130.46 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.834 0.825 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.0 ttp -99.97 136.34 40.03 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.736 0.779 . . . . 0.0 110.043 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.79 164.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.26 138.58 54.45 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.07 0.938 . . . . 0.0 110.229 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.04 164.96 15.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.69 -13.55 40.36 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.487 2.125 . . . . 0.0 111.671 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.78 -5.52 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.376 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.35 8.13 83.88 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -84.69 159.45 20.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.624 -0.927 . . . . 0.0 110.566 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 428' ' ' ILE . 31.6 mm -105.43 128.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.739 0.78 . . . . 0.0 109.493 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -127.88 144.88 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.525 0.679 . . . . 0.0 109.636 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -124.71 136.0 53.51 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.694 . . . . 0.0 110.072 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 35.6 mt -127.47 147.81 63.89 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.88 158.27 58.55 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.429 2.086 . . . . 0.0 112.593 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.31 141.42 24.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.973 0.892 . . . . 0.0 110.661 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.4 84.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.28 150.78 46.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.686 -0.89 . . . . 0.0 110.278 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.1 p -127.24 173.5 9.69 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.929 0.871 . . . . 0.0 110.227 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.64 62.32 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . 0.417 ' CD1' ' CE1' ' A' ' 442' ' ' TYR . 0.2 OUTLIER -62.92 -45.88 90.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.589 -0.695 . . . . 0.0 109.363 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . 0.407 ' O ' ' OG ' ' A' ' 443' ' ' SER . 85.1 t80 -60.76 -44.35 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.765 -0.584 . . . . 0.0 109.8 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.43 90.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . 0.417 ' CE1' ' CD1' ' A' ' 438' ' ' LEU . 5.5 m-85 -68.37 -36.73 79.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' SER . . . . . 0.595 ' HG ' ' N ' ' A' ' 444' ' ' LEU . 70.3 p -60.27 -38.28 83.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.72 -0.612 . . . . 0.0 109.478 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.595 ' N ' ' HG ' ' A' ' 443' ' ' SER . 85.1 mt -71.88 -75.37 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.491 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -140.48 -179.38 5.98 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 13.0 m -102.42 -59.05 1.77 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.469 -0.77 . . . . 0.0 110.293 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 37.8 p-10 -63.21 -44.04 96.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.026 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.529 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -63.96 -45.12 90.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.511 -0.743 . . . . 0.0 109.065 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.33 92.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.08 -36.15 83.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.737 -0.86 . . . . 0.0 109.557 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.22 20.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.794 -0.566 . . . . 0.0 109.673 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 10.4 t -77.73 120.71 23.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.2 -4.94 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.46 178.3 48.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.49 148.19 39.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.977 . . . . 0.0 109.958 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -129.54 121.41 27.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.65 0.738 . . . . 0.0 109.694 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.13 132.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.776 0.798 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 54.84 43.9 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.599 0.714 . . . . 0.0 109.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.86 15.07 2.09 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -118.2 134.58 54.89 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.829 0.823 . . . . 0.0 109.815 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.27 134.37 50.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.673 0.749 . . . . 0.0 110.061 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.06 150.35 41.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.725 -0.609 . . . . 0.0 109.787 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.62 163.17 33.91 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.598 2.199 . . . . 0.0 112.826 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.73 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.149 0.5 . . . . 0.0 109.693 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 5.6 t -75.53 8.15 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.645 -0.659 . . . . 0.0 109.668 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -68.22 134.37 50.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 109.676 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.12 130.21 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.777 0.798 . . . . 0.0 109.922 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.9 mt -75.97 144.24 41.08 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.564 0.697 . . . . 0.0 110.243 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -115.24 145.55 42.32 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.892 0.853 . . . . 0.0 110.118 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.4 t -66.01 139.99 58.25 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.461 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.44 -32.78 5.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -74.73 145.32 43.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.895 . . . . 0.0 110.904 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -86.85 144.76 26.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.519 0.676 . . . . 0.0 109.268 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.69 132.53 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.937 0.875 . . . . 0.0 110.127 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -135.74 141.51 44.86 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.455 0.645 . . . . 0.0 109.305 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.93 131.73 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.859 0.838 . . . . 0.0 110.005 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.12 131.21 45.32 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.469 0.652 . . . . 0.0 109.668 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.9 t -133.45 131.82 40.36 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.628 0.728 . . . . 0.0 109.507 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 6.4 t -94.46 -0.32 54.82 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 481' ' ' SER . 68.6 mttm 56.19 44.55 24.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 480' ' ' LYS . 13.5 m -59.04 -151.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.693 0.759 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 8.1 mp 47.78 84.22 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.947 0.879 . . . . 0.0 109.366 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 483' ' ' GLU . 58.0 mp0 -82.12 137.48 34.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.772 0.796 . . . . 0.0 110.387 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 486' ' ' HIS . 1.7 p-80 -88.41 153.01 21.52 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.51 0.671 . . . . 0.0 110.341 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.488 ' O ' ' CG ' ' A' ' 486' ' ' HIS . 2.8 m170 69.38 -48.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' A' ' 485' ' ' HIS . 10.6 p80 40.2 40.33 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.707 0.765 . . . . 0.0 109.753 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 486' ' ' HIS . 78.0 m80 45.86 -176.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.496 0.665 . . . . 0.0 111.053 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.12 -40.09 86.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.535 -0.728 . . . . 0.0 109.276 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.392 179.619 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.49 163.76 26.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.739 . . . . 0.0 110.119 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.1 130.75 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' MET . . . . . 0.41 ' H ' ' HG ' ' A' ' 470' ' ' SER . 51.1 ttm -95.53 133.77 39.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.646 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.76 163.52 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.53 140.48 52.96 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.615 0.722 . . . . 0.0 109.613 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.1 175.82 2.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.4 -30.04 90.15 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.372 2.048 . . . . 0.0 111.561 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -81.22 -4.09 54.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 109.204 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.69 9.18 85.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.77 151.88 45.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -1.078 . . . . 0.0 110.414 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.77 122.67 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.462 -0.774 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -128.05 131.36 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -108.04 134.82 50.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.656 -0.653 . . . . 0.0 109.36 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.99 157.43 69.42 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.697 -0.627 . . . . 0.0 109.393 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.94 150.25 79.24 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.208 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -54.34 137.26 42.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -0.838 . . . . 0.0 110.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.09 13.3 74.73 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -65.45 159.35 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -1.08 . . . . 0.0 110.057 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.3 p -126.93 171.97 10.84 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.691 0.758 . . . . 0.0 110.014 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.6 62.88 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.664 -0.647 . . . . 0.0 109.953 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -46.59 87.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.091 -1.006 . . . . 0.0 109.383 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.47 -39.24 93.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.421 -0.799 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -60.83 -44.96 96.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.58 92.99 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -67.59 -36.35 80.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 11.7 t -59.82 -43.6 94.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.775 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.21 -74.91 0.09 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.758 ' HD1' ' H ' ' A' ' 446' ' ' SER . 1.2 t-80 -135.7 -179.73 5.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.467 -0.77 . . . . 0.0 109.673 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' SER . . . . . 0.758 ' H ' ' HD1' ' A' ' 445' ' ' HIS . 29.9 p -103.09 -56.11 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.694 -0.629 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 36.9 p-10 -66.85 -41.66 86.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -64.37 -44.54 91.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.329 -0.857 . . . . 0.0 109.025 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.32 93.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -70.9 -11.31 60.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -1.095 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -104.55 14.87 29.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 11.2 t -77.7 123.53 26.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 109.756 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 453' ' ' ILE . 37.8 pt -102.64 -4.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -174.42 176.46 46.75 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.537 -1.315 . . . . 0.0 109.898 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.16 147.05 45.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -1.056 . . . . 0.0 109.049 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -133.01 121.49 22.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.82 133.78 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.425 0.631 . . . . 0.0 109.543 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 57.28 44.1 22.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.495 0.664 . . . . 0.0 109.708 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 55.77 17.56 2.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.028 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -122.02 142.21 50.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.489 -0.757 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.51 132.81 45.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.69 -0.631 . . . . 0.0 109.896 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.43 150.22 50.55 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.079 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.63 162.05 40.96 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.567 2.178 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 466' ' ' TYR . 10.7 mp -63.35 -38.5 91.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.9 m -75.02 8.8 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.125 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 464' ' ' LEU . 93.0 t80 -67.58 134.21 50.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.01 132.04 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.852 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.88 148.09 40.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.634 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -123.8 145.09 49.3 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.545 0.688 . . . . 0.0 109.454 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' SER . . . . . 0.41 ' HG ' ' H ' ' A' ' 420' ' ' MET . 18.8 m -66.45 144.72 56.33 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.589 0.709 . . . . 0.0 111.224 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.12 -30.32 5.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -74.9 153.47 38.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -1.09 . . . . 0.0 110.783 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -98.17 128.97 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.34 131.34 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.97 144.39 45.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.2 m -109.88 132.18 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.556 0.693 . . . . 0.0 109.722 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.18 129.63 42.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.47 -0.769 . . . . 0.0 109.212 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.3 m -133.8 126.81 31.36 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.593 -0.692 . . . . 0.0 109.528 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 78.1 p -66.26 -34.23 77.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.697 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -72.15 133.72 45.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 18.7 m -159.24 -36.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.267 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.55 1.39 23.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 485' ' ' HIS . 79.7 mm-40 54.54 -120.91 1.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.647 -0.658 . . . . 0.0 110.326 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . 0.437 ' CG ' ' O ' ' A' ' 484' ' ' HIS . 37.0 t-80 48.45 12.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.367 -0.833 . . . . 0.0 109.37 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 483' ' ' GLU . 51.9 p-80 -67.93 -39.01 83.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.384 -0.823 . . . . 0.0 109.491 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . 0.402 ' N ' ' CG ' ' A' ' 485' ' ' HIS . 59.8 t-80 50.29 86.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . 0.63 ' CD2' ' H ' ' A' ' 489' ' ' HIS . 82.2 t60 -72.37 149.79 44.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.0 110.387 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.92 -41.78 96.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.416 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . 0.63 ' H ' ' CD2' ' A' ' 487' ' ' HIS . 80.8 t60 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.87 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.519 0.676 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.96 158.48 25.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 0.0 110.047 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.4 131.31 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.485 0.66 . . . . 0.0 109.449 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 12.3 ptm -97.3 147.51 24.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.646 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.51 161.78 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.03 120.59 42.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.55 0.69 . . . . 0.0 109.646 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.6 p -88.48 154.13 50.96 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.18 -13.13 14.89 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.279 1.986 . . . . 0.0 111.284 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -85.02 -3.68 58.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.28 3.67 88.59 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.88 159.49 19.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.959 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 428' ' ' ILE . 35.2 mm -113.1 129.6 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.478 -0.763 . . . . 0.0 109.542 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -121.87 137.57 54.73 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -105.01 131.19 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 109.91 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.95 147.43 46.29 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.06 154.44 74.06 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.86 137.96 37.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.581 0.705 . . . . 0.0 110.573 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.0 13.24 75.12 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.94 155.58 40.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -1.047 . . . . 0.0 110.207 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.4 p -127.09 175.33 8.2 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.664 0.745 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.2 -33.36 67.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.693 -0.629 . . . . 0.0 110.125 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.03 -41.97 99.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.117 -0.989 . . . . 0.0 109.794 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -60.44 -43.31 96.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.33 -0.856 . . . . 0.0 109.814 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . 0.415 ' O ' ' OG ' ' A' ' 443' ' ' SER . 70.3 t80 -61.52 -43.45 98.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.429 -0.795 . . . . 0.0 109.98 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.45 -44.6 80.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.89 -36.34 84.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 440' ' ' PHE . 50.7 p -58.98 -34.36 71.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.78 -76.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.686 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -143.49 -173.8 4.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.265 -0.897 . . . . 0.0 110.101 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 29.7 t -104.17 -55.22 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.412 0.625 . . . . 0.0 109.512 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.485 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 25.7 p-10 -63.01 -48.83 77.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.817 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.457 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -63.97 -43.15 96.63 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.471 -0.768 . . . . 0.0 109.198 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -64.35 -41.13 98.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 66.3 t0 -69.42 -27.41 65.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -1.066 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . 0.485 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 34.5 m80 -87.72 18.11 4.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.277 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 42.6 m -80.23 117.04 20.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -0.875 . . . . 0.0 109.663 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.94 -2.54 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.751 . . . . 0.0 109.377 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.16 178.03 43.78 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.402 -1.38 . . . . 0.0 110.288 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.89 150.5 29.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -1.024 . . . . 0.0 109.067 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -135.79 131.9 36.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.571 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.47 130.83 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.567 0.699 . . . . 0.0 109.538 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 55.84 43.35 27.76 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.45 0.643 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.481 ' O ' ' ND1' ' A' ' 459' ' ' HIS . 59.0 t-80 57.9 12.98 1.91 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 109.965 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -113.83 135.34 54.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 47.8 tp -66.68 135.08 53.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 110.109 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.04 151.2 37.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.099 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.17 161.89 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.483 2.122 . . . . 0.0 112.344 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 464' ' ' LEU . 10.6 mp -63.05 -38.31 90.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.646 -0.659 . . . . 0.0 109.504 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.5 p -75.07 9.43 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.977 . . . . 0.0 109.3 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.419 ' H ' ' C ' ' A' ' 464' ' ' LEU . 92.6 t80 -68.88 135.26 50.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.404 -0.81 . . . . 0.0 110.206 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.35 130.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.306 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.63 147.51 37.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 110.174 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -125.46 146.61 49.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.607 -0.683 . . . . 0.0 109.909 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 68.2 m -70.49 141.43 51.98 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.565 0.698 . . . . 0.0 110.865 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.48 -22.72 39.31 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.32 171.04 13.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.198 -1.178 . . . . 0.0 110.529 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.69 127.38 56.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.82 131.7 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.371 -0.831 . . . . 0.0 109.911 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.54 116.05 14.6 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 3.6 m -85.05 130.93 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.35 143.67 26.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.558 -0.714 . . . . 0.0 109.652 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 480' ' ' LYS . 70.2 m -123.64 154.96 38.6 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 85.3 p -70.55 37.84 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.474 -0.766 . . . . 0.0 109.87 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 478' ' ' SER . 44.4 mmtm -87.36 -7.86 57.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.461 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 482' ' ' LEU . 19.2 p -171.42 -131.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.956 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.551 ' N ' ' OG ' ' A' ' 481' ' ' SER . 32.8 mt 60.46 49.45 6.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -42.52 137.42 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -73.33 140.94 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.591 -0.693 . . . . 0.0 109.955 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 486' ' ' HIS . 59.1 t-80 -108.46 142.95 38.08 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 487' ' ' HIS . 34.2 p80 -65.51 141.48 58.46 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 486' ' ' HIS . 61.1 t-80 59.43 135.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.501 0.667 . . . . 0.0 110.21 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -103.33 129.75 50.44 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.688 0.756 . . . . 0.0 109.687 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.932 -179.83 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.2 mp0 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.65 131.26 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.711 0.767 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.6 ttm -94.89 131.7 40.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.232 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.03 164.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -123.78 144.47 49.68 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.412 0.625 . . . . 0.0 109.51 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.8 176.27 1.98 Allowed Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -34.53 84.54 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -81.35 -3.68 53.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.575 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.32 9.34 85.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -69.91 150.81 46.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.286 . . . . 0.0 110.299 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.3 mm -90.06 124.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -131.5 112.4 12.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -94.02 136.19 34.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.501 -0.75 . . . . 0.0 109.219 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.3 mt -122.31 148.18 51.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.493 2.129 . . . . 0.0 112.717 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -56.01 139.31 47.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.62 12.63 77.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.06 154.8 41.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.7 p -127.49 174.57 8.92 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.55 0.69 . . . . 0.0 109.984 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.62 71.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.507 -0.746 . . . . 0.0 109.444 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.76 -42.45 99.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -61.49 -43.02 99.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.79 . . . . 0.0 110.088 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 444' ' ' LEU . 57.1 t80 -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.54 80.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.178 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -64.96 -36.54 84.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.336 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.5 m -58.49 -41.56 85.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.459 HD11 ' CE2' ' A' ' 440' ' ' PHE . 78.0 mt -68.16 -73.77 0.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.32 -179.8 6.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.924 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 73.5 m -100.11 -59.57 1.69 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.568 -0.708 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.425 ' OD1' ' CD2' ' A' ' 451' ' ' HIS . 49.2 t0 -60.17 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.867 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.6 -43.41 97.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.227 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 449' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.49 -37.46 94.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.05 -16.41 63.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.054 -1.263 . . . . 0.0 109.381 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.425 ' CD2' ' OD1' ' A' ' 447' ' ' ASP . 45.3 m-70 -95.79 17.26 15.48 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 25.6 p -74.29 116.77 15.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.388 -0.82 . . . . 0.0 109.539 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.2 pt -99.44 -2.79 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -0.766 . . . . 0.0 109.247 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.26 -171.6 39.41 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.022 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -148.71 148.02 29.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -1.178 . . . . 0.0 109.126 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -135.63 120.86 18.99 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.01 133.14 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.557 0.694 . . . . 0.0 109.92 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.407 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 0.2 OUTLIER 56.51 43.27 26.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.681 -0.637 . . . . 0.0 109.671 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 55.33 10.38 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.625 -0.672 . . . . 0.0 109.957 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.24 145.25 42.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.564 -0.71 . . . . 0.0 109.652 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 461' ' ' LEU . 4.3 mm? -72.93 141.37 47.84 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.38 148.38 22.19 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.02 162.6 37.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.274 1.982 . . . . 0.0 112.68 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.71 -40.3 96.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.443 -0.785 . . . . 0.0 109.624 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 93.1 p -75.75 10.38 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.039 -1.038 . . . . 0.0 109.434 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -68.33 135.35 51.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 110.347 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.43 131.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.31 144.09 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.675 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -115.2 150.56 35.93 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.42 0.629 . . . . 0.0 109.421 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 15.6 p -70.78 155.34 40.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.0 -36.57 1.47 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.6 145.14 54.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.246 . . . . 0.0 111.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -86.29 140.23 30.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.763 . . . . 0.0 109.175 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.08 132.1 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.543 -0.723 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -136.82 116.02 12.55 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.35 138.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.92 130.89 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.275 -179.859 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.54 129.97 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.82 142.9 31.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.0 109.648 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.84 164.5 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.54 137.1 54.56 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.603 0.716 . . . . 0.0 109.479 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.05 165.55 14.7 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.85 -14.42 44.52 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.548 2.165 . . . . 0.0 111.232 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -85.22 -5.11 59.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.576 -0.702 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.34 9.3 82.1 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 4.5 mp0 -84.19 162.04 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.288 -1.125 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.92 129.22 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -127.99 132.04 49.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -109.6 139.39 44.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 109.527 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 97.4 mt -136.4 147.9 61.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.488 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.46 158.65 56.58 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.486 2.124 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -56.63 146.34 25.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.55 77.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.57 154.42 41.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.687 -0.89 . . . . 0.0 110.142 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 69.5 p -127.57 170.47 12.59 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.595 0.712 . . . . 0.0 109.693 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.73 74.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 109.321 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.68 -42.09 99.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.44 -43.68 98.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.507 ' CE2' HD21 ' A' ' 444' ' ' LEU . 85.2 t80 -61.29 -44.68 96.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 109.523 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.74 -36.51 83.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.191 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.4 t -61.57 -39.54 91.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.578 -0.701 . . . . 0.0 110.132 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.507 HD21 ' CE2' ' A' ' 440' ' ' PHE . 89.2 mt -48.44 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' A' ' 447' ' ' ASP . 99.3 m-70 -151.24 20.46 0.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 m 68.52 -37.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.624 . . . . 0.0 109.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 445' ' ' HIS . 99.7 m-20 -62.15 -44.23 97.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.5 mm? -63.72 -43.06 97.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.825 . . . . 0.0 108.983 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -71.25 -29.65 68.24 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -76.44 -9.77 58.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -1.072 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -138.83 28.47 2.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.19 109.23 13.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.5 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.4 pt -100.65 -2.52 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.511 -0.743 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.32 176.51 45.99 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.066 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.6 149.99 29.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -1.083 . . . . 0.0 109.106 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -135.56 124.59 24.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 0.0 108.89 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.0 t -122.16 133.02 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.565 -0.709 . . . . 0.0 109.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 3.3 t30 55.79 42.97 28.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.603 -0.686 . . . . 0.0 109.687 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m80 54.86 13.82 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.864 -0.523 . . . . 0.0 110.264 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -117.91 137.4 52.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 109.133 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.57 135.22 54.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.13 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.32 150.82 56.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.74 160.77 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.253 1.969 . . . . 0.0 112.547 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.2 mp -62.72 -40.33 96.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 465' ' ' SER . 3.4 t -77.7 15.06 0.89 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.507 -0.745 . . . . 0.0 109.167 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 464' ' ' LEU . 86.8 t80 -67.54 134.11 50.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.907 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.96 131.39 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.785 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.95 145.66 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.806 . . . . 0.0 110.243 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -119.58 146.18 45.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.537 0.684 . . . . 0.0 109.175 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.1 t -64.93 141.24 58.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 110.68 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.7 -32.83 4.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -72.73 147.04 46.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.251 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.34 144.16 28.22 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.81 132.95 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-O 121.668 0.747 . . . . 0.0 109.786 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -139.62 128.62 23.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.94 128.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.007 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.22 100.0 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.025 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 110.025 -179.744 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.3 mp0 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.05 131.07 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.684 0.754 . . . . 0.0 109.486 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.7 ttp -98.22 129.97 44.96 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.723 0.773 . . . . 0.0 110.458 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.33 164.47 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.33 137.35 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.856 0.836 . . . . 0.0 109.96 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.39 159.66 30.67 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.93 -16.22 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.251 1.967 . . . . 0.0 111.413 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -83.27 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.03 6.42 88.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 429' ' ' LYS . 82.7 tt0 -86.6 152.48 22.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.943 . . . . 0.0 110.705 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.9 mm -84.18 129.2 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.492 0.663 . . . . 0.0 109.804 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 427' ' ' GLU . 34.9 mmtm -132.76 109.4 9.64 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.597 0.713 . . . . 0.0 110.13 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -102.37 128.67 48.86 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.6 mt -122.47 152.69 61.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.14 145.94 24.51 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.459 2.106 . . . . 0.0 112.745 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -58.39 137.01 57.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.847 0.832 . . . . 0.0 110.634 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.23 13.93 72.84 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -72.61 166.54 22.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.913 . . . . 0.0 110.209 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 p -127.13 172.34 10.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.992 0.901 . . . . 0.0 110.581 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.61 -26.6 61.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.09 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.72 -45.4 92.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.418 -0.801 . . . . 0.0 109.719 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -64.82 -38.39 90.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.691 -0.631 . . . . 0.0 109.421 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 444' ' ' LEU . 84.5 t80 -61.23 -45.34 94.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.786 -0.571 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.51 91.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.646 -0.659 . . . . 0.0 109.515 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 438' ' ' LEU . 8.7 m-85 -68.64 -34.09 75.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.494 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 30.8 m -58.08 -42.07 84.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.81 -0.556 . . . . 0.0 109.706 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.8 mt -64.08 -70.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.714 -0.616 . . . . 0.0 109.603 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -149.2 -176.17 5.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.559 -0.713 . . . . 0.0 109.904 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 37.6 t -92.45 -71.01 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.498 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 27.2 t70 -55.78 -48.63 75.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.793 -0.567 . . . . 0.0 110.231 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.523 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.9 -44.5 95.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.531 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.07 -38.73 92.66 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.75 -10.7 59.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.874 . . . . 0.0 109.501 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 16.0 m80 -99.66 20.8 13.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.97 117.9 22.55 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.585 0.707 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.6 pt -101.16 -3.46 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.49 176.94 46.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.71 146.34 37.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.797 -0.825 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -134.75 122.27 21.9 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.394 0.616 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -122.44 132.76 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.702 0.763 . . . . 0.0 109.8 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 458' ' ' ASN . 2.9 t30 54.42 45.69 26.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.653 0.739 . . . . 0.0 109.796 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 58.1 t-80 56.41 14.04 1.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.055 0.455 . . . . 0.0 109.969 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.44 141.15 47.44 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.725 0.774 . . . . 0.0 110.159 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -79.58 112.31 16.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.544 0.688 . . . . 0.0 109.522 -179.281 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.527 ' N ' HD13 ' A' ' 461' ' ' LEU . 3.6 m -120.95 151.02 54.35 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.85 163.3 36.01 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.604 2.202 . . . . 0.0 112.648 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.62 -39.93 95.36 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.6 m -75.45 8.35 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.773 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 91.1 t80 -67.54 135.01 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.698 0.761 . . . . 0.0 110.406 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.426 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 79.8 t -78.53 131.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.828 0.823 . . . . 0.0 109.757 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.4 mt -74.41 143.39 44.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.654 0.74 . . . . 0.0 110.407 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -116.26 144.6 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.767 0.794 . . . . 0.0 109.801 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.5 t -66.76 139.81 57.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.756 0.789 . . . . 0.0 110.564 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.28 -34.99 4.18 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.05 144.21 48.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.732 -0.864 . . . . 0.0 110.872 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -87.44 144.22 26.85 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.499 0.666 . . . . 0.0 109.562 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.42 131.31 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.575 0.703 . . . . 0.0 109.969 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -133.07 137.98 46.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.03 130.94 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.64 0.734 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.01 131.74 42.09 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.536 0.684 . . . . 0.0 109.676 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.694 0.759 . . . . 0.0 109.721 -179.8 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.1 mp0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.387 0.613 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.45 131.03 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.55 0.69 . . . . 0.0 109.301 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' MET . . . . . 0.517 ' SD ' HG23 ' A' ' 428' ' ' ILE . 50.8 ttp -97.88 136.54 38.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.523 -0.735 . . . . 0.0 109.768 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.11 161.55 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -115.33 134.59 54.97 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.659 0.742 . . . . 0.0 109.787 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 166.27 13.63 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.71 -15.05 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.531 2.154 . . . . 0.0 111.471 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -85.91 -6.2 59.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.196 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.72 11.9 78.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.449 ' C ' HD12 ' A' ' 428' ' ' ILE . 79.8 mm-40 -85.84 161.77 18.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.143 . . . . 0.0 110.206 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.517 HG23 ' SD ' ' A' ' 420' ' ' MET . 1.3 mp -107.78 129.03 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.92 123.35 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -102.08 127.87 48.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 14.1 mt -118.49 158.21 47.56 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.53 149.17 83.7 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.33 2.02 . . . . 0.0 112.873 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -57.48 134.21 55.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.458 -0.777 . . . . 0.0 110.418 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.73 76.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -63.54 167.87 5.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -1.148 . . . . 0.0 110.246 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 70.0 p -127.52 172.33 10.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.666 0.746 . . . . 0.0 110.002 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -30.07 68.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.477 -0.764 . . . . 0.0 109.219 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 464' ' ' LEU . 89.6 mt -63.05 -43.12 99.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 0.0 109.309 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.68 -41.35 99.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 444' ' ' LEU . 54.7 t80 -61.43 -43.65 98.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.96 -44.8 87.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -65.49 -35.73 81.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.404 -0.81 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 26.2 m -58.64 -41.47 86.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.753 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.456 HD11 ' CE2' ' A' ' 440' ' ' PHE . 76.5 mt -68.96 -77.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.651 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 445' ' ' HIS . 6.1 m80 -124.29 -151.18 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.604 -0.685 . . . . 0.0 109.2 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 26.5 m -128.54 -70.49 0.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.59 -0.694 . . . . 0.0 109.251 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.446 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.6 m-20 -64.19 -39.5 94.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.512 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.08 -44.95 95.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.059 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.14 93.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 452' ' ' CYS . 35.4 t70 -64.43 -38.36 90.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -1.09 . . . . 0.0 109.605 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.446 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 60.9 m80 -78.6 28.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 8.8 t -79.21 123.97 27.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.0 pt -97.6 -5.01 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.214 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . 175.88 179.74 46.55 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.75 149.54 43.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.995 . . . . 0.0 109.122 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -132.41 122.6 25.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.33 132.88 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.692 -0.63 . . . . 0.0 109.643 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.422 ' HA ' HD21 ' A' ' 458' ' ' ASN . 8.4 m120 55.9 42.37 28.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.721 -0.612 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.8 m80 57.15 12.03 1.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.739 -0.6 . . . . 0.0 109.879 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.96 136.25 53.21 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.632 0.73 . . . . 0.0 109.653 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.92 134.63 52.4 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.577 -0.702 . . . . 0.0 109.863 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.09 150.9 57.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.795 . . . . 0.0 109.294 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.5 161.6 42.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.558 2.172 . . . . 0.0 113.01 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -63.27 -40.16 96.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.699 -0.626 . . . . 0.0 109.451 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 8.4 t -76.43 8.19 3.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.207 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 90.1 t80 -61.26 134.91 57.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.512 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.411 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 76.1 t -76.9 130.09 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.478 -0.764 . . . . 0.0 109.98 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.8 147.71 33.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 110.409 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -125.7 145.19 50.29 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.621 0.724 . . . . 0.0 109.518 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 97.6 p -65.4 145.17 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.658 0.742 . . . . 0.0 110.846 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.43 -32.53 4.69 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -72.73 145.77 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 110.821 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.88 139.67 30.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.17 131.93 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.569 0.7 . . . . 0.0 109.992 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.91 114.01 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.61 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.88 114.24 26.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 109.594 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.535 -0.728 . . . . 0.0 110.224 -179.561 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.9 mp0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.317 0.58 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.0 131.73 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.737 0.78 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.6 ttm -90.33 132.9 35.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.758 0.79 . . . . 0.0 110.084 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 429' ' ' LYS . 18.4 m -131.63 163.46 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.404 0.621 . . . . 0.0 109.425 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 428' ' ' ILE . 85.9 m-85 -123.57 138.68 54.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.013 0.911 . . . . 0.0 109.929 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 159.39 29.87 Favored Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.41 -34.81 33.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.331 2.021 . . . . 0.0 112.221 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.81 -4.13 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.818 -0.551 . . . . 0.0 109.696 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.36 7.45 82.62 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -74.09 153.21 39.71 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.676 0.75 . . . . 0.0 110.682 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.435 HD12 ' CE2' ' A' ' 422' ' ' PHE . 20.4 mm -104.97 122.5 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.406 0.622 . . . . 0.0 109.629 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.401 ' O ' HG22 ' A' ' 421' ' ' VAL . 72.0 mmtt -127.31 135.91 51.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.846 0.831 . . . . 0.0 110.235 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -108.11 132.86 53.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 31.5 mt -122.14 152.45 60.25 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 147.84 28.91 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.262 1.975 . . . . 0.0 112.86 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.21 129.32 41.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.646 0.736 . . . . 0.0 110.58 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 13.95 76.19 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.36 173.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.671 0.748 . . . . 0.0 110.604 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 33.0 p -127.97 172.01 11.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.874 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.71 65.8 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.09 -42.47 99.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.97 -42.05 98.7 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 444' ' ' LEU . 56.2 t80 -62.1 -42.87 99.66 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.98 92.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.0 -36.6 83.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.3 m -58.95 -42.87 90.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.565 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 77.6 mt -66.61 -59.93 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.734 -0.604 . . . . 0.0 109.789 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.4 m-70 -158.85 -176.06 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.441 0.638 . . . . 0.0 109.858 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 39.9 t -101.58 -61.72 1.34 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.09 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.51 -44.96 95.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.742 -0.599 . . . . 0.0 109.935 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.12 -45.11 93.53 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.15 89.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.98 -34.35 78.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.885 -0.773 . . . . 0.0 109.406 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -85.12 16.5 3.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 49.7 t -72.79 116.67 13.56 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.597 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.2 pt -102.53 -0.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLY . . . . . 0.449 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -173.03 170.86 44.01 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.745 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.12 149.51 31.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.069 -0.665 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -138.82 130.59 27.7 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 64.7 t -119.97 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.663 0.744 . . . . 0.0 109.677 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 58.49 41.64 22.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 56.94 12.99 1.33 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -113.05 115.36 28.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.896 0.855 . . . . 0.0 109.792 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.1 tp -51.32 133.92 28.5 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.556 0.694 . . . . 0.0 110.229 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.1 152.34 39.6 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.13 161.57 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.595 2.196 . . . . 0.0 112.651 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.79 -38.2 89.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.1 m -75.05 7.45 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.847 -0.533 . . . . 0.0 109.663 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -69.58 134.08 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.564 0.697 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 82.8 t -78.61 131.04 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.596 0.713 . . . . 0.0 109.865 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.71 146.24 42.43 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.629 0.728 . . . . 0.0 110.631 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -121.11 144.54 48.51 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.866 0.841 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 140.75 58.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.659 0.743 . . . . 0.0 111.121 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.57 -25.89 18.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.32 163.29 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.666 -0.903 . . . . 0.0 110.946 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -109.31 120.72 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 20.9 t -93.09 132.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.841 0.829 . . . . 0.0 110.622 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.5 0.667 . . . . 0.0 109.316 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.23 130.82 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.805 0.812 . . . . 0.0 110.455 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.65 106.35 18.61 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.588 0.709 . . . . 0.0 109.213 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.588 0.708 . . . . 0.0 110.171 179.845 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.3 mp0 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 18.2 m -119.32 130.94 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.592 -0.692 . . . . 0.0 109.215 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 49.5 ttp -96.66 137.94 34.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.74 165.18 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -113.32 138.51 49.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.515 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.6 162.49 21.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 108.784 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.27 -32.29 40.52 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.191 1.928 . . . . 0.0 111.998 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.53 -1.64 34.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.05 -1.031 . . . . 0.0 109.323 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.22 12.09 81.29 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.24 158.83 32.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -1.163 . . . . 0.0 110.55 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.6 mm -106.24 124.41 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.463 -0.773 . . . . 0.0 109.077 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -128.67 132.94 48.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -0.758 . . . . 0.0 109.016 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -106.74 138.41 42.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.1 mt -131.64 147.6 66.69 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.92 157.31 62.36 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.375 2.05 . . . . 0.0 112.705 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.41 143.01 25.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.64 12.62 74.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.06 42.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 110.364 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.2 p -127.45 172.03 11.04 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.588 0.709 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.28 69.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.49 -0.756 . . . . 0.0 109.593 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.58 -42.26 99.45 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 109.197 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.59 -44.71 93.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 444' ' ' LEU . 65.0 t80 -61.5 -43.65 98.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.11 85.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.152 -0.968 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -64.31 -36.87 85.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.0 m -59.01 -42.29 89.75 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.96 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.5 mt -66.71 -57.36 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.991 -1.068 . . . . 0.0 109.658 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.612 ' CG ' ' H ' ' A' ' 446' ' ' SER . 30.2 t-80 -161.48 -173.48 3.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.144 -0.972 . . . . 0.0 109.333 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' SER . . . . . 0.612 ' H ' ' CG ' ' A' ' 445' ' ' HIS . 8.7 m -103.41 -60.53 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.74 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 451' ' ' HIS . 43.5 t0 -62.16 -45.7 92.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.501 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.07 -43.89 97.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 108.816 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 449' ' ' GLY . . . . . 0.447 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.67 -35.51 92.02 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -73.41 -10.77 60.08 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.28 -1.13 . . . . 0.0 109.36 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 59.5 m-70 -97.36 7.85 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 108.841 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 29.9 p -73.55 116.44 14.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.392 -0.818 . . . . 0.0 109.822 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.08 -2.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.05 177.54 43.95 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.55 142.79 41.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -1.074 . . . . 0.0 108.958 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.74 121.9 21.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.5 133.85 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 3.5 t30 57.38 43.95 22.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.764 0.792 . . . . 0.0 109.356 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 54.17 13.27 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.747 . . . . 0.0 110.224 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -114.71 136.65 52.83 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.54 -0.725 . . . . 0.0 109.418 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.1 tp -67.83 134.46 50.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.89 151.2 48.65 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 108.861 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.55 162.08 38.47 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.598 2.199 . . . . 0.0 112.746 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -62.92 -39.34 94.25 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.717 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.3 m -75.19 7.85 3.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.115 -0.991 . . . . 0.0 109.181 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -66.21 134.95 53.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.242 -0.911 . . . . 0.0 110.255 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.71 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.43 144.63 44.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.234 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 100.0 m-20 -117.18 151.68 36.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.686 -0.634 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.3 p -68.92 154.12 42.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.522 -0.736 . . . . 0.0 110.848 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.45 -37.2 1.59 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.94 145.4 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.398 . . . . 0.0 110.964 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -87.43 149.79 24.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.51 -0.743 . . . . 0.0 109.508 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 440' ' ' PHE . 61.9 t -118.62 132.8 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.521 -0.737 . . . . 0.0 109.749 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -138.08 113.78 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.0 139.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 110.011 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.4 111.7 23.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.418 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.2 mp0 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.03 130.86 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.692 0.758 . . . . 0.0 109.071 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.2 ttp -100.2 140.62 34.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.856 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 166.3 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.82 138.74 50.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.804 0.811 . . . . 0.0 109.837 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.52 165.79 14.08 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.96 -16.01 53.31 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.569 2.179 . . . . 0.0 111.446 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.27 -3.68 59.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 108.914 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.42 84.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.94 167.36 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 110.419 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.0 mm -108.09 128.71 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.592 -0.692 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.01 131.47 53.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.525 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -107.82 132.67 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.9 mt -126.57 147.87 62.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.673 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.54 158.14 56.82 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -56.42 139.58 48.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.32 76.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.67 154.89 41.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -1.086 . . . . 0.0 110.104 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.5 p -127.05 172.72 10.26 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.829 0.823 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -30.6 66.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.707 -0.621 . . . . 0.0 110.053 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 464' ' ' LEU . 83.6 mt -63.33 -43.01 98.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.56 -40.72 97.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 109.725 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 444' ' ' LEU . 77.8 t80 -61.08 -42.88 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.451 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.16 93.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.809 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.43 -37.37 80.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 91.1 p -61.56 -35.96 79.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.49 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.574 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 92.4 mt -63.95 -43.58 95.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.174 -0.954 . . . . 0.0 109.63 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.2 m-70 -162.12 -120.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.739 . . . . 0.0 109.384 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 5.7 p -158.83 -68.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.17 -39.04 92.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.87 -43.26 99.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.238 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.2 89.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.6 -34.27 77.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -82.41 21.34 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 42.1 t -76.67 122.92 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -0.843 . . . . 0.0 109.664 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -105.48 -4.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.85 -177.32 46.54 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.32 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.19 148.94 30.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -1.144 . . . . 0.0 109.209 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -132.01 126.54 34.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.76 130.56 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.645 0.736 . . . . 0.0 109.72 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.488 HD21 ' CB ' ' A' ' 472' ' ' ASP . 11.2 m120 55.55 41.79 30.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 109.81 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 57.55 16.27 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -118.51 138.76 52.29 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.703 0.763 . . . . 0.0 109.86 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.87 139.04 53.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.2 m -151.06 149.8 25.86 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.43 162.08 42.2 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.339 2.026 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.2 mp -63.11 -39.31 94.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.469 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.0 m -75.3 8.14 2.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.274 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.3 t80 -65.64 135.4 54.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.42 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 77.5 t -77.09 130.72 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.673 0.749 . . . . 0.0 110.019 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.74 145.23 38.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.0 110.175 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -118.5 147.64 43.44 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.677 0.751 . . . . 0.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 94.1 p -65.24 151.43 46.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 80.2 -38.35 2.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' ASP . . . . . 0.488 ' CB ' HD21 ' A' ' 458' ' ' ASN . 99.4 m-20 -68.42 144.27 54.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -1.037 . . . . 0.0 110.796 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -89.23 145.47 25.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.486 -0.759 . . . . 0.0 109.172 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.98 133.24 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.551 -0.718 . . . . 0.0 109.75 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -132.73 142.22 48.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.75 131.2 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.6 0.714 . . . . 0.0 109.74 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.0 mt -92.67 137.38 32.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.773 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 109.528 -179.777 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.146 0.498 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.45 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' MET . . . . . 0.401 ' SD ' HG23 ' A' ' 428' ' ' ILE . 31.5 ttm -99.96 144.48 28.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.721 -0.612 . . . . 0.0 109.703 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.51 163.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.24 137.63 53.53 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.676 0.75 . . . . 0.0 109.734 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.67 177.67 1.57 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -29.99 85.65 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.453 2.102 . . . . 0.0 111.595 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.9 -4.52 59.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.16 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.04 13.99 80.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.41 147.17 46.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 428' ' ' ILE . 1.4 mp -90.92 127.58 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -131.23 110.07 10.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -90.24 137.41 32.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.759 -0.588 . . . . 0.0 109.718 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.77 148.45 69.98 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.52 155.01 72.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.466 2.11 . . . . 0.0 112.464 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.23 145.84 10.14 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.668 0.746 . . . . 0.0 110.434 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.63 13.02 79.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.0 150.93 47.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.976 . . . . 0.0 110.267 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.5 p -127.46 172.72 10.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.645 0.736 . . . . 0.0 109.799 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.24 -30.47 66.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.673 -0.642 . . . . 0.0 109.643 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.62 -43.23 97.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.57 -42.05 99.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 444' ' ' LEU . 78.4 t80 -61.37 -43.68 98.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.558 -0.714 . . . . 0.0 109.841 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.42 83.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 0.0 109.804 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.87 -36.16 83.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.8 m -59.66 -39.31 83.99 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.603 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 93.3 mt -63.1 -44.31 96.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.762 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.5 m-70 -161.97 -120.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.644 . . . . 0.0 109.521 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 6.0 p -152.93 -76.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.562 -0.712 . . . . 0.0 109.079 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.67 -42.34 98.07 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.441 0.638 . . . . 0.0 109.574 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.11 -44.6 95.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.331 -0.856 . . . . 0.0 108.924 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 449' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -65.87 -43.83 93.09 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.83 -29.28 67.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.993 . . . . 0.0 109.607 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -80.62 18.49 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.376 -0.828 . . . . 0.0 108.825 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 63.8 m -79.79 133.04 36.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.588 -0.695 . . . . 0.0 109.951 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.21 -4.24 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.614 -0.678 . . . . 0.0 109.476 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.89 47.4 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.18 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.05 151.99 48.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.509 -0.995 . . . . 0.0 109.703 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' LYS . . . . . 0.525 ' HZ3' ' HA ' ' A' ' 459' ' ' HIS . 39.9 tttm -133.23 119.98 20.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.652 -0.655 . . . . 0.0 109.308 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.89 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.714 HD22 ' CG ' ' A' ' 472' ' ' ASP . 93.0 m-20 57.45 37.8 27.96 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.525 ' HA ' ' HZ3' ' A' ' 456' ' ' LYS . 29.1 m170 58.83 13.64 2.84 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.78 156.42 26.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.548 0.69 . . . . 0.0 109.816 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -87.02 113.43 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.482 -0.762 . . . . 0.0 109.703 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.512 ' N ' HD13 ' A' ' 461' ' ' LEU . 5.3 m -116.99 150.69 46.38 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.74 162.28 38.07 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.636 2.224 . . . . 0.0 112.697 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.86 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.653 -0.655 . . . . 0.0 109.517 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.9 m -75.33 4.35 7.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.326 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -62.72 135.68 57.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.799 . . . . 0.0 110.44 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.22 132.3 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.576 0.703 . . . . 0.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.79 148.07 46.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.631 -0.668 . . . . 0.0 110.509 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -124.23 142.21 51.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.646 0.736 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.8 t -66.84 141.09 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.619 0.724 . . . . 0.0 110.801 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 91.02 -36.44 3.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' ASP . . . . . 0.714 ' CG ' HD22 ' A' ' 458' ' ' ASN . 91.8 m-20 -70.27 144.01 51.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.438 -1.037 . . . . 0.0 110.454 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.2 143.01 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.556 -0.715 . . . . 0.0 109.391 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.08 132.35 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.42 0.629 . . . . 0.0 109.803 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -140.5 126.1 19.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 34.9 m -94.4 132.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.499 -0.75 . . . . 0.0 109.843 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.87 111.9 23.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.639 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.586 0.708 . . . . 0.0 110.016 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 9.7 m -109.92 130.5 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' MET . . . . . 0.412 ' CE ' ' NH2' ' A' ' 430' ' ' ARG . 39.0 ttm -91.03 134.21 34.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.807 . . . . 0.0 109.308 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.23 162.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.14 138.77 52.69 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.488 0.661 . . . . 0.0 109.596 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 165.62 14.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.09 -14.74 45.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.179 1.919 . . . . 0.0 111.129 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.98 -4.27 59.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.467 -0.77 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.65 85.36 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.08 165.9 18.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 110.069 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.3 mm -110.91 128.4 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.52 -0.737 . . . . 0.0 109.022 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -126.85 140.22 52.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.412 ' NH2' ' CE ' ' A' ' 420' ' ' MET . 95.9 mtt-85 -113.35 136.79 52.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.632 -0.668 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.25 147.33 63.27 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.15 159.78 51.1 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.257 1.972 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -57.05 148.89 20.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.468 -0.77 . . . . 0.0 110.302 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 10.46 81.64 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.03 44.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -1.046 . . . . 0.0 109.759 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.1 p -127.57 173.58 9.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.631 -0.668 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.98 -34.36 69.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.93 -43.03 99.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 109.638 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.87 -41.8 98.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.409 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 79.7 t80 -60.78 -44.58 96.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.055 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.75 86.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.04 -1.038 . . . . 0.0 109.939 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -64.04 -37.89 89.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.08 . . . . 0.0 109.673 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 60.6 p -59.77 -37.12 78.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 89.2 mt -63.46 -54.19 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.987 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 99.6 m-70 -161.93 -126.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 19.4 m -146.63 -64.7 0.29 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.011 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.93 -45.36 92.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.0 109.98 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.92 -44.83 95.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.9 90.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.09 -18.47 63.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -1.196 . . . . 0.0 110.011 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -103.29 42.35 1.17 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.392 -0.818 . . . . 0.0 109.321 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.32 127.43 44.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.446 -0.784 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.1 pt -101.57 -5.2 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.12 178.55 48.22 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.56 149.31 48.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.645 -0.915 . . . . 0.0 108.704 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' LYS . . . . . 0.465 ' NZ ' ' C ' ' A' ' 459' ' ' HIS . 44.8 tttm -132.88 120.83 22.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 94.1 t -123.57 133.83 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.542 -0.724 . . . . 0.0 109.705 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.33 43.59 19.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.465 ' C ' ' NZ ' ' A' ' 456' ' ' LYS . 79.5 m80 53.13 13.16 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 110.653 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -118.09 137.04 53.2 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.378 -0.826 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.3 134.83 54.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.628 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.29 150.93 53.64 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.34 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.636 2.224 . . . . 0.0 112.716 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.45 -39.09 92.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.216 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -74.64 7.74 2.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.338 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -65.45 133.78 52.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.949 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 78.2 t -79.56 132.18 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.49 149.23 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.378 -0.826 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -124.1 145.37 49.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.616 -0.677 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.7 t -65.69 142.44 58.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -0.799 . . . . 0.0 110.495 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.89 -32.46 5.1 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -73.08 149.37 43.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.349 -1.089 . . . . 0.0 109.716 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -95.53 130.14 42.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 22.1 t -103.55 131.66 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.455 -0.778 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -134.51 143.14 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.46 132.46 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.479 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.81 128.65 46.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.327 -0.858 . . . . 0.0 109.248 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.498 1.937 0 O-C-N 121.547 -0.721 . . . . 0.0 109.567 -179.832 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.365 0.602 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.1 131.58 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.631 0.729 . . . . 0.0 109.519 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 54.6 ttm -96.99 133.69 41.33 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.687 0.756 . . . . 0.0 110.405 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.08 163.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -115.69 142.35 46.86 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.902 0.858 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.71 176.71 1.78 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.33 -29.92 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.071 1.847 . . . . 0.0 111.429 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.11 -4.91 59.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.173 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.5 79.95 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.59 157.55 37.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.52 -0.988 . . . . 0.0 110.485 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.3 mm -99.68 123.98 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.646 -0.659 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -127.43 126.33 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -106.62 133.86 50.65 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.26 0.552 . . . . 0.0 109.646 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.76 152.96 77.82 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.54 147.82 22.11 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.36 2.04 . . . . 0.0 112.492 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.14 132.37 52.74 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.914 0.864 . . . . 0.0 110.632 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.6 13.59 75.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.3 170.9 0.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.986 . . . . 0.0 110.677 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.9 p -127.54 171.08 11.93 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.143 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.77 67.96 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.327 0.584 . . . . 0.0 109.968 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.39 -42.56 98.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.69 -39.85 95.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.712 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.535 ' CE2' HD11 ' A' ' 444' ' ' LEU . 84.7 t80 -61.27 -43.68 98.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.792 . . . . 0.0 109.156 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.3 95.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.627 -0.671 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -65.03 -36.68 85.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 38.9 m -58.81 -41.57 87.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.535 HD11 ' CE2' ' A' ' 440' ' ' PHE . 88.0 mt -72.04 -76.71 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -138.42 179.05 6.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.419 -0.801 . . . . 0.0 109.897 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 33.6 t -103.95 -55.06 2.44 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.378 0.609 . . . . 0.0 109.612 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.58 -49.68 74.31 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.512 0.673 . . . . 0.0 109.659 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.516 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -64.95 -44.71 88.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.739 0.78 . . . . 0.0 109.611 -179.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 449' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.73 -42.19 93.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.8 t0 -66.63 -35.46 80.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.942 . . . . 0.0 109.864 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 451' ' ' HIS . 11.1 t-160 -81.74 20.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.197 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 28.7 p -74.53 129.98 38.75 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.498 0.666 . . . . 0.0 109.947 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.43 -4.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.37 48.48 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 147.04 40.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.58 -0.953 . . . . 0.0 109.709 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -131.66 124.04 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.08 131.84 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.614 0.721 . . . . 0.0 109.998 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.436 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 0.2 OUTLIER 54.7 44.06 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 109.937 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.436 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 54.0 t-80 58.49 13.39 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.281 0.562 . . . . 0.0 109.68 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.02 144.53 43.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.751 . . . . 0.0 109.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -82.13 113.53 20.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.423 0.63 . . . . 0.0 109.589 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 461' ' ' LEU . 6.4 m -120.75 151.69 54.85 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.07 162.78 36.68 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.497 2.131 . . . . 0.0 112.375 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -63.32 -39.42 94.52 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.402 0.62 . . . . 0.0 109.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.6 t -75.56 10.52 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.286 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' TYR . . . . . 0.433 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.0 t80 -69.1 135.48 50.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.788 0.804 . . . . 0.0 110.518 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.433 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 81.7 t -81.2 131.48 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 121.721 0.772 . . . . 0.0 109.778 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.61 145.08 45.67 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.617 0.722 . . . . 0.0 110.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -117.02 144.18 44.9 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.67 0.747 . . . . 0.0 109.877 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 42.6 t -68.62 140.18 55.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.947 0.879 . . . . 0.0 111.143 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.11 -26.19 16.28 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.95 163.31 25.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.986 . . . . 0.0 111.359 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -103.43 134.51 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 51.3 t -114.48 132.2 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.699 0.761 . . . . 0.0 110.301 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.79 146.23 39.2 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.29 131.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.727 0.775 . . . . 0.0 110.188 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.5 131.91 34.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.573 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 121.68 0.752 . . . . 0.0 110.235 -179.447 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.8 130.88 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.429 -0.794 . . . . 0.0 108.964 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.6 ttm -92.5 138.43 31.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.786 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.48 164.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.03 137.39 53.57 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 171.51 5.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.94 -29.5 82.49 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.939 1.759 . . . . 0.0 111.113 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -81.24 -4.35 55.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.626 . . . . 0.0 109.623 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.0 83.46 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -73.87 156.65 37.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -1.171 . . . . 0.0 110.198 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.7 mm -103.12 125.14 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.08 132.9 47.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.565 -0.709 . . . . 0.0 109.262 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -107.25 134.99 49.52 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 49.2 mt -131.0 153.07 81.68 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.6 147.17 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.985 1.79 . . . . 0.0 112.707 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -54.87 130.34 40.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.673 -0.642 . . . . 0.0 110.092 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.03 76.36 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -52.09 172.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 109.864 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.7 p -128.22 171.42 11.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.551 -0.718 . . . . 0.0 109.958 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.73 71.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.06 -43.55 98.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.432 -0.793 . . . . 0.0 109.532 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.427 ' CE2' HD11 ' A' ' 444' ' ' LEU . 63.4 t80 -61.12 -43.85 98.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.01 -45.53 79.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.439 -0.788 . . . . 0.0 109.842 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -62.16 -37.95 87.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.832 . . . . 0.0 109.744 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.2 m -58.87 -41.55 87.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.81 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 440' ' ' PHE . 86.6 mt -62.97 -43.93 97.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.308 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 446' ' ' SER . 28.2 t-80 -173.68 -130.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.421 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' SER . . . . . 0.626 ' H ' ' CG ' ' A' ' 445' ' ' HIS . 8.1 t -145.42 -64.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.65 -44.95 94.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.449 -0.782 . . . . 0.0 109.731 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.99 -46.0 89.76 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 449' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -68.74 -39.11 86.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -37.88 89.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.511 -0.993 . . . . 0.0 109.839 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -83.17 20.06 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 109.498 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 27.7 p -71.09 122.47 20.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.675 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.9 pt -99.64 -2.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.793 . . . . 0.0 109.777 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.54 179.66 45.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.24 146.29 36.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 109.053 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -134.01 122.06 22.48 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.263 -0.898 . . . . 0.0 108.951 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.06 134.46 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.678 -0.639 . . . . 0.0 109.607 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 58.09 41.94 23.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 55.2 18.45 2.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.627 . . . . 0.0 110.141 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -122.75 144.09 49.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.628 -0.67 . . . . 0.0 109.213 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 41.9 tp -70.17 134.28 47.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.33 149.87 53.01 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.05 162.18 41.1 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.486 2.124 . . . . 0.0 112.617 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.71 -0.619 . . . . 0.0 109.65 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 96.6 p -75.96 10.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.749 . . . . 0.0 109.627 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.5 t80 -65.09 135.94 56.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 110.226 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.434 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 22.3 t -79.29 131.26 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.89 149.32 39.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.395 -0.816 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -124.14 141.97 51.61 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.537 0.684 . . . . 0.0 109.396 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.9 t -66.19 142.45 57.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.69 . . . . 0.0 110.781 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.33 10.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -78.87 161.14 26.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -1.043 . . . . 0.0 109.998 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -105.56 122.82 46.81 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.5 t -97.4 132.24 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.458 -0.776 . . . . 0.0 110.244 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.0 141.72 47.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.16 130.8 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.447 -0.783 . . . . 0.0 109.64 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.17 137.92 31.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 97.4 p . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.446 -0.784 . . . . 0.0 109.676 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 121.378 0.608 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.1 m -114.31 131.25 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.651 0.739 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -95.02 135.4 36.61 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.525 0.679 . . . . 0.0 110.003 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.18 164.68 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.09 141.24 48.69 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.678 0.751 . . . . 0.0 109.73 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.52 176.25 2.04 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.28 -33.48 85.07 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.896 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.94 -4.21 54.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 80.91 10.68 84.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.85 155.73 40.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.636 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.22 124.33 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -127.19 131.88 50.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -105.71 135.52 46.98 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.451 0.643 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 23.1 mt -138.69 150.77 66.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.69 156.13 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.429 2.086 . . . . 0.0 112.719 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.16 154.49 7.78 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.291 1.043 . . . . 0.0 111.101 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 78.71 7.03 88.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.58 153.35 43.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.356 -1.085 . . . . 0.0 110.443 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 47.8 p -127.04 171.21 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.772 0.796 . . . . 0.0 110.159 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.3 -28.52 63.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.564 0.697 . . . . 0.0 109.829 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.81 -46.67 86.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 109.578 -179.098 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.68 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 444' ' ' LEU . 67.5 t80 -61.13 -44.33 97.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.677 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.1 -47.37 83.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.0 -34.73 78.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.539 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 34.4 m -59.23 -41.2 88.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.579 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 440' ' ' PHE . 88.2 mt -69.38 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.95 -151.19 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.373 -0.83 . . . . 0.0 109.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 82.1 p -127.32 -73.99 0.6 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.583 0.706 . . . . 0.0 110.034 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.525 ' N ' ' OG ' ' A' ' 446' ' ' SER . 99.6 m-20 -64.13 -43.28 95.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.41 -46.58 87.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.007 0.908 . . . . 0.0 109.295 -179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 449' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.25 -40.21 94.68 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 452' ' ' CYS . 65.3 t0 -65.62 -37.92 87.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -1.066 . . . . 0.0 109.946 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -76.77 26.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.196 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 21.6 p -79.7 121.11 24.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.65 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 38.6 pt -101.38 -3.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.48 179.51 47.47 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.244 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.05 152.8 32.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -1.072 . . . . 0.0 109.364 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -131.01 131.31 44.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.742 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.15 132.56 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.44 0.638 . . . . 0.0 109.511 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 56.43 39.38 30.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.518 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 78.1 m80 58.94 13.13 2.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.453 0.644 . . . . 0.0 109.69 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.77 136.83 49.25 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.778 0.799 . . . . 0.0 109.62 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.0 tp -66.44 131.74 46.73 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.707 0.765 . . . . 0.0 110.473 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 7.0 m -146.87 149.93 37.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.8 158.6 55.47 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.423 2.082 . . . . 0.0 112.421 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.52 -38.45 90.0 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.668 0.747 . . . . 0.0 109.761 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.8 m -75.27 8.34 2.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 109.41 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' TYR . . . . . 0.471 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 94.3 t80 -66.21 137.36 56.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.899 . . . . 0.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.471 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 82.1 t -75.88 130.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.067 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.8 mt -78.77 142.99 36.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.547 0.689 . . . . 0.0 110.624 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 99.7 m-20 -116.16 148.03 40.78 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.57 0.7 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 16.5 m -74.26 140.66 45.13 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.793 0.806 . . . . 0.0 110.947 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.16 -23.13 37.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 42.3 p-10 -84.48 171.8 12.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.291 -1.123 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -110.94 129.03 56.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.1 131.61 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.584 -0.697 . . . . 0.0 109.747 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -130.44 138.22 50.2 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.33 130.54 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.727 0.775 . . . . 0.0 110.221 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.74 141.4 30.02 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.468 0.652 . . . . 0.0 109.409 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.604 0.716 . . . . 0.0 109.694 -179.759 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 419' ' ' VAL . 35.2 m -119.17 130.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' MET . . . . . 0.492 ' SD ' ' CG2' ' A' ' 428' ' ' ILE . 49.2 ttp -100.31 143.87 29.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.631 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.27 161.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.73 125.86 54.78 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.547 0.689 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 423' ' ' THR . 0.2 OUTLIER -89.19 156.23 48.89 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.97 -15.96 42.26 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.148 1.899 . . . . 0.0 111.238 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.9 -3.18 53.59 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.449 -0.782 . . . . 0.0 109.178 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.07 161.22 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -1.133 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.492 ' CG2' ' SD ' ' A' ' 420' ' ' MET . 35.0 mm -110.14 129.2 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.511 -0.743 . . . . 0.0 109.068 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -125.91 134.54 51.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -106.3 133.27 51.26 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.639 -0.663 . . . . 0.0 109.513 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.72 147.18 52.63 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.05 158.19 55.84 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.318 2.012 . . . . 0.0 111.97 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -56.09 143.05 34.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.281 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 11.54 81.12 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.61 152.46 44.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.569 -0.959 . . . . 0.0 109.791 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.7 p -127.57 172.9 10.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.6 -0.687 . . . . 0.0 109.686 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.65 65.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.461 -0.774 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.82 -42.44 99.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.319 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -61.15 -43.6 98.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 109.956 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 444' ' ' LEU . 66.3 t80 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.11 -42.63 81.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.619 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -67.36 -38.02 84.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.148 -0.97 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 91.1 p -59.8 -37.02 77.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 109.664 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.461 HD11 ' CE2' ' A' ' 440' ' ' PHE . 91.3 mt -63.32 -42.8 99.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 109.231 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' A' ' 446' ' ' SER . 38.7 t-80 -173.49 -119.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' SER . . . . . 0.594 ' H ' ' CG ' ' A' ' 445' ' ' HIS . 37.3 p -155.62 -64.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 451' ' ' HIS . 64.0 t0 -61.82 -48.78 79.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.492 -0.755 . . . . 0.0 109.803 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.487 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.99 -45.45 92.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.275 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 449' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -67.18 -40.8 92.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 450' ' ' ASP . 64.6 t0 -63.72 -37.26 86.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.099 . . . . 0.0 109.522 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' A' ' 447' ' ' ASP . 51.5 m80 -81.15 27.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 109.2 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 13.2 p -77.35 129.78 36.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 24.6 pt -102.92 -5.26 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 0.0 109.313 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 175.68 -175.12 47.23 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.15 150.57 42.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 108.836 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -132.82 121.6 23.2 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.3 t -122.73 134.34 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.692 . . . . 0.0 109.289 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 55.59 39.52 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.526 0.679 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 57.1 t-80 57.86 8.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 110.232 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -111.47 146.68 36.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.452 -0.78 . . . . 0.0 109.285 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 461' ' ' LEU . 4.3 mm? -72.43 142.06 48.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.5 -0.75 . . . . 0.0 109.704 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.84 148.87 34.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.19 159.94 49.8 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.06 1.84 . . . . 0.0 112.368 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -62.35 -40.16 95.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.578 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -75.85 7.44 3.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.21 136.6 58.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.86 130.17 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 109.641 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.55 146.55 36.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.468 -0.77 . . . . 0.0 109.79 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 94.6 m-20 -123.98 151.7 43.36 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.547 -0.721 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 11.6 p -75.24 145.39 41.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.822 . . . . 0.0 110.458 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.81 -21.45 41.44 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 49.4 p-10 -84.18 172.05 12.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -1.145 . . . . 0.0 109.893 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -115.1 131.93 56.77 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.424 HG11 ' CD2' ' A' ' 440' ' ' PHE . 64.0 t -109.92 131.64 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.815 . . . . 0.0 110.014 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -135.72 113.3 10.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.53 137.34 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.807 . . . . 0.0 110.27 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.5 mt -96.6 135.0 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 109.255 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.53 -0.732 . . . . 0.0 109.77 -179.672 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.16 129.63 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.419 0.628 . . . . 0.0 109.61 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.3 ttm -102.91 132.87 48.83 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.49 163.54 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -117.66 144.09 45.55 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.905 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.27 174.3 3.17 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.49 -31.85 87.44 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.226 1.95 . . . . 0.0 111.289 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.99 -3.99 55.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.51 -0.744 . . . . 0.0 109.215 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.11 11.68 83.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.79 154.96 41.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -1.199 . . . . 0.0 110.517 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 36.3 mm -94.3 124.25 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -129.95 106.99 9.03 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -97.45 127.86 43.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.464 -0.773 . . . . 0.0 109.415 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 40.0 mt -120.09 148.88 47.96 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 154.29 74.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.15 1.9 . . . . 0.0 112.193 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -52.62 146.59 9.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.875 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.13 7.38 80.37 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.0 151.47 47.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.747 -0.855 . . . . 0.0 110.159 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -127.38 171.55 11.43 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.494 0.664 . . . . 0.0 109.544 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.36 65.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 464' ' ' LEU . 88.4 mt -63.19 -46.06 88.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.84 -42.99 99.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 444' ' ' LEU . 89.0 t80 -61.8 -44.94 95.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.77 . . . . 0.0 109.613 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.89 84.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 0.0 109.611 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.84 -34.03 77.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.1 m -58.63 -43.02 89.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 62.4 mt -63.3 -47.97 80.03 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 109.759 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 37.0 m80 -166.01 -166.1 0.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 71.7 p -109.45 -37.24 5.78 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.42 -48.31 73.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 109.64 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.8 mm? -63.76 -41.07 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.579 -0.701 . . . . 0.0 109.295 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.09 -33.06 86.22 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -87.49 -24.2 24.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.393 -1.063 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -100.01 14.53 30.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 109.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 7.9 t -80.35 110.41 15.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.179 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.78 0.73 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.651 -0.656 . . . . 0.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -172.96 173.17 45.52 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.194 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.92 29.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -1.052 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -133.15 122.44 24.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.23 131.56 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.569 0.699 . . . . 0.0 109.943 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 56.18 45.05 24.03 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.308 0.575 . . . . 0.0 109.861 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.7 12.24 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.666 -0.646 . . . . 0.0 109.814 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.21 132.54 56.58 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.547 0.689 . . . . 0.0 109.384 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.03 135.1 51.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.24 151.57 44.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.0 109.45 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.49 161.63 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.442 2.095 . . . . 0.0 112.336 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.8 -38.63 91.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.591 -0.693 . . . . 0.0 109.605 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.9 m -74.85 7.92 2.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.2 -0.938 . . . . 0.0 109.335 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.2 t80 -69.47 134.63 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.421 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 25.3 t -77.21 131.26 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.843 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 71.8 mt -75.15 144.74 42.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.293 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -115.96 147.92 40.64 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.422 0.63 . . . . 0.0 109.367 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.1 p -65.52 153.14 42.3 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.658 0.742 . . . . 0.0 111.214 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 81.36 -40.07 2.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.0 144.24 54.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.12 . . . . 0.0 111.016 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 474' ' ' VAL . 21.5 tm0? -85.81 143.35 28.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.518 ' O ' ' NE2' ' A' ' 473' ' ' GLN . 66.7 t -116.42 132.14 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.571 -0.705 . . . . 0.0 109.935 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 12.4 m -109.85 133.83 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.64 -0.662 . . . . 0.0 110.046 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -89.84 108.33 19.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.726 . . . . 0.0 109.267 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.792 -179.777 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.507 0.67 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.0 130.84 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.695 0.759 . . . . 0.0 109.051 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.2 ttp -99.36 139.59 34.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.616 0.722 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.79 165.08 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.58 139.4 53.57 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.779 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 165.71 14.71 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.85 -9.74 26.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.707 2.271 . . . . 0.0 111.632 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -90.9 -5.32 55.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.115 -0.991 . . . . 0.0 109.492 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.47 6.23 77.81 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -83.44 160.75 21.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -1.221 . . . . 0.0 110.318 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 32.0 mm -105.83 128.01 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -127.07 134.41 50.28 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -110.42 136.28 49.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.72 -0.613 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 85.1 mt -135.83 147.97 63.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.91 154.2 71.32 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.284 1.989 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.504 ' CD ' ' N ' ' A' ' 433' ' ' GLN . 2.4 pm0 -55.1 147.42 16.09 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.723 0.773 . . . . 0.0 110.991 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.2 81.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.33 157.45 35.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.522 -0.987 . . . . 0.0 110.17 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 58.1 p -126.54 167.63 15.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.859 0.838 . . . . 0.0 109.928 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.35 68.28 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.522 0.677 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.01 -43.59 98.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.587 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.45 -42.87 99.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.669 0.747 . . . . 0.0 109.656 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 474' ' ' VAL . 83.2 t80 -61.77 -44.79 96.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.502 -0.749 . . . . 0.0 110.157 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.15 84.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.75 -36.28 83.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.76 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 444' ' ' LEU . 39.1 t -63.49 -36.6 84.31 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 443' ' ' SER . 96.3 mt -52.59 -105.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.23 -2.24 37.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 t 70.81 -55.8 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.597 0.713 . . . . 0.0 109.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.1 t0 -65.46 -38.79 90.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 448' ' ' LEU . 7.3 tt -62.8 -41.6 99.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.692 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -49.19 -9.4 0.12 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 451' ' ' HIS . 8.2 p-10 -91.28 -22.68 20.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.046 -1.267 . . . . 0.0 109.434 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.578 ' N ' ' OD1' ' A' ' 450' ' ' ASP . 40.2 m80 -100.91 -1.18 35.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.361 -0.837 . . . . 0.0 109.053 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 452' ' ' CYS . 26.1 p -61.98 118.1 6.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 41.1 pt -105.84 -5.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.806 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.33 176.44 46.01 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.11 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.0 151.96 38.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -1.162 . . . . 0.0 109.515 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -132.5 123.8 27.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.551 -0.718 . . . . 0.0 109.194 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -123.1 133.25 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.724 0.773 . . . . 0.0 109.812 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.711 HD22 ' CG ' ' A' ' 472' ' ' ASP . 61.4 m-20 55.69 40.89 30.9 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.516 0.675 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m80 56.21 13.01 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.426 0.631 . . . . 0.0 109.364 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.13 135.35 54.01 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.743 0.783 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.9 tp -66.74 134.98 53.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 0.0 109.813 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.32 150.68 49.07 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.357 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.37 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.505 2.136 . . . . 0.0 112.444 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -63.55 -37.09 86.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.7 m -75.02 3.92 7.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 109.33 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -62.87 135.46 57.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.368 -0.832 . . . . 0.0 110.426 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.31 130.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.625 0.726 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.89 147.52 38.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.61 -0.681 . . . . 0.0 110.494 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -124.26 148.06 47.65 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.815 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 41.6 t -64.19 140.01 58.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.913 0.863 . . . . 0.0 111.123 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.15 -31.16 6.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' ASP . . . . . 0.711 ' CG ' HD22 ' A' ' 458' ' ' ASN . 98.8 m-20 -73.2 147.7 44.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -1.101 . . . . 0.0 111.026 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -95.53 141.93 28.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.72 . . . . 0.0 109.786 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.437 HG11 ' CD2' ' A' ' 440' ' ' PHE . 64.5 t -116.2 132.22 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.647 0.737 . . . . 0.0 109.787 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -138.12 113.58 9.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 109.046 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.0 134.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.77 96.19 8.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.452 -0.78 . . . . 0.0 109.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.739 0.781 . . . . 0.0 110.381 -179.511 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.6 mp0 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.2 m -112.52 131.4 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.3 ttm -98.36 136.09 39.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' VAL . . . . . 0.437 HG12 ' OD1' ' A' ' 472' ' ' ASP . 33.2 m -131.19 164.61 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.92 140.74 49.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.103 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 176.66 1.89 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.09 -34.22 97.29 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 111.912 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -81.43 -3.87 54.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 109.143 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.57 82.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -71.82 153.11 42.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.317 . . . . 0.0 110.371 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.25 127.17 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -129.15 113.71 15.42 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.69 127.62 45.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.9 mt -131.83 156.12 80.52 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.07 144.79 56.27 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.904 1.736 . . . . 0.0 112.677 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -62.4 141.08 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.545 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.48 84.41 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -66.05 179.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -1.071 . . . . 0.0 110.136 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.0 p -127.67 169.5 13.72 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.96 -26.33 64.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.03 -43.01 99.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.353 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.73 -40.16 96.34 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.845 . . . . 0.0 109.116 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 83.1 t80 -61.46 -43.93 97.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.603 -0.686 . . . . 0.0 109.365 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.51 87.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.81 -33.85 76.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.355 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 7.1 t -59.92 -44.2 94.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.798 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.564 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 70.1 mt -65.16 -55.87 16.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.179 -0.95 . . . . 0.0 109.847 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.8 m-70 -160.02 -167.34 1.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.546 -0.721 . . . . 0.0 109.776 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 69.6 m -110.37 -62.42 1.52 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.613 -0.68 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.46 -48.44 79.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.506 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -64.11 -43.66 94.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.486 -0.759 . . . . 0.0 109.032 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.37 -43.19 95.43 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 59.9 t0 -73.64 -10.34 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -100.94 22.75 11.67 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 84.4 m -81.95 130.74 35.16 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.47 -4.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.9 45.59 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -150.38 152.17 33.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -1.176 . . . . 0.0 109.123 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -133.15 127.11 33.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 109.191 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.89 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 90.0 m-20 53.0 57.56 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.787 -0.571 . . . . 0.0 110.342 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 458' ' ' ASN . 35.1 p80 41.67 30.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.233 0.54 . . . . 0.0 110.182 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.75 135.48 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.89 134.46 52.1 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.522 -0.736 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.76 150.57 63.36 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.67 160.43 49.49 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.393 2.062 . . . . 0.0 112.256 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.4 mp -63.07 -39.0 93.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.484 -0.76 . . . . 0.0 109.229 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 94.8 p -74.98 10.3 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.244 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -67.02 133.34 49.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.101 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.96 131.02 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.86 145.75 42.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 110.129 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -121.83 134.63 54.89 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.533 0.682 . . . . 0.0 109.427 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -55.68 135.9 51.04 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 96.31 -12.53 66.55 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' ASP . . . . . 0.437 ' OD1' HG12 ' A' ' 421' ' ' VAL . 36.4 p-10 -83.69 171.35 13.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -1.163 . . . . 0.0 110.47 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -122.19 114.26 20.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 18.9 t -93.16 131.79 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -133.0 113.84 13.28 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.9 m -83.73 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.3 mt -99.97 131.95 45.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.514 -0.741 . . . . 0.0 109.038 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.698 . . . . 0.0 109.752 -179.297 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.6 m -112.29 130.53 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.4 ttm -97.11 135.98 38.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 109.765 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.53 165.24 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.564 -0.71 . . . . 0.0 109.238 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' A' ' 428' ' ' ILE . 78.8 m-85 -111.07 141.44 44.56 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.995 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' THR . . . . . 0.459 ' OG1' ' N ' ' A' ' 427' ' ' GLU . 82.1 p -96.39 151.44 38.07 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.7 -17.68 51.05 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.563 1.509 . . . . 0.0 110.685 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.431 -0.793 . . . . 0.0 109.176 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.77 1.17 65.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 23.2 mp0 -88.19 155.81 19.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.034 -1.274 . . . . 0.0 109.177 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' A' ' 422' ' ' PHE . 2.7 tp -106.91 140.26 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.46 132.77 53.49 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -103.81 133.45 48.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.275 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.8 mt -132.83 148.05 67.93 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.49 157.8 59.6 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.214 1.943 . . . . 0.0 112.157 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.81 148.66 12.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.391 -0.818 . . . . 0.0 110.085 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.9 81.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.84 41.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -127.21 174.44 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.509 -0.744 . . . . 0.0 109.663 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.77 71.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.951 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.97 -42.18 98.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.029 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.96 -43.27 95.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.925 . . . . 0.0 109.703 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 444' ' ' LEU . 85.0 t80 -60.44 -45.06 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.06 85.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.983 . . . . 0.0 109.801 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -63.93 -36.94 85.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.02 . . . . 0.0 109.643 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.6 m -58.02 -41.84 83.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.887 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.459 HD11 ' CE2' ' A' ' 440' ' ' PHE . 70.2 mt -65.92 -75.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -141.89 -178.46 5.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 109.589 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 78.2 p -101.29 -54.01 2.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.407 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.1 m-20 -62.33 -45.95 90.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.55 -43.49 96.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.003 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 449' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.44 -38.81 93.83 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.91 -11.8 61.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 109.202 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -105.01 13.43 30.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 30.3 p -74.75 120.8 20.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.935 . . . . 0.0 109.816 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.9 pt -101.81 -3.1 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 109.439 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.54 45.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -153.05 150.3 29.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.265 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -135.5 133.03 38.06 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.419 -0.801 . . . . 0.0 109.391 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.33 131.24 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.404 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 3.3 t30 56.47 44.55 24.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.317 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 54.21 15.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.75 . . . . 0.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -113.85 137.1 52.12 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.471 -0.768 . . . . 0.0 109.241 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.25 135.25 53.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.859 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.13 151.28 33.92 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.918 . . . . 0.0 108.984 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.31 162.08 42.0 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.473 2.115 . . . . 0.0 112.615 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -61.88 -40.35 95.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.739 . . . . 0.0 109.546 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 92.7 p -75.29 10.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -67.23 135.66 53.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.684 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 72.7 t -78.46 132.58 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -0.872 . . . . 0.0 109.681 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -74.97 148.97 39.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 109.77 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -123.19 145.59 48.5 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 36.9 t -65.37 144.22 57.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.55 -40.67 3.03 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.37 145.4 51.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -1.107 . . . . 0.0 109.799 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -87.62 149.95 23.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.153 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.91 131.29 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -131.66 138.76 48.88 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.87 130.12 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 109.384 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.72 136.18 33.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 109.434 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.601 -0.687 . . . . 0.0 109.426 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.599 0.714 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.89 130.46 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.834 0.825 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.0 ttp -99.97 136.34 40.03 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.736 0.779 . . . . 0.0 110.043 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.79 164.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.26 138.58 54.45 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.07 0.938 . . . . 0.0 110.229 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.04 164.96 15.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.69 -13.55 40.36 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.487 2.125 . . . . 0.0 111.671 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.78 -5.52 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.376 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.35 8.13 83.88 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -84.69 159.45 20.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.624 -0.927 . . . . 0.0 110.566 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -105.43 128.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.739 0.78 . . . . 0.0 109.493 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -127.88 144.88 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.525 0.679 . . . . 0.0 109.636 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -124.71 136.0 53.51 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.694 . . . . 0.0 110.072 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 35.6 mt -127.47 147.81 63.89 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.88 158.27 58.55 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.429 2.086 . . . . 0.0 112.593 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.31 141.42 24.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.973 0.892 . . . . 0.0 110.661 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.4 84.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.28 150.78 46.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.686 -0.89 . . . . 0.0 110.278 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.1 p -127.24 173.5 9.69 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.929 0.871 . . . . 0.0 110.227 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.64 62.32 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.519 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.92 -45.88 90.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.589 -0.695 . . . . 0.0 109.363 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.499 ' CE2' HD11 ' A' ' 444' ' ' LEU . 85.1 t80 -60.76 -44.35 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.765 -0.584 . . . . 0.0 109.8 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.43 90.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' TYR . . . . . 0.417 ' CE1' ' CD1' ' A' ' 438' ' ' LEU . 5.5 m-85 -68.37 -36.73 79.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 70.3 p -60.27 -38.28 83.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.72 -0.612 . . . . 0.0 109.478 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.499 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.1 mt -71.88 -75.37 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.491 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -140.48 -179.38 5.98 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 13.0 m -102.42 -59.05 1.77 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.469 -0.77 . . . . 0.0 110.293 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 37.8 p-10 -63.21 -44.04 96.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.026 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.53 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.96 -45.12 90.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.511 -0.743 . . . . 0.0 109.065 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.33 92.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.08 -36.15 83.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.737 -0.86 . . . . 0.0 109.557 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.22 20.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.794 -0.566 . . . . 0.0 109.673 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 10.4 t -77.73 120.71 23.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.2 -4.94 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.46 178.3 48.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.49 148.19 39.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.977 . . . . 0.0 109.958 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -129.54 121.41 27.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.65 0.738 . . . . 0.0 109.694 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.13 132.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.776 0.798 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.473 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 0.2 OUTLIER 54.84 43.9 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.599 0.714 . . . . 0.0 109.734 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.86 15.07 2.09 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -118.2 134.58 54.89 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.829 0.823 . . . . 0.0 109.815 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.27 134.37 50.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.673 0.749 . . . . 0.0 110.061 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.06 150.35 41.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.725 -0.609 . . . . 0.0 109.787 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.62 163.17 33.91 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.598 2.199 . . . . 0.0 112.826 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -62.73 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.149 0.5 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 5.6 t -75.53 8.15 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.645 -0.659 . . . . 0.0 109.668 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -68.22 134.37 50.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 109.676 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.12 130.21 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.777 0.798 . . . . 0.0 109.922 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.9 mt -75.97 144.24 41.08 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.564 0.697 . . . . 0.0 110.243 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -115.24 145.55 42.32 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.892 0.853 . . . . 0.0 110.118 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.4 t -66.01 139.99 58.25 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.461 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.44 -32.78 5.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -74.73 145.32 43.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.895 . . . . 0.0 110.904 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -86.85 144.76 26.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.519 0.676 . . . . 0.0 109.268 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.69 132.53 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.937 0.875 . . . . 0.0 110.127 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -135.74 141.51 44.86 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.455 0.645 . . . . 0.0 109.305 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.93 131.73 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.859 0.838 . . . . 0.0 110.005 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.12 131.21 45.32 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.469 0.652 . . . . 0.0 109.668 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.628 0.728 . . . . 0.0 109.507 179.627 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.295 0.569 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.1 130.75 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 51.1 ttm -95.53 133.77 39.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.646 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.76 163.52 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.53 140.48 52.96 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.615 0.722 . . . . 0.0 109.613 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.1 175.82 2.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.4 -30.04 90.15 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.372 2.048 . . . . 0.0 111.561 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -81.22 -4.09 54.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 109.204 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.69 9.18 85.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.77 151.88 45.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -1.078 . . . . 0.0 110.414 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.77 122.67 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.462 -0.774 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -128.05 131.36 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -108.04 134.82 50.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.656 -0.653 . . . . 0.0 109.36 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.99 157.43 69.42 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.697 -0.627 . . . . 0.0 109.393 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.94 150.25 79.24 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.208 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -54.34 137.26 42.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -0.838 . . . . 0.0 110.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.09 13.3 74.73 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -65.45 159.35 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -1.08 . . . . 0.0 110.057 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.3 p -126.93 171.97 10.84 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.691 0.758 . . . . 0.0 110.014 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.6 62.88 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.664 -0.647 . . . . 0.0 109.953 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.57 -46.59 87.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.091 -1.006 . . . . 0.0 109.383 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.47 -39.24 93.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.421 -0.799 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.419 ' CE2' HD11 ' A' ' 444' ' ' LEU . 88.0 t80 -60.83 -44.96 96.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.58 92.99 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' TYR . . . . . 0.431 ' CE1' HD11 ' A' ' 438' ' ' LEU . 4.8 m-85 -67.59 -36.35 80.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 11.7 t -59.82 -43.6 94.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.775 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 440' ' ' PHE . 79.5 mt -64.21 -74.91 0.09 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -135.7 -179.73 5.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.467 -0.77 . . . . 0.0 109.673 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 29.9 p -103.09 -56.11 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.694 -0.629 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 36.9 p-10 -66.85 -41.66 86.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -64.37 -44.54 91.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.329 -0.857 . . . . 0.0 109.025 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.32 93.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -70.9 -11.31 60.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -1.095 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -104.55 14.87 29.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 11.2 t -77.7 123.53 26.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 109.756 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.64 -4.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -174.42 176.46 46.75 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.537 -1.315 . . . . 0.0 109.898 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.16 147.05 45.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -1.056 . . . . 0.0 109.049 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -133.01 121.49 22.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.82 133.78 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.425 0.631 . . . . 0.0 109.543 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 458' ' ' ASN . 3.3 t30 57.28 44.1 22.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.495 0.664 . . . . 0.0 109.708 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 55.77 17.56 2.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.028 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -122.02 142.21 50.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.489 -0.757 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.51 132.81 45.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.69 -0.631 . . . . 0.0 109.896 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.43 150.22 50.55 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.079 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.63 162.05 40.96 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.567 2.178 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -63.35 -38.5 91.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.9 m -75.02 8.8 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.125 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -67.58 134.21 50.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.01 132.04 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.852 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.88 148.09 40.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.634 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -123.8 145.09 49.3 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.545 0.688 . . . . 0.0 109.454 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.8 m -66.45 144.72 56.33 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.589 0.709 . . . . 0.0 111.224 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.12 -30.32 5.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -74.9 153.47 38.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -1.09 . . . . 0.0 110.783 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -98.17 128.97 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.34 131.34 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.97 144.39 45.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.2 m -109.88 132.18 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.556 0.693 . . . . 0.0 109.722 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.18 129.63 42.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.47 -0.769 . . . . 0.0 109.212 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.593 -0.692 . . . . 0.0 109.528 -179.779 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.016 0.436 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.4 131.31 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.485 0.66 . . . . 0.0 109.449 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 12.3 ptm -97.3 147.51 24.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.646 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.51 161.78 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.03 120.59 42.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.55 0.69 . . . . 0.0 109.646 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.6 p -88.48 154.13 50.96 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.18 -13.13 14.89 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.279 1.986 . . . . 0.0 111.284 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -85.02 -3.68 58.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.28 3.67 88.59 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.88 159.49 19.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.959 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.2 mm -113.1 129.6 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.478 -0.763 . . . . 0.0 109.542 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -121.87 137.57 54.73 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -105.01 131.19 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 109.91 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.95 147.43 46.29 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.06 154.44 74.06 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.86 137.96 37.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.581 0.705 . . . . 0.0 110.573 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.0 13.24 75.12 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.94 155.58 40.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -1.047 . . . . 0.0 110.207 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.4 p -127.09 175.33 8.2 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.664 0.745 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.2 -33.36 67.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.693 -0.629 . . . . 0.0 110.125 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.03 -41.97 99.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.117 -0.989 . . . . 0.0 109.794 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -60.44 -43.31 96.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.33 -0.856 . . . . 0.0 109.814 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.449 ' CE2' HD11 ' A' ' 444' ' ' LEU . 70.3 t80 -61.52 -43.45 98.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.429 -0.795 . . . . 0.0 109.98 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.45 -44.6 80.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.89 -36.34 84.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.7 p -58.98 -34.36 71.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.449 HD11 ' CE2' ' A' ' 440' ' ' PHE . 86.8 mt -73.78 -76.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.686 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -143.49 -173.8 4.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.265 -0.897 . . . . 0.0 110.101 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 29.7 t -104.17 -55.22 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.412 0.625 . . . . 0.0 109.512 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.485 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 25.7 p-10 -63.01 -48.83 77.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.817 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.97 -43.15 96.63 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.471 -0.768 . . . . 0.0 109.198 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -64.35 -41.13 98.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 66.3 t0 -69.42 -27.41 65.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -1.066 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.485 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 34.5 m80 -87.72 18.11 4.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.277 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 42.6 m -80.23 117.04 20.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -0.875 . . . . 0.0 109.663 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.94 -2.54 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.751 . . . . 0.0 109.377 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.16 178.03 43.78 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.402 -1.38 . . . . 0.0 110.288 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.89 150.5 29.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -1.024 . . . . 0.0 109.067 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' LYS . . . . . 0.525 ' HZ2' ' HB2' ' A' ' 456' ' ' LYS . 3.2 ttmp? -135.79 131.9 36.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.571 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.47 130.83 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.567 0.699 . . . . 0.0 109.538 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 55.84 43.35 27.76 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.45 0.643 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 459' ' ' HIS . 59.0 t-80 57.9 12.98 1.91 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 109.965 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -113.83 135.34 54.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 47.8 tp -66.68 135.08 53.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 110.109 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.04 151.2 37.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.099 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.17 161.89 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.483 2.122 . . . . 0.0 112.344 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -63.05 -38.31 90.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.646 -0.659 . . . . 0.0 109.504 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.5 p -75.07 9.43 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.977 . . . . 0.0 109.3 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -68.88 135.26 50.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.404 -0.81 . . . . 0.0 110.206 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.35 130.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.306 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.63 147.51 37.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 110.174 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -125.46 146.61 49.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.607 -0.683 . . . . 0.0 109.909 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 68.2 m -70.49 141.43 51.98 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.565 0.698 . . . . 0.0 110.865 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.48 -22.72 39.31 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.32 171.04 13.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.198 -1.178 . . . . 0.0 110.529 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.69 127.38 56.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 440' ' ' PHE . 60.2 t -102.82 131.7 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.371 -0.831 . . . . 0.0 109.911 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.54 116.05 14.6 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 476' ' ' VAL . 3.6 m -85.05 130.93 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.35 143.67 26.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.558 -0.714 . . . . 0.0 109.652 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.422 ' OG ' HD11 ' A' ' 448' ' ' LEU . 70.2 m . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.1 ptm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.452 0.644 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.2 mp0 -83.35 165.54 19.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.406 -0.809 . . . . 0.0 109.518 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.65 131.26 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.711 0.767 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.6 ttm -94.89 131.7 40.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.232 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.03 164.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -123.78 144.47 49.68 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.412 0.625 . . . . 0.0 109.51 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.8 176.27 1.98 Allowed Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -34.53 84.54 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -81.35 -3.68 53.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.575 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.32 9.34 85.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -69.91 150.81 46.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.286 . . . . 0.0 110.299 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.3 mm -90.06 124.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -131.5 112.4 12.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -94.02 136.19 34.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.501 -0.75 . . . . 0.0 109.219 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.3 mt -122.31 148.18 51.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.493 2.129 . . . . 0.0 112.717 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -56.01 139.31 47.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.62 12.63 77.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.06 154.8 41.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.7 p -127.49 174.57 8.92 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.55 0.69 . . . . 0.0 109.984 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.62 71.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.507 -0.746 . . . . 0.0 109.444 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.76 -42.45 99.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -61.49 -43.02 99.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.79 . . . . 0.0 110.088 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 444' ' ' LEU . 57.1 t80 -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.54 80.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.178 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -64.96 -36.54 84.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.336 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.5 m -58.49 -41.56 85.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.459 HD11 ' CE2' ' A' ' 440' ' ' PHE . 78.0 mt -68.16 -73.77 0.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.32 -179.8 6.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.924 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 73.5 m -100.11 -59.57 1.69 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.568 -0.708 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.425 ' OD1' ' CD2' ' A' ' 451' ' ' HIS . 49.2 t0 -60.17 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.867 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.6 -43.41 97.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.227 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.49 -37.46 94.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.05 -16.41 63.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.054 -1.263 . . . . 0.0 109.381 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.425 ' CD2' ' OD1' ' A' ' 447' ' ' ASP . 45.3 m-70 -95.79 17.26 15.48 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 25.6 p -74.29 116.77 15.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.388 -0.82 . . . . 0.0 109.539 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.2 pt -99.44 -2.79 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -0.766 . . . . 0.0 109.247 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.26 -171.6 39.41 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.022 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -148.71 148.02 29.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -1.178 . . . . 0.0 109.126 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -135.63 120.86 18.99 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.01 133.14 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.557 0.694 . . . . 0.0 109.92 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.407 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 0.2 OUTLIER 56.51 43.27 26.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.681 -0.637 . . . . 0.0 109.671 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 55.33 10.38 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.625 -0.672 . . . . 0.0 109.957 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.24 145.25 42.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.564 -0.71 . . . . 0.0 109.652 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 461' ' ' LEU . 4.3 mm? -72.93 141.37 47.84 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.38 148.38 22.19 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.02 162.6 37.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.274 1.982 . . . . 0.0 112.68 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.71 -40.3 96.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.443 -0.785 . . . . 0.0 109.624 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 93.1 p -75.75 10.38 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.039 -1.038 . . . . 0.0 109.434 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -68.33 135.35 51.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 110.347 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.43 131.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.31 144.09 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.675 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -115.2 150.56 35.93 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.42 0.629 . . . . 0.0 109.421 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 15.6 p -70.78 155.34 40.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.0 -36.57 1.47 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.6 145.14 54.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.246 . . . . 0.0 111.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -86.29 140.23 30.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.763 . . . . 0.0 109.175 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.08 132.1 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.543 -0.723 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -136.82 116.02 12.55 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.35 138.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.92 130.89 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.7 t -139.95 146.24 38.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.275 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 480' ' ' LYS . 88.3 p -81.74 -8.24 59.68 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.808 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 479' ' ' SER . 53.1 mtmt 39.14 34.63 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.732 0.777 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 18.1 m -62.84 142.32 58.28 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 110.26 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.49 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 88.9 mt -95.58 2.9 54.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.92 143.72 57.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.939 . . . . 0.0 110.208 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 69.3 m80 -141.14 160.07 40.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.0 m80 55.67 19.11 3.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.559 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.8 -44.7 96.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.356 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -89.34 153.97 20.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.059 -1.025 . . . . 0.0 110.027 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -74.2 130.9 40.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 110.535 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.058 -0.973 . . . . 0.0 109.63 179.844 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.5 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -132.38 148.44 52.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.233 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.54 129.97 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.82 142.9 31.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.0 109.648 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.84 164.5 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.54 137.1 54.56 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.603 0.716 . . . . 0.0 109.479 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.05 165.55 14.7 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.85 -14.42 44.52 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.548 2.165 . . . . 0.0 111.232 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -85.22 -5.11 59.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.576 -0.702 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.34 9.3 82.1 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 4.5 mp0 -84.19 162.04 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.288 -1.125 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.92 129.22 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -127.99 132.04 49.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -109.6 139.39 44.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 109.527 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 97.4 mt -136.4 147.9 61.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.488 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.46 158.65 56.58 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.486 2.124 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -56.63 146.34 25.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.55 77.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.57 154.42 41.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.687 -0.89 . . . . 0.0 110.142 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 69.5 p -127.57 170.47 12.59 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.595 0.712 . . . . 0.0 109.693 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.73 74.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 109.321 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.68 -42.09 99.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.44 -43.68 98.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.507 ' CE2' HD21 ' A' ' 444' ' ' LEU . 85.2 t80 -61.29 -44.68 96.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 109.523 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.74 -36.51 83.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.191 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.4 t -61.57 -39.54 91.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.578 -0.701 . . . . 0.0 110.132 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.507 HD21 ' CE2' ' A' ' 440' ' ' PHE . 89.2 mt -48.44 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' A' ' 447' ' ' ASP . 99.3 m-70 -151.24 20.46 0.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 m 68.52 -37.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.624 . . . . 0.0 109.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 445' ' ' HIS . 99.7 m-20 -62.15 -44.23 97.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.5 mm? -63.72 -43.06 97.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.825 . . . . 0.0 108.983 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -71.25 -29.65 68.24 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -76.44 -9.77 58.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -1.072 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -138.83 28.47 2.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.19 109.23 13.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.5 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.4 pt -100.65 -2.52 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.511 -0.743 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.32 176.51 45.99 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.066 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.6 149.99 29.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -1.083 . . . . 0.0 109.106 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -135.56 124.59 24.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 0.0 108.89 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.0 t -122.16 133.02 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.565 -0.709 . . . . 0.0 109.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 3.3 t30 55.79 42.97 28.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.603 -0.686 . . . . 0.0 109.687 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m80 54.86 13.82 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.864 -0.523 . . . . 0.0 110.264 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -117.91 137.4 52.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 109.133 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.57 135.22 54.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.13 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.32 150.82 56.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.74 160.77 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.253 1.969 . . . . 0.0 112.547 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.2 mp -62.72 -40.33 96.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 465' ' ' SER . 3.4 t -77.7 15.06 0.89 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.507 -0.745 . . . . 0.0 109.167 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 464' ' ' LEU . 86.8 t80 -67.54 134.11 50.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.907 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.96 131.39 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.785 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.95 145.66 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.806 . . . . 0.0 110.243 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -119.58 146.18 45.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.537 0.684 . . . . 0.0 109.175 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.1 t -64.93 141.24 58.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 110.68 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.7 -32.83 4.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -72.73 147.04 46.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.251 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.34 144.16 28.22 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.81 132.95 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-O 121.668 0.747 . . . . 0.0 109.786 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -139.62 128.62 23.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.94 128.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.007 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.22 100.0 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.025 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.0 p -84.26 166.4 17.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 110.025 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 38.5 t -80.38 -2.54 46.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.54 -0.725 . . . . 0.0 109.193 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -53.57 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 110.244 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 12.6 m -173.28 70.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 85.9 mt -91.82 -1.97 57.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -77.32 118.01 19.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.537 -0.727 . . . . 0.0 109.943 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 80.9 m80 41.36 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.453 0.644 . . . . 0.0 110.315 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.59 -8.48 59.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.077 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 78.4 m80 51.14 179.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.701 . . . . 0.0 110.688 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' HIS . . . . . 0.53 ' CG ' ' N ' ' A' ' 488' ' ' HIS . 86.3 t60 55.06 166.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.434 0.635 . . . . 0.0 110.396 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.53 ' N ' ' CG ' ' A' ' 487' ' ' HIS . 79.7 m80 -102.65 129.83 49.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.532 -0.73 . . . . 0.0 110.267 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.915 -1.041 . . . . 0.0 109.955 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 417' ' ' MET . . . . . 0.488 ' SD ' ' OE1' ' A' ' 433' ' ' GLN . 55.8 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 121.669 0.747 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.3 mp0 -135.83 166.23 23.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.05 131.07 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.684 0.754 . . . . 0.0 109.486 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.7 ttp -98.22 129.97 44.96 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.723 0.773 . . . . 0.0 110.458 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.33 164.47 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.33 137.35 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.856 0.836 . . . . 0.0 109.96 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.39 159.66 30.67 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.93 -16.22 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.251 1.967 . . . . 0.0 111.413 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -83.27 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.03 6.42 88.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 429' ' ' LYS . 82.7 tt0 -86.6 152.48 22.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.943 . . . . 0.0 110.705 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.9 mm -84.18 129.2 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.492 0.663 . . . . 0.0 109.804 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 427' ' ' GLU . 34.9 mmtm -132.76 109.4 9.64 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.597 0.713 . . . . 0.0 110.13 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -102.37 128.67 48.86 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.6 mt -122.47 152.69 61.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.14 145.94 24.51 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.459 2.106 . . . . 0.0 112.745 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.488 ' OE1' ' SD ' ' A' ' 417' ' ' MET . 59.1 tt0 -58.39 137.01 57.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.847 0.832 . . . . 0.0 110.634 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.23 13.93 72.84 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -72.61 166.54 22.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.913 . . . . 0.0 110.209 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 p -127.13 172.34 10.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.992 0.901 . . . . 0.0 110.581 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.61 -26.6 61.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.09 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.72 -45.4 92.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.418 -0.801 . . . . 0.0 109.719 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -64.82 -38.39 90.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.691 -0.631 . . . . 0.0 109.421 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 444' ' ' LEU . 84.5 t80 -61.23 -45.34 94.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.786 -0.571 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.51 91.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.646 -0.659 . . . . 0.0 109.515 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 438' ' ' LEU . 8.7 m-85 -68.64 -34.09 75.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.494 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 30.8 m -58.08 -42.07 84.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.81 -0.556 . . . . 0.0 109.706 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.8 mt -64.08 -70.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.714 -0.616 . . . . 0.0 109.603 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -149.2 -176.17 5.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.559 -0.713 . . . . 0.0 109.904 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 37.6 t -92.45 -71.01 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.498 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 27.2 t70 -55.78 -48.63 75.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.793 -0.567 . . . . 0.0 110.231 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.523 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.9 -44.5 95.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.531 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.07 -38.73 92.66 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.75 -10.7 59.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.874 . . . . 0.0 109.501 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 16.0 m80 -99.66 20.8 13.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.97 117.9 22.55 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.585 0.707 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.6 pt -101.16 -3.46 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.49 176.94 46.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.71 146.34 37.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.797 -0.825 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -134.75 122.27 21.9 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.394 0.616 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -122.44 132.76 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.702 0.763 . . . . 0.0 109.8 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 458' ' ' ASN . 2.9 t30 54.42 45.69 26.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.653 0.739 . . . . 0.0 109.796 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 58.1 t-80 56.41 14.04 1.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.055 0.455 . . . . 0.0 109.969 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.44 141.15 47.44 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.725 0.774 . . . . 0.0 110.159 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -79.58 112.31 16.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.544 0.688 . . . . 0.0 109.522 -179.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.527 ' N ' HD13 ' A' ' 461' ' ' LEU . 3.6 m -120.95 151.02 54.35 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.85 163.3 36.01 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.604 2.202 . . . . 0.0 112.648 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.62 -39.93 95.36 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.6 m -75.45 8.35 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.773 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 91.1 t80 -67.54 135.01 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.698 0.761 . . . . 0.0 110.406 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.426 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 79.8 t -78.53 131.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.828 0.823 . . . . 0.0 109.757 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.4 mt -74.41 143.39 44.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.654 0.74 . . . . 0.0 110.407 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -116.26 144.6 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.767 0.794 . . . . 0.0 109.801 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.5 t -66.76 139.81 57.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.756 0.789 . . . . 0.0 110.564 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.28 -34.99 4.18 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.05 144.21 48.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.732 -0.864 . . . . 0.0 110.872 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -87.44 144.22 26.85 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.499 0.666 . . . . 0.0 109.562 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.42 131.31 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.575 0.703 . . . . 0.0 109.969 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -133.07 137.98 46.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.03 130.94 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.64 0.734 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.01 131.74 42.09 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.536 0.684 . . . . 0.0 109.676 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 55.9 m -126.78 152.19 47.24 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.694 0.759 . . . . 0.0 109.721 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 93.6 p -73.13 68.39 0.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.794 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -95.14 -7.11 40.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 482' ' ' LEU . 51.9 p -146.31 -124.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.631 -0.668 . . . . 0.0 110.014 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.547 ' N ' ' OG ' ' A' ' 481' ' ' SER . 58.0 mt 59.2 1.3 0.22 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 481' ' ' SER . 79.2 mm-40 -51.55 111.14 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.927 0.87 . . . . 0.0 109.996 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.01 -35.89 77.17 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.737 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 29.0 t60 69.42 127.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.801 0.81 . . . . 0.0 110.556 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 32.4 m80 52.12 92.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.644 0.735 . . . . 0.0 110.203 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -69.01 135.52 51.02 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.749 0.785 . . . . 0.0 109.907 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -151.9 -1.77 0.3 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.276 179.793 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 417' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.1 mp0 -80.56 164.11 23.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 110.279 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.45 131.03 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.55 0.69 . . . . 0.0 109.301 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' MET . . . . . 0.517 ' SD ' HG23 ' A' ' 428' ' ' ILE . 50.8 ttp -97.88 136.54 38.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.523 -0.735 . . . . 0.0 109.768 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.11 161.55 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -115.33 134.59 54.97 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.659 0.742 . . . . 0.0 109.787 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 166.27 13.63 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.71 -15.05 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.531 2.154 . . . . 0.0 111.471 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -85.91 -6.2 59.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.196 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.72 11.9 78.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.449 ' C ' HD12 ' A' ' 428' ' ' ILE . 79.8 mm-40 -85.84 161.77 18.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.143 . . . . 0.0 110.206 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.517 HG23 ' SD ' ' A' ' 420' ' ' MET . 1.3 mp -107.78 129.03 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.92 123.35 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -102.08 127.87 48.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 14.1 mt -118.49 158.21 47.56 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.53 149.17 83.7 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.33 2.02 . . . . 0.0 112.873 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -57.48 134.21 55.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.458 -0.777 . . . . 0.0 110.418 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.73 76.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -63.54 167.87 5.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -1.148 . . . . 0.0 110.246 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 70.0 p -127.52 172.33 10.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.666 0.746 . . . . 0.0 110.002 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -30.07 68.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.477 -0.764 . . . . 0.0 109.219 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 464' ' ' LEU . 89.6 mt -63.05 -43.12 99.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 0.0 109.309 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.68 -41.35 99.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 444' ' ' LEU . 54.7 t80 -61.43 -43.65 98.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.96 -44.8 87.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -65.49 -35.73 81.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.404 -0.81 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 26.2 m -58.64 -41.47 86.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.753 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.456 HD11 ' CE2' ' A' ' 440' ' ' PHE . 76.5 mt -68.96 -77.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.651 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 445' ' ' HIS . 6.1 m80 -124.29 -151.18 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.604 -0.685 . . . . 0.0 109.2 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 26.5 m -128.54 -70.49 0.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.59 -0.694 . . . . 0.0 109.251 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.446 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.6 m-20 -64.19 -39.5 94.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.512 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.08 -44.95 95.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.059 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.14 93.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 452' ' ' CYS . 35.4 t70 -64.43 -38.36 90.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -1.09 . . . . 0.0 109.605 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.446 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 60.9 m80 -78.6 28.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 8.8 t -79.21 123.97 27.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.0 pt -97.6 -5.01 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.214 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . 175.88 179.74 46.55 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.75 149.54 43.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.995 . . . . 0.0 109.122 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -132.41 122.6 25.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.33 132.88 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.692 -0.63 . . . . 0.0 109.643 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.422 ' HA ' HD21 ' A' ' 458' ' ' ASN . 8.4 m120 55.9 42.37 28.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.721 -0.612 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.8 m80 57.15 12.03 1.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.739 -0.6 . . . . 0.0 109.879 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.96 136.25 53.21 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.632 0.73 . . . . 0.0 109.653 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.92 134.63 52.4 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.577 -0.702 . . . . 0.0 109.863 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.09 150.9 57.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.795 . . . . 0.0 109.294 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.5 161.6 42.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.558 2.172 . . . . 0.0 113.01 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -63.27 -40.16 96.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.699 -0.626 . . . . 0.0 109.451 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 8.4 t -76.43 8.19 3.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.207 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 90.1 t80 -61.26 134.91 57.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.512 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.411 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 76.1 t -76.9 130.09 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.478 -0.764 . . . . 0.0 109.98 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.8 147.71 33.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 110.409 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -125.7 145.19 50.29 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.621 0.724 . . . . 0.0 109.518 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 97.6 p -65.4 145.17 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.658 0.742 . . . . 0.0 110.846 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.43 -32.53 4.69 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -72.73 145.77 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 110.821 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.88 139.67 30.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.17 131.93 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.569 0.7 . . . . 0.0 109.992 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.91 114.01 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.61 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.88 114.24 26.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 109.594 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 95.2 p -85.57 172.83 10.63 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.535 -0.728 . . . . 0.0 110.224 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 94.1 p -84.79 -3.51 58.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.447 -0.783 . . . . 0.0 109.624 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.9 135.91 56.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.157 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 88.9 p -66.29 149.06 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 0.0 110.612 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.5 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 87.4 mt -98.47 3.93 48.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.0 109.117 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.99 139.31 58.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 70.9 m80 -146.18 157.76 43.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -96.69 102.2 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.808 . . . . 0.0 109.896 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -91.16 -8.89 47.4 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 86.2 t60 52.71 72.94 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.468 -0.77 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -152.9 139.7 18.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.62 -179.733 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 47.3 ttp . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.9 mp0 -80.9 168.2 19.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.317 0.58 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.0 131.73 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.737 0.78 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.6 ttm -90.33 132.9 35.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.758 0.79 . . . . 0.0 110.084 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 429' ' ' LYS . 18.4 m -131.63 163.46 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.404 0.621 . . . . 0.0 109.425 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 428' ' ' ILE . 85.9 m-85 -123.57 138.68 54.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.013 0.911 . . . . 0.0 109.929 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 159.39 29.87 Favored Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.41 -34.81 33.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.331 2.021 . . . . 0.0 112.221 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.81 -4.13 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.818 -0.551 . . . . 0.0 109.696 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.36 7.45 82.62 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -74.09 153.21 39.71 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.676 0.75 . . . . 0.0 110.682 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.435 HD12 ' CE2' ' A' ' 422' ' ' PHE . 20.4 mm -104.97 122.5 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.406 0.622 . . . . 0.0 109.629 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.401 ' O ' HG22 ' A' ' 421' ' ' VAL . 72.0 mmtt -127.31 135.91 51.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.846 0.831 . . . . 0.0 110.235 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -108.11 132.86 53.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 31.5 mt -122.14 152.45 60.25 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 147.84 28.91 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.262 1.975 . . . . 0.0 112.86 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.21 129.32 41.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.646 0.736 . . . . 0.0 110.58 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 13.95 76.19 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.36 173.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.671 0.748 . . . . 0.0 110.604 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 33.0 p -127.97 172.01 11.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.874 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.71 65.8 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.09 -42.47 99.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.97 -42.05 98.7 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 444' ' ' LEU . 56.2 t80 -62.1 -42.87 99.66 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.98 92.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.0 -36.6 83.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.3 m -58.95 -42.87 90.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.565 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 77.6 mt -66.61 -59.93 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.734 -0.604 . . . . 0.0 109.789 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.4 m-70 -158.85 -176.06 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.441 0.638 . . . . 0.0 109.858 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 39.9 t -101.58 -61.72 1.34 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.09 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.51 -44.96 95.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.742 -0.599 . . . . 0.0 109.935 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.12 -45.11 93.53 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.15 89.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.98 -34.35 78.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.885 -0.773 . . . . 0.0 109.406 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -85.12 16.5 3.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 49.7 t -72.79 116.67 13.56 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.597 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.2 pt -102.53 -0.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLY . . . . . 0.449 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -173.03 170.86 44.01 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.745 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.12 149.51 31.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.069 -0.665 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -138.82 130.59 27.7 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 64.7 t -119.97 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.663 0.744 . . . . 0.0 109.677 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 58.49 41.64 22.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 56.94 12.99 1.33 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -113.05 115.36 28.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.896 0.855 . . . . 0.0 109.792 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.1 tp -51.32 133.92 28.5 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.556 0.694 . . . . 0.0 110.229 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.1 152.34 39.6 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.13 161.57 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.595 2.196 . . . . 0.0 112.651 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.79 -38.2 89.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.1 m -75.05 7.45 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.847 -0.533 . . . . 0.0 109.663 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -69.58 134.08 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.564 0.697 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 82.8 t -78.61 131.04 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.596 0.713 . . . . 0.0 109.865 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.71 146.24 42.43 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.629 0.728 . . . . 0.0 110.631 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -121.11 144.54 48.51 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.866 0.841 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 140.75 58.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.659 0.743 . . . . 0.0 111.121 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.57 -25.89 18.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.32 163.29 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.666 -0.903 . . . . 0.0 110.946 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -109.31 120.72 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 20.9 t -93.09 132.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.841 0.829 . . . . 0.0 110.622 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.5 0.667 . . . . 0.0 109.316 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.23 130.82 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.805 0.812 . . . . 0.0 110.455 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.65 106.35 18.61 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.588 0.709 . . . . 0.0 109.213 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 480' ' ' LYS . 18.7 p -87.57 169.31 12.29 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.588 0.708 . . . . 0.0 110.171 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.7 m -77.27 32.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.25 0.548 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 478' ' ' SER . 9.9 mtpm? -81.45 -4.65 56.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 483' ' ' GLU . 10.3 p -46.09 107.88 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.563 0.697 . . . . 0.0 109.894 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.659 ' N ' HD22 ' A' ' 482' ' ' LEU . 3.3 mm? 56.29 6.12 0.23 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 481' ' ' SER . 48.5 mt-10 46.81 -168.51 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.49 0.662 . . . . 0.0 110.379 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -149.58 163.88 36.66 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.764 0.792 . . . . 0.0 110.12 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -68.99 129.59 40.36 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.626 0.727 . . . . 0.0 110.557 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -82.75 128.14 34.1 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.591 0.71 . . . . 0.0 110.257 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -109.29 124.6 51.19 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.404 0.621 . . . . 0.0 109.972 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.55 126.57 52.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.786 0.803 . . . . 0.0 110.383 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.777 -1.106 . . . . 0.0 109.85 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.3 mp0 -135.87 145.06 45.96 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 18.2 m -119.32 130.94 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.592 -0.692 . . . . 0.0 109.215 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 49.5 ttp -96.66 137.94 34.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.74 165.18 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -113.32 138.51 49.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.515 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.6 162.49 21.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 108.784 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.27 -32.29 40.52 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.191 1.928 . . . . 0.0 111.998 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.53 -1.64 34.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.05 -1.031 . . . . 0.0 109.323 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.22 12.09 81.29 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.24 158.83 32.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -1.163 . . . . 0.0 110.55 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.6 mm -106.24 124.41 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.463 -0.773 . . . . 0.0 109.077 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -128.67 132.94 48.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -0.758 . . . . 0.0 109.016 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -106.74 138.41 42.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.1 mt -131.64 147.6 66.69 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.92 157.31 62.36 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.375 2.05 . . . . 0.0 112.705 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.41 143.01 25.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.64 12.62 74.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.06 42.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 110.364 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.2 p -127.45 172.03 11.04 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.588 0.709 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.28 69.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.49 -0.756 . . . . 0.0 109.593 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.58 -42.26 99.45 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 109.197 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.59 -44.71 93.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 444' ' ' LEU . 65.0 t80 -61.5 -43.65 98.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.11 85.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.152 -0.968 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -64.31 -36.87 85.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.0 m -59.01 -42.29 89.75 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.96 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.5 mt -66.71 -57.36 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.991 -1.068 . . . . 0.0 109.658 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.612 ' CG ' ' H ' ' A' ' 446' ' ' SER . 30.2 t-80 -161.48 -173.48 3.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.144 -0.972 . . . . 0.0 109.333 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' SER . . . . . 0.612 ' H ' ' CG ' ' A' ' 445' ' ' HIS . 8.7 m -103.41 -60.53 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.74 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 451' ' ' HIS . 43.5 t0 -62.16 -45.7 92.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.501 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.07 -43.89 97.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 108.816 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 449' ' ' GLY . . . . . 0.447 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.67 -35.51 92.02 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -73.41 -10.77 60.08 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.28 -1.13 . . . . 0.0 109.36 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 59.5 m-70 -97.36 7.85 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 108.841 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 29.9 p -73.55 116.44 14.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.392 -0.818 . . . . 0.0 109.822 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.08 -2.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.05 177.54 43.95 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.55 142.79 41.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -1.074 . . . . 0.0 108.958 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.74 121.9 21.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.5 133.85 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 3.5 t30 57.38 43.95 22.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.764 0.792 . . . . 0.0 109.356 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 54.17 13.27 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.747 . . . . 0.0 110.224 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -114.71 136.65 52.83 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.54 -0.725 . . . . 0.0 109.418 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.1 tp -67.83 134.46 50.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.89 151.2 48.65 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 108.861 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.55 162.08 38.47 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.598 2.199 . . . . 0.0 112.746 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -62.92 -39.34 94.25 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.717 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.3 m -75.19 7.85 3.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.115 -0.991 . . . . 0.0 109.181 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -66.21 134.95 53.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.242 -0.911 . . . . 0.0 110.255 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.71 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.43 144.63 44.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.234 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 100.0 m-20 -117.18 151.68 36.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.686 -0.634 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.3 p -68.92 154.12 42.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.522 -0.736 . . . . 0.0 110.848 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.45 -37.2 1.59 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.94 145.4 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.398 . . . . 0.0 110.964 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -87.43 149.79 24.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.51 -0.743 . . . . 0.0 109.508 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 440' ' ' PHE . 61.9 t -118.62 132.8 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.521 -0.737 . . . . 0.0 109.749 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -138.08 113.78 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.0 139.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 110.011 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.4 111.7 23.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.418 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 5.8 t -107.59 35.62 3.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 1.3 p 54.45 17.8 1.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.777 . . . . 0.0 109.731 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -67.9 138.45 56.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.184 -0.948 . . . . 0.0 110.277 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 9.1 p -75.31 139.42 42.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.772 . . . . 0.0 109.705 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.79 -22.87 10.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.03 131.93 47.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.227 -0.92 . . . . 0.0 110.2 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -91.14 130.27 37.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.779 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -78.6 155.53 29.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 110.93 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' HIS . . . . . 0.453 ' O ' ' ND1' ' A' ' 486' ' ' HIS . 57.3 t-80 57.46 41.91 25.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' HIS . . . . . 0.439 ' CG ' ' N ' ' A' ' 488' ' ' HIS . 86.2 t60 -79.86 162.0 25.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.466 -0.771 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.439 ' N ' ' CG ' ' A' ' 487' ' ' HIS . 39.7 p-80 -150.65 153.6 35.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 489' ' ' HIS . . . . . 0.441 ' CD2' ' H ' ' A' ' 489' ' ' HIS . 6.2 p80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.135 -0.936 . . . . 0.0 109.877 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 19.7 tpp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.404 0.621 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.2 mp0 -135.67 149.86 49.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.336 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.03 130.86 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.692 0.758 . . . . 0.0 109.071 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.2 ttp -100.2 140.62 34.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.856 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 166.3 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.82 138.74 50.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.804 0.811 . . . . 0.0 109.837 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.52 165.79 14.08 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.96 -16.01 53.31 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.569 2.179 . . . . 0.0 111.446 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.27 -3.68 59.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 108.914 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.42 84.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.94 167.36 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 110.419 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.0 mm -108.09 128.71 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.592 -0.692 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.01 131.47 53.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.525 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -107.82 132.67 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.9 mt -126.57 147.87 62.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.673 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.54 158.14 56.82 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -56.42 139.58 48.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.32 76.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.67 154.89 41.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -1.086 . . . . 0.0 110.104 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.5 p -127.05 172.72 10.26 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.829 0.823 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -30.6 66.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.707 -0.621 . . . . 0.0 110.053 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 464' ' ' LEU . 83.6 mt -63.33 -43.01 98.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.56 -40.72 97.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 109.725 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 444' ' ' LEU . 77.8 t80 -61.08 -42.88 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.451 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.16 93.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.809 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.43 -37.37 80.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 91.1 p -61.56 -35.96 79.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.49 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.574 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 92.4 mt -63.95 -43.58 95.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.174 -0.954 . . . . 0.0 109.63 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.2 m-70 -162.12 -120.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.739 . . . . 0.0 109.384 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 5.7 p -158.83 -68.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.17 -39.04 92.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.87 -43.26 99.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.238 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.2 89.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.6 -34.27 77.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -82.41 21.34 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 42.1 t -76.67 122.92 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -0.843 . . . . 0.0 109.664 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -105.48 -4.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.85 -177.32 46.54 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.32 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.19 148.94 30.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -1.144 . . . . 0.0 109.209 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -132.01 126.54 34.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.76 130.56 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.645 0.736 . . . . 0.0 109.72 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.488 HD21 ' CB ' ' A' ' 472' ' ' ASP . 11.2 m120 55.55 41.79 30.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 109.81 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 57.55 16.27 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -118.51 138.76 52.29 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.703 0.763 . . . . 0.0 109.86 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.87 139.04 53.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.2 m -151.06 149.8 25.86 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.43 162.08 42.2 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.339 2.026 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.2 mp -63.11 -39.31 94.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.469 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.0 m -75.3 8.14 2.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.274 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.3 t80 -65.64 135.4 54.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.42 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 77.5 t -77.09 130.72 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.673 0.749 . . . . 0.0 110.019 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.74 145.23 38.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.0 110.175 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -118.5 147.64 43.44 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.677 0.751 . . . . 0.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 94.1 p -65.24 151.43 46.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 80.2 -38.35 2.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' ASP . . . . . 0.488 ' CB ' HD21 ' A' ' 458' ' ' ASN . 99.4 m-20 -68.42 144.27 54.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -1.037 . . . . 0.0 110.796 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -89.23 145.47 25.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.486 -0.759 . . . . 0.0 109.172 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.98 133.24 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.551 -0.718 . . . . 0.0 109.75 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -132.73 142.22 48.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.75 131.2 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.6 0.714 . . . . 0.0 109.74 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.0 mt -92.67 137.38 32.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.773 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 57.3 m -127.3 154.15 45.28 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 109.528 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 71.3 p -88.92 85.8 6.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -87.35 -8.62 56.44 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 97.0 p -77.24 168.05 20.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.847 . . . . 0.0 110.756 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 482' ' ' LEU . 3.3 mm? -83.76 -2.56 56.56 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 55.14 166.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.712 0.767 . . . . 0.0 110.979 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -80.03 164.76 23.18 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.786 0.803 . . . . 0.0 110.4 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -58.59 -41.43 85.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.811 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -72.44 129.82 39.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -82.5 134.5 35.21 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.744 0.783 . . . . 0.0 110.398 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 85.4 t60 45.71 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.627 0.727 . . . . 0.0 110.314 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 75.6 m80 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.969 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 417' ' ' MET . . . . . 0.425 ' SD ' ' OE1' ' A' ' 433' ' ' GLN . 11.9 ptt? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 -82.37 157.74 23.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.438 -0.789 . . . . 0.0 110.012 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.45 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' MET . . . . . 0.401 ' SD ' HG23 ' A' ' 428' ' ' ILE . 31.5 ttm -99.96 144.48 28.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.721 -0.612 . . . . 0.0 109.703 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.51 163.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.24 137.63 53.53 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.676 0.75 . . . . 0.0 109.734 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.67 177.67 1.57 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -29.99 85.65 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.453 2.102 . . . . 0.0 111.595 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.9 -4.52 59.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.16 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.04 13.99 80.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.41 147.17 46.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 428' ' ' ILE . 1.4 mp -90.92 127.58 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -131.23 110.07 10.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -90.24 137.41 32.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.759 -0.588 . . . . 0.0 109.718 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.77 148.45 69.98 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.52 155.01 72.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.466 2.11 . . . . 0.0 112.464 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.425 ' OE1' ' SD ' ' A' ' 417' ' ' MET . 51.1 tt0 -52.23 145.84 10.14 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.668 0.746 . . . . 0.0 110.434 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.63 13.02 79.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.0 150.93 47.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.976 . . . . 0.0 110.267 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.5 p -127.46 172.72 10.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.645 0.736 . . . . 0.0 109.799 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.24 -30.47 66.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.673 -0.642 . . . . 0.0 109.643 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.62 -43.23 97.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.57 -42.05 99.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 444' ' ' LEU . 78.4 t80 -61.37 -43.68 98.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.558 -0.714 . . . . 0.0 109.841 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.42 83.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 0.0 109.804 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.87 -36.16 83.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.8 m -59.66 -39.31 83.99 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.603 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 93.3 mt -63.1 -44.31 96.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.762 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.5 m-70 -161.97 -120.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.644 . . . . 0.0 109.521 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 6.0 p -152.93 -76.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.562 -0.712 . . . . 0.0 109.079 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.67 -42.34 98.07 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.441 0.638 . . . . 0.0 109.574 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.11 -44.6 95.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.331 -0.856 . . . . 0.0 108.924 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 449' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -65.87 -43.83 93.09 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.83 -29.28 67.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.993 . . . . 0.0 109.607 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -80.62 18.49 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.376 -0.828 . . . . 0.0 108.825 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 63.8 m -79.79 133.04 36.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.588 -0.695 . . . . 0.0 109.951 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.21 -4.24 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.614 -0.678 . . . . 0.0 109.476 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.89 47.4 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.18 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.05 151.99 48.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.509 -0.995 . . . . 0.0 109.703 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' LYS . . . . . 0.525 ' HZ3' ' HA ' ' A' ' 459' ' ' HIS . 39.9 tttm -133.23 119.98 20.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.652 -0.655 . . . . 0.0 109.308 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.89 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.714 HD22 ' CG ' ' A' ' 472' ' ' ASP . 93.0 m-20 57.45 37.8 27.96 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.525 ' HA ' ' HZ3' ' A' ' 456' ' ' LYS . 29.1 m170 58.83 13.64 2.84 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.78 156.42 26.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.548 0.69 . . . . 0.0 109.816 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -87.02 113.43 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.482 -0.762 . . . . 0.0 109.703 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.512 ' N ' HD13 ' A' ' 461' ' ' LEU . 5.3 m -116.99 150.69 46.38 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.74 162.28 38.07 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.636 2.224 . . . . 0.0 112.697 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.86 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.653 -0.655 . . . . 0.0 109.517 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.9 m -75.33 4.35 7.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.326 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -62.72 135.68 57.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.799 . . . . 0.0 110.44 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.22 132.3 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.576 0.703 . . . . 0.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.79 148.07 46.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.631 -0.668 . . . . 0.0 110.509 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -124.23 142.21 51.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.646 0.736 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.8 t -66.84 141.09 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.619 0.724 . . . . 0.0 110.801 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 91.02 -36.44 3.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' ASP . . . . . 0.714 ' CG ' HD22 ' A' ' 458' ' ' ASN . 91.8 m-20 -70.27 144.01 51.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.438 -1.037 . . . . 0.0 110.454 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.2 143.01 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.556 -0.715 . . . . 0.0 109.391 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.08 132.35 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.42 0.629 . . . . 0.0 109.803 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -140.5 126.1 19.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 34.9 m -94.4 132.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.499 -0.75 . . . . 0.0 109.843 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.87 111.9 23.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.639 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 480' ' ' LYS . 8.2 t -89.66 172.75 8.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.586 0.708 . . . . 0.0 110.016 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 30.19 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 0.0 109.68 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 478' ' ' SER . 43.7 mmtm -71.75 145.11 48.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 110.689 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 96.2 p -71.71 107.36 4.5 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.753 0.787 . . . . 0.0 110.151 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.56 9.66 42.73 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 57.54 104.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.613 0.721 . . . . 0.0 110.331 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -61.47 -39.99 92.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.706 -0.621 . . . . 0.0 109.887 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -75.82 66.88 2.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -61.67 -40.9 96.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.548 -0.72 . . . . 0.0 109.279 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -151.3 164.39 36.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -84.87 122.65 29.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 109.971 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.734 -179.825 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 417' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 418' ' ' GLU . 11.4 tmm? . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.496 ' O ' ' SD ' ' A' ' 417' ' ' MET . 97.3 mt-10 -114.1 145.73 41.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 9.7 m -109.92 130.5 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' MET . . . . . 0.412 ' CE ' ' NH2' ' A' ' 430' ' ' ARG . 39.0 ttm -91.03 134.21 34.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.807 . . . . 0.0 109.308 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.23 162.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.14 138.77 52.69 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.488 0.661 . . . . 0.0 109.596 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 165.62 14.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.09 -14.74 45.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.179 1.919 . . . . 0.0 111.129 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.98 -4.27 59.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.467 -0.77 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.65 85.36 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.08 165.9 18.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 110.069 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.3 mm -110.91 128.4 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.52 -0.737 . . . . 0.0 109.022 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -126.85 140.22 52.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.412 ' NH2' ' CE ' ' A' ' 420' ' ' MET . 95.9 mtt-85 -113.35 136.79 52.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.632 -0.668 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.25 147.33 63.27 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.15 159.78 51.1 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.257 1.972 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -57.05 148.89 20.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.468 -0.77 . . . . 0.0 110.302 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 10.46 81.64 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.03 44.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -1.046 . . . . 0.0 109.759 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.1 p -127.57 173.58 9.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.631 -0.668 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.98 -34.36 69.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.93 -43.03 99.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 109.638 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.87 -41.8 98.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.409 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 79.7 t80 -60.78 -44.58 96.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.055 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.75 86.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.04 -1.038 . . . . 0.0 109.939 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -64.04 -37.89 89.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.08 . . . . 0.0 109.673 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 60.6 p -59.77 -37.12 78.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 89.2 mt -63.46 -54.19 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.987 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 99.6 m-70 -161.93 -126.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 19.4 m -146.63 -64.7 0.29 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.011 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.93 -45.36 92.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.0 109.98 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.92 -44.83 95.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.9 90.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.09 -18.47 63.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -1.196 . . . . 0.0 110.011 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -103.29 42.35 1.17 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.392 -0.818 . . . . 0.0 109.321 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.32 127.43 44.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.446 -0.784 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.1 pt -101.57 -5.2 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.12 178.55 48.22 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.56 149.31 48.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.645 -0.915 . . . . 0.0 108.704 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' LYS . . . . . 0.465 ' NZ ' ' C ' ' A' ' 459' ' ' HIS . 44.8 tttm -132.88 120.83 22.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 94.1 t -123.57 133.83 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.542 -0.724 . . . . 0.0 109.705 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.33 43.59 19.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.465 ' C ' ' NZ ' ' A' ' 456' ' ' LYS . 79.5 m80 53.13 13.16 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 110.653 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -118.09 137.04 53.2 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.378 -0.826 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.3 134.83 54.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.628 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.29 150.93 53.64 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.34 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.636 2.224 . . . . 0.0 112.716 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.45 -39.09 92.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.216 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -74.64 7.74 2.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.338 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -65.45 133.78 52.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.949 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 78.2 t -79.56 132.18 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.49 149.23 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.378 -0.826 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -124.1 145.37 49.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.616 -0.677 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.7 t -65.69 142.44 58.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -0.799 . . . . 0.0 110.495 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.89 -32.46 5.1 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -73.08 149.37 43.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.349 -1.089 . . . . 0.0 109.716 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -95.53 130.14 42.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 22.1 t -103.55 131.66 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.455 -0.778 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -134.51 143.14 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.46 132.46 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.479 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.81 128.65 46.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.327 -0.858 . . . . 0.0 109.248 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 73.0 m -130.8 119.19 21.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.547 -0.721 . . . . 0.0 109.567 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 83.7 p -91.22 -4.9 55.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 109.001 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.448 ' NZ ' HD22 ' A' ' 448' ' ' LEU . 72.0 mmtt 46.4 90.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.444 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 27.9 m -79.57 105.86 11.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.637 -0.664 . . . . 0.0 109.739 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.444 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 84.5 mt -96.01 -0.58 50.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.07 139.98 57.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 110.395 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 75.1 m80 -141.35 23.72 2.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 486' ' ' HIS . 86.4 t60 -139.61 176.85 8.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.448 -0.783 . . . . 0.0 109.78 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 485' ' ' HIS . 56.2 t-80 55.58 84.29 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.713 -0.617 . . . . 0.0 109.939 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -133.59 19.62 3.91 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -151.13 162.67 40.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.195 -0.941 . . . . 0.0 110.145 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.756 -179.759 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 55.5 ttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.746 0.784 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.4 167.97 20.9 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.365 0.602 . . . . 0.0 110.178 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.1 131.58 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.631 0.729 . . . . 0.0 109.519 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 54.6 ttm -96.99 133.69 41.33 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.687 0.756 . . . . 0.0 110.405 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.08 163.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -115.69 142.35 46.86 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.902 0.858 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.71 176.71 1.78 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.33 -29.92 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.071 1.847 . . . . 0.0 111.429 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.11 -4.91 59.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.173 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.5 79.95 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.59 157.55 37.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.52 -0.988 . . . . 0.0 110.485 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.3 mm -99.68 123.98 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.646 -0.659 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -127.43 126.33 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -106.62 133.86 50.65 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.26 0.552 . . . . 0.0 109.646 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.76 152.96 77.82 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.54 147.82 22.11 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.36 2.04 . . . . 0.0 112.492 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.14 132.37 52.74 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.914 0.864 . . . . 0.0 110.632 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.6 13.59 75.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.3 170.9 0.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.986 . . . . 0.0 110.677 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.9 p -127.54 171.08 11.93 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.143 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.77 67.96 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.327 0.584 . . . . 0.0 109.968 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.39 -42.56 98.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.69 -39.85 95.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.712 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.535 ' CE2' HD11 ' A' ' 444' ' ' LEU . 84.7 t80 -61.27 -43.68 98.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.792 . . . . 0.0 109.156 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.3 95.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.627 -0.671 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -65.03 -36.68 85.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 38.9 m -58.81 -41.57 87.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.535 HD11 ' CE2' ' A' ' 440' ' ' PHE . 88.0 mt -72.04 -76.71 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -138.42 179.05 6.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.419 -0.801 . . . . 0.0 109.897 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 33.6 t -103.95 -55.06 2.44 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.378 0.609 . . . . 0.0 109.612 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.58 -49.68 74.31 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.512 0.673 . . . . 0.0 109.659 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.516 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -64.95 -44.71 88.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.739 0.78 . . . . 0.0 109.611 -179.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 449' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.73 -42.19 93.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.8 t0 -66.63 -35.46 80.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.942 . . . . 0.0 109.864 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 451' ' ' HIS . 21.0 t60 -81.74 20.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.197 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 28.7 p -74.53 129.98 38.75 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.498 0.666 . . . . 0.0 109.947 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.43 -4.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.37 48.48 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 147.04 40.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.58 -0.953 . . . . 0.0 109.709 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -131.66 124.04 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.08 131.84 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.614 0.721 . . . . 0.0 109.998 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.436 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 0.2 OUTLIER 54.7 44.06 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 109.937 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.436 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 54.0 t-80 58.49 13.39 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.281 0.562 . . . . 0.0 109.68 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.02 144.53 43.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.751 . . . . 0.0 109.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -82.13 113.53 20.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.423 0.63 . . . . 0.0 109.589 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 461' ' ' LEU . 6.4 m -120.75 151.69 54.85 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.07 162.78 36.68 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.497 2.131 . . . . 0.0 112.375 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -63.32 -39.42 94.52 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.402 0.62 . . . . 0.0 109.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.6 t -75.56 10.52 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.286 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' TYR . . . . . 0.433 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.0 t80 -69.1 135.48 50.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.788 0.804 . . . . 0.0 110.518 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.433 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 81.7 t -81.2 131.48 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 121.721 0.772 . . . . 0.0 109.778 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.61 145.08 45.67 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.617 0.722 . . . . 0.0 110.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -117.02 144.18 44.9 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.67 0.747 . . . . 0.0 109.877 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 42.6 t -68.62 140.18 55.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.947 0.879 . . . . 0.0 111.143 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.11 -26.19 16.28 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.95 163.31 25.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.986 . . . . 0.0 111.359 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -103.43 134.51 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 51.3 t -114.48 132.2 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.699 0.761 . . . . 0.0 110.301 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.79 146.23 39.2 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.29 131.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.727 0.775 . . . . 0.0 110.188 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.5 131.91 34.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.573 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.7 m -130.32 153.97 48.13 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.68 0.752 . . . . 0.0 110.235 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.4 p -90.41 83.64 5.93 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.499 0.666 . . . . 0.0 109.491 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -113.64 5.58 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 87.5 p -85.14 -1.37 56.8 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.606 0.717 . . . . 0.0 109.267 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 482' ' ' LEU . 8.3 mp -80.78 -5.79 57.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -73.3 147.07 44.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.626 -0.671 . . . . 0.0 110.177 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -146.78 139.46 25.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -0.816 . . . . 0.0 109.881 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 485' ' ' HIS . 46.6 t-80 -81.78 57.12 3.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.79 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -73.84 147.47 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -59.91 -42.98 95.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.773 -0.579 . . . . 0.0 109.929 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -119.84 118.37 30.62 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.619 0.723 . . . . 0.0 109.512 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.745 -179.795 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.5 159.19 42.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.471 -0.768 . . . . 0.0 109.076 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.8 130.88 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.429 -0.794 . . . . 0.0 108.964 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.6 ttm -92.5 138.43 31.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.786 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.48 164.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.03 137.39 53.57 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 171.51 5.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.94 -29.5 82.49 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.939 1.759 . . . . 0.0 111.113 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -81.24 -4.35 55.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.626 . . . . 0.0 109.623 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.0 83.46 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -73.87 156.65 37.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -1.171 . . . . 0.0 110.198 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.7 mm -103.12 125.14 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.08 132.9 47.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.565 -0.709 . . . . 0.0 109.262 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -107.25 134.99 49.52 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 49.2 mt -131.0 153.07 81.68 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.6 147.17 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.985 1.79 . . . . 0.0 112.707 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -54.87 130.34 40.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.673 -0.642 . . . . 0.0 110.092 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.03 76.36 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -52.09 172.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 109.864 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.7 p -128.22 171.42 11.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.551 -0.718 . . . . 0.0 109.958 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.73 71.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.06 -43.55 98.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.432 -0.793 . . . . 0.0 109.532 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.427 ' CE2' HD11 ' A' ' 444' ' ' LEU . 63.4 t80 -61.12 -43.85 98.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.01 -45.53 79.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.439 -0.788 . . . . 0.0 109.842 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -62.16 -37.95 87.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.832 . . . . 0.0 109.744 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.2 m -58.87 -41.55 87.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.81 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 440' ' ' PHE . 86.6 mt -62.97 -43.93 97.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.308 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 446' ' ' SER . 28.2 t-80 -173.68 -130.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.421 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' SER . . . . . 0.626 ' H ' ' CG ' ' A' ' 445' ' ' HIS . 8.1 t -145.42 -64.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.65 -44.95 94.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.449 -0.782 . . . . 0.0 109.731 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.99 -46.0 89.76 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 449' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -68.74 -39.11 86.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -37.88 89.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.511 -0.993 . . . . 0.0 109.839 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -83.17 20.06 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 109.498 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 27.7 p -71.09 122.47 20.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.675 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.9 pt -99.64 -2.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.793 . . . . 0.0 109.777 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.54 179.66 45.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.24 146.29 36.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 109.053 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -134.01 122.06 22.48 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.263 -0.898 . . . . 0.0 108.951 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.06 134.46 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.678 -0.639 . . . . 0.0 109.607 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 58.09 41.94 23.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 55.2 18.45 2.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.627 . . . . 0.0 110.141 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -122.75 144.09 49.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.628 -0.67 . . . . 0.0 109.213 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 41.9 tp -70.17 134.28 47.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.33 149.87 53.01 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.05 162.18 41.1 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.486 2.124 . . . . 0.0 112.617 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.71 -0.619 . . . . 0.0 109.65 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 96.6 p -75.96 10.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.749 . . . . 0.0 109.627 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.5 t80 -65.09 135.94 56.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 110.226 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.434 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 22.3 t -79.29 131.26 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.89 149.32 39.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.395 -0.816 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -124.14 141.97 51.61 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.537 0.684 . . . . 0.0 109.396 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.9 t -66.19 142.45 57.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.69 . . . . 0.0 110.781 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.33 10.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -78.87 161.14 26.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -1.043 . . . . 0.0 109.998 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -105.56 122.82 46.81 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.5 t -97.4 132.24 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.458 -0.776 . . . . 0.0 110.244 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.0 141.72 47.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.16 130.8 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.447 -0.783 . . . . 0.0 109.64 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.17 137.92 31.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 97.4 p -137.02 157.64 46.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.446 -0.784 . . . . 0.0 109.676 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 92.0 p -85.36 -3.69 58.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.497 -0.752 . . . . 0.0 109.847 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.32 -144.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.775 . . . . 0.0 110.266 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 481' ' ' SER . 10.4 t 56.53 26.15 10.64 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.403 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 88.6 mt -92.67 11.4 26.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.749 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 56.95 160.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.539 0.685 . . . . 0.0 110.543 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -80.66 108.18 14.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.69 -0.631 . . . . 0.0 109.809 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -67.36 -39.54 85.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.68 -0.637 . . . . 0.0 110.043 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -50.93 144.96 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -150.47 165.77 32.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.522 -0.737 . . . . 0.0 109.478 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -150.7 151.71 32.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 109.136 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 489' ' ' HIS . 85.9 t60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 -115.64 165.67 12.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.601 -0.687 . . . . 0.0 109.643 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.1 m -114.31 131.25 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.651 0.739 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -95.02 135.4 36.61 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.525 0.679 . . . . 0.0 110.003 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.18 164.68 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.09 141.24 48.69 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.678 0.751 . . . . 0.0 109.73 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.52 176.25 2.04 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.28 -33.48 85.07 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.896 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.94 -4.21 54.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 80.91 10.68 84.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.85 155.73 40.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.636 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.22 124.33 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -127.19 131.88 50.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -105.71 135.52 46.98 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.451 0.643 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 23.1 mt -138.69 150.77 66.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.69 156.13 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.429 2.086 . . . . 0.0 112.719 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.16 154.49 7.78 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.291 1.043 . . . . 0.0 111.101 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 78.71 7.03 88.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.58 153.35 43.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.356 -1.085 . . . . 0.0 110.443 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 47.8 p -127.04 171.21 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.772 0.796 . . . . 0.0 110.159 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.3 -28.52 63.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.564 0.697 . . . . 0.0 109.829 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.81 -46.67 86.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 109.578 -179.098 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.68 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 444' ' ' LEU . 67.5 t80 -61.13 -44.33 97.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.677 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.1 -47.37 83.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.0 -34.73 78.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.539 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 34.4 m -59.23 -41.2 88.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.579 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 440' ' ' PHE . 88.2 mt -69.38 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.95 -151.19 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.373 -0.83 . . . . 0.0 109.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 82.1 p -127.32 -73.99 0.6 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.583 0.706 . . . . 0.0 110.034 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.525 ' N ' ' OG ' ' A' ' 446' ' ' SER . 99.6 m-20 -64.13 -43.28 95.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.41 -46.58 87.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.007 0.908 . . . . 0.0 109.295 -179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 449' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.25 -40.21 94.68 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 452' ' ' CYS . 65.3 t0 -65.62 -37.92 87.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -1.066 . . . . 0.0 109.946 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -76.77 26.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.196 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 21.6 p -79.7 121.11 24.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.65 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 38.6 pt -101.38 -3.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.48 179.51 47.47 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.244 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.05 152.8 32.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -1.072 . . . . 0.0 109.364 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -131.01 131.31 44.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.742 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.15 132.56 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.44 0.638 . . . . 0.0 109.511 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 56.43 39.38 30.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.518 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 78.1 m80 58.94 13.13 2.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.453 0.644 . . . . 0.0 109.69 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.77 136.83 49.25 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.778 0.799 . . . . 0.0 109.62 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.0 tp -66.44 131.74 46.73 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.707 0.765 . . . . 0.0 110.473 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 7.0 m -146.87 149.93 37.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.8 158.6 55.47 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.423 2.082 . . . . 0.0 112.421 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.52 -38.45 90.0 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.668 0.747 . . . . 0.0 109.761 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.8 m -75.27 8.34 2.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 109.41 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' TYR . . . . . 0.471 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 94.3 t80 -66.21 137.36 56.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.899 . . . . 0.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.471 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 82.1 t -75.88 130.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.067 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.8 mt -78.77 142.99 36.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.547 0.689 . . . . 0.0 110.624 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 99.7 m-20 -116.16 148.03 40.78 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.57 0.7 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 16.5 m -74.26 140.66 45.13 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.793 0.806 . . . . 0.0 110.947 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.16 -23.13 37.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 42.3 p-10 -84.48 171.8 12.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.291 -1.123 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -110.94 129.03 56.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.1 131.61 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.584 -0.697 . . . . 0.0 109.747 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -130.44 138.22 50.2 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.33 130.54 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.727 0.775 . . . . 0.0 110.221 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.74 141.4 30.02 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.468 0.652 . . . . 0.0 109.409 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.5 p -137.25 158.28 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.604 0.716 . . . . 0.0 109.694 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 480' ' ' LYS . 92.9 p -82.49 -6.08 59.1 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 479' ' ' SER . 68.4 mttm 40.66 34.09 0.23 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.897 0.856 . . . . 0.0 110.085 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 67.6 m -80.66 -3.51 50.85 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.492 -0.755 . . . . 0.0 109.153 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 482' ' ' LEU . 0.3 OUTLIER -93.11 75.29 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.04 121.41 27.37 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 485' ' ' HIS . 84.3 t60 -173.24 124.8 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 109.331 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 484' ' ' HIS . 78.0 m80 -154.93 21.67 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -61.91 -43.23 99.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.394 -0.817 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -74.42 138.27 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.805 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.466 ' ND1' ' O ' ' A' ' 488' ' ' HIS . 58.6 t-80 56.17 10.93 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.408 0.623 . . . . 0.0 110.122 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 75.9 m80 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.119 179.445 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 44.3 tpp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.11 158.68 22.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.654 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 419' ' ' VAL . 35.2 m -119.17 130.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' MET . . . . . 0.492 ' SD ' ' CG2' ' A' ' 428' ' ' ILE . 49.2 ttp -100.31 143.87 29.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.631 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.27 161.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.73 125.86 54.78 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.547 0.689 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 423' ' ' THR . 0.2 OUTLIER -89.19 156.23 48.89 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.97 -15.96 42.26 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.148 1.899 . . . . 0.0 111.238 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.9 -3.18 53.59 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.449 -0.782 . . . . 0.0 109.178 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.07 161.22 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -1.133 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.492 ' CG2' ' SD ' ' A' ' 420' ' ' MET . 35.0 mm -110.14 129.2 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.511 -0.743 . . . . 0.0 109.068 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -125.91 134.54 51.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -106.3 133.27 51.26 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.639 -0.663 . . . . 0.0 109.513 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.72 147.18 52.63 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.05 158.19 55.84 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.318 2.012 . . . . 0.0 111.97 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -56.09 143.05 34.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.281 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 11.54 81.12 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.61 152.46 44.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.569 -0.959 . . . . 0.0 109.791 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.7 p -127.57 172.9 10.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.6 -0.687 . . . . 0.0 109.686 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.65 65.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.461 -0.774 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.82 -42.44 99.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.319 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -61.15 -43.6 98.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 109.956 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 444' ' ' LEU . 66.3 t80 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.11 -42.63 81.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.619 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -67.36 -38.02 84.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.148 -0.97 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 91.1 p -59.8 -37.02 77.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 109.664 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.461 HD11 ' CE2' ' A' ' 440' ' ' PHE . 91.3 mt -63.32 -42.8 99.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 109.231 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' A' ' 446' ' ' SER . 38.7 t-80 -173.49 -119.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' SER . . . . . 0.594 ' H ' ' CG ' ' A' ' 445' ' ' HIS . 37.3 p -155.62 -64.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 451' ' ' HIS . 64.0 t0 -61.82 -48.78 79.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.492 -0.755 . . . . 0.0 109.803 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.99 -45.45 92.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.275 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 449' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -67.18 -40.8 92.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 450' ' ' ASP . 64.6 t0 -63.72 -37.26 86.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.099 . . . . 0.0 109.522 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' A' ' 447' ' ' ASP . 51.5 m80 -81.15 27.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 109.2 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 13.2 p -77.35 129.78 36.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 24.6 pt -102.92 -5.26 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 0.0 109.313 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 175.68 -175.12 47.23 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.15 150.57 42.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 108.836 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -132.82 121.6 23.2 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.3 t -122.73 134.34 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.692 . . . . 0.0 109.289 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 55.59 39.52 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.526 0.679 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 57.1 t-80 57.86 8.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 110.232 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -111.47 146.68 36.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.452 -0.78 . . . . 0.0 109.285 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 461' ' ' LEU . 4.3 mm? -72.43 142.06 48.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.5 -0.75 . . . . 0.0 109.704 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.84 148.87 34.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.19 159.94 49.8 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.06 1.84 . . . . 0.0 112.368 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 464' ' ' LEU . 10.5 mp -62.35 -40.16 95.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.578 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -75.85 7.44 3.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.21 136.6 58.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.86 130.17 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 109.641 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.55 146.55 36.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.468 -0.77 . . . . 0.0 109.79 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 94.6 m-20 -123.98 151.7 43.36 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.547 -0.721 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 11.6 p -75.24 145.39 41.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.822 . . . . 0.0 110.458 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.81 -21.45 41.44 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 49.4 p-10 -84.18 172.05 12.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -1.145 . . . . 0.0 109.893 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -115.1 131.93 56.77 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.424 HG11 ' CD2' ' A' ' 440' ' ' PHE . 64.0 t -109.92 131.64 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.815 . . . . 0.0 110.014 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -135.72 113.3 10.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.53 137.34 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.807 . . . . 0.0 110.27 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.5 mt -96.6 135.0 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 109.255 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.5 m -127.79 154.48 45.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.53 -0.732 . . . . 0.0 109.77 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.2 p -90.62 87.27 6.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.18 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.38 -168.66 0.34 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 110.309 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 14.7 m -87.03 93.82 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 109.783 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 482' ' ' LEU . 9.0 mp -95.45 -9.8 31.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 483' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 485' ' ' HIS . 97.4 mt-10 56.15 153.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.63 0.729 . . . . 0.0 110.899 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 484' ' ' HIS . 29.9 t-80 48.78 12.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.38 -0.825 . . . . 0.0 109.548 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 483' ' ' GLU . 36.3 p-80 -87.36 146.62 25.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.324 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 45.37 -165.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.484 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -148.21 168.62 22.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.858 . . . . 0.0 109.856 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 58.16 50.02 10.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.883 -1.056 . . . . 0.0 109.918 179.657 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 417' ' ' MET . . . . . 0.606 ' SD ' ' N ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 -83.68 167.28 17.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 109.659 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.16 129.63 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.419 0.628 . . . . 0.0 109.61 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.3 ttm -102.91 132.87 48.83 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.49 163.54 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -117.66 144.09 45.55 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.905 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.27 174.3 3.17 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.49 -31.85 87.44 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.226 1.95 . . . . 0.0 111.289 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.99 -3.99 55.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.51 -0.744 . . . . 0.0 109.215 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.11 11.68 83.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.79 154.96 41.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -1.199 . . . . 0.0 110.517 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 36.3 mm -94.3 124.25 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -129.95 106.99 9.03 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -97.45 127.86 43.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.464 -0.773 . . . . 0.0 109.415 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 40.0 mt -120.09 148.88 47.96 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 154.29 74.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.15 1.9 . . . . 0.0 112.193 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -52.62 146.59 9.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.875 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.13 7.38 80.37 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.0 151.47 47.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.747 -0.855 . . . . 0.0 110.159 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -127.38 171.55 11.43 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.494 0.664 . . . . 0.0 109.544 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.36 65.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 464' ' ' LEU . 88.4 mt -63.19 -46.06 88.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.84 -42.99 99.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 444' ' ' LEU . 89.0 t80 -61.8 -44.94 95.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.77 . . . . 0.0 109.613 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.89 84.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 0.0 109.611 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.84 -34.03 77.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.1 m -58.63 -43.02 89.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 62.4 mt -63.3 -47.97 80.03 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 109.759 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 37.0 m80 -166.01 -166.1 0.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 71.7 p -109.45 -37.24 5.78 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.42 -48.31 73.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 109.64 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.8 mm? -63.76 -41.07 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.579 -0.701 . . . . 0.0 109.295 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.09 -33.06 86.22 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -87.49 -24.2 24.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.393 -1.063 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -100.01 14.53 30.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 109.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 7.9 t -80.35 110.41 15.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.179 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.78 0.73 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.651 -0.656 . . . . 0.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -172.96 173.17 45.52 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.194 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.92 29.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -1.052 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -133.15 122.44 24.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.23 131.56 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.569 0.699 . . . . 0.0 109.943 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 56.18 45.05 24.03 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.308 0.575 . . . . 0.0 109.861 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.7 12.24 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.666 -0.646 . . . . 0.0 109.814 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.21 132.54 56.58 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.547 0.689 . . . . 0.0 109.384 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.03 135.1 51.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.24 151.57 44.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.0 109.45 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.49 161.63 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.442 2.095 . . . . 0.0 112.336 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.8 -38.63 91.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.591 -0.693 . . . . 0.0 109.605 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.9 m -74.85 7.92 2.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.2 -0.938 . . . . 0.0 109.335 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.2 t80 -69.47 134.63 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.421 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 25.3 t -77.21 131.26 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.843 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 71.8 mt -75.15 144.74 42.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.293 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -115.96 147.92 40.64 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.422 0.63 . . . . 0.0 109.367 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.1 p -65.52 153.14 42.3 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.658 0.742 . . . . 0.0 111.214 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 81.36 -40.07 2.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.0 144.24 54.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.12 . . . . 0.0 111.016 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 474' ' ' VAL . 21.5 tm0? -85.81 143.35 28.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.518 ' O ' ' NE2' ' A' ' 473' ' ' GLN . 66.7 t -116.42 132.14 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.571 -0.705 . . . . 0.0 109.935 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 12.4 m -109.85 133.83 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.64 -0.662 . . . . 0.0 110.046 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -89.84 108.33 19.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.726 . . . . 0.0 109.267 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 p -84.44 169.35 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.792 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.7 t -98.43 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 0.0 109.085 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -60.41 139.43 57.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.784 . . . . 0.0 110.173 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 69.0 m -62.53 147.42 49.05 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.71 0.767 . . . . 0.0 110.501 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 482' ' ' LEU . 3.7 mm? -86.81 -3.13 59.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 483' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 484' ' ' HIS . 80.0 mm-40 -60.44 -112.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.66 -0.65 . . . . 0.0 110.079 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 483' ' ' GLU . 57.0 t-80 57.62 120.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.642 0.734 . . . . 0.0 110.003 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -154.47 152.48 30.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -111.43 106.47 15.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.717 -0.614 . . . . 0.0 109.573 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 489' ' ' HIS . 84.2 t60 -171.25 130.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 488' ' ' HIS . 55.0 t-80 52.06 8.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 487' ' ' HIS . 86.0 t60 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.101 -0.952 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' MET . . . . . 0.608 ' SD ' ' N ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.723 0.773 . . . . 0.0 109.012 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 -81.11 161.43 24.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.507 -0.746 . . . . 0.0 110.094 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.0 130.84 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.695 0.759 . . . . 0.0 109.051 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.2 ttp -99.36 139.59 34.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.616 0.722 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.79 165.08 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.58 139.4 53.57 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.779 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 165.71 14.71 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.85 -9.74 26.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.707 2.271 . . . . 0.0 111.632 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -90.9 -5.32 55.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.115 -0.991 . . . . 0.0 109.492 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.47 6.23 77.81 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -83.44 160.75 21.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -1.221 . . . . 0.0 110.318 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 32.0 mm -105.83 128.01 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -127.07 134.41 50.28 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -110.42 136.28 49.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.72 -0.613 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 85.1 mt -135.83 147.97 63.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.91 154.2 71.32 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.284 1.989 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.504 ' CD ' ' N ' ' A' ' 433' ' ' GLN . 2.4 pm0 -55.1 147.42 16.09 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.723 0.773 . . . . 0.0 110.991 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.2 81.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.33 157.45 35.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.522 -0.987 . . . . 0.0 110.17 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 58.1 p -126.54 167.63 15.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.859 0.838 . . . . 0.0 109.928 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.35 68.28 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.522 0.677 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.01 -43.59 98.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.587 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.45 -42.87 99.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.669 0.747 . . . . 0.0 109.656 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 474' ' ' VAL . 83.2 t80 -61.77 -44.79 96.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.502 -0.749 . . . . 0.0 110.157 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.15 84.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.75 -36.28 83.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.76 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 444' ' ' LEU . 39.1 t -63.49 -36.6 84.31 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 443' ' ' SER . 96.3 mt -52.59 -105.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.23 -2.24 37.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 t 70.81 -55.8 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.597 0.713 . . . . 0.0 109.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.1 t0 -65.46 -38.79 90.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 448' ' ' LEU . 7.3 tt -62.8 -41.6 99.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.692 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -49.19 -9.4 0.12 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 451' ' ' HIS . 8.2 p-10 -91.28 -22.68 20.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.046 -1.267 . . . . 0.0 109.434 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.578 ' N ' ' OD1' ' A' ' 450' ' ' ASP . 40.2 m80 -100.91 -1.18 35.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.361 -0.837 . . . . 0.0 109.053 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 452' ' ' CYS . 26.1 p -61.98 118.1 6.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 41.1 pt -105.84 -5.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.806 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.33 176.44 46.01 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.11 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.0 151.96 38.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -1.162 . . . . 0.0 109.515 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -132.5 123.8 27.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.551 -0.718 . . . . 0.0 109.194 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -123.1 133.25 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.724 0.773 . . . . 0.0 109.812 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.711 HD22 ' CG ' ' A' ' 472' ' ' ASP . 61.4 m-20 55.69 40.89 30.9 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.516 0.675 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m80 56.21 13.01 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.426 0.631 . . . . 0.0 109.364 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.13 135.35 54.01 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.743 0.783 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.9 tp -66.74 134.98 53.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 0.0 109.813 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.32 150.68 49.07 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.357 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.37 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.505 2.136 . . . . 0.0 112.444 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -63.55 -37.09 86.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.7 m -75.02 3.92 7.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 109.33 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -62.87 135.46 57.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.368 -0.832 . . . . 0.0 110.426 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.31 130.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.625 0.726 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.89 147.52 38.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.61 -0.681 . . . . 0.0 110.494 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -124.26 148.06 47.65 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.815 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 41.6 t -64.19 140.01 58.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.913 0.863 . . . . 0.0 111.123 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.15 -31.16 6.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' ASP . . . . . 0.711 ' CG ' HD22 ' A' ' 458' ' ' ASN . 98.8 m-20 -73.2 147.7 44.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -1.101 . . . . 0.0 111.026 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -95.53 141.93 28.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.72 . . . . 0.0 109.786 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.437 HG11 ' CD2' ' A' ' 440' ' ' PHE . 64.5 t -116.2 132.22 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.647 0.737 . . . . 0.0 109.787 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -138.12 113.58 9.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 109.046 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.0 134.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.77 96.19 8.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.452 -0.78 . . . . 0.0 109.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 96.0 p -85.29 166.37 16.54 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.739 0.781 . . . . 0.0 110.381 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.2 m -87.6 -4.61 58.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.077 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.83 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 5.0 m -76.43 101.7 5.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.68 -1.09 47.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.9 96.57 7.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.397 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -95.13 -14.65 23.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -101.81 13.42 34.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.228 -0.92 . . . . 0.0 109.096 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 75.7 m80 54.89 -92.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.675 -0.64 . . . . 0.0 110.023 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.52 141.23 46.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -152.12 164.12 37.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.635 -0.666 . . . . 0.0 109.383 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.893 -1.051 . . . . 0.0 108.914 179.875 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.6 mp0 -110.64 167.07 10.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.547 -0.721 . . . . 0.0 109.534 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.2 m -112.52 131.4 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.3 ttm -98.36 136.09 39.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' VAL . . . . . 0.437 HG12 ' OD1' ' A' ' 472' ' ' ASP . 33.2 m -131.19 164.61 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.92 140.74 49.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.103 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 176.66 1.89 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.09 -34.22 97.29 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 111.912 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -81.43 -3.87 54.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 109.143 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.57 82.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -71.82 153.11 42.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.317 . . . . 0.0 110.371 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.25 127.17 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -129.15 113.71 15.42 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.69 127.62 45.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.9 mt -131.83 156.12 80.52 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.07 144.79 56.27 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.904 1.736 . . . . 0.0 112.677 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -62.4 141.08 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.545 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.48 84.41 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -66.05 179.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -1.071 . . . . 0.0 110.136 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.0 p -127.67 169.5 13.72 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.96 -26.33 64.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.03 -43.01 99.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.353 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.73 -40.16 96.34 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.845 . . . . 0.0 109.116 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 83.1 t80 -61.46 -43.93 97.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.603 -0.686 . . . . 0.0 109.365 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.51 87.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.81 -33.85 76.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.355 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 7.1 t -59.92 -44.2 94.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.798 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.564 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 70.1 mt -65.16 -55.87 16.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.179 -0.95 . . . . 0.0 109.847 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.8 m-70 -160.02 -167.34 1.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.546 -0.721 . . . . 0.0 109.776 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 69.6 m -110.37 -62.42 1.52 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.613 -0.68 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.46 -48.44 79.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.506 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -64.11 -43.66 94.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.486 -0.759 . . . . 0.0 109.032 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.37 -43.19 95.43 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 59.9 t0 -73.64 -10.34 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -100.94 22.75 11.67 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 84.4 m -81.95 130.74 35.16 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.47 -4.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.9 45.59 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -150.38 152.17 33.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -1.176 . . . . 0.0 109.123 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -133.15 127.11 33.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 109.191 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.89 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 90.0 m-20 53.0 57.56 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.787 -0.571 . . . . 0.0 110.342 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 458' ' ' ASN . 35.1 p80 41.67 30.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.233 0.54 . . . . 0.0 110.182 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.75 135.48 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.89 134.46 52.1 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.522 -0.736 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.76 150.57 63.36 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.67 160.43 49.49 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.393 2.062 . . . . 0.0 112.256 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.4 mp -63.07 -39.0 93.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.484 -0.76 . . . . 0.0 109.229 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 94.8 p -74.98 10.3 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.244 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -67.02 133.34 49.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.101 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.96 131.02 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.86 145.75 42.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 110.129 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -121.83 134.63 54.89 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.533 0.682 . . . . 0.0 109.427 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -55.68 135.9 51.04 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 96.31 -12.53 66.55 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' ASP . . . . . 0.437 ' OD1' HG12 ' A' ' 421' ' ' VAL . 36.4 p-10 -83.69 171.35 13.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -1.163 . . . . 0.0 110.47 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -122.19 114.26 20.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 18.9 t -93.16 131.79 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -133.0 113.84 13.28 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.9 m -83.73 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.3 mt -99.97 131.95 45.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.514 -0.741 . . . . 0.0 109.038 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 45.2 t -136.37 145.91 45.91 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.698 . . . . 0.0 109.752 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 480' ' ' LYS . 94.9 p -85.53 -4.04 59.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.76 . . . . 0.0 108.959 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 479' ' ' SER . 99.0 mttt 52.66 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.725 0.774 . . . . 0.0 110.618 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 11.4 p -64.22 -36.94 85.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.466 -0.771 . . . . 0.0 109.495 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 79.5 mt 56.37 42.27 27.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.628 -0.67 . . . . 0.0 109.895 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.05 71.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.137 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -66.79 -39.21 87.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 109.529 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -59.42 131.4 50.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.299 -0.875 . . . . 0.0 109.694 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -111.05 143.59 41.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.612 -0.68 . . . . 0.0 109.835 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 487' ' ' HIS . 48.2 t-80 -141.7 44.96 1.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -152.26 164.07 38.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.411 -0.806 . . . . 0.0 109.653 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.933 179.898 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 39.9 tpp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.2 149.07 41.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.617 -0.677 . . . . 0.0 109.292 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.6 m -112.29 130.53 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.4 ttm -97.11 135.98 38.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 109.765 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.53 165.24 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.564 -0.71 . . . . 0.0 109.238 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' A' ' 428' ' ' ILE . 78.8 m-85 -111.07 141.44 44.56 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.995 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' THR . . . . . 0.459 ' OG1' ' N ' ' A' ' 427' ' ' GLU . 82.1 p -96.39 151.44 38.07 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.7 -17.68 51.05 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.563 1.509 . . . . 0.0 110.685 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.431 -0.793 . . . . 0.0 109.176 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.77 1.17 65.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 23.2 mp0 -88.19 155.81 19.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.034 -1.274 . . . . 0.0 109.177 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' A' ' 422' ' ' PHE . 2.7 tp -106.91 140.26 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.46 132.77 53.49 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -103.81 133.45 48.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.275 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.8 mt -132.83 148.05 67.93 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.49 157.8 59.6 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.214 1.943 . . . . 0.0 112.157 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.81 148.66 12.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.391 -0.818 . . . . 0.0 110.085 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.9 81.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.84 41.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -127.21 174.44 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.509 -0.744 . . . . 0.0 109.663 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.77 71.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.951 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.97 -42.18 98.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.029 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.96 -43.27 95.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.925 . . . . 0.0 109.703 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 444' ' ' LEU . 85.0 t80 -60.44 -45.06 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.06 85.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.983 . . . . 0.0 109.801 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -63.93 -36.94 85.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.02 . . . . 0.0 109.643 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.6 m -58.02 -41.84 83.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.887 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.459 HD11 ' CE2' ' A' ' 440' ' ' PHE . 70.2 mt -65.92 -75.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -141.89 -178.46 5.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 109.589 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 78.2 p -101.29 -54.01 2.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.407 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.1 m-20 -62.33 -45.95 90.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.55 -43.49 96.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.003 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 449' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.44 -38.81 93.83 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.91 -11.8 61.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 109.202 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -105.01 13.43 30.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 30.3 p -74.75 120.8 20.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.935 . . . . 0.0 109.816 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.9 pt -101.81 -3.1 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 109.439 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.54 45.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -153.05 150.3 29.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.265 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -135.5 133.03 38.06 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.419 -0.801 . . . . 0.0 109.391 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.33 131.24 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.404 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 3.3 t30 56.47 44.55 24.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.317 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 54.21 15.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.75 . . . . 0.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -113.85 137.1 52.12 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.471 -0.768 . . . . 0.0 109.241 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.25 135.25 53.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.859 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.13 151.28 33.92 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.918 . . . . 0.0 108.984 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.31 162.08 42.0 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.473 2.115 . . . . 0.0 112.615 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -61.88 -40.35 95.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.739 . . . . 0.0 109.546 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 92.7 p -75.29 10.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -67.23 135.66 53.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.684 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 72.7 t -78.46 132.58 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -0.872 . . . . 0.0 109.681 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -74.97 148.97 39.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 109.77 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -123.19 145.59 48.5 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 36.9 t -65.37 144.22 57.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.55 -40.67 3.03 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.37 145.4 51.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -1.107 . . . . 0.0 109.799 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -87.62 149.95 23.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.153 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.91 131.29 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -131.66 138.76 48.88 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.87 130.12 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 109.384 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.72 136.18 33.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 109.434 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.6 m -129.68 156.9 43.51 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.601 -0.687 . . . . 0.0 109.426 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 93.9 p -78.48 -2.41 38.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 482' ' ' LEU . 45.7 mmtm -76.26 144.96 40.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.308 -0.87 . . . . 0.0 109.956 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 71.0 m -64.03 71.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.673 -0.642 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 480' ' ' LYS . 2.3 pp -89.66 -1.88 58.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.233 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.27 -5.03 59.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 0.0 109.586 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -108.35 117.91 35.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.469 -0.769 . . . . 0.0 109.703 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.455 ' O ' ' N ' ' A' ' 487' ' ' HIS . 98.8 m-70 -58.38 -77.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 486' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 488' ' ' HIS . 73.2 m80 47.0 18.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 485' ' ' HIS . 69.4 t60 59.64 -70.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.439 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.555 ' N ' ' O ' ' A' ' 486' ' ' HIS . 75.0 m80 -70.62 136.44 49.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.981 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.447 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -90.14 162.11 15.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.599 0.714 . . . . 0.0 110.086 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.89 130.46 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.834 0.825 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.0 ttp -99.97 136.34 40.03 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.736 0.779 . . . . 0.0 110.043 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.79 164.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.26 138.58 54.45 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.07 0.938 . . . . 0.0 110.229 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.04 164.96 15.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.69 -13.55 40.36 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.487 2.125 . . . . 0.0 111.671 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.78 -5.52 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.376 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.35 8.13 83.88 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -84.69 159.45 20.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.624 -0.927 . . . . 0.0 110.566 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -105.43 128.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.739 0.78 . . . . 0.0 109.493 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -127.88 144.88 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.525 0.679 . . . . 0.0 109.636 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -124.71 136.0 53.51 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.694 . . . . 0.0 110.072 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 35.6 mt -127.47 147.81 63.89 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.88 158.27 58.55 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.429 2.086 . . . . 0.0 112.593 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.31 141.42 24.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.973 0.892 . . . . 0.0 110.661 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.4 84.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.28 150.78 46.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.686 -0.89 . . . . 0.0 110.278 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.1 p -127.24 173.5 9.69 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.929 0.871 . . . . 0.0 110.227 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.64 62.32 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.519 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.92 -45.88 90.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.589 -0.695 . . . . 0.0 109.363 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.499 ' CE2' HD11 ' A' ' 444' ' ' LEU . 85.1 t80 -60.76 -44.35 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.765 -0.584 . . . . 0.0 109.8 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.43 90.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' TYR . . . . . 0.417 ' CE1' ' CD1' ' A' ' 438' ' ' LEU . 5.5 m-85 -68.37 -36.73 79.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 70.3 p -60.27 -38.28 83.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.72 -0.612 . . . . 0.0 109.478 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.499 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.1 mt -71.88 -75.37 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.491 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -140.48 -179.38 5.98 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 13.0 m -102.42 -59.05 1.77 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.469 -0.77 . . . . 0.0 110.293 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 37.8 p-10 -63.21 -44.04 96.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.026 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.53 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.96 -45.12 90.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.511 -0.743 . . . . 0.0 109.065 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.33 92.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.08 -36.15 83.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.737 -0.86 . . . . 0.0 109.557 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.22 20.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.794 -0.566 . . . . 0.0 109.673 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 10.4 t -77.73 120.71 23.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.2 -4.94 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.46 178.3 48.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.49 148.19 39.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.977 . . . . 0.0 109.958 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -129.54 121.41 27.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.65 0.738 . . . . 0.0 109.694 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.13 132.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.776 0.798 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.473 ' O ' ' ND2' ' A' ' 458' ' ' ASN . 0.2 OUTLIER 54.84 43.9 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.599 0.714 . . . . 0.0 109.734 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.86 15.07 2.09 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -118.2 134.58 54.89 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.829 0.823 . . . . 0.0 109.815 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.27 134.37 50.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.673 0.749 . . . . 0.0 110.061 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.06 150.35 41.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.725 -0.609 . . . . 0.0 109.787 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.62 163.17 33.91 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.598 2.199 . . . . 0.0 112.826 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -62.73 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.149 0.5 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 5.6 t -75.53 8.15 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.645 -0.659 . . . . 0.0 109.668 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -68.22 134.37 50.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 109.676 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.12 130.21 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.777 0.798 . . . . 0.0 109.922 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.9 mt -75.97 144.24 41.08 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.564 0.697 . . . . 0.0 110.243 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -115.24 145.55 42.32 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.892 0.853 . . . . 0.0 110.118 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.4 t -66.01 139.99 58.25 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.461 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.44 -32.78 5.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -74.73 145.32 43.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.895 . . . . 0.0 110.904 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -86.85 144.76 26.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.519 0.676 . . . . 0.0 109.268 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.69 132.53 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.937 0.875 . . . . 0.0 110.127 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -135.74 141.51 44.86 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.455 0.645 . . . . 0.0 109.305 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.93 131.73 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.859 0.838 . . . . 0.0 110.005 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.12 131.21 45.32 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.469 0.652 . . . . 0.0 109.668 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.9 t -133.45 131.82 40.36 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.628 0.728 . . . . 0.0 109.507 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 6.4 t -94.46 -0.32 54.82 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 481' ' ' SER . 68.6 mttm 56.19 44.55 24.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 480' ' ' LYS . 13.5 m -59.04 -151.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.693 0.759 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 482' ' ' LEU . 8.1 mp 47.78 84.22 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.947 0.879 . . . . 0.0 109.366 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 483' ' ' GLU . 58.0 mp0 -82.12 137.48 34.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.772 0.796 . . . . 0.0 110.387 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -88.41 153.01 21.52 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.51 0.671 . . . . 0.0 110.341 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.488 ' O ' ' CG ' ' A' ' 486' ' ' HIS . 2.2 m-70 69.38 -48.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 486' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' A' ' 485' ' ' HIS . 18.6 p-80 40.2 40.33 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.707 0.765 . . . . 0.0 109.753 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 487' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 486' ' ' HIS . 78.0 m80 45.86 -176.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.496 0.665 . . . . 0.0 111.053 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.12 -40.09 86.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.535 -0.728 . . . . 0.0 109.276 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.392 179.619 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.49 163.76 26.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.739 . . . . 0.0 110.119 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.1 130.75 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 51.1 ttm -95.53 133.77 39.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.646 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.76 163.52 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.53 140.48 52.96 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.615 0.722 . . . . 0.0 109.613 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.1 175.82 2.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.4 -30.04 90.15 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.372 2.048 . . . . 0.0 111.561 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -81.22 -4.09 54.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 109.204 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.69 9.18 85.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.77 151.88 45.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -1.078 . . . . 0.0 110.414 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.77 122.67 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.462 -0.774 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -128.05 131.36 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -108.04 134.82 50.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.656 -0.653 . . . . 0.0 109.36 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.99 157.43 69.42 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.697 -0.627 . . . . 0.0 109.393 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.94 150.25 79.24 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.208 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -54.34 137.26 42.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -0.838 . . . . 0.0 110.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.09 13.3 74.73 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -65.45 159.35 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -1.08 . . . . 0.0 110.057 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.3 p -126.93 171.97 10.84 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.691 0.758 . . . . 0.0 110.014 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.6 62.88 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.664 -0.647 . . . . 0.0 109.953 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.57 -46.59 87.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.091 -1.006 . . . . 0.0 109.383 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.47 -39.24 93.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.421 -0.799 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.419 ' CE2' HD11 ' A' ' 444' ' ' LEU . 88.0 t80 -60.83 -44.96 96.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.58 92.99 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' TYR . . . . . 0.431 ' CE1' HD11 ' A' ' 438' ' ' LEU . 4.8 m-85 -67.59 -36.35 80.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 11.7 t -59.82 -43.6 94.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.775 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 440' ' ' PHE . 79.5 mt -64.21 -74.91 0.09 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -135.7 -179.73 5.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.467 -0.77 . . . . 0.0 109.673 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 29.9 p -103.09 -56.11 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.694 -0.629 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 36.9 p-10 -66.85 -41.66 86.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -64.37 -44.54 91.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.329 -0.857 . . . . 0.0 109.025 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.32 93.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -70.9 -11.31 60.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -1.095 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -104.55 14.87 29.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 11.2 t -77.7 123.53 26.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 109.756 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.64 -4.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -174.42 176.46 46.75 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.537 -1.315 . . . . 0.0 109.898 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.16 147.05 45.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -1.056 . . . . 0.0 109.049 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -133.01 121.49 22.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.82 133.78 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.425 0.631 . . . . 0.0 109.543 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 458' ' ' ASN . 3.3 t30 57.28 44.1 22.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.495 0.664 . . . . 0.0 109.708 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 55.77 17.56 2.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.028 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -122.02 142.21 50.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.489 -0.757 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.51 132.81 45.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.69 -0.631 . . . . 0.0 109.896 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.43 150.22 50.55 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.079 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.63 162.05 40.96 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.567 2.178 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -63.35 -38.5 91.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.9 m -75.02 8.8 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.125 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -67.58 134.21 50.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.01 132.04 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.852 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.88 148.09 40.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.634 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -123.8 145.09 49.3 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.545 0.688 . . . . 0.0 109.454 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.8 m -66.45 144.72 56.33 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.589 0.709 . . . . 0.0 111.224 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.12 -30.32 5.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -74.9 153.47 38.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -1.09 . . . . 0.0 110.783 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -98.17 128.97 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.34 131.34 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.97 144.39 45.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.2 m -109.88 132.18 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.556 0.693 . . . . 0.0 109.722 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.18 129.63 42.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.47 -0.769 . . . . 0.0 109.212 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.3 m -133.8 126.81 31.36 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.593 -0.692 . . . . 0.0 109.528 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 78.1 p -66.26 -34.23 77.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.697 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -72.15 133.72 45.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 18.7 m -159.24 -36.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.267 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 482' ' ' LEU . 0.5 OUTLIER -107.55 1.39 23.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 483' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 485' ' ' HIS . 79.7 mm-40 54.54 -120.91 1.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.647 -0.658 . . . . 0.0 110.326 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 484' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 484' ' ' HIS . 37.0 t-80 48.45 12.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.367 -0.833 . . . . 0.0 109.37 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 483' ' ' GLU . 51.9 p-80 -67.93 -39.01 83.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.384 -0.823 . . . . 0.0 109.491 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 486' ' ' HIS . . . . . 0.402 ' N ' ' CG ' ' A' ' 485' ' ' HIS . 59.8 t-80 50.29 86.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -72.37 149.79 44.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.0 110.387 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.92 -41.78 96.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.416 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' HIS . . . . . 0.504 ' OXT' ' CG ' ' A' ' 489' ' ' HIS . 80.8 t60 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.87 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.519 0.676 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.96 158.48 25.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 0.0 110.047 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.4 131.31 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.485 0.66 . . . . 0.0 109.449 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 12.3 ptm -97.3 147.51 24.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.646 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.51 161.78 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.03 120.59 42.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.55 0.69 . . . . 0.0 109.646 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.6 p -88.48 154.13 50.96 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.18 -13.13 14.89 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.279 1.986 . . . . 0.0 111.284 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -85.02 -3.68 58.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.28 3.67 88.59 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.88 159.49 19.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.959 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.2 mm -113.1 129.6 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.478 -0.763 . . . . 0.0 109.542 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -121.87 137.57 54.73 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -105.01 131.19 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 109.91 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.95 147.43 46.29 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.06 154.44 74.06 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.86 137.96 37.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.581 0.705 . . . . 0.0 110.573 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.0 13.24 75.12 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.94 155.58 40.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -1.047 . . . . 0.0 110.207 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.4 p -127.09 175.33 8.2 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.664 0.745 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.2 -33.36 67.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.693 -0.629 . . . . 0.0 110.125 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.03 -41.97 99.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.117 -0.989 . . . . 0.0 109.794 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -60.44 -43.31 96.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.33 -0.856 . . . . 0.0 109.814 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.449 ' CE2' HD11 ' A' ' 444' ' ' LEU . 70.3 t80 -61.52 -43.45 98.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.429 -0.795 . . . . 0.0 109.98 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.45 -44.6 80.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.89 -36.34 84.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.7 p -58.98 -34.36 71.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.449 HD11 ' CE2' ' A' ' 440' ' ' PHE . 86.8 mt -73.78 -76.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.686 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -143.49 -173.8 4.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.265 -0.897 . . . . 0.0 110.101 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 29.7 t -104.17 -55.22 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.412 0.625 . . . . 0.0 109.512 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.485 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 25.7 p-10 -63.01 -48.83 77.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.817 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.97 -43.15 96.63 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.471 -0.768 . . . . 0.0 109.198 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -64.35 -41.13 98.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 66.3 t0 -69.42 -27.41 65.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -1.066 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.485 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 34.5 m80 -87.72 18.11 4.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.277 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 42.6 m -80.23 117.04 20.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -0.875 . . . . 0.0 109.663 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.94 -2.54 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.751 . . . . 0.0 109.377 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.16 178.03 43.78 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.402 -1.38 . . . . 0.0 110.288 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.89 150.5 29.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -1.024 . . . . 0.0 109.067 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' LYS . . . . . 0.525 ' HZ2' ' HB2' ' A' ' 456' ' ' LYS . 3.2 ttmp? -135.79 131.9 36.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.571 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.47 130.83 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.567 0.699 . . . . 0.0 109.538 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 55.84 43.35 27.76 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.45 0.643 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 459' ' ' HIS . 59.0 t-80 57.9 12.98 1.91 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 109.965 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -113.83 135.34 54.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 47.8 tp -66.68 135.08 53.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 110.109 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.04 151.2 37.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.099 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.17 161.89 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.483 2.122 . . . . 0.0 112.344 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -63.05 -38.31 90.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.646 -0.659 . . . . 0.0 109.504 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.5 p -75.07 9.43 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.977 . . . . 0.0 109.3 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -68.88 135.26 50.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.404 -0.81 . . . . 0.0 110.206 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.35 130.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.306 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.63 147.51 37.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 110.174 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -125.46 146.61 49.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.607 -0.683 . . . . 0.0 109.909 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 68.2 m -70.49 141.43 51.98 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.565 0.698 . . . . 0.0 110.865 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.48 -22.72 39.31 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.32 171.04 13.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.198 -1.178 . . . . 0.0 110.529 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.69 127.38 56.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 440' ' ' PHE . 60.2 t -102.82 131.7 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.371 -0.831 . . . . 0.0 109.911 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.54 116.05 14.6 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 476' ' ' VAL . 3.6 m -85.05 130.93 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.35 143.67 26.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.558 -0.714 . . . . 0.0 109.652 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 480' ' ' LYS . 70.2 m -123.64 154.96 38.6 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 85.3 p -70.55 37.84 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.474 -0.766 . . . . 0.0 109.87 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 478' ' ' SER . 44.4 mmtm -87.36 -7.86 57.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.461 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 482' ' ' LEU . 19.2 p -171.42 -131.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.956 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.551 ' N ' ' OG ' ' A' ' 481' ' ' SER . 32.8 mt 60.46 49.45 6.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -42.52 137.42 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -73.33 140.94 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.591 -0.693 . . . . 0.0 109.955 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 486' ' ' HIS . 59.1 t-80 -108.46 142.95 38.08 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 486' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 487' ' ' HIS . 34.2 p80 -65.51 141.48 58.46 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 486' ' ' HIS . 61.1 t-80 59.43 135.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.501 0.667 . . . . 0.0 110.21 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -103.33 129.75 50.44 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.688 0.756 . . . . 0.0 109.687 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.932 -179.83 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.2 mp0 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.65 131.26 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.711 0.767 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.6 ttm -94.89 131.7 40.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.232 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.03 164.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -123.78 144.47 49.68 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.412 0.625 . . . . 0.0 109.51 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.8 176.27 1.98 Allowed Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -34.53 84.54 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -81.35 -3.68 53.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.575 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.32 9.34 85.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -69.91 150.81 46.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.286 . . . . 0.0 110.299 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.3 mm -90.06 124.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -131.5 112.4 12.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -94.02 136.19 34.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.501 -0.75 . . . . 0.0 109.219 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.3 mt -122.31 148.18 51.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.493 2.129 . . . . 0.0 112.717 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -56.01 139.31 47.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.62 12.63 77.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.06 154.8 41.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.7 p -127.49 174.57 8.92 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.55 0.69 . . . . 0.0 109.984 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.62 71.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.507 -0.746 . . . . 0.0 109.444 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.76 -42.45 99.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -61.49 -43.02 99.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.79 . . . . 0.0 110.088 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 444' ' ' LEU . 57.1 t80 -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.54 80.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.178 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -64.96 -36.54 84.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.336 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.5 m -58.49 -41.56 85.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.459 HD11 ' CE2' ' A' ' 440' ' ' PHE . 78.0 mt -68.16 -73.77 0.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.32 -179.8 6.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.924 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 73.5 m -100.11 -59.57 1.69 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.568 -0.708 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.425 ' OD1' ' CD2' ' A' ' 451' ' ' HIS . 49.2 t0 -60.17 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.867 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.6 -43.41 97.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.227 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.49 -37.46 94.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.05 -16.41 63.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.054 -1.263 . . . . 0.0 109.381 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.425 ' CD2' ' OD1' ' A' ' 447' ' ' ASP . 45.3 m-70 -95.79 17.26 15.48 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 25.6 p -74.29 116.77 15.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.388 -0.82 . . . . 0.0 109.539 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.2 pt -99.44 -2.79 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -0.766 . . . . 0.0 109.247 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.26 -171.6 39.41 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.022 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -148.71 148.02 29.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -1.178 . . . . 0.0 109.126 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -135.63 120.86 18.99 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.01 133.14 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.557 0.694 . . . . 0.0 109.92 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 56.51 43.27 26.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.681 -0.637 . . . . 0.0 109.671 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 55.33 10.38 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.625 -0.672 . . . . 0.0 109.957 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.24 145.25 42.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.564 -0.71 . . . . 0.0 109.652 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 461' ' ' LEU . 4.3 mm? -72.93 141.37 47.84 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.38 148.38 22.19 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.02 162.6 37.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.274 1.982 . . . . 0.0 112.68 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.71 -40.3 96.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.443 -0.785 . . . . 0.0 109.624 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 93.1 p -75.75 10.38 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.039 -1.038 . . . . 0.0 109.434 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -68.33 135.35 51.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 110.347 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.43 131.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.31 144.09 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.675 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -115.2 150.56 35.93 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.42 0.629 . . . . 0.0 109.421 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 15.6 p -70.78 155.34 40.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.0 -36.57 1.47 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.6 145.14 54.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.246 . . . . 0.0 111.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -86.29 140.23 30.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.763 . . . . 0.0 109.175 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.08 132.1 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.543 -0.723 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -136.82 116.02 12.55 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.35 138.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.92 130.89 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.275 -179.859 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.54 129.97 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.82 142.9 31.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.0 109.648 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.84 164.5 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.54 137.1 54.56 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.603 0.716 . . . . 0.0 109.479 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.05 165.55 14.7 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.85 -14.42 44.52 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.548 2.165 . . . . 0.0 111.232 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -85.22 -5.11 59.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.576 -0.702 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.34 9.3 82.1 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 4.5 mp0 -84.19 162.04 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.288 -1.125 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.92 129.22 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -127.99 132.04 49.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -109.6 139.39 44.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 109.527 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 97.4 mt -136.4 147.9 61.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.488 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.46 158.65 56.58 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.486 2.124 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -56.63 146.34 25.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.55 77.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.57 154.42 41.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.687 -0.89 . . . . 0.0 110.142 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 69.5 p -127.57 170.47 12.59 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.595 0.712 . . . . 0.0 109.693 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.73 74.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 109.321 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.68 -42.09 99.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.44 -43.68 98.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.507 ' CE2' HD21 ' A' ' 444' ' ' LEU . 85.2 t80 -61.29 -44.68 96.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 109.523 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.74 -36.51 83.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.191 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.4 t -61.57 -39.54 91.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.578 -0.701 . . . . 0.0 110.132 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.507 HD21 ' CE2' ' A' ' 440' ' ' PHE . 89.2 mt -48.44 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' A' ' 447' ' ' ASP . 99.3 m-70 -151.24 20.46 0.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 m 68.52 -37.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.624 . . . . 0.0 109.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 445' ' ' HIS . 99.7 m-20 -62.15 -44.23 97.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.5 mm? -63.72 -43.06 97.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.825 . . . . 0.0 108.983 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -71.25 -29.65 68.24 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -76.44 -9.77 58.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -1.072 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -138.83 28.47 2.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.19 109.23 13.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.5 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.4 pt -100.65 -2.52 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.511 -0.743 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.32 176.51 45.99 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.066 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.6 149.99 29.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -1.083 . . . . 0.0 109.106 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -135.56 124.59 24.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 0.0 108.89 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.0 t -122.16 133.02 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.565 -0.709 . . . . 0.0 109.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 55.79 42.97 28.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.603 -0.686 . . . . 0.0 109.687 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m80 54.86 13.82 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.864 -0.523 . . . . 0.0 110.264 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -117.91 137.4 52.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 109.133 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.57 135.22 54.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.13 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.32 150.82 56.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.74 160.77 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.253 1.969 . . . . 0.0 112.547 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.2 mp -62.72 -40.33 96.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 465' ' ' SER . 3.4 t -77.7 15.06 0.89 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.507 -0.745 . . . . 0.0 109.167 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 464' ' ' LEU . 86.8 t80 -67.54 134.11 50.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.907 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.96 131.39 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.785 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.95 145.66 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.806 . . . . 0.0 110.243 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -119.58 146.18 45.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.537 0.684 . . . . 0.0 109.175 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.1 t -64.93 141.24 58.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 110.68 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.7 -32.83 4.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -72.73 147.04 46.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.251 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.34 144.16 28.22 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.81 132.95 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-O 121.668 0.747 . . . . 0.0 109.786 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -139.62 128.62 23.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.94 128.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.007 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.22 100.0 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.025 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 110.025 -179.744 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.3 mp0 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.05 131.07 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.684 0.754 . . . . 0.0 109.486 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.7 ttp -98.22 129.97 44.96 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.723 0.773 . . . . 0.0 110.458 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.33 164.47 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.33 137.35 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.856 0.836 . . . . 0.0 109.96 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.39 159.66 30.67 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.93 -16.22 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.251 1.967 . . . . 0.0 111.413 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -83.27 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.03 6.42 88.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 429' ' ' LYS . 82.7 tt0 -86.6 152.48 22.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.943 . . . . 0.0 110.705 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.9 mm -84.18 129.2 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.492 0.663 . . . . 0.0 109.804 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 427' ' ' GLU . 34.9 mmtm -132.76 109.4 9.64 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.597 0.713 . . . . 0.0 110.13 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -102.37 128.67 48.86 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.6 mt -122.47 152.69 61.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.14 145.94 24.51 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.459 2.106 . . . . 0.0 112.745 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -58.39 137.01 57.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.847 0.832 . . . . 0.0 110.634 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.23 13.93 72.84 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -72.61 166.54 22.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.913 . . . . 0.0 110.209 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 p -127.13 172.34 10.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.992 0.901 . . . . 0.0 110.581 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.61 -26.6 61.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.09 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.72 -45.4 92.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.418 -0.801 . . . . 0.0 109.719 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -64.82 -38.39 90.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.691 -0.631 . . . . 0.0 109.421 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 444' ' ' LEU . 84.5 t80 -61.23 -45.34 94.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.786 -0.571 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.51 91.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.646 -0.659 . . . . 0.0 109.515 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 438' ' ' LEU . 8.7 m-85 -68.64 -34.09 75.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.494 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 30.8 m -58.08 -42.07 84.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.81 -0.556 . . . . 0.0 109.706 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.8 mt -64.08 -70.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.714 -0.616 . . . . 0.0 109.603 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -149.2 -176.17 5.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.559 -0.713 . . . . 0.0 109.904 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 37.6 t -92.45 -71.01 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.498 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 27.2 t70 -55.78 -48.63 75.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.793 -0.567 . . . . 0.0 110.231 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.523 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.9 -44.5 95.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.531 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.07 -38.73 92.66 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.75 -10.7 59.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.874 . . . . 0.0 109.501 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 16.0 m80 -99.66 20.8 13.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.97 117.9 22.55 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.585 0.707 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.6 pt -101.16 -3.46 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.49 176.94 46.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.71 146.34 37.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.797 -0.825 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -134.75 122.27 21.9 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.394 0.616 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -122.44 132.76 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.702 0.763 . . . . 0.0 109.8 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 54.42 45.69 26.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.653 0.739 . . . . 0.0 109.796 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 58.1 t-80 56.41 14.04 1.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.055 0.455 . . . . 0.0 109.969 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.44 141.15 47.44 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.725 0.774 . . . . 0.0 110.159 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -79.58 112.31 16.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.544 0.688 . . . . 0.0 109.522 -179.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.527 ' N ' HD13 ' A' ' 461' ' ' LEU . 3.6 m -120.95 151.02 54.35 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.85 163.3 36.01 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.604 2.202 . . . . 0.0 112.648 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.62 -39.93 95.36 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.6 m -75.45 8.35 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.773 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 91.1 t80 -67.54 135.01 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.698 0.761 . . . . 0.0 110.406 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.426 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 79.8 t -78.53 131.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.828 0.823 . . . . 0.0 109.757 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.4 mt -74.41 143.39 44.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.654 0.74 . . . . 0.0 110.407 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -116.26 144.6 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.767 0.794 . . . . 0.0 109.801 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.5 t -66.76 139.81 57.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.756 0.789 . . . . 0.0 110.564 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.28 -34.99 4.18 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.05 144.21 48.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.732 -0.864 . . . . 0.0 110.872 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -87.44 144.22 26.85 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.499 0.666 . . . . 0.0 109.562 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.42 131.31 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.575 0.703 . . . . 0.0 109.969 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -133.07 137.98 46.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.03 130.94 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.64 0.734 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.01 131.74 42.09 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.536 0.684 . . . . 0.0 109.676 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.694 0.759 . . . . 0.0 109.721 -179.8 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.1 mp0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.387 0.613 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.45 131.03 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.55 0.69 . . . . 0.0 109.301 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . 0.517 ' SD ' HG23 ' A' ' 428' ' ' ILE . 50.8 ttp -97.88 136.54 38.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.523 -0.735 . . . . 0.0 109.768 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.11 161.55 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -115.33 134.59 54.97 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.659 0.742 . . . . 0.0 109.787 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 166.27 13.63 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.71 -15.05 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.531 2.154 . . . . 0.0 111.471 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -85.91 -6.2 59.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.196 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.72 11.9 78.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.449 ' C ' HD12 ' A' ' 428' ' ' ILE . 79.8 mm-40 -85.84 161.77 18.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.143 . . . . 0.0 110.206 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.517 HG23 ' SD ' ' A' ' 420' ' ' MET . 1.3 mp -107.78 129.03 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.92 123.35 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -102.08 127.87 48.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 14.1 mt -118.49 158.21 47.56 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.53 149.17 83.7 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.33 2.02 . . . . 0.0 112.873 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -57.48 134.21 55.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.458 -0.777 . . . . 0.0 110.418 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.73 76.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -63.54 167.87 5.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -1.148 . . . . 0.0 110.246 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 70.0 p -127.52 172.33 10.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.666 0.746 . . . . 0.0 110.002 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -30.07 68.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.477 -0.764 . . . . 0.0 109.219 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 464' ' ' LEU . 89.6 mt -63.05 -43.12 99.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 0.0 109.309 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.68 -41.35 99.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 444' ' ' LEU . 54.7 t80 -61.43 -43.65 98.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.96 -44.8 87.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -65.49 -35.73 81.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.404 -0.81 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 26.2 m -58.64 -41.47 86.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.753 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.456 HD11 ' CE2' ' A' ' 440' ' ' PHE . 76.5 mt -68.96 -77.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.651 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 445' ' ' HIS . 6.1 m80 -124.29 -151.18 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.604 -0.685 . . . . 0.0 109.2 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 26.5 m -128.54 -70.49 0.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.59 -0.694 . . . . 0.0 109.251 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.446 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.6 m-20 -64.19 -39.5 94.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.512 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.08 -44.95 95.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.059 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.14 93.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 452' ' ' CYS . 35.4 t70 -64.43 -38.36 90.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -1.09 . . . . 0.0 109.605 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.446 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 60.9 m80 -78.6 28.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 8.8 t -79.21 123.97 27.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.0 pt -97.6 -5.01 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.214 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . 175.88 179.74 46.55 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.75 149.54 43.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.995 . . . . 0.0 109.122 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -132.41 122.6 25.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.33 132.88 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.692 -0.63 . . . . 0.0 109.643 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . 0.562 HD21 ' CG ' ' A' ' 472' ' ' ASP . 98.0 m-20 55.9 42.37 28.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.721 -0.612 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.8 m80 57.15 12.03 1.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.739 -0.6 . . . . 0.0 109.879 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.96 136.25 53.21 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.632 0.73 . . . . 0.0 109.653 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.92 134.63 52.4 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.577 -0.702 . . . . 0.0 109.863 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.09 150.9 57.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.795 . . . . 0.0 109.294 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.5 161.6 42.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.558 2.172 . . . . 0.0 113.01 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -63.27 -40.16 96.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.699 -0.626 . . . . 0.0 109.451 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 8.4 t -76.43 8.19 3.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.207 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 90.1 t80 -61.26 134.91 57.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.512 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.411 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 76.1 t -76.9 130.09 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.478 -0.764 . . . . 0.0 109.98 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.8 147.71 33.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 110.409 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -125.7 145.19 50.29 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.621 0.724 . . . . 0.0 109.518 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 97.6 p -65.4 145.17 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.658 0.742 . . . . 0.0 110.846 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.43 -32.53 4.69 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . 0.562 ' CG ' HD21 ' A' ' 458' ' ' ASN . 88.7 m-20 -72.73 145.77 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.88 139.67 30.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.17 131.93 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.569 0.7 . . . . 0.0 109.992 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.91 114.01 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.61 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.88 114.24 26.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 109.594 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 95.2 p . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.535 -0.728 . . . . 0.0 110.224 -179.561 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.9 mp0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.317 0.58 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.0 131.73 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.737 0.78 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.6 ttm -90.33 132.9 35.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.758 0.79 . . . . 0.0 110.084 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 429' ' ' LYS . 18.4 m -131.63 163.46 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.404 0.621 . . . . 0.0 109.425 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 428' ' ' ILE . 85.9 m-85 -123.57 138.68 54.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.013 0.911 . . . . 0.0 109.929 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 159.39 29.87 Favored Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.41 -34.81 33.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.331 2.021 . . . . 0.0 112.221 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.81 -4.13 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.818 -0.551 . . . . 0.0 109.696 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.36 7.45 82.62 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -74.09 153.21 39.71 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.676 0.75 . . . . 0.0 110.682 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.435 HD12 ' CE2' ' A' ' 422' ' ' PHE . 20.4 mm -104.97 122.5 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.406 0.622 . . . . 0.0 109.629 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.401 ' O ' HG22 ' A' ' 421' ' ' VAL . 72.0 mmtt -127.31 135.91 51.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.846 0.831 . . . . 0.0 110.235 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -108.11 132.86 53.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 31.5 mt -122.14 152.45 60.25 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 147.84 28.91 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.262 1.975 . . . . 0.0 112.86 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.21 129.32 41.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.646 0.736 . . . . 0.0 110.58 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 13.95 76.19 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.36 173.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.671 0.748 . . . . 0.0 110.604 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 33.0 p -127.97 172.01 11.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.874 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.71 65.8 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.09 -42.47 99.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.97 -42.05 98.7 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 444' ' ' LEU . 56.2 t80 -62.1 -42.87 99.66 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.98 92.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.0 -36.6 83.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.3 m -58.95 -42.87 90.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.565 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 77.6 mt -66.61 -59.93 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.734 -0.604 . . . . 0.0 109.789 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.4 m-70 -158.85 -176.06 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.441 0.638 . . . . 0.0 109.858 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 39.9 t -101.58 -61.72 1.34 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.09 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.51 -44.96 95.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.742 -0.599 . . . . 0.0 109.935 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.12 -45.11 93.53 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.15 89.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.98 -34.35 78.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.885 -0.773 . . . . 0.0 109.406 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -85.12 16.5 3.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 49.7 t -72.79 116.67 13.56 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.597 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.2 pt -102.53 -0.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . 0.449 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -173.03 170.86 44.01 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.745 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.12 149.51 31.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.069 -0.665 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -138.82 130.59 27.7 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 64.7 t -119.97 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.663 0.744 . . . . 0.0 109.677 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 58.49 41.64 22.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 56.94 12.99 1.33 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -113.05 115.36 28.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.896 0.855 . . . . 0.0 109.792 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.1 tp -51.32 133.92 28.5 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.556 0.694 . . . . 0.0 110.229 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.1 152.34 39.6 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.13 161.57 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.595 2.196 . . . . 0.0 112.651 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.79 -38.2 89.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.1 m -75.05 7.45 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.847 -0.533 . . . . 0.0 109.663 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -69.58 134.08 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.564 0.697 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 82.8 t -78.61 131.04 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.596 0.713 . . . . 0.0 109.865 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.71 146.24 42.43 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.629 0.728 . . . . 0.0 110.631 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -121.11 144.54 48.51 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.866 0.841 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 140.75 58.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.659 0.743 . . . . 0.0 111.121 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.57 -25.89 18.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.32 163.29 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.666 -0.903 . . . . 0.0 110.946 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -109.31 120.72 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 20.9 t -93.09 132.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.841 0.829 . . . . 0.0 110.622 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.5 0.667 . . . . 0.0 109.316 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.23 130.82 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.805 0.812 . . . . 0.0 110.455 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.65 106.35 18.61 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.588 0.709 . . . . 0.0 109.213 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.588 0.708 . . . . 0.0 110.171 179.845 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.3 mp0 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 18.2 m -119.32 130.94 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.592 -0.692 . . . . 0.0 109.215 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 49.5 ttp -96.66 137.94 34.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.74 165.18 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -113.32 138.51 49.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.515 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.6 162.49 21.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 108.784 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.27 -32.29 40.52 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.191 1.928 . . . . 0.0 111.998 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.53 -1.64 34.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.05 -1.031 . . . . 0.0 109.323 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.22 12.09 81.29 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.24 158.83 32.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -1.163 . . . . 0.0 110.55 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.6 mm -106.24 124.41 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.463 -0.773 . . . . 0.0 109.077 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -128.67 132.94 48.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -0.758 . . . . 0.0 109.016 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -106.74 138.41 42.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.1 mt -131.64 147.6 66.69 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.92 157.31 62.36 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.375 2.05 . . . . 0.0 112.705 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.41 143.01 25.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.64 12.62 74.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.06 42.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 110.364 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.2 p -127.45 172.03 11.04 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.588 0.709 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.28 69.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.49 -0.756 . . . . 0.0 109.593 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.58 -42.26 99.45 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 109.197 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.59 -44.71 93.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 444' ' ' LEU . 65.0 t80 -61.5 -43.65 98.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.11 85.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.152 -0.968 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -64.31 -36.87 85.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.0 m -59.01 -42.29 89.75 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.96 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.5 mt -66.71 -57.36 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.991 -1.068 . . . . 0.0 109.658 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.652 ' CD2' ' H ' ' A' ' 446' ' ' SER . 65.6 t60 -161.48 -173.48 3.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.144 -0.972 . . . . 0.0 109.333 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . 0.652 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 8.7 m -103.41 -60.53 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.74 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 451' ' ' HIS . 43.5 t0 -62.16 -45.7 92.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.501 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.07 -43.89 97.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 108.816 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . 0.447 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.67 -35.51 92.02 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -73.41 -10.77 60.08 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.28 -1.13 . . . . 0.0 109.36 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 59.5 m-70 -97.36 7.85 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 108.841 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 29.9 p -73.55 116.44 14.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.392 -0.818 . . . . 0.0 109.822 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.08 -2.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.05 177.54 43.95 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.55 142.79 41.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -1.074 . . . . 0.0 108.958 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.74 121.9 21.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.5 133.85 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 57.38 43.95 22.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.764 0.792 . . . . 0.0 109.356 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 54.17 13.27 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.747 . . . . 0.0 110.224 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -114.71 136.65 52.83 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.54 -0.725 . . . . 0.0 109.418 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.1 tp -67.83 134.46 50.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.89 151.2 48.65 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 108.861 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.55 162.08 38.47 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.598 2.199 . . . . 0.0 112.746 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -62.92 -39.34 94.25 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.717 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.3 m -75.19 7.85 3.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.115 -0.991 . . . . 0.0 109.181 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -66.21 134.95 53.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.242 -0.911 . . . . 0.0 110.255 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.71 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.43 144.63 44.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.234 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 100.0 m-20 -117.18 151.68 36.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.686 -0.634 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.3 p -68.92 154.12 42.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.522 -0.736 . . . . 0.0 110.848 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.45 -37.2 1.59 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.94 145.4 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.398 . . . . 0.0 110.964 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -87.43 149.79 24.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.51 -0.743 . . . . 0.0 109.508 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 440' ' ' PHE . 61.9 t -118.62 132.8 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.521 -0.737 . . . . 0.0 109.749 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -138.08 113.78 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.0 139.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 110.011 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.4 111.7 23.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.418 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.2 mp0 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.03 130.86 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.692 0.758 . . . . 0.0 109.071 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.2 ttp -100.2 140.62 34.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.856 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 166.3 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.82 138.74 50.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.804 0.811 . . . . 0.0 109.837 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.52 165.79 14.08 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.96 -16.01 53.31 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.569 2.179 . . . . 0.0 111.446 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.27 -3.68 59.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 108.914 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.42 84.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.94 167.36 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 110.419 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.0 mm -108.09 128.71 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.592 -0.692 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.01 131.47 53.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.525 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -107.82 132.67 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.9 mt -126.57 147.87 62.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.673 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.54 158.14 56.82 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -56.42 139.58 48.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.32 76.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.67 154.89 41.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -1.086 . . . . 0.0 110.104 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.5 p -127.05 172.72 10.26 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.829 0.823 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -30.6 66.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.707 -0.621 . . . . 0.0 110.053 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 464' ' ' LEU . 83.6 mt -63.33 -43.01 98.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.56 -40.72 97.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 109.725 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 444' ' ' LEU . 77.8 t80 -61.08 -42.88 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.451 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.16 93.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.809 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.43 -37.37 80.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 91.1 p -61.56 -35.96 79.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.49 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.574 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 92.4 mt -63.95 -43.58 95.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.174 -0.954 . . . . 0.0 109.63 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.2 m-70 -162.12 -120.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.739 . . . . 0.0 109.384 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 5.7 p -158.83 -68.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.17 -39.04 92.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.87 -43.26 99.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.238 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.2 89.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.6 -34.27 77.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -82.41 21.34 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 42.1 t -76.67 122.92 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -0.843 . . . . 0.0 109.664 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -105.48 -4.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.85 -177.32 46.54 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.32 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.19 148.94 30.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -1.144 . . . . 0.0 109.209 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -132.01 126.54 34.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.76 130.56 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.645 0.736 . . . . 0.0 109.72 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . 0.488 HD21 ' CB ' ' A' ' 472' ' ' ASP . 11.2 m120 55.55 41.79 30.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 109.81 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 57.55 16.27 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -118.51 138.76 52.29 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.703 0.763 . . . . 0.0 109.86 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.87 139.04 53.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.2 m -151.06 149.8 25.86 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.43 162.08 42.2 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.339 2.026 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.2 mp -63.11 -39.31 94.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.469 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.0 m -75.3 8.14 2.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.274 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.3 t80 -65.64 135.4 54.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.42 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 77.5 t -77.09 130.72 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.673 0.749 . . . . 0.0 110.019 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.74 145.23 38.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.0 110.175 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -118.5 147.64 43.44 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.677 0.751 . . . . 0.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 94.1 p -65.24 151.43 46.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 80.2 -38.35 2.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . 0.488 ' CB ' HD21 ' A' ' 458' ' ' ASN . 99.4 m-20 -68.42 144.27 54.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -1.037 . . . . 0.0 110.796 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -89.23 145.47 25.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.486 -0.759 . . . . 0.0 109.172 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.98 133.24 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.551 -0.718 . . . . 0.0 109.75 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -132.73 142.22 48.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.75 131.2 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.6 0.714 . . . . 0.0 109.74 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.0 mt -92.67 137.38 32.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.773 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 109.528 -179.777 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.146 0.498 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.45 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . 0.401 ' SD ' HG23 ' A' ' 428' ' ' ILE . 31.5 ttm -99.96 144.48 28.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.721 -0.612 . . . . 0.0 109.703 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.51 163.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.24 137.63 53.53 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.676 0.75 . . . . 0.0 109.734 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.67 177.67 1.57 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -29.99 85.65 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.453 2.102 . . . . 0.0 111.595 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.9 -4.52 59.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.16 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.04 13.99 80.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.41 147.17 46.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 428' ' ' ILE . 1.4 mp -90.92 127.58 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -131.23 110.07 10.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -90.24 137.41 32.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.759 -0.588 . . . . 0.0 109.718 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.77 148.45 69.98 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.52 155.01 72.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.466 2.11 . . . . 0.0 112.464 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.23 145.84 10.14 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.668 0.746 . . . . 0.0 110.434 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.63 13.02 79.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.0 150.93 47.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.976 . . . . 0.0 110.267 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.5 p -127.46 172.72 10.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.645 0.736 . . . . 0.0 109.799 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.24 -30.47 66.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.673 -0.642 . . . . 0.0 109.643 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.62 -43.23 97.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.57 -42.05 99.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 444' ' ' LEU . 78.4 t80 -61.37 -43.68 98.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.558 -0.714 . . . . 0.0 109.841 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.42 83.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 0.0 109.804 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.87 -36.16 83.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.8 m -59.66 -39.31 83.99 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.603 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 93.3 mt -63.1 -44.31 96.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.762 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.5 m-70 -161.97 -120.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.644 . . . . 0.0 109.521 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 6.0 p -152.93 -76.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.562 -0.712 . . . . 0.0 109.079 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.67 -42.34 98.07 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.441 0.638 . . . . 0.0 109.574 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.11 -44.6 95.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.331 -0.856 . . . . 0.0 108.924 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -65.87 -43.83 93.09 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.83 -29.28 67.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.993 . . . . 0.0 109.607 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -80.62 18.49 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.376 -0.828 . . . . 0.0 108.825 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 63.8 m -79.79 133.04 36.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.588 -0.695 . . . . 0.0 109.951 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.21 -4.24 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.614 -0.678 . . . . 0.0 109.476 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.89 47.4 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.18 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.05 151.99 48.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.509 -0.995 . . . . 0.0 109.703 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . 0.525 ' HZ3' ' HA ' ' A' ' 459' ' ' HIS . 39.9 tttm -133.23 119.98 20.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.652 -0.655 . . . . 0.0 109.308 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.89 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . 0.587 HD21 ' CB ' ' A' ' 472' ' ' ASP . 14.4 m120 57.45 37.8 27.96 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.525 ' HA ' ' HZ3' ' A' ' 456' ' ' LYS . 29.1 m170 58.83 13.64 2.84 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.78 156.42 26.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.548 0.69 . . . . 0.0 109.816 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -87.02 113.43 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.482 -0.762 . . . . 0.0 109.703 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.512 ' N ' HD13 ' A' ' 461' ' ' LEU . 5.3 m -116.99 150.69 46.38 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.74 162.28 38.07 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.636 2.224 . . . . 0.0 112.697 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.86 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.653 -0.655 . . . . 0.0 109.517 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.9 m -75.33 4.35 7.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.326 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -62.72 135.68 57.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.799 . . . . 0.0 110.44 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.22 132.3 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.576 0.703 . . . . 0.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.79 148.07 46.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.631 -0.668 . . . . 0.0 110.509 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.23 142.21 51.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.646 0.736 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.8 t -66.84 141.09 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.619 0.724 . . . . 0.0 110.801 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 91.02 -36.44 3.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . 0.587 ' CB ' HD21 ' A' ' 458' ' ' ASN . 91.8 m-20 -70.27 144.01 51.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.438 -1.037 . . . . 0.0 110.454 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.2 143.01 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.556 -0.715 . . . . 0.0 109.391 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.08 132.35 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.42 0.629 . . . . 0.0 109.803 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -140.5 126.1 19.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 34.9 m -94.4 132.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.499 -0.75 . . . . 0.0 109.843 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.87 111.9 23.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.639 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.586 0.708 . . . . 0.0 110.016 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 9.7 m -109.92 130.5 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . 0.412 ' CE ' ' NH2' ' A' ' 430' ' ' ARG . 39.0 ttm -91.03 134.21 34.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.807 . . . . 0.0 109.308 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.23 162.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.14 138.77 52.69 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.488 0.661 . . . . 0.0 109.596 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 165.62 14.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.09 -14.74 45.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.179 1.919 . . . . 0.0 111.129 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.98 -4.27 59.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.467 -0.77 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.65 85.36 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.08 165.9 18.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 110.069 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.3 mm -110.91 128.4 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.52 -0.737 . . . . 0.0 109.022 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -126.85 140.22 52.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.412 ' NH2' ' CE ' ' A' ' 420' ' ' MET . 95.9 mtt-85 -113.35 136.79 52.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.632 -0.668 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.25 147.33 63.27 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.15 159.78 51.1 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.257 1.972 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -57.05 148.89 20.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.468 -0.77 . . . . 0.0 110.302 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 10.46 81.64 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.03 44.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -1.046 . . . . 0.0 109.759 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.1 p -127.57 173.58 9.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.631 -0.668 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.98 -34.36 69.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.93 -43.03 99.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 109.638 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.87 -41.8 98.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.409 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 79.7 t80 -60.78 -44.58 96.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.055 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.75 86.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.04 -1.038 . . . . 0.0 109.939 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -64.04 -37.89 89.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.08 . . . . 0.0 109.673 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 60.6 p -59.77 -37.12 78.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 89.2 mt -63.46 -54.19 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.987 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 99.6 m-70 -161.93 -126.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 19.4 m -146.63 -64.7 0.29 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.011 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.93 -45.36 92.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.0 109.98 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.92 -44.83 95.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.9 90.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.09 -18.47 63.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -1.196 . . . . 0.0 110.011 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -103.29 42.35 1.17 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.392 -0.818 . . . . 0.0 109.321 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.32 127.43 44.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.446 -0.784 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.1 pt -101.57 -5.2 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.12 178.55 48.22 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.56 149.31 48.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.645 -0.915 . . . . 0.0 108.704 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . 0.465 ' NZ ' ' C ' ' A' ' 459' ' ' HIS . 44.8 tttm -132.88 120.83 22.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 94.1 t -123.57 133.83 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.542 -0.724 . . . . 0.0 109.705 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.33 43.59 19.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.465 ' C ' ' NZ ' ' A' ' 456' ' ' LYS . 79.5 m80 53.13 13.16 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 110.653 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -118.09 137.04 53.2 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.378 -0.826 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.3 134.83 54.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.628 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.29 150.93 53.64 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.34 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.636 2.224 . . . . 0.0 112.716 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.45 -39.09 92.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.216 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -74.64 7.74 2.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.338 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -65.45 133.78 52.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.949 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 78.2 t -79.56 132.18 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.49 149.23 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.378 -0.826 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -124.1 145.37 49.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.616 -0.677 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.7 t -65.69 142.44 58.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -0.799 . . . . 0.0 110.495 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.89 -32.46 5.1 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -73.08 149.37 43.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.349 -1.089 . . . . 0.0 109.716 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -95.53 130.14 42.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 22.1 t -103.55 131.66 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.455 -0.778 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -134.51 143.14 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.46 132.46 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.479 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.81 128.65 46.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.327 -0.858 . . . . 0.0 109.248 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.498 1.937 0 O-C-N 121.547 -0.721 . . . . 0.0 109.567 -179.832 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.365 0.602 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.1 131.58 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.631 0.729 . . . . 0.0 109.519 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 54.6 ttm -96.99 133.69 41.33 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.687 0.756 . . . . 0.0 110.405 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.08 163.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -115.69 142.35 46.86 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.902 0.858 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.71 176.71 1.78 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.33 -29.92 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.071 1.847 . . . . 0.0 111.429 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.11 -4.91 59.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.173 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.5 79.95 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.59 157.55 37.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.52 -0.988 . . . . 0.0 110.485 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.3 mm -99.68 123.98 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.646 -0.659 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -127.43 126.33 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -106.62 133.86 50.65 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.26 0.552 . . . . 0.0 109.646 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.76 152.96 77.82 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.54 147.82 22.11 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.36 2.04 . . . . 0.0 112.492 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.14 132.37 52.74 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.914 0.864 . . . . 0.0 110.632 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.6 13.59 75.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.3 170.9 0.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.986 . . . . 0.0 110.677 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.9 p -127.54 171.08 11.93 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.143 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.77 67.96 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.327 0.584 . . . . 0.0 109.968 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.39 -42.56 98.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.69 -39.85 95.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.712 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.535 ' CE2' HD11 ' A' ' 444' ' ' LEU . 84.7 t80 -61.27 -43.68 98.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.792 . . . . 0.0 109.156 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.3 95.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.627 -0.671 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -65.03 -36.68 85.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 38.9 m -58.81 -41.57 87.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.535 HD11 ' CE2' ' A' ' 440' ' ' PHE . 88.0 mt -72.04 -76.71 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -138.42 179.05 6.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.419 -0.801 . . . . 0.0 109.897 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 33.6 t -103.95 -55.06 2.44 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.378 0.609 . . . . 0.0 109.612 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.58 -49.68 74.31 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.512 0.673 . . . . 0.0 109.659 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.516 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -64.95 -44.71 88.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.739 0.78 . . . . 0.0 109.611 -179.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.73 -42.19 93.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.8 t0 -66.63 -35.46 80.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.942 . . . . 0.0 109.864 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 451' ' ' HIS . 11.1 t-160 -81.74 20.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.197 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 28.7 p -74.53 129.98 38.75 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.498 0.666 . . . . 0.0 109.947 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.43 -4.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.37 48.48 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 147.04 40.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.58 -0.953 . . . . 0.0 109.709 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -131.66 124.04 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.08 131.84 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.614 0.721 . . . . 0.0 109.998 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 54.7 44.06 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 109.937 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.436 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 54.0 t-80 58.49 13.39 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.281 0.562 . . . . 0.0 109.68 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.02 144.53 43.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.751 . . . . 0.0 109.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -82.13 113.53 20.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.423 0.63 . . . . 0.0 109.589 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 461' ' ' LEU . 6.4 m -120.75 151.69 54.85 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.07 162.78 36.68 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.497 2.131 . . . . 0.0 112.375 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -63.32 -39.42 94.52 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.402 0.62 . . . . 0.0 109.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.6 t -75.56 10.52 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.286 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . 0.433 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.0 t80 -69.1 135.48 50.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.788 0.804 . . . . 0.0 110.518 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.433 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 81.7 t -81.2 131.48 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 121.721 0.772 . . . . 0.0 109.778 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.61 145.08 45.67 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.617 0.722 . . . . 0.0 110.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.02 144.18 44.9 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.67 0.747 . . . . 0.0 109.877 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 42.6 t -68.62 140.18 55.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.947 0.879 . . . . 0.0 111.143 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.11 -26.19 16.28 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.95 163.31 25.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.986 . . . . 0.0 111.359 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -103.43 134.51 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 51.3 t -114.48 132.2 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.699 0.761 . . . . 0.0 110.301 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.79 146.23 39.2 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.29 131.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.727 0.775 . . . . 0.0 110.188 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.5 131.91 34.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.573 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 121.68 0.752 . . . . 0.0 110.235 -179.447 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.8 130.88 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.429 -0.794 . . . . 0.0 108.964 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.6 ttm -92.5 138.43 31.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.786 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.48 164.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.03 137.39 53.57 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 171.51 5.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.94 -29.5 82.49 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.939 1.759 . . . . 0.0 111.113 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -81.24 -4.35 55.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.626 . . . . 0.0 109.623 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.0 83.46 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -73.87 156.65 37.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -1.171 . . . . 0.0 110.198 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.7 mm -103.12 125.14 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.08 132.9 47.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.565 -0.709 . . . . 0.0 109.262 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -107.25 134.99 49.52 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 49.2 mt -131.0 153.07 81.68 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.6 147.17 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.985 1.79 . . . . 0.0 112.707 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -54.87 130.34 40.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.673 -0.642 . . . . 0.0 110.092 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.03 76.36 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -52.09 172.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 109.864 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.7 p -128.22 171.42 11.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.551 -0.718 . . . . 0.0 109.958 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.73 71.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.06 -43.55 98.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.432 -0.793 . . . . 0.0 109.532 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.427 ' CE2' HD11 ' A' ' 444' ' ' LEU . 63.4 t80 -61.12 -43.85 98.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.01 -45.53 79.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.439 -0.788 . . . . 0.0 109.842 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -62.16 -37.95 87.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.832 . . . . 0.0 109.744 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.2 m -58.87 -41.55 87.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.81 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 440' ' ' PHE . 86.6 mt -62.97 -43.93 97.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.308 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.72 ' CD2' ' H ' ' A' ' 446' ' ' SER . 73.5 t60 -173.68 -130.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.421 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . 0.72 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 8.1 t -145.42 -64.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.65 -44.95 94.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.449 -0.782 . . . . 0.0 109.731 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.99 -46.0 89.76 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -68.74 -39.11 86.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -37.88 89.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.511 -0.993 . . . . 0.0 109.839 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -83.17 20.06 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 109.498 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 27.7 p -71.09 122.47 20.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.675 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.9 pt -99.64 -2.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.793 . . . . 0.0 109.777 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.54 179.66 45.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.24 146.29 36.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 109.053 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -134.01 122.06 22.48 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.263 -0.898 . . . . 0.0 108.951 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.06 134.46 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.678 -0.639 . . . . 0.0 109.607 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 58.09 41.94 23.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 55.2 18.45 2.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.627 . . . . 0.0 110.141 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -122.75 144.09 49.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.628 -0.67 . . . . 0.0 109.213 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 41.9 tp -70.17 134.28 47.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.33 149.87 53.01 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.05 162.18 41.1 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.486 2.124 . . . . 0.0 112.617 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.71 -0.619 . . . . 0.0 109.65 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 96.6 p -75.96 10.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.749 . . . . 0.0 109.627 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.5 t80 -65.09 135.94 56.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 110.226 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.434 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 22.3 t -79.29 131.26 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.89 149.32 39.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.395 -0.816 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -124.14 141.97 51.61 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.537 0.684 . . . . 0.0 109.396 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.9 t -66.19 142.45 57.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.69 . . . . 0.0 110.781 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.33 10.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -78.87 161.14 26.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -1.043 . . . . 0.0 109.998 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -105.56 122.82 46.81 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.5 t -97.4 132.24 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.458 -0.776 . . . . 0.0 110.244 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.0 141.72 47.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.16 130.8 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.447 -0.783 . . . . 0.0 109.64 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.17 137.92 31.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 97.4 p . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.446 -0.784 . . . . 0.0 109.676 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 121.378 0.608 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.1 m -114.31 131.25 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.651 0.739 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -95.02 135.4 36.61 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.525 0.679 . . . . 0.0 110.003 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.18 164.68 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.09 141.24 48.69 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.678 0.751 . . . . 0.0 109.73 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.52 176.25 2.04 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.28 -33.48 85.07 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.896 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.94 -4.21 54.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 80.91 10.68 84.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.85 155.73 40.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.636 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.22 124.33 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -127.19 131.88 50.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -105.71 135.52 46.98 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.451 0.643 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 23.1 mt -138.69 150.77 66.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.69 156.13 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.429 2.086 . . . . 0.0 112.719 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.16 154.49 7.78 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.291 1.043 . . . . 0.0 111.101 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 78.71 7.03 88.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.58 153.35 43.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.356 -1.085 . . . . 0.0 110.443 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 47.8 p -127.04 171.21 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.772 0.796 . . . . 0.0 110.159 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.3 -28.52 63.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.564 0.697 . . . . 0.0 109.829 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.81 -46.67 86.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 109.578 -179.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.68 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 444' ' ' LEU . 67.5 t80 -61.13 -44.33 97.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.677 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.1 -47.37 83.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.0 -34.73 78.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.539 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 34.4 m -59.23 -41.2 88.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.579 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 440' ' ' PHE . 88.2 mt -69.38 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.95 -151.19 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.373 -0.83 . . . . 0.0 109.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 82.1 p -127.32 -73.99 0.6 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.583 0.706 . . . . 0.0 110.034 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.525 ' N ' ' OG ' ' A' ' 446' ' ' SER . 99.6 m-20 -64.13 -43.28 95.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.41 -46.58 87.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.007 0.908 . . . . 0.0 109.295 -179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.25 -40.21 94.68 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 452' ' ' CYS . 65.3 t0 -65.62 -37.92 87.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -1.066 . . . . 0.0 109.946 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 73.6 m-70 -76.77 26.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.196 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 21.6 p -79.7 121.11 24.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.65 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 38.6 pt -101.38 -3.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.48 179.51 47.47 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.244 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.05 152.8 32.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -1.072 . . . . 0.0 109.364 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -131.01 131.31 44.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.742 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.15 132.56 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.44 0.638 . . . . 0.0 109.511 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 56.43 39.38 30.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.518 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 78.1 m80 58.94 13.13 2.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.453 0.644 . . . . 0.0 109.69 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.77 136.83 49.25 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.778 0.799 . . . . 0.0 109.62 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.0 tp -66.44 131.74 46.73 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.707 0.765 . . . . 0.0 110.473 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 7.0 m -146.87 149.93 37.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.8 158.6 55.47 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.423 2.082 . . . . 0.0 112.421 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.52 -38.45 90.0 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.668 0.747 . . . . 0.0 109.761 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.8 m -75.27 8.34 2.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 109.41 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . 0.471 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 94.3 t80 -66.21 137.36 56.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.899 . . . . 0.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.471 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 82.1 t -75.88 130.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.067 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.8 mt -78.77 142.99 36.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.547 0.689 . . . . 0.0 110.624 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 99.7 m-20 -116.16 148.03 40.78 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.57 0.7 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 16.5 m -74.26 140.66 45.13 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.793 0.806 . . . . 0.0 110.947 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.16 -23.13 37.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 42.3 p-10 -84.48 171.8 12.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.291 -1.123 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -110.94 129.03 56.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.1 131.61 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.584 -0.697 . . . . 0.0 109.747 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -130.44 138.22 50.2 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.33 130.54 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.727 0.775 . . . . 0.0 110.221 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.74 141.4 30.02 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.468 0.652 . . . . 0.0 109.409 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.604 0.716 . . . . 0.0 109.694 -179.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 419' ' ' VAL . 35.2 m -119.17 130.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . 0.492 ' SD ' ' CG2' ' A' ' 428' ' ' ILE . 49.2 ttp -100.31 143.87 29.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.631 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.27 161.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.73 125.86 54.78 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.547 0.689 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 423' ' ' THR . 0.2 OUTLIER -89.19 156.23 48.89 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.97 -15.96 42.26 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.148 1.899 . . . . 0.0 111.238 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.9 -3.18 53.59 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.449 -0.782 . . . . 0.0 109.178 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.07 161.22 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -1.133 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.492 ' CG2' ' SD ' ' A' ' 420' ' ' MET . 35.0 mm -110.14 129.2 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.511 -0.743 . . . . 0.0 109.068 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -125.91 134.54 51.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -106.3 133.27 51.26 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.639 -0.663 . . . . 0.0 109.513 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.72 147.18 52.63 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.05 158.19 55.84 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.318 2.012 . . . . 0.0 111.97 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -56.09 143.05 34.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.281 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 11.54 81.12 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.61 152.46 44.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.569 -0.959 . . . . 0.0 109.791 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.7 p -127.57 172.9 10.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.6 -0.687 . . . . 0.0 109.686 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.65 65.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.461 -0.774 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.82 -42.44 99.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.319 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -61.15 -43.6 98.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 109.956 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 444' ' ' LEU . 66.3 t80 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.11 -42.63 81.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.619 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -67.36 -38.02 84.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.148 -0.97 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 91.1 p -59.8 -37.02 77.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 109.664 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.461 HD11 ' CE2' ' A' ' 440' ' ' PHE . 91.3 mt -63.32 -42.8 99.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 109.231 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.69 ' CD2' ' H ' ' A' ' 446' ' ' SER . 85.8 t60 -173.49 -119.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . 0.69 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 37.3 p -155.62 -64.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 451' ' ' HIS . 64.0 t0 -61.82 -48.78 79.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.492 -0.755 . . . . 0.0 109.803 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.487 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.99 -45.45 92.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.275 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -67.18 -40.8 92.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 450' ' ' ASP . 64.6 t0 -63.72 -37.26 86.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.099 . . . . 0.0 109.522 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' A' ' 447' ' ' ASP . 51.5 m80 -81.15 27.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 109.2 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 13.2 p -77.35 129.78 36.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 24.6 pt -102.92 -5.26 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 0.0 109.313 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 175.68 -175.12 47.23 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.15 150.57 42.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 108.836 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -132.82 121.6 23.2 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.3 t -122.73 134.34 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.692 . . . . 0.0 109.289 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.2 m120 55.59 39.52 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.526 0.679 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 57.1 t-80 57.86 8.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 110.232 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -111.47 146.68 36.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.452 -0.78 . . . . 0.0 109.285 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 461' ' ' LEU . 4.3 mm? -72.43 142.06 48.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.5 -0.75 . . . . 0.0 109.704 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.84 148.87 34.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.19 159.94 49.8 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.06 1.84 . . . . 0.0 112.368 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -62.35 -40.16 95.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.578 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -75.85 7.44 3.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.21 136.6 58.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.86 130.17 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 109.641 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.55 146.55 36.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.468 -0.77 . . . . 0.0 109.79 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 94.6 m-20 -123.98 151.7 43.36 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.547 -0.721 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 11.6 p -75.24 145.39 41.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.822 . . . . 0.0 110.458 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.81 -21.45 41.44 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 49.4 p-10 -84.18 172.05 12.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -1.145 . . . . 0.0 109.893 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -115.1 131.93 56.77 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.424 HG11 ' CD2' ' A' ' 440' ' ' PHE . 64.0 t -109.92 131.64 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.815 . . . . 0.0 110.014 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -135.72 113.3 10.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.53 137.34 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.807 . . . . 0.0 110.27 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.5 mt -96.6 135.0 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 109.255 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.53 -0.732 . . . . 0.0 109.77 -179.672 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.16 129.63 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.419 0.628 . . . . 0.0 109.61 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.3 ttm -102.91 132.87 48.83 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.49 163.54 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -117.66 144.09 45.55 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.905 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.27 174.3 3.17 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.49 -31.85 87.44 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.226 1.95 . . . . 0.0 111.289 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.99 -3.99 55.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.51 -0.744 . . . . 0.0 109.215 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.11 11.68 83.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.79 154.96 41.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -1.199 . . . . 0.0 110.517 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 36.3 mm -94.3 124.25 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -129.95 106.99 9.03 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -97.45 127.86 43.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.464 -0.773 . . . . 0.0 109.415 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 40.0 mt -120.09 148.88 47.96 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 154.29 74.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.15 1.9 . . . . 0.0 112.193 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -52.62 146.59 9.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.875 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.13 7.38 80.37 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.0 151.47 47.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.747 -0.855 . . . . 0.0 110.159 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -127.38 171.55 11.43 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.494 0.664 . . . . 0.0 109.544 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.36 65.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 464' ' ' LEU . 88.4 mt -63.19 -46.06 88.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.84 -42.99 99.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 444' ' ' LEU . 89.0 t80 -61.8 -44.94 95.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.77 . . . . 0.0 109.613 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.89 84.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 0.0 109.611 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.84 -34.03 77.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.1 m -58.63 -43.02 89.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 62.4 mt -63.3 -47.97 80.03 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 109.759 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 78.7 m-70 -166.01 -166.1 0.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 71.7 p -109.45 -37.24 5.78 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.42 -48.31 73.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 109.64 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.8 mm? -63.76 -41.07 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.579 -0.701 . . . . 0.0 109.295 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.09 -33.06 86.22 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -87.49 -24.2 24.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.393 -1.063 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -100.01 14.53 30.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 109.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 7.9 t -80.35 110.41 15.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.179 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.78 0.73 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.651 -0.656 . . . . 0.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -172.96 173.17 45.52 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.194 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.92 29.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -1.052 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -133.15 122.44 24.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.23 131.56 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.569 0.699 . . . . 0.0 109.943 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 56.18 45.05 24.03 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.308 0.575 . . . . 0.0 109.861 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.7 12.24 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.666 -0.646 . . . . 0.0 109.814 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.21 132.54 56.58 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.547 0.689 . . . . 0.0 109.384 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.03 135.1 51.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.24 151.57 44.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.0 109.45 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.49 161.63 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.442 2.095 . . . . 0.0 112.336 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.8 -38.63 91.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.591 -0.693 . . . . 0.0 109.605 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.9 m -74.85 7.92 2.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.2 -0.938 . . . . 0.0 109.335 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.2 t80 -69.47 134.63 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.421 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 25.3 t -77.21 131.26 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.843 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 71.8 mt -75.15 144.74 42.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.293 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -115.96 147.92 40.64 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.422 0.63 . . . . 0.0 109.367 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.1 p -65.52 153.14 42.3 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.658 0.742 . . . . 0.0 111.214 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 81.36 -40.07 2.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.0 144.24 54.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.12 . . . . 0.0 111.016 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 474' ' ' VAL . 21.5 tm0? -85.81 143.35 28.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.518 ' O ' ' NE2' ' A' ' 473' ' ' GLN . 66.7 t -116.42 132.14 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.571 -0.705 . . . . 0.0 109.935 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 12.4 m -109.85 133.83 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.64 -0.662 . . . . 0.0 110.046 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -89.84 108.33 19.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.726 . . . . 0.0 109.267 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.792 -179.777 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.507 0.67 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.0 130.84 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.695 0.759 . . . . 0.0 109.051 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.2 ttp -99.36 139.59 34.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.616 0.722 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.79 165.08 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.58 139.4 53.57 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.779 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 165.71 14.71 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.85 -9.74 26.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.707 2.271 . . . . 0.0 111.632 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -90.9 -5.32 55.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.115 -0.991 . . . . 0.0 109.492 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.47 6.23 77.81 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -83.44 160.75 21.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -1.221 . . . . 0.0 110.318 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 32.0 mm -105.83 128.01 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -127.07 134.41 50.28 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -110.42 136.28 49.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.72 -0.613 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 85.1 mt -135.83 147.97 63.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.91 154.2 71.32 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.284 1.989 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.765 ' H ' ' NE2' ' A' ' 433' ' ' GLN . 0.0 OUTLIER -55.1 147.42 16.09 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.723 0.773 . . . . 0.0 110.991 -179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.2 81.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.33 157.45 35.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.522 -0.987 . . . . 0.0 110.17 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 58.1 p -126.54 167.63 15.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.859 0.838 . . . . 0.0 109.928 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.35 68.28 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.522 0.677 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.01 -43.59 98.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.587 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.45 -42.87 99.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.669 0.747 . . . . 0.0 109.656 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 474' ' ' VAL . 83.2 t80 -61.77 -44.79 96.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.502 -0.749 . . . . 0.0 110.157 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.15 84.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.75 -36.28 83.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.76 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 444' ' ' LEU . 39.1 t -63.49 -36.6 84.31 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 443' ' ' SER . 96.3 mt -52.59 -105.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.23 -2.24 37.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 t 70.81 -55.8 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.597 0.713 . . . . 0.0 109.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.1 t0 -65.46 -38.79 90.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 448' ' ' LEU . 7.3 tt -62.8 -41.6 99.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.692 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -49.19 -9.4 0.12 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 451' ' ' HIS . 8.2 p-10 -91.28 -22.68 20.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.046 -1.267 . . . . 0.0 109.434 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.578 ' N ' ' OD1' ' A' ' 450' ' ' ASP . 40.2 m80 -100.91 -1.18 35.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.361 -0.837 . . . . 0.0 109.053 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 452' ' ' CYS . 26.1 p -61.98 118.1 6.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 41.1 pt -105.84 -5.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.806 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.33 176.44 46.01 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.11 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.0 151.96 38.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -1.162 . . . . 0.0 109.515 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -132.5 123.8 27.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.551 -0.718 . . . . 0.0 109.194 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -123.1 133.25 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.724 0.773 . . . . 0.0 109.812 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . 0.615 HD21 ' CB ' ' A' ' 472' ' ' ASP . 12.3 m120 55.69 40.89 30.9 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.516 0.675 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m80 56.21 13.01 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.426 0.631 . . . . 0.0 109.364 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.13 135.35 54.01 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.743 0.783 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.9 tp -66.74 134.98 53.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 0.0 109.813 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.32 150.68 49.07 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.357 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.37 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.505 2.136 . . . . 0.0 112.444 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -63.55 -37.09 86.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.7 m -75.02 3.92 7.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 109.33 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -62.87 135.46 57.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.368 -0.832 . . . . 0.0 110.426 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.31 130.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.625 0.726 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.89 147.52 38.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.61 -0.681 . . . . 0.0 110.494 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -124.26 148.06 47.65 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.815 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 41.6 t -64.19 140.01 58.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.913 0.863 . . . . 0.0 111.123 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.15 -31.16 6.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . 0.615 ' CB ' HD21 ' A' ' 458' ' ' ASN . 98.8 m-20 -73.2 147.7 44.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -1.101 . . . . 0.0 111.026 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -95.53 141.93 28.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.72 . . . . 0.0 109.786 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.437 HG11 ' CD2' ' A' ' 440' ' ' PHE . 64.5 t -116.2 132.22 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.647 0.737 . . . . 0.0 109.787 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -138.12 113.58 9.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 109.046 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.0 134.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.77 96.19 8.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.452 -0.78 . . . . 0.0 109.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.739 0.781 . . . . 0.0 110.381 -179.511 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.6 mp0 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.2 m -112.52 131.4 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.3 ttm -98.36 136.09 39.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . 0.437 HG12 ' OD1' ' A' ' 472' ' ' ASP . 33.2 m -131.19 164.61 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.92 140.74 49.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.103 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 176.66 1.89 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.09 -34.22 97.29 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 111.912 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -81.43 -3.87 54.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 109.143 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.57 82.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -71.82 153.11 42.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.317 . . . . 0.0 110.371 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.25 127.17 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -129.15 113.71 15.42 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.69 127.62 45.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.9 mt -131.83 156.12 80.52 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.07 144.79 56.27 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.904 1.736 . . . . 0.0 112.677 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -62.4 141.08 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.545 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.48 84.41 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -66.05 179.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -1.071 . . . . 0.0 110.136 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.0 p -127.67 169.5 13.72 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.96 -26.33 64.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.03 -43.01 99.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.353 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.73 -40.16 96.34 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.845 . . . . 0.0 109.116 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 83.1 t80 -61.46 -43.93 97.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.603 -0.686 . . . . 0.0 109.365 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.51 87.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.81 -33.85 76.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.355 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 7.1 t -59.92 -44.2 94.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.798 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.564 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 70.1 mt -65.16 -55.87 16.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.179 -0.95 . . . . 0.0 109.847 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.8 m-70 -160.02 -167.34 1.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.546 -0.721 . . . . 0.0 109.776 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 69.6 m -110.37 -62.42 1.52 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.613 -0.68 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.46 -48.44 79.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.506 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -64.11 -43.66 94.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.486 -0.759 . . . . 0.0 109.032 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.37 -43.19 95.43 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 59.9 t0 -73.64 -10.34 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -100.94 22.75 11.67 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 84.4 m -81.95 130.74 35.16 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.47 -4.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.9 45.59 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -150.38 152.17 33.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -1.176 . . . . 0.0 109.123 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -133.15 127.11 33.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 109.191 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.89 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 14.8 m120 53.0 57.56 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.787 -0.571 . . . . 0.0 110.342 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 458' ' ' ASN . 35.1 p80 41.67 30.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.233 0.54 . . . . 0.0 110.182 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.75 135.48 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.89 134.46 52.1 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.522 -0.736 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.76 150.57 63.36 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.67 160.43 49.49 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.393 2.062 . . . . 0.0 112.256 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.4 mp -63.07 -39.0 93.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.484 -0.76 . . . . 0.0 109.229 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 94.8 p -74.98 10.3 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.244 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -67.02 133.34 49.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.101 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.96 131.02 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.86 145.75 42.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 110.129 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -121.83 134.63 54.89 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.533 0.682 . . . . 0.0 109.427 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -55.68 135.9 51.04 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 96.31 -12.53 66.55 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . 0.437 ' OD1' HG12 ' A' ' 421' ' ' VAL . 36.4 p-10 -83.69 171.35 13.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -1.163 . . . . 0.0 110.47 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -122.19 114.26 20.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 18.9 t -93.16 131.79 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -133.0 113.84 13.28 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.9 m -83.73 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.3 mt -99.97 131.95 45.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.514 -0.741 . . . . 0.0 109.038 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.698 . . . . 0.0 109.752 -179.297 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.6 m -112.29 130.53 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.4 ttm -97.11 135.98 38.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 109.765 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.53 165.24 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.564 -0.71 . . . . 0.0 109.238 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' A' ' 428' ' ' ILE . 78.8 m-85 -111.07 141.44 44.56 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.995 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . 0.459 ' OG1' ' N ' ' A' ' 427' ' ' GLU . 82.1 p -96.39 151.44 38.07 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.7 -17.68 51.05 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.563 1.509 . . . . 0.0 110.685 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.431 -0.793 . . . . 0.0 109.176 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.77 1.17 65.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 23.2 mp0 -88.19 155.81 19.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.034 -1.274 . . . . 0.0 109.177 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' A' ' 422' ' ' PHE . 2.7 tp -106.91 140.26 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.46 132.77 53.49 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -103.81 133.45 48.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.275 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.8 mt -132.83 148.05 67.93 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.49 157.8 59.6 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.214 1.943 . . . . 0.0 112.157 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.81 148.66 12.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.391 -0.818 . . . . 0.0 110.085 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.9 81.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.84 41.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -127.21 174.44 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.509 -0.744 . . . . 0.0 109.663 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.77 71.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.951 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.97 -42.18 98.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.029 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.96 -43.27 95.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.925 . . . . 0.0 109.703 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 444' ' ' LEU . 85.0 t80 -60.44 -45.06 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.06 85.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.983 . . . . 0.0 109.801 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -63.93 -36.94 85.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.02 . . . . 0.0 109.643 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.6 m -58.02 -41.84 83.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.887 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.459 HD11 ' CE2' ' A' ' 440' ' ' PHE . 70.2 mt -65.92 -75.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -141.89 -178.46 5.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 109.589 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 78.2 p -101.29 -54.01 2.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.407 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.1 m-20 -62.33 -45.95 90.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.55 -43.49 96.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.003 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.44 -38.81 93.83 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.91 -11.8 61.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 109.202 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -105.01 13.43 30.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 30.3 p -74.75 120.8 20.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.935 . . . . 0.0 109.816 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.9 pt -101.81 -3.1 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 109.439 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.54 45.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -153.05 150.3 29.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.265 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -135.5 133.03 38.06 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.419 -0.801 . . . . 0.0 109.391 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.33 131.24 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 56.47 44.55 24.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.317 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 54.21 15.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.75 . . . . 0.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -113.85 137.1 52.12 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.471 -0.768 . . . . 0.0 109.241 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.25 135.25 53.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.859 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.13 151.28 33.92 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.918 . . . . 0.0 108.984 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.31 162.08 42.0 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.473 2.115 . . . . 0.0 112.615 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -61.88 -40.35 95.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.739 . . . . 0.0 109.546 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 92.7 p -75.29 10.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -67.23 135.66 53.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.684 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 72.7 t -78.46 132.58 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -0.872 . . . . 0.0 109.681 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -74.97 148.97 39.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 109.77 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -123.19 145.59 48.5 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 36.9 t -65.37 144.22 57.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.55 -40.67 3.03 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.37 145.4 51.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -1.107 . . . . 0.0 109.799 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -87.62 149.95 23.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.153 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.91 131.29 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -131.66 138.76 48.88 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.87 130.12 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 109.384 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.72 136.18 33.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 109.434 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.601 -0.687 . . . . 0.0 109.426 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.599 0.714 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.89 130.46 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.834 0.825 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.0 ttp -99.97 136.34 40.03 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.736 0.779 . . . . 0.0 110.043 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.79 164.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.26 138.58 54.45 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.07 0.938 . . . . 0.0 110.229 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.04 164.96 15.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.69 -13.55 40.36 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.487 2.125 . . . . 0.0 111.671 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.78 -5.52 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.376 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.35 8.13 83.88 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -84.69 159.45 20.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.624 -0.927 . . . . 0.0 110.566 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -105.43 128.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.739 0.78 . . . . 0.0 109.493 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -127.88 144.88 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.525 0.679 . . . . 0.0 109.636 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -124.71 136.0 53.51 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.694 . . . . 0.0 110.072 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 35.6 mt -127.47 147.81 63.89 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.88 158.27 58.55 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.429 2.086 . . . . 0.0 112.593 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.31 141.42 24.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.973 0.892 . . . . 0.0 110.661 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.4 84.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.28 150.78 46.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.686 -0.89 . . . . 0.0 110.278 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.1 p -127.24 173.5 9.69 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.929 0.871 . . . . 0.0 110.227 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.64 62.32 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.519 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.92 -45.88 90.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.589 -0.695 . . . . 0.0 109.363 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.499 ' CE2' HD11 ' A' ' 444' ' ' LEU . 85.1 t80 -60.76 -44.35 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.765 -0.584 . . . . 0.0 109.8 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.43 90.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . 0.417 ' CE1' ' CD1' ' A' ' 438' ' ' LEU . 5.5 m-85 -68.37 -36.73 79.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 70.3 p -60.27 -38.28 83.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.72 -0.612 . . . . 0.0 109.478 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.499 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.1 mt -71.88 -75.37 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.491 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -140.48 -179.38 5.98 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 13.0 m -102.42 -59.05 1.77 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.469 -0.77 . . . . 0.0 110.293 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 37.8 p-10 -63.21 -44.04 96.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.026 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.53 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.96 -45.12 90.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.511 -0.743 . . . . 0.0 109.065 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.33 92.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.08 -36.15 83.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.737 -0.86 . . . . 0.0 109.557 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.22 20.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.794 -0.566 . . . . 0.0 109.673 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 10.4 t -77.73 120.71 23.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.2 -4.94 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.46 178.3 48.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.49 148.19 39.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.977 . . . . 0.0 109.958 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -129.54 121.41 27.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.65 0.738 . . . . 0.0 109.694 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.13 132.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.776 0.798 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 54.84 43.9 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.599 0.714 . . . . 0.0 109.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.86 15.07 2.09 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -118.2 134.58 54.89 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.829 0.823 . . . . 0.0 109.815 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.27 134.37 50.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.673 0.749 . . . . 0.0 110.061 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.06 150.35 41.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.725 -0.609 . . . . 0.0 109.787 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.62 163.17 33.91 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.598 2.199 . . . . 0.0 112.826 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -62.73 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.149 0.5 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 5.6 t -75.53 8.15 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.645 -0.659 . . . . 0.0 109.668 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -68.22 134.37 50.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 109.676 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.12 130.21 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.777 0.798 . . . . 0.0 109.922 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.9 mt -75.97 144.24 41.08 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.564 0.697 . . . . 0.0 110.243 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -115.24 145.55 42.32 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.892 0.853 . . . . 0.0 110.118 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.4 t -66.01 139.99 58.25 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.461 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.44 -32.78 5.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -74.73 145.32 43.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.895 . . . . 0.0 110.904 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -86.85 144.76 26.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.519 0.676 . . . . 0.0 109.268 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.69 132.53 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.937 0.875 . . . . 0.0 110.127 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -135.74 141.51 44.86 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.455 0.645 . . . . 0.0 109.305 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.93 131.73 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.859 0.838 . . . . 0.0 110.005 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.12 131.21 45.32 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.469 0.652 . . . . 0.0 109.668 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.628 0.728 . . . . 0.0 109.507 179.627 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.295 0.569 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.1 130.75 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 51.1 ttm -95.53 133.77 39.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.646 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.76 163.52 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.53 140.48 52.96 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.615 0.722 . . . . 0.0 109.613 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.1 175.82 2.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.4 -30.04 90.15 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.372 2.048 . . . . 0.0 111.561 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -81.22 -4.09 54.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 109.204 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.69 9.18 85.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.77 151.88 45.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -1.078 . . . . 0.0 110.414 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.77 122.67 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.462 -0.774 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -128.05 131.36 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -108.04 134.82 50.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.656 -0.653 . . . . 0.0 109.36 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.99 157.43 69.42 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.697 -0.627 . . . . 0.0 109.393 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.94 150.25 79.24 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.208 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -54.34 137.26 42.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -0.838 . . . . 0.0 110.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.09 13.3 74.73 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -65.45 159.35 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -1.08 . . . . 0.0 110.057 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.3 p -126.93 171.97 10.84 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.691 0.758 . . . . 0.0 110.014 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.6 62.88 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.664 -0.647 . . . . 0.0 109.953 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.57 -46.59 87.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.091 -1.006 . . . . 0.0 109.383 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.47 -39.24 93.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.421 -0.799 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.419 ' CE2' HD11 ' A' ' 444' ' ' LEU . 88.0 t80 -60.83 -44.96 96.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.58 92.99 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . 0.431 ' CE1' HD11 ' A' ' 438' ' ' LEU . 4.8 m-85 -67.59 -36.35 80.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 11.7 t -59.82 -43.6 94.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.775 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 440' ' ' PHE . 79.5 mt -64.21 -74.91 0.09 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -135.7 -179.73 5.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.467 -0.77 . . . . 0.0 109.673 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 29.9 p -103.09 -56.11 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.694 -0.629 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 36.9 p-10 -66.85 -41.66 86.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -64.37 -44.54 91.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.329 -0.857 . . . . 0.0 109.025 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.32 93.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -70.9 -11.31 60.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -1.095 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -104.55 14.87 29.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 11.2 t -77.7 123.53 26.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 109.756 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.64 -4.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -174.42 176.46 46.75 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.537 -1.315 . . . . 0.0 109.898 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.16 147.05 45.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -1.056 . . . . 0.0 109.049 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -133.01 121.49 22.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.82 133.78 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.425 0.631 . . . . 0.0 109.543 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 57.28 44.1 22.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.495 0.664 . . . . 0.0 109.708 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 55.77 17.56 2.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.028 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -122.02 142.21 50.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.489 -0.757 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.51 132.81 45.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.69 -0.631 . . . . 0.0 109.896 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.43 150.22 50.55 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.079 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.63 162.05 40.96 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.567 2.178 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -63.35 -38.5 91.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.9 m -75.02 8.8 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.125 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -67.58 134.21 50.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.01 132.04 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.852 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.88 148.09 40.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.634 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -123.8 145.09 49.3 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.545 0.688 . . . . 0.0 109.454 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.8 m -66.45 144.72 56.33 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.589 0.709 . . . . 0.0 111.224 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.12 -30.32 5.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -74.9 153.47 38.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -1.09 . . . . 0.0 110.783 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -98.17 128.97 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.34 131.34 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.97 144.39 45.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.2 m -109.88 132.18 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.556 0.693 . . . . 0.0 109.722 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.18 129.63 42.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.47 -0.769 . . . . 0.0 109.212 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.593 -0.692 . . . . 0.0 109.528 -179.779 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.016 0.436 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.4 131.31 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.485 0.66 . . . . 0.0 109.449 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 12.3 ptm -97.3 147.51 24.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.646 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.51 161.78 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.03 120.59 42.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.55 0.69 . . . . 0.0 109.646 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.6 p -88.48 154.13 50.96 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.18 -13.13 14.89 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.279 1.986 . . . . 0.0 111.284 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -85.02 -3.68 58.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.28 3.67 88.59 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.88 159.49 19.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.959 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.2 mm -113.1 129.6 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.478 -0.763 . . . . 0.0 109.542 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -121.87 137.57 54.73 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -105.01 131.19 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 109.91 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.95 147.43 46.29 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.06 154.44 74.06 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.86 137.96 37.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.581 0.705 . . . . 0.0 110.573 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.0 13.24 75.12 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.94 155.58 40.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -1.047 . . . . 0.0 110.207 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.4 p -127.09 175.33 8.2 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.664 0.745 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.2 -33.36 67.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.693 -0.629 . . . . 0.0 110.125 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.03 -41.97 99.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.117 -0.989 . . . . 0.0 109.794 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -60.44 -43.31 96.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.33 -0.856 . . . . 0.0 109.814 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.449 ' CE2' HD11 ' A' ' 444' ' ' LEU . 70.3 t80 -61.52 -43.45 98.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.429 -0.795 . . . . 0.0 109.98 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.45 -44.6 80.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.89 -36.34 84.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.7 p -58.98 -34.36 71.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.449 HD11 ' CE2' ' A' ' 440' ' ' PHE . 86.8 mt -73.78 -76.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.686 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -143.49 -173.8 4.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.265 -0.897 . . . . 0.0 110.101 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 29.7 t -104.17 -55.22 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.412 0.625 . . . . 0.0 109.512 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.485 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 25.7 p-10 -63.01 -48.83 77.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.817 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.97 -43.15 96.63 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.471 -0.768 . . . . 0.0 109.198 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -64.35 -41.13 98.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 66.3 t0 -69.42 -27.41 65.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -1.066 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.485 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 34.5 m80 -87.72 18.11 4.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.277 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 42.6 m -80.23 117.04 20.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -0.875 . . . . 0.0 109.663 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.94 -2.54 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.751 . . . . 0.0 109.377 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.16 178.03 43.78 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.402 -1.38 . . . . 0.0 110.288 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.89 150.5 29.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -1.024 . . . . 0.0 109.067 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' LYS . . . . . 0.525 ' HZ2' ' HB2' ' A' ' 456' ' ' LYS . 3.2 ttmp? -135.79 131.9 36.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.571 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.47 130.83 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.567 0.699 . . . . 0.0 109.538 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 55.84 43.35 27.76 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.45 0.643 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 459' ' ' HIS . 59.0 t-80 57.9 12.98 1.91 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 109.965 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -113.83 135.34 54.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 47.8 tp -66.68 135.08 53.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 110.109 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.04 151.2 37.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.099 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.17 161.89 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.483 2.122 . . . . 0.0 112.344 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -63.05 -38.31 90.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.646 -0.659 . . . . 0.0 109.504 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.5 p -75.07 9.43 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.977 . . . . 0.0 109.3 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -68.88 135.26 50.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.404 -0.81 . . . . 0.0 110.206 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.35 130.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.306 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.63 147.51 37.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 110.174 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -125.46 146.61 49.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.607 -0.683 . . . . 0.0 109.909 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 68.2 m -70.49 141.43 51.98 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.565 0.698 . . . . 0.0 110.865 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.48 -22.72 39.31 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.32 171.04 13.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.198 -1.178 . . . . 0.0 110.529 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.69 127.38 56.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 440' ' ' PHE . 60.2 t -102.82 131.7 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.371 -0.831 . . . . 0.0 109.911 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.54 116.05 14.6 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 476' ' ' VAL . 3.6 m -85.05 130.93 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.35 143.67 26.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.558 -0.714 . . . . 0.0 109.652 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.422 ' OG ' HD11 ' A' ' 448' ' ' LEU . 70.2 m . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.1 ptm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.452 0.644 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.2 mp0 -83.35 165.54 19.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.406 -0.809 . . . . 0.0 109.518 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.65 131.26 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.711 0.767 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.6 ttm -94.89 131.7 40.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.505 -0.747 . . . . 0.0 109.232 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.03 164.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -123.78 144.47 49.68 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.412 0.625 . . . . 0.0 109.51 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.8 176.27 1.98 Allowed Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -34.53 84.54 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -81.35 -3.68 53.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.575 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.32 9.34 85.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -69.91 150.81 46.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.286 . . . . 0.0 110.299 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.3 mm -90.06 124.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -131.5 112.4 12.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -94.02 136.19 34.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.501 -0.75 . . . . 0.0 109.219 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.3 mt -122.31 148.18 51.66 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.493 2.129 . . . . 0.0 112.717 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -56.01 139.31 47.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.62 12.63 77.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.06 154.8 41.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.7 p -127.49 174.57 8.92 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.55 0.69 . . . . 0.0 109.984 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.62 71.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.507 -0.746 . . . . 0.0 109.444 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.76 -42.45 99.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -61.49 -43.02 99.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.79 . . . . 0.0 110.088 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 444' ' ' LEU . 57.1 t80 -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.54 80.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.178 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -64.96 -36.54 84.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.336 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.5 m -58.49 -41.56 85.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.459 HD11 ' CE2' ' A' ' 440' ' ' PHE . 78.0 mt -68.16 -73.77 0.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.32 -179.8 6.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.924 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 73.5 m -100.11 -59.57 1.69 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.568 -0.708 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.425 ' OD1' ' CD2' ' A' ' 451' ' ' HIS . 49.2 t0 -60.17 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.867 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.6 -43.41 97.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.227 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.49 -37.46 94.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.05 -16.41 63.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.054 -1.263 . . . . 0.0 109.381 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.425 ' CD2' ' OD1' ' A' ' 447' ' ' ASP . 45.3 m-70 -95.79 17.26 15.48 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 25.6 p -74.29 116.77 15.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.388 -0.82 . . . . 0.0 109.539 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.2 pt -99.44 -2.79 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -0.766 . . . . 0.0 109.247 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.26 -171.6 39.41 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.022 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -148.71 148.02 29.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -1.178 . . . . 0.0 109.126 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -135.63 120.86 18.99 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.01 133.14 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.557 0.694 . . . . 0.0 109.92 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 56.51 43.27 26.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.681 -0.637 . . . . 0.0 109.671 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 55.33 10.38 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.625 -0.672 . . . . 0.0 109.957 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.24 145.25 42.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.564 -0.71 . . . . 0.0 109.652 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 461' ' ' LEU . 4.3 mm? -72.93 141.37 47.84 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.38 148.38 22.19 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.02 162.6 37.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.274 1.982 . . . . 0.0 112.68 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.71 -40.3 96.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.443 -0.785 . . . . 0.0 109.624 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 93.1 p -75.75 10.38 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.039 -1.038 . . . . 0.0 109.434 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -68.33 135.35 51.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 110.347 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.43 131.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.31 144.09 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.675 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -115.2 150.56 35.93 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.42 0.629 . . . . 0.0 109.421 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 15.6 p -70.78 155.34 40.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.0 -36.57 1.47 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.6 145.14 54.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.246 . . . . 0.0 111.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -86.29 140.23 30.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.763 . . . . 0.0 109.175 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.08 132.1 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.543 -0.723 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -136.82 116.02 12.55 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.35 138.43 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.92 130.89 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.7 t -139.95 146.24 38.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.275 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 480' ' ' LYS . 88.3 p -81.74 -8.24 59.68 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.808 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 479' ' ' SER . 53.1 mtmt 39.14 34.63 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.732 0.777 . . . . 0.0 109.724 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 18.1 m -62.84 142.32 58.28 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 110.26 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.49 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 88.9 mt -95.58 2.9 54.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.92 143.72 57.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.939 . . . . 0.0 110.208 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 69.3 m80 -141.14 160.07 40.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.0 m80 55.67 19.11 3.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.559 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.8 -44.7 96.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.356 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -89.34 153.97 20.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.059 -1.025 . . . . 0.0 110.027 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -74.2 130.9 40.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 110.535 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . 0.439 ' CD2' ' H ' ' A' ' 489' ' ' HIS . 16.6 p80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.058 -0.973 . . . . 0.0 109.63 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.5 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -132.38 148.44 52.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.233 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.54 129.97 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.82 142.9 31.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.0 109.648 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.84 164.5 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.54 137.1 54.56 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.603 0.716 . . . . 0.0 109.479 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.05 165.55 14.7 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.85 -14.42 44.52 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.548 2.165 . . . . 0.0 111.232 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -85.22 -5.11 59.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.576 -0.702 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.34 9.3 82.1 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 4.5 mp0 -84.19 162.04 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.288 -1.125 . . . . 0.0 109.758 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 33.0 mm -110.92 129.22 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -127.99 132.04 49.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -109.6 139.39 44.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.68 -0.637 . . . . 0.0 109.527 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 97.4 mt -136.4 147.9 61.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.488 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.46 158.65 56.58 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.486 2.124 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -56.63 146.34 25.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.55 77.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.57 154.42 41.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.687 -0.89 . . . . 0.0 110.142 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 69.5 p -127.57 170.47 12.59 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.595 0.712 . . . . 0.0 109.693 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.73 74.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 109.321 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.68 -42.09 99.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -61.44 -43.68 98.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.507 ' CE2' HD21 ' A' ' 444' ' ' LEU . 85.2 t80 -61.29 -44.68 96.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 109.523 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.74 -36.51 83.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 109.191 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.4 t -61.57 -39.54 91.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.578 -0.701 . . . . 0.0 110.132 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.507 HD21 ' CE2' ' A' ' 440' ' ' PHE . 89.2 mt -48.44 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' A' ' 447' ' ' ASP . 99.3 m-70 -151.24 20.46 0.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 m 68.52 -37.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.624 . . . . 0.0 109.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 445' ' ' HIS . 99.7 m-20 -62.15 -44.23 97.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.5 mm? -63.72 -43.06 97.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.379 -0.825 . . . . 0.0 108.983 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -71.25 -29.65 68.24 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -76.44 -9.77 58.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -1.072 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -138.83 28.47 2.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.19 109.23 13.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.5 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.4 pt -100.65 -2.52 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.511 -0.743 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.32 176.51 45.99 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.066 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.6 149.99 29.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -1.083 . . . . 0.0 109.106 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -135.56 124.59 24.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 0.0 108.89 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.0 t -122.16 133.02 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.565 -0.709 . . . . 0.0 109.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 55.79 42.97 28.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.603 -0.686 . . . . 0.0 109.687 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m80 54.86 13.82 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.864 -0.523 . . . . 0.0 110.264 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -117.91 137.4 52.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 109.133 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.57 135.22 54.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.13 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.32 150.82 56.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.74 160.77 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.253 1.969 . . . . 0.0 112.547 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.2 mp -62.72 -40.33 96.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 465' ' ' SER . 3.4 t -77.7 15.06 0.89 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.507 -0.745 . . . . 0.0 109.167 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 464' ' ' LEU . 86.8 t80 -67.54 134.11 50.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.907 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.96 131.39 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.785 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.95 145.66 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.806 . . . . 0.0 110.243 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -119.58 146.18 45.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.537 0.684 . . . . 0.0 109.175 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.1 t -64.93 141.24 58.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 110.68 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.7 -32.83 4.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -72.73 147.04 46.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.251 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.34 144.16 28.22 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.81 132.95 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-O 121.668 0.747 . . . . 0.0 109.786 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -139.62 128.62 23.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.94 128.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.007 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.22 100.0 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.025 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.0 p -84.26 166.4 17.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 110.025 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 38.5 t -80.38 -2.54 46.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.54 -0.725 . . . . 0.0 109.193 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -53.57 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 110.244 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 12.6 m -173.28 70.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 85.9 mt -91.82 -1.97 57.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -77.32 118.01 19.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.537 -0.727 . . . . 0.0 109.943 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 80.9 m80 41.36 90.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.453 0.644 . . . . 0.0 110.315 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.59 -8.48 59.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.077 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 78.4 m80 51.14 179.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.701 . . . . 0.0 110.688 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . 0.53 ' CG ' ' N ' ' A' ' 488' ' ' HIS . 86.3 t60 55.06 166.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.434 0.635 . . . . 0.0 110.396 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.53 ' N ' ' CG ' ' A' ' 487' ' ' HIS . 79.7 m80 -102.65 129.83 49.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.532 -0.73 . . . . 0.0 110.267 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.915 -1.041 . . . . 0.0 109.955 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . 0.488 ' SD ' ' OE1' ' A' ' 433' ' ' GLN . 55.8 ttm . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 121.669 0.747 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.3 mp0 -135.83 166.23 23.77 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.05 131.07 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.684 0.754 . . . . 0.0 109.486 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.7 ttp -98.22 129.97 44.96 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.723 0.773 . . . . 0.0 110.458 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.33 164.47 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.33 137.35 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.856 0.836 . . . . 0.0 109.96 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.39 159.66 30.67 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.93 -16.22 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.251 1.967 . . . . 0.0 111.413 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -83.27 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.03 6.42 88.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 429' ' ' LYS . 82.7 tt0 -86.6 152.48 22.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.943 . . . . 0.0 110.705 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.9 mm -84.18 129.2 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.492 0.663 . . . . 0.0 109.804 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 427' ' ' GLU . 34.9 mmtm -132.76 109.4 9.64 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.597 0.713 . . . . 0.0 110.13 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -102.37 128.67 48.86 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.6 mt -122.47 152.69 61.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.14 145.94 24.51 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.459 2.106 . . . . 0.0 112.745 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.488 ' OE1' ' SD ' ' A' ' 417' ' ' MET . 59.1 tt0 -58.39 137.01 57.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.847 0.832 . . . . 0.0 110.634 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.23 13.93 72.84 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -72.61 166.54 22.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.648 -0.913 . . . . 0.0 110.209 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 p -127.13 172.34 10.62 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.992 0.901 . . . . 0.0 110.581 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.61 -26.6 61.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.09 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.72 -45.4 92.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.418 -0.801 . . . . 0.0 109.719 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -64.82 -38.39 90.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.691 -0.631 . . . . 0.0 109.421 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 444' ' ' LEU . 84.5 t80 -61.23 -45.34 94.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.786 -0.571 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.51 91.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.646 -0.659 . . . . 0.0 109.515 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 438' ' ' LEU . 8.7 m-85 -68.64 -34.09 75.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.494 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 30.8 m -58.08 -42.07 84.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.81 -0.556 . . . . 0.0 109.706 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.8 mt -64.08 -70.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.714 -0.616 . . . . 0.0 109.603 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -149.2 -176.17 5.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.559 -0.713 . . . . 0.0 109.904 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 37.6 t -92.45 -71.01 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.498 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 27.2 t70 -55.78 -48.63 75.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.793 -0.567 . . . . 0.0 110.231 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.523 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.9 -44.5 95.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.531 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.07 -38.73 92.66 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.75 -10.7 59.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.874 . . . . 0.0 109.501 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 16.0 m80 -99.66 20.8 13.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.97 117.9 22.55 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.585 0.707 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.6 pt -101.16 -3.46 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.49 176.94 46.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -140.71 146.34 37.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.797 -0.825 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -134.75 122.27 21.9 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.394 0.616 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -122.44 132.76 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.702 0.763 . . . . 0.0 109.8 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 54.42 45.69 26.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.653 0.739 . . . . 0.0 109.796 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 58.1 t-80 56.41 14.04 1.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.055 0.455 . . . . 0.0 109.969 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.44 141.15 47.44 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.725 0.774 . . . . 0.0 110.159 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -79.58 112.31 16.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.544 0.688 . . . . 0.0 109.522 -179.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.527 ' N ' HD13 ' A' ' 461' ' ' LEU . 3.6 m -120.95 151.02 54.35 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.85 163.3 36.01 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.604 2.202 . . . . 0.0 112.648 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.62 -39.93 95.36 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.6 m -75.45 8.35 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.773 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 91.1 t80 -67.54 135.01 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.698 0.761 . . . . 0.0 110.406 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.426 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 79.8 t -78.53 131.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.828 0.823 . . . . 0.0 109.757 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.4 mt -74.41 143.39 44.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.654 0.74 . . . . 0.0 110.407 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -116.26 144.6 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.767 0.794 . . . . 0.0 109.801 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.5 t -66.76 139.81 57.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.756 0.789 . . . . 0.0 110.564 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.28 -34.99 4.18 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.05 144.21 48.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.732 -0.864 . . . . 0.0 110.872 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -87.44 144.22 26.85 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.499 0.666 . . . . 0.0 109.562 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.42 131.31 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.575 0.703 . . . . 0.0 109.969 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -133.07 137.98 46.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 9.0 m -111.03 130.94 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-O 121.64 0.734 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.01 131.74 42.09 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.536 0.684 . . . . 0.0 109.676 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 55.9 m -126.78 152.19 47.24 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.694 0.759 . . . . 0.0 109.721 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 93.6 p -73.13 68.39 0.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.794 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -95.14 -7.11 40.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 482' ' ' LEU . 51.9 p -146.31 -124.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.631 -0.668 . . . . 0.0 110.014 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.547 ' N ' ' OG ' ' A' ' 481' ' ' SER . 58.0 mt 59.2 1.3 0.22 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 481' ' ' SER . 79.2 mm-40 -51.55 111.14 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.927 0.87 . . . . 0.0 109.996 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.01 -35.89 77.17 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.737 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.598 ' CE1' ' CD2' ' A' ' 486' ' ' HIS . 13.4 t-80 69.42 127.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.801 0.81 . . . . 0.0 110.556 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . 0.598 ' CD2' ' CE1' ' A' ' 485' ' ' HIS . 72.6 m-70 52.12 92.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.644 0.735 . . . . 0.0 110.203 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -69.01 135.52 51.02 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.749 0.785 . . . . 0.0 109.907 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -151.9 -1.77 0.3 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.276 179.793 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.1 mp0 -80.56 164.11 23.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 110.279 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.45 131.03 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.55 0.69 . . . . 0.0 109.301 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . 0.517 ' SD ' HG23 ' A' ' 428' ' ' ILE . 50.8 ttp -97.88 136.54 38.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.523 -0.735 . . . . 0.0 109.768 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.11 161.55 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -115.33 134.59 54.97 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.659 0.742 . . . . 0.0 109.787 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 166.27 13.63 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.71 -15.05 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.531 2.154 . . . . 0.0 111.471 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -85.91 -6.2 59.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.196 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.72 11.9 78.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.449 ' C ' HD12 ' A' ' 428' ' ' ILE . 79.8 mm-40 -85.84 161.77 18.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.143 . . . . 0.0 110.206 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.517 HG23 ' SD ' ' A' ' 420' ' ' MET . 1.3 mp -107.78 129.03 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.92 123.35 32.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -102.08 127.87 48.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 14.1 mt -118.49 158.21 47.56 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.53 149.17 83.7 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.33 2.02 . . . . 0.0 112.873 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -57.48 134.21 55.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.458 -0.777 . . . . 0.0 110.418 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.73 76.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -63.54 167.87 5.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -1.148 . . . . 0.0 110.246 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 70.0 p -127.52 172.33 10.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.666 0.746 . . . . 0.0 110.002 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -30.07 68.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.477 -0.764 . . . . 0.0 109.219 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 464' ' ' LEU . 89.6 mt -63.05 -43.12 99.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 0.0 109.309 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.68 -41.35 99.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 444' ' ' LEU . 54.7 t80 -61.43 -43.65 98.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.96 -44.8 87.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -65.49 -35.73 81.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.404 -0.81 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 26.2 m -58.64 -41.47 86.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.753 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.456 HD11 ' CE2' ' A' ' 440' ' ' PHE . 76.5 mt -68.96 -77.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.881 . . . . 0.0 109.651 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 445' ' ' HIS . 6.1 m80 -124.29 -151.18 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.604 -0.685 . . . . 0.0 109.2 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 26.5 m -128.54 -70.49 0.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.59 -0.694 . . . . 0.0 109.251 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.446 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.6 m-20 -64.19 -39.5 94.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.512 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.08 -44.95 95.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.059 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.14 93.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 452' ' ' CYS . 35.4 t70 -64.43 -38.36 90.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -1.09 . . . . 0.0 109.605 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.446 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 60.9 m80 -78.6 28.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.201 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 8.8 t -79.21 123.97 27.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.0 pt -97.6 -5.01 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.214 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . 175.88 179.74 46.55 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.75 149.54 43.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.509 -0.995 . . . . 0.0 109.122 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -132.41 122.6 25.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.33 132.88 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.692 -0.63 . . . . 0.0 109.643 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . 0.562 HD21 ' CG ' ' A' ' 472' ' ' ASP . 98.0 m-20 55.9 42.37 28.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.721 -0.612 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.8 m80 57.15 12.03 1.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.739 -0.6 . . . . 0.0 109.879 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.96 136.25 53.21 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.632 0.73 . . . . 0.0 109.653 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.92 134.63 52.4 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.577 -0.702 . . . . 0.0 109.863 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.09 150.9 57.38 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.795 . . . . 0.0 109.294 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.5 161.6 42.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.558 2.172 . . . . 0.0 113.01 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -63.27 -40.16 96.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.699 -0.626 . . . . 0.0 109.451 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 8.4 t -76.43 8.19 3.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.207 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 90.1 t80 -61.26 134.91 57.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.512 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.411 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 76.1 t -76.9 130.09 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.478 -0.764 . . . . 0.0 109.98 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.8 147.71 33.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 110.409 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -125.7 145.19 50.29 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.621 0.724 . . . . 0.0 109.518 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 97.6 p -65.4 145.17 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.658 0.742 . . . . 0.0 110.846 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.43 -32.53 4.69 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . 0.562 ' CG ' HD21 ' A' ' 458' ' ' ASN . 88.7 m-20 -72.73 145.77 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.88 139.67 30.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.17 131.93 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.569 0.7 . . . . 0.0 109.992 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.91 114.01 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.61 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.88 114.24 26.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.447 -0.783 . . . . 0.0 109.594 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 95.2 p -85.57 172.83 10.63 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.535 -0.728 . . . . 0.0 110.224 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 94.1 p -84.79 -3.51 58.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.447 -0.783 . . . . 0.0 109.624 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.9 135.91 56.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.157 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 88.9 p -66.29 149.06 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 0.0 110.612 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.5 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 87.4 mt -98.47 3.93 48.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.0 109.117 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.99 139.31 58.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 110.238 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 70.9 m80 -146.18 157.76 43.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -96.69 102.2 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.808 . . . . 0.0 109.896 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -91.16 -8.89 47.4 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 86.2 t60 52.71 72.94 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.468 -0.77 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -152.9 139.7 18.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 109.551 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.62 -179.733 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 47.3 ttp . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.9 mp0 -80.9 168.2 19.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.317 0.58 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.0 131.73 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.737 0.78 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.6 ttm -90.33 132.9 35.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.758 0.79 . . . . 0.0 110.084 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 429' ' ' LYS . 18.4 m -131.63 163.46 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.404 0.621 . . . . 0.0 109.425 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 428' ' ' ILE . 85.9 m-85 -123.57 138.68 54.51 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.013 0.911 . . . . 0.0 109.929 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 159.39 29.87 Favored Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.41 -34.81 33.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.331 2.021 . . . . 0.0 112.221 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.81 -4.13 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.818 -0.551 . . . . 0.0 109.696 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.36 7.45 82.62 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -74.09 153.21 39.71 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.676 0.75 . . . . 0.0 110.682 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.435 HD12 ' CE2' ' A' ' 422' ' ' PHE . 20.4 mm -104.97 122.5 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.406 0.622 . . . . 0.0 109.629 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.401 ' O ' HG22 ' A' ' 421' ' ' VAL . 72.0 mmtt -127.31 135.91 51.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.846 0.831 . . . . 0.0 110.235 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -108.11 132.86 53.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 31.5 mt -122.14 152.45 60.25 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 147.84 28.91 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.262 1.975 . . . . 0.0 112.86 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -58.21 129.32 41.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.646 0.736 . . . . 0.0 110.58 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 13.95 76.19 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.36 173.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.671 0.748 . . . . 0.0 110.604 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 33.0 p -127.97 172.01 11.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.874 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.71 65.8 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.09 -42.47 99.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.97 -42.05 98.7 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 444' ' ' LEU . 56.2 t80 -62.1 -42.87 99.66 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.98 92.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.0 -36.6 83.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.3 m -58.95 -42.87 90.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.565 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 77.6 mt -66.61 -59.93 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.734 -0.604 . . . . 0.0 109.789 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.4 m-70 -158.85 -176.06 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.441 0.638 . . . . 0.0 109.858 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 39.9 t -101.58 -61.72 1.34 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.09 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.51 -44.96 95.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.742 -0.599 . . . . 0.0 109.935 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.12 -45.11 93.53 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.15 89.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.98 -34.35 78.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.885 -0.773 . . . . 0.0 109.406 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -85.12 16.5 3.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 49.7 t -72.79 116.67 13.56 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.597 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.2 pt -102.53 -0.57 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . 0.449 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -173.03 170.86 44.01 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.745 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.12 149.51 31.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.069 -0.665 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -138.82 130.59 27.7 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 64.7 t -119.97 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.663 0.744 . . . . 0.0 109.677 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 58.49 41.64 22.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 56.94 12.99 1.33 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -113.05 115.36 28.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.896 0.855 . . . . 0.0 109.792 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.1 tp -51.32 133.92 28.5 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.556 0.694 . . . . 0.0 110.229 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.1 152.34 39.6 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.13 161.57 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.595 2.196 . . . . 0.0 112.651 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.79 -38.2 89.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.1 m -75.05 7.45 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.847 -0.533 . . . . 0.0 109.663 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -69.58 134.08 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.564 0.697 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 82.8 t -78.61 131.04 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.596 0.713 . . . . 0.0 109.865 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.71 146.24 42.43 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.629 0.728 . . . . 0.0 110.631 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -121.11 144.54 48.51 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.866 0.841 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 140.75 58.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.659 0.743 . . . . 0.0 111.121 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.57 -25.89 18.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.32 163.29 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.666 -0.903 . . . . 0.0 110.946 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -109.31 120.72 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 20.9 t -93.09 132.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.841 0.829 . . . . 0.0 110.622 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.5 0.667 . . . . 0.0 109.316 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.23 130.82 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.805 0.812 . . . . 0.0 110.455 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.65 106.35 18.61 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.588 0.709 . . . . 0.0 109.213 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 480' ' ' LYS . 18.7 p -87.57 169.31 12.29 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.588 0.708 . . . . 0.0 110.171 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.7 m -77.27 32.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.25 0.548 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 478' ' ' SER . 9.9 mtpm? -81.45 -4.65 56.47 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 483' ' ' GLU . 10.3 p -46.09 107.88 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.563 0.697 . . . . 0.0 109.894 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.659 ' N ' HD22 ' A' ' 482' ' ' LEU . 3.3 mm? 56.29 6.12 0.23 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 481' ' ' SER . 48.5 mt-10 46.81 -168.51 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.49 0.662 . . . . 0.0 110.379 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -149.58 163.88 36.66 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.764 0.792 . . . . 0.0 110.12 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -68.99 129.59 40.36 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.626 0.727 . . . . 0.0 110.557 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -82.75 128.14 34.1 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.591 0.71 . . . . 0.0 110.257 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -109.29 124.6 51.19 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.404 0.621 . . . . 0.0 109.972 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.55 126.57 52.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.786 0.803 . . . . 0.0 110.383 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.777 -1.106 . . . . 0.0 109.85 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.3 mp0 -135.87 145.06 45.96 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 18.2 m -119.32 130.94 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.592 -0.692 . . . . 0.0 109.215 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 49.5 ttp -96.66 137.94 34.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.74 165.18 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -113.32 138.51 49.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 109.515 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.6 162.49 21.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 108.784 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.27 -32.29 40.52 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.191 1.928 . . . . 0.0 111.998 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.53 -1.64 34.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.05 -1.031 . . . . 0.0 109.323 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.22 12.09 81.29 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.24 158.83 32.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -1.163 . . . . 0.0 110.55 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.6 mm -106.24 124.41 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.463 -0.773 . . . . 0.0 109.077 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -128.67 132.94 48.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -0.758 . . . . 0.0 109.016 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -106.74 138.41 42.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.679 -0.638 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.1 mt -131.64 147.6 66.69 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.92 157.31 62.36 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.375 2.05 . . . . 0.0 112.705 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.41 143.01 25.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.64 12.62 74.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.06 42.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 110.364 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.2 p -127.45 172.03 11.04 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.588 0.709 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.28 69.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.49 -0.756 . . . . 0.0 109.593 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.58 -42.26 99.45 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 109.197 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.59 -44.71 93.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 444' ' ' LEU . 65.0 t80 -61.5 -43.65 98.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.11 85.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.152 -0.968 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -64.31 -36.87 85.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.0 m -59.01 -42.29 89.75 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.96 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.5 mt -66.71 -57.36 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.991 -1.068 . . . . 0.0 109.658 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.652 ' CD2' ' H ' ' A' ' 446' ' ' SER . 65.6 t60 -161.48 -173.48 3.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.144 -0.972 . . . . 0.0 109.333 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . 0.652 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 8.7 m -103.41 -60.53 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.74 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 451' ' ' HIS . 43.5 t0 -62.16 -45.7 92.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.501 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.07 -43.89 97.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 108.816 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . 0.447 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -64.67 -35.51 92.02 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -73.41 -10.77 60.08 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.28 -1.13 . . . . 0.0 109.36 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 59.5 m-70 -97.36 7.85 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 108.841 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 29.9 p -73.55 116.44 14.13 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.392 -0.818 . . . . 0.0 109.822 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.08 -2.82 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.05 177.54 43.95 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.55 142.79 41.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -1.074 . . . . 0.0 108.958 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.74 121.9 21.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.5 133.85 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 57.38 43.95 22.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.764 0.792 . . . . 0.0 109.356 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 54.17 13.27 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.747 . . . . 0.0 110.224 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -114.71 136.65 52.83 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.54 -0.725 . . . . 0.0 109.418 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 44.1 tp -67.83 134.46 50.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.89 151.2 48.65 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 108.861 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.55 162.08 38.47 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.598 2.199 . . . . 0.0 112.746 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -62.92 -39.34 94.25 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.717 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.3 m -75.19 7.85 3.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.115 -0.991 . . . . 0.0 109.181 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -66.21 134.95 53.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.242 -0.911 . . . . 0.0 110.255 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.3 t -78.71 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 110.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.43 144.63 44.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.234 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 100.0 m-20 -117.18 151.68 36.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.686 -0.634 . . . . 0.0 109.588 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.3 p -68.92 154.12 42.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.522 -0.736 . . . . 0.0 110.848 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 77.45 -37.2 1.59 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.94 145.4 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.398 . . . . 0.0 110.964 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -87.43 149.79 24.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.51 -0.743 . . . . 0.0 109.508 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 440' ' ' PHE . 61.9 t -118.62 132.8 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.521 -0.737 . . . . 0.0 109.749 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -138.08 113.78 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.0 139.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 110.011 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.4 111.7 23.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.418 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 5.8 t -107.59 35.62 3.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 1.3 p 54.45 17.8 1.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.777 . . . . 0.0 109.731 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -67.9 138.45 56.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.184 -0.948 . . . . 0.0 110.277 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 9.1 p -75.31 139.42 42.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.772 . . . . 0.0 109.705 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.79 -22.87 10.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.03 131.93 47.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.227 -0.92 . . . . 0.0 110.2 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -91.14 130.27 37.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.779 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -78.6 155.53 29.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 110.93 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . 0.453 ' O ' ' ND1' ' A' ' 486' ' ' HIS . 57.3 t-80 57.46 41.91 25.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . 0.439 ' CG ' ' N ' ' A' ' 488' ' ' HIS . 86.2 t60 -79.86 162.0 25.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.466 -0.771 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.439 ' N ' ' CG ' ' A' ' 487' ' ' HIS . 39.7 p-80 -150.65 153.6 35.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . 0.441 ' CD2' ' H ' ' A' ' 489' ' ' HIS . 6.2 p80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.135 -0.936 . . . . 0.0 109.877 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 19.7 tpp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.404 0.621 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.2 mp0 -135.67 149.86 49.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.336 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.03 130.86 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.692 0.758 . . . . 0.0 109.071 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.2 ttp -100.2 140.62 34.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.856 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 166.3 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.82 138.74 50.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.804 0.811 . . . . 0.0 109.837 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.52 165.79 14.08 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.96 -16.01 53.31 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.569 2.179 . . . . 0.0 111.446 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.27 -3.68 59.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 108.914 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.42 84.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.94 167.36 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 110.419 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.0 mm -108.09 128.71 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.592 -0.692 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -125.01 131.47 53.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.565 -0.71 . . . . 0.0 109.525 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -107.82 132.67 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.9 mt -126.57 147.87 62.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.673 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.54 158.14 56.82 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -56.42 139.58 48.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.504 -0.747 . . . . 0.0 110.084 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.32 76.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.67 154.89 41.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -1.086 . . . . 0.0 110.104 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.5 p -127.05 172.72 10.26 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.829 0.823 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -30.6 66.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.707 -0.621 . . . . 0.0 110.053 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 464' ' ' LEU . 83.6 mt -63.33 -43.01 98.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.56 -40.72 97.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 109.725 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 444' ' ' LEU . 77.8 t80 -61.08 -42.88 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.451 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.16 93.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.809 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.43 -37.37 80.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 91.1 p -61.56 -35.96 79.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.49 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.574 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 92.4 mt -63.95 -43.58 95.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.174 -0.954 . . . . 0.0 109.63 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.2 m-70 -162.12 -120.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.739 . . . . 0.0 109.384 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 5.7 p -158.83 -68.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.17 -39.04 92.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.87 -43.26 99.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.238 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.2 89.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.6 -34.27 77.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -82.41 21.34 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 42.1 t -76.67 122.92 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -0.843 . . . . 0.0 109.664 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -105.48 -4.42 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.85 -177.32 46.54 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.32 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -149.19 148.94 30.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -1.144 . . . . 0.0 109.209 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -132.01 126.54 34.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.76 130.56 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.645 0.736 . . . . 0.0 109.72 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . 0.488 HD21 ' CB ' ' A' ' 472' ' ' ASP . 11.2 m120 55.55 41.79 30.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 109.81 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 57.55 16.27 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -118.51 138.76 52.29 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.703 0.763 . . . . 0.0 109.86 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.87 139.04 53.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.2 m -151.06 149.8 25.86 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.43 162.08 42.2 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.339 2.026 . . . . 0.0 112.738 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.2 mp -63.11 -39.31 94.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.469 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.0 m -75.3 8.14 2.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.274 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.3 t80 -65.64 135.4 54.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.519 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.42 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 77.5 t -77.09 130.72 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.673 0.749 . . . . 0.0 110.019 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.74 145.23 38.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.0 110.175 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -118.5 147.64 43.44 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.677 0.751 . . . . 0.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 94.1 p -65.24 151.43 46.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 80.2 -38.35 2.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . 0.488 ' CB ' HD21 ' A' ' 458' ' ' ASN . 99.4 m-20 -68.42 144.27 54.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -1.037 . . . . 0.0 110.796 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -89.23 145.47 25.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.486 -0.759 . . . . 0.0 109.172 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.98 133.24 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.551 -0.718 . . . . 0.0 109.75 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -132.73 142.22 48.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.75 131.2 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.6 0.714 . . . . 0.0 109.74 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.0 mt -92.67 137.38 32.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.773 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 57.3 m -127.3 154.15 45.28 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 109.528 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 71.3 p -88.92 85.8 6.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -87.35 -8.62 56.44 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 97.0 p -77.24 168.05 20.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.847 . . . . 0.0 110.756 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 482' ' ' LEU . 3.3 mm? -83.76 -2.56 56.56 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 55.14 166.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.712 0.767 . . . . 0.0 110.979 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -80.03 164.76 23.18 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.786 0.803 . . . . 0.0 110.4 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.521 ' CD2' ' H ' ' A' ' 485' ' ' HIS . 7.3 p80 -58.59 -41.43 85.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.811 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -72.44 129.82 39.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -82.5 134.5 35.21 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.744 0.783 . . . . 0.0 110.398 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 85.4 t60 45.71 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.627 0.727 . . . . 0.0 110.314 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 75.6 m80 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.969 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . 0.425 ' SD ' ' OE1' ' A' ' 433' ' ' GLN . 11.9 ptt? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 -82.37 157.74 23.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.438 -0.789 . . . . 0.0 110.012 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.45 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . 0.401 ' SD ' HG23 ' A' ' 428' ' ' ILE . 31.5 ttm -99.96 144.48 28.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.721 -0.612 . . . . 0.0 109.703 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.51 163.26 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.24 137.63 53.53 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.676 0.75 . . . . 0.0 109.734 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.67 177.67 1.57 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -29.99 85.65 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.453 2.102 . . . . 0.0 111.595 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.9 -4.52 59.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.16 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.04 13.99 80.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.41 147.17 46.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 428' ' ' ILE . 1.4 mp -90.92 127.58 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -131.23 110.07 10.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -90.24 137.41 32.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.759 -0.588 . . . . 0.0 109.718 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.77 148.45 69.98 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.52 155.01 72.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.466 2.11 . . . . 0.0 112.464 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.425 ' OE1' ' SD ' ' A' ' 417' ' ' MET . 51.1 tt0 -52.23 145.84 10.14 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.668 0.746 . . . . 0.0 110.434 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.63 13.02 79.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.0 150.93 47.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.976 . . . . 0.0 110.267 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.5 p -127.46 172.72 10.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.645 0.736 . . . . 0.0 109.799 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.24 -30.47 66.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.673 -0.642 . . . . 0.0 109.643 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.62 -43.23 97.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.57 -42.05 99.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 444' ' ' LEU . 78.4 t80 -61.37 -43.68 98.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.558 -0.714 . . . . 0.0 109.841 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.42 83.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 0.0 109.804 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.87 -36.16 83.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.8 m -59.66 -39.31 83.99 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.603 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 93.3 mt -63.1 -44.31 96.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.762 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 97.5 m-70 -161.97 -120.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.644 . . . . 0.0 109.521 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 6.0 p -152.93 -76.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.562 -0.712 . . . . 0.0 109.079 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.67 -42.34 98.07 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.441 0.638 . . . . 0.0 109.574 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.11 -44.6 95.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.331 -0.856 . . . . 0.0 108.924 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -65.87 -43.83 93.09 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.83 -29.28 67.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.993 . . . . 0.0 109.607 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -80.62 18.49 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.376 -0.828 . . . . 0.0 108.825 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 63.8 m -79.79 133.04 36.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.588 -0.695 . . . . 0.0 109.951 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.21 -4.24 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.614 -0.678 . . . . 0.0 109.476 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.89 47.4 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.18 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.05 151.99 48.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.509 -0.995 . . . . 0.0 109.703 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . 0.525 ' HZ3' ' HA ' ' A' ' 459' ' ' HIS . 39.9 tttm -133.23 119.98 20.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.652 -0.655 . . . . 0.0 109.308 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.89 136.26 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . 0.587 HD21 ' CB ' ' A' ' 472' ' ' ASP . 14.4 m120 57.45 37.8 27.96 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.525 ' HA ' ' HZ3' ' A' ' 456' ' ' LYS . 29.1 m170 58.83 13.64 2.84 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.159 0.504 . . . . 0.0 109.85 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.78 156.42 26.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.548 0.69 . . . . 0.0 109.816 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -87.02 113.43 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.482 -0.762 . . . . 0.0 109.703 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.512 ' N ' HD13 ' A' ' 461' ' ' LEU . 5.3 m -116.99 150.69 46.38 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.74 162.28 38.07 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.636 2.224 . . . . 0.0 112.697 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.86 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.653 -0.655 . . . . 0.0 109.517 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.9 m -75.33 4.35 7.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.326 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -62.72 135.68 57.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.799 . . . . 0.0 110.44 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.22 132.3 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 121.576 0.703 . . . . 0.0 110.115 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.79 148.07 46.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.631 -0.668 . . . . 0.0 110.509 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.23 142.21 51.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.646 0.736 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.8 t -66.84 141.09 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.619 0.724 . . . . 0.0 110.801 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 91.02 -36.44 3.62 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . 0.587 ' CB ' HD21 ' A' ' 458' ' ' ASN . 91.8 m-20 -70.27 144.01 51.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.438 -1.037 . . . . 0.0 110.454 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.2 143.01 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.556 -0.715 . . . . 0.0 109.391 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.08 132.35 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.42 0.629 . . . . 0.0 109.803 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -140.5 126.1 19.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 34.9 m -94.4 132.89 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.499 -0.75 . . . . 0.0 109.843 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.87 111.9 23.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.639 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 480' ' ' LYS . 8.2 t -89.66 172.75 8.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.586 0.708 . . . . 0.0 110.016 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 30.19 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 0.0 109.68 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 478' ' ' SER . 43.7 mmtm -71.75 145.11 48.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 110.689 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 96.2 p -71.71 107.36 4.5 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.753 0.787 . . . . 0.0 110.151 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.56 9.66 42.73 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 57.54 104.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.613 0.721 . . . . 0.0 110.331 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -61.47 -39.99 92.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.706 -0.621 . . . . 0.0 109.887 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -75.82 66.88 2.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -61.67 -40.9 96.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.548 -0.72 . . . . 0.0 109.279 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -151.3 164.39 36.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -84.87 122.65 29.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 109.971 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.734 -179.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 418' ' ' GLU . 11.4 tmm? . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.496 ' O ' ' SD ' ' A' ' 417' ' ' MET . 97.3 mt-10 -114.1 145.73 41.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 9.7 m -109.92 130.5 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . 0.412 ' CE ' ' NH2' ' A' ' 430' ' ' ARG . 39.0 ttm -91.03 134.21 34.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.807 . . . . 0.0 109.308 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.23 162.35 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.14 138.77 52.69 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.488 0.661 . . . . 0.0 109.596 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 165.62 14.75 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.09 -14.74 45.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.179 1.919 . . . . 0.0 111.129 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.98 -4.27 59.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.467 -0.77 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.65 85.36 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.08 165.9 18.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 110.069 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 34.3 mm -110.91 128.4 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.52 -0.737 . . . . 0.0 109.022 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -126.85 140.22 52.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.412 ' NH2' ' CE ' ' A' ' 420' ' ' MET . 95.9 mtt-85 -113.35 136.79 52.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.632 -0.668 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.25 147.33 63.27 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.15 159.78 51.1 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.257 1.972 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -57.05 148.89 20.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.468 -0.77 . . . . 0.0 110.302 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.58 10.46 81.64 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.03 44.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -1.046 . . . . 0.0 109.759 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.1 p -127.57 173.58 9.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.631 -0.668 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.98 -34.36 69.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.93 -43.03 99.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 109.638 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.87 -41.8 98.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 0.0 109.93 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.409 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 79.7 t80 -60.78 -44.58 96.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.055 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.75 86.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.04 -1.038 . . . . 0.0 109.939 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -64.04 -37.89 89.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.08 . . . . 0.0 109.673 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 60.6 p -59.77 -37.12 78.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 89.2 mt -63.46 -54.19 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.987 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 99.6 m-70 -161.93 -126.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.516 -0.74 . . . . 0.0 109.504 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 19.4 m -146.63 -64.7 0.29 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.011 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.93 -45.36 92.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.0 109.98 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.92 -44.83 95.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.9 90.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.09 -18.47 63.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -1.196 . . . . 0.0 110.011 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -103.29 42.35 1.17 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.392 -0.818 . . . . 0.0 109.321 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.32 127.43 44.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.446 -0.784 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 42.1 pt -101.57 -5.2 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.12 178.55 48.22 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.56 149.31 48.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.645 -0.915 . . . . 0.0 108.704 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . 0.465 ' NZ ' ' C ' ' A' ' 459' ' ' HIS . 44.8 tttm -132.88 120.83 22.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 94.1 t -123.57 133.83 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.542 -0.724 . . . . 0.0 109.705 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.33 43.59 19.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.465 ' C ' ' NZ ' ' A' ' 456' ' ' LYS . 79.5 m80 53.13 13.16 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 110.653 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -118.09 137.04 53.2 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.378 -0.826 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.3 134.83 54.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.628 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.29 150.93 53.64 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.34 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.636 2.224 . . . . 0.0 112.716 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.45 -39.09 92.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.216 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -74.64 7.74 2.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.338 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -65.45 133.78 52.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.949 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 78.2 t -79.56 132.18 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.49 149.23 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.378 -0.826 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -124.1 145.37 49.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.616 -0.677 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 40.7 t -65.69 142.44 58.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -0.799 . . . . 0.0 110.495 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 90.89 -32.46 5.1 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -73.08 149.37 43.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.349 -1.089 . . . . 0.0 109.716 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -95.53 130.14 42.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 22.1 t -103.55 131.66 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.455 -0.778 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -134.51 143.14 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.46 132.46 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.479 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.81 128.65 46.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.327 -0.858 . . . . 0.0 109.248 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 73.0 m -130.8 119.19 21.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.547 -0.721 . . . . 0.0 109.567 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 83.7 p -91.22 -4.9 55.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 109.001 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.448 ' NZ ' HD22 ' A' ' 448' ' ' LEU . 72.0 mmtt 46.4 90.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.444 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 27.9 m -79.57 105.86 11.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.637 -0.664 . . . . 0.0 109.739 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.444 ' O ' ' ND1' ' A' ' 484' ' ' HIS . 84.5 mt -96.01 -0.58 50.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -67.07 139.98 57.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 110.395 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 482' ' ' LEU . 75.1 m80 -141.35 23.72 2.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 486' ' ' HIS . 86.4 t60 -139.61 176.85 8.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.448 -0.783 . . . . 0.0 109.78 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 485' ' ' HIS . 56.2 t-80 55.58 84.29 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.713 -0.617 . . . . 0.0 109.939 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -133.59 19.62 3.91 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -151.13 162.67 40.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.195 -0.941 . . . . 0.0 110.145 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.756 -179.759 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 55.5 ttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.746 0.784 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.4 167.97 20.9 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.365 0.602 . . . . 0.0 110.178 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.1 131.58 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.631 0.729 . . . . 0.0 109.519 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 54.6 ttm -96.99 133.69 41.33 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.687 0.756 . . . . 0.0 110.405 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.08 163.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -115.69 142.35 46.86 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.902 0.858 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.71 176.71 1.78 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.33 -29.92 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.071 1.847 . . . . 0.0 111.429 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -84.11 -4.91 59.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.601 -0.687 . . . . 0.0 109.173 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.5 79.95 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.59 157.55 37.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.52 -0.988 . . . . 0.0 110.485 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.3 mm -99.68 123.98 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.646 -0.659 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -127.43 126.33 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -106.62 133.86 50.65 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.26 0.552 . . . . 0.0 109.646 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.76 152.96 77.82 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.54 147.82 22.11 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.36 2.04 . . . . 0.0 112.492 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.14 132.37 52.74 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.914 0.864 . . . . 0.0 110.632 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.6 13.59 75.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -59.3 170.9 0.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.986 . . . . 0.0 110.677 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.9 p -127.54 171.08 11.93 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.143 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.98 -28.77 67.96 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.327 0.584 . . . . 0.0 109.968 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.39 -42.56 98.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.69 -39.85 95.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.712 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.535 ' CE2' HD11 ' A' ' 444' ' ' LEU . 84.7 t80 -61.27 -43.68 98.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.792 . . . . 0.0 109.156 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.3 95.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.627 -0.671 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -65.03 -36.68 85.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 38.9 m -58.81 -41.57 87.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.535 HD11 ' CE2' ' A' ' 440' ' ' PHE . 88.0 mt -72.04 -76.71 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -138.42 179.05 6.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.419 -0.801 . . . . 0.0 109.897 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 33.6 t -103.95 -55.06 2.44 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.378 0.609 . . . . 0.0 109.612 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.58 -49.68 74.31 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.512 0.673 . . . . 0.0 109.659 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.516 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -64.95 -44.71 88.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.739 0.78 . . . . 0.0 109.611 -179.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.73 -42.19 93.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.8 t0 -66.63 -35.46 80.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.598 -0.942 . . . . 0.0 109.864 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 451' ' ' HIS . 11.1 t-160 -81.74 20.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.197 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 28.7 p -74.53 129.98 38.75 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.498 0.666 . . . . 0.0 109.947 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.43 -4.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.37 48.48 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 147.04 40.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.58 -0.953 . . . . 0.0 109.709 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -131.66 124.04 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.08 131.84 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.614 0.721 . . . . 0.0 109.998 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 54.7 44.06 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 109.937 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.436 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 54.0 t-80 58.49 13.39 2.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.281 0.562 . . . . 0.0 109.68 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.02 144.53 43.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.751 . . . . 0.0 109.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 462' ' ' VAL . 0.3 OUTLIER -82.13 113.53 20.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.423 0.63 . . . . 0.0 109.589 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 461' ' ' LEU . 6.4 m -120.75 151.69 54.85 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.07 162.78 36.68 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.497 2.131 . . . . 0.0 112.375 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -63.32 -39.42 94.52 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.402 0.62 . . . . 0.0 109.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.6 t -75.56 10.52 1.66 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.286 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . 0.433 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.0 t80 -69.1 135.48 50.8 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.788 0.804 . . . . 0.0 110.518 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.433 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 81.7 t -81.2 131.48 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 121.721 0.772 . . . . 0.0 109.778 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.61 145.08 45.67 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.617 0.722 . . . . 0.0 110.549 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.02 144.18 44.9 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.67 0.747 . . . . 0.0 109.877 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 42.6 t -68.62 140.18 55.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.947 0.879 . . . . 0.0 111.143 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.11 -26.19 16.28 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.95 163.31 25.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.986 . . . . 0.0 111.359 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -103.43 134.51 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 51.3 t -114.48 132.2 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.699 0.761 . . . . 0.0 110.301 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.79 146.23 39.2 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.29 131.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.727 0.775 . . . . 0.0 110.188 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.5 131.91 34.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.573 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.7 m -130.32 153.97 48.13 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.68 0.752 . . . . 0.0 110.235 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.4 p -90.41 83.64 5.93 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.499 0.666 . . . . 0.0 109.491 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -113.64 5.58 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 87.5 p -85.14 -1.37 56.8 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.606 0.717 . . . . 0.0 109.267 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 482' ' ' LEU . 8.3 mp -80.78 -5.79 57.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -73.3 147.07 44.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.626 -0.671 . . . . 0.0 110.177 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -146.78 139.46 25.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -0.816 . . . . 0.0 109.881 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 485' ' ' HIS . 86.5 t60 -81.78 57.12 3.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.79 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -73.84 147.47 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -59.91 -42.98 95.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.773 -0.579 . . . . 0.0 109.929 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -119.84 118.37 30.62 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.619 0.723 . . . . 0.0 109.512 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.227 -0.892 . . . . 0.0 109.745 -179.795 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.5 159.19 42.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.471 -0.768 . . . . 0.0 109.076 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.8 130.88 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.429 -0.794 . . . . 0.0 108.964 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.6 ttm -92.5 138.43 31.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.786 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.48 164.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.03 137.39 53.57 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 171.51 5.65 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.94 -29.5 82.49 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.939 1.759 . . . . 0.0 111.113 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -81.24 -4.35 55.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.626 . . . . 0.0 109.623 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.0 83.46 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -73.87 156.65 37.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -1.171 . . . . 0.0 110.198 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.7 mm -103.12 125.14 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.08 132.9 47.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.565 -0.709 . . . . 0.0 109.262 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -107.25 134.99 49.52 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 49.2 mt -131.0 153.07 81.68 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.6 147.17 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.985 1.79 . . . . 0.0 112.707 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -54.87 130.34 40.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.673 -0.642 . . . . 0.0 110.092 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.03 76.36 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -52.09 172.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 109.864 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.7 p -128.22 171.42 11.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.551 -0.718 . . . . 0.0 109.958 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.73 71.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.655 -0.653 . . . . 0.0 110.064 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.06 -43.55 98.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.432 -0.793 . . . . 0.0 109.532 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.427 ' CE2' HD11 ' A' ' 444' ' ' LEU . 63.4 t80 -61.12 -43.85 98.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.01 -45.53 79.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.439 -0.788 . . . . 0.0 109.842 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -62.16 -37.95 87.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.832 . . . . 0.0 109.744 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.2 m -58.87 -41.55 87.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.81 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 440' ' ' PHE . 86.6 mt -62.97 -43.93 97.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.337 -0.852 . . . . 0.0 109.308 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.72 ' CD2' ' H ' ' A' ' 446' ' ' SER . 73.5 t60 -173.68 -130.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.421 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . 0.72 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 8.1 t -145.42 -64.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.65 -44.95 94.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.449 -0.782 . . . . 0.0 109.731 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.99 -46.0 89.76 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -68.74 -39.11 86.2 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -37.88 89.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.511 -0.993 . . . . 0.0 109.839 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -83.17 20.06 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.0 109.498 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 27.7 p -71.09 122.47 20.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.675 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 40.9 pt -99.64 -2.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.793 . . . . 0.0 109.777 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -174.54 179.66 45.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.24 146.29 36.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.475 -1.015 . . . . 0.0 109.053 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -134.01 122.06 22.48 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.263 -0.898 . . . . 0.0 108.951 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.06 134.46 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.678 -0.639 . . . . 0.0 109.607 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 58.09 41.94 23.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 55.2 18.45 2.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.627 . . . . 0.0 110.141 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -122.75 144.09 49.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.628 -0.67 . . . . 0.0 109.213 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 41.9 tp -70.17 134.28 47.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.33 149.87 53.01 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.05 162.18 41.1 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.486 2.124 . . . . 0.0 112.617 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.8 mp -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.71 -0.619 . . . . 0.0 109.65 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 96.6 p -75.96 10.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.749 . . . . 0.0 109.627 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 93.5 t80 -65.09 135.94 56.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 110.226 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.434 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 22.3 t -79.29 131.26 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 78.9 mt -74.89 149.32 39.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.395 -0.816 . . . . 0.0 110.439 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -124.14 141.97 51.61 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.537 0.684 . . . . 0.0 109.396 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.9 t -66.19 142.45 57.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.69 . . . . 0.0 110.781 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.33 10.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -78.87 161.14 26.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -1.043 . . . . 0.0 109.998 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -105.56 122.82 46.81 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.5 t -97.4 132.24 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.458 -0.776 . . . . 0.0 110.244 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.0 141.72 47.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.16 130.8 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.447 -0.783 . . . . 0.0 109.64 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.17 137.92 31.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 97.4 p -137.02 157.64 46.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.446 -0.784 . . . . 0.0 109.676 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 92.0 p -85.36 -3.69 58.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.497 -0.752 . . . . 0.0 109.847 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -62.32 -144.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.461 -0.775 . . . . 0.0 110.266 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 481' ' ' SER . 10.4 t 56.53 26.15 10.64 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.442 0.639 . . . . 0.0 109.403 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 88.6 mt -92.67 11.4 26.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.749 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 56.95 160.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.539 0.685 . . . . 0.0 110.543 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -80.66 108.18 14.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.69 -0.631 . . . . 0.0 109.809 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -67.36 -39.54 85.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.68 -0.637 . . . . 0.0 110.043 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -50.93 144.96 7.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -150.47 165.77 32.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.522 -0.737 . . . . 0.0 109.478 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -150.7 151.71 32.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 109.136 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 489' ' ' HIS . 85.9 t60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.67 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 -115.64 165.67 12.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.601 -0.687 . . . . 0.0 109.643 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.1 m -114.31 131.25 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.651 0.739 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 63.8 ttp -95.02 135.4 36.61 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.525 0.679 . . . . 0.0 110.003 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.18 164.68 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.09 141.24 48.69 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.678 0.751 . . . . 0.0 109.73 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.52 176.25 2.04 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.28 -33.48 85.07 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.896 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.94 -4.21 54.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 80.91 10.68 84.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.85 155.73 40.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.636 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.22 124.33 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -127.19 131.88 50.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -105.71 135.52 46.98 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.451 0.643 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 23.1 mt -138.69 150.77 66.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.69 156.13 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.429 2.086 . . . . 0.0 112.719 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.16 154.49 7.78 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.291 1.043 . . . . 0.0 111.101 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 78.71 7.03 88.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.58 153.35 43.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.356 -1.085 . . . . 0.0 110.443 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 47.8 p -127.04 171.21 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.772 0.796 . . . . 0.0 110.159 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.3 -28.52 63.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.564 0.697 . . . . 0.0 109.829 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.81 -46.67 86.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 109.578 -179.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.26 -38.32 90.61 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.68 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 444' ' ' LEU . 67.5 t80 -61.13 -44.33 97.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.677 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.1 -47.37 83.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.0 -34.73 78.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.539 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 34.4 m -59.23 -41.2 88.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.579 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 440' ' ' PHE . 88.2 mt -69.38 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.95 -151.19 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.373 -0.83 . . . . 0.0 109.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 82.1 p -127.32 -73.99 0.6 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.583 0.706 . . . . 0.0 110.034 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.525 ' N ' ' OG ' ' A' ' 446' ' ' SER . 99.6 m-20 -64.13 -43.28 95.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.41 -46.58 87.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.007 0.908 . . . . 0.0 109.295 -179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.25 -40.21 94.68 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 452' ' ' CYS . 65.3 t0 -65.62 -37.92 87.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -1.066 . . . . 0.0 109.946 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 447' ' ' ASP . 73.6 m-70 -76.77 26.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.196 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 21.6 p -79.7 121.11 24.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.65 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 38.6 pt -101.38 -3.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -176.48 179.51 47.47 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.244 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.05 152.8 32.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -1.072 . . . . 0.0 109.364 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -131.01 131.31 44.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.742 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.15 132.56 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 121.44 0.638 . . . . 0.0 109.511 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 56.43 39.38 30.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.523 0.678 . . . . 0.0 109.518 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 78.1 m80 58.94 13.13 2.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.453 0.644 . . . . 0.0 109.69 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.77 136.83 49.25 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.778 0.799 . . . . 0.0 109.62 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.0 tp -66.44 131.74 46.73 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.707 0.765 . . . . 0.0 110.473 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 7.0 m -146.87 149.93 37.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.8 158.6 55.47 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.423 2.082 . . . . 0.0 112.421 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.52 -38.45 90.0 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.668 0.747 . . . . 0.0 109.761 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.8 m -75.27 8.34 2.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 109.41 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . 0.471 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 94.3 t80 -66.21 137.36 56.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.899 . . . . 0.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.471 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 82.1 t -75.88 130.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.067 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.8 mt -78.77 142.99 36.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.547 0.689 . . . . 0.0 110.624 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 99.7 m-20 -116.16 148.03 40.78 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.57 0.7 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 16.5 m -74.26 140.66 45.13 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.793 0.806 . . . . 0.0 110.947 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.16 -23.13 37.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 42.3 p-10 -84.48 171.8 12.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.291 -1.123 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -110.94 129.03 56.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.1 131.61 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.584 -0.697 . . . . 0.0 109.747 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -130.44 138.22 50.2 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.33 130.54 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.727 0.775 . . . . 0.0 110.221 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.74 141.4 30.02 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.468 0.652 . . . . 0.0 109.409 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.5 p -137.25 158.28 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.604 0.716 . . . . 0.0 109.694 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 480' ' ' LYS . 92.9 p -82.49 -6.08 59.1 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 479' ' ' SER . 68.4 mttm 40.66 34.09 0.23 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.897 0.856 . . . . 0.0 110.085 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 67.6 m -80.66 -3.51 50.85 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.492 -0.755 . . . . 0.0 109.153 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 482' ' ' LEU . 0.3 OUTLIER -93.11 75.29 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.04 121.41 27.37 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 485' ' ' HIS . 84.3 t60 -173.24 124.8 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 109.331 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 484' ' ' HIS . 78.0 m80 -154.93 21.67 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -61.91 -43.23 99.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.394 -0.817 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -74.42 138.27 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.805 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.466 ' ND1' ' O ' ' A' ' 488' ' ' HIS . 58.6 t-80 56.17 10.93 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.408 0.623 . . . . 0.0 110.122 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 75.9 m80 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.119 179.445 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 44.3 tpp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.11 158.68 22.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.654 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 419' ' ' VAL . 35.2 m -119.17 130.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . 0.492 ' SD ' ' CG2' ' A' ' 428' ' ' ILE . 49.2 ttp -100.31 143.87 29.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.631 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.27 161.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -112.73 125.86 54.78 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.547 0.689 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 423' ' ' THR . 0.2 OUTLIER -89.19 156.23 48.89 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.97 -15.96 42.26 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.148 1.899 . . . . 0.0 111.238 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.9 -3.18 53.59 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.449 -0.782 . . . . 0.0 109.178 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.07 161.22 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -1.133 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.492 ' CG2' ' SD ' ' A' ' 420' ' ' MET . 35.0 mm -110.14 129.2 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.511 -0.743 . . . . 0.0 109.068 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -125.91 134.54 51.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -106.3 133.27 51.26 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.639 -0.663 . . . . 0.0 109.513 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.72 147.18 52.63 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.05 158.19 55.84 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.318 2.012 . . . . 0.0 111.97 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -56.09 143.05 34.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.281 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 11.54 81.12 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -69.61 152.46 44.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.569 -0.959 . . . . 0.0 109.791 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.7 p -127.57 172.9 10.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.6 -0.687 . . . . 0.0 109.686 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.65 65.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.461 -0.774 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.82 -42.44 99.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.319 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -61.15 -43.6 98.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 109.956 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 444' ' ' LEU . 66.3 t80 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.11 -42.63 81.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.619 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -67.36 -38.02 84.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.148 -0.97 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 91.1 p -59.8 -37.02 77.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 109.664 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.461 HD11 ' CE2' ' A' ' 440' ' ' PHE . 91.3 mt -63.32 -42.8 99.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 109.231 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.69 ' CD2' ' H ' ' A' ' 446' ' ' SER . 85.8 t60 -173.49 -119.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . 0.69 ' H ' ' CD2' ' A' ' 445' ' ' HIS . 37.3 p -155.62 -64.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 451' ' ' HIS . 64.0 t0 -61.82 -48.78 79.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.492 -0.755 . . . . 0.0 109.803 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 448' ' ' LEU . 0.2 OUTLIER -62.99 -45.45 92.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.275 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -67.18 -40.8 92.53 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 450' ' ' ASP . 64.6 t0 -63.72 -37.26 86.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.099 . . . . 0.0 109.522 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' A' ' 447' ' ' ASP . 51.5 m80 -81.15 27.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 109.2 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 449' ' ' GLY . 13.2 p -77.35 129.78 36.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 24.6 pt -102.92 -5.26 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 0.0 109.313 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 175.68 -175.12 47.23 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.15 150.57 42.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 108.836 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -132.82 121.6 23.2 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.3 t -122.73 134.34 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.692 . . . . 0.0 109.289 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.2 m120 55.59 39.52 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.526 0.679 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 57.1 t-80 57.86 8.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.71 -0.619 . . . . 0.0 110.232 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -111.47 146.68 36.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.452 -0.78 . . . . 0.0 109.285 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 461' ' ' LEU . 4.3 mm? -72.43 142.06 48.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.5 -0.75 . . . . 0.0 109.704 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.84 148.87 34.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.19 159.94 49.8 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.06 1.84 . . . . 0.0 112.368 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 464' ' ' LEU . 10.5 mp -62.35 -40.16 95.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.578 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.5 m -75.85 7.44 3.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.21 136.6 58.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.86 130.17 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 109.641 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.55 146.55 36.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.468 -0.77 . . . . 0.0 109.79 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 472' ' ' ASP . 94.6 m-20 -123.98 151.7 43.36 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.547 -0.721 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 11.6 p -75.24 145.39 41.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.822 . . . . 0.0 110.458 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 93.81 -21.45 41.44 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 469' ' ' ASN . 49.4 p-10 -84.18 172.05 12.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -1.145 . . . . 0.0 109.893 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -115.1 131.93 56.77 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.424 HG11 ' CD2' ' A' ' 440' ' ' PHE . 64.0 t -109.92 131.64 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.395 -0.815 . . . . 0.0 110.014 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -135.72 113.3 10.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.53 137.34 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.807 . . . . 0.0 110.27 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.5 mt -96.6 135.0 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.468 -0.77 . . . . 0.0 109.255 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.5 m -127.79 154.48 45.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.53 -0.732 . . . . 0.0 109.77 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.2 p -90.62 87.27 6.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.18 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.38 -168.66 0.34 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 110.309 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 14.7 m -87.03 93.82 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 109.783 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 482' ' ' LEU . 9.0 mp -95.45 -9.8 31.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.272 -0.892 . . . . 0.0 109.133 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 485' ' ' HIS . 97.4 mt-10 56.15 153.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.63 0.729 . . . . 0.0 110.899 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 484' ' ' HIS . 29.9 t-80 48.78 12.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.38 -0.825 . . . . 0.0 109.548 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 483' ' ' GLU . 36.3 p-80 -87.36 146.62 25.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.324 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 45.37 -165.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.484 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -148.21 168.62 22.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.858 . . . . 0.0 109.856 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 58.16 50.02 10.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.503 -0.748 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.883 -1.056 . . . . 0.0 109.918 179.657 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . 0.606 ' SD ' ' N ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 57.7 mp0 -83.68 167.28 17.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 109.659 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.16 129.63 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.419 0.628 . . . . 0.0 109.61 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.3 ttm -102.91 132.87 48.83 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.49 163.54 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -117.66 144.09 45.55 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.905 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.27 174.3 3.17 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.49 -31.85 87.44 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.226 1.95 . . . . 0.0 111.289 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.99 -3.99 55.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.51 -0.744 . . . . 0.0 109.215 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.11 11.68 83.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.79 154.96 41.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -1.199 . . . . 0.0 110.517 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 36.3 mm -94.3 124.25 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -129.95 106.99 9.03 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -97.45 127.86 43.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.464 -0.773 . . . . 0.0 109.415 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 40.0 mt -120.09 148.88 47.96 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 154.29 74.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.15 1.9 . . . . 0.0 112.193 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -52.62 146.59 9.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.875 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.13 7.38 80.37 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.0 151.47 47.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.747 -0.855 . . . . 0.0 110.159 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -127.38 171.55 11.43 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.494 0.664 . . . . 0.0 109.544 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.36 65.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 464' ' ' LEU . 88.4 mt -63.19 -46.06 88.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.84 -42.99 99.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.571 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 444' ' ' LEU . 89.0 t80 -61.8 -44.94 95.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.77 . . . . 0.0 109.613 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.89 84.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 0.0 109.611 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.84 -34.03 77.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.1 m -58.63 -43.02 89.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 62.4 mt -63.3 -47.97 80.03 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 109.759 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 78.7 m-70 -166.01 -166.1 0.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 71.7 p -109.45 -37.24 5.78 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.42 -48.31 73.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 109.64 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 448' ' ' LEU . 3.8 mm? -63.76 -41.07 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.579 -0.701 . . . . 0.0 109.295 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -63.09 -33.06 86.22 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -87.49 -24.2 24.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.393 -1.063 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -100.01 14.53 30.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 109.413 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 7.9 t -80.35 110.41 15.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.179 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.78 0.73 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.651 -0.656 . . . . 0.0 109.378 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -172.96 173.17 45.52 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.194 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.92 29.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -1.052 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -133.15 122.44 24.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.23 131.56 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.569 0.699 . . . . 0.0 109.943 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 56.18 45.05 24.03 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.308 0.575 . . . . 0.0 109.861 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.7 12.24 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.666 -0.646 . . . . 0.0 109.814 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -115.21 132.54 56.58 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.547 0.689 . . . . 0.0 109.384 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.03 135.1 51.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.24 151.57 44.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.0 109.45 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.49 161.63 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.442 2.095 . . . . 0.0 112.336 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -62.8 -38.63 91.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.591 -0.693 . . . . 0.0 109.605 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 66.9 m -74.85 7.92 2.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.2 -0.938 . . . . 0.0 109.335 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 467' ' ' VAL . 92.2 t80 -69.47 134.63 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.421 ' O ' ' CE2' ' A' ' 466' ' ' TYR . 25.3 t -77.21 131.26 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.843 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 71.8 mt -75.15 144.74 42.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.293 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -115.96 147.92 40.64 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.422 0.63 . . . . 0.0 109.367 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.1 p -65.52 153.14 42.3 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.658 0.742 . . . . 0.0 111.214 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 81.36 -40.07 2.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.0 144.24 54.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.12 . . . . 0.0 111.016 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 474' ' ' VAL . 21.5 tm0? -85.81 143.35 28.33 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.518 ' O ' ' NE2' ' A' ' 473' ' ' GLN . 66.7 t -116.42 132.14 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.571 -0.705 . . . . 0.0 109.935 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 12.4 m -109.85 133.83 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.64 -0.662 . . . . 0.0 110.046 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 80.2 mt -89.84 108.33 19.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.726 . . . . 0.0 109.267 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.6 p -84.44 169.35 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.556 -0.715 . . . . 0.0 109.792 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.7 t -98.43 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.807 . . . . 0.0 109.085 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -60.41 139.43 57.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.784 . . . . 0.0 110.173 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 69.0 m -62.53 147.42 49.05 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.71 0.767 . . . . 0.0 110.501 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 482' ' ' LEU . 3.7 mm? -86.81 -3.13 59.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 484' ' ' HIS . 80.0 mm-40 -60.44 -112.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.66 -0.65 . . . . 0.0 110.079 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 483' ' ' GLU . 57.0 t-80 57.62 120.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.642 0.734 . . . . 0.0 110.003 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -154.47 152.48 30.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -111.43 106.47 15.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.717 -0.614 . . . . 0.0 109.573 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 489' ' ' HIS . 84.2 t60 -171.25 130.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 488' ' ' HIS . 55.0 t-80 52.06 8.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 487' ' ' HIS . 86.0 t60 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.101 -0.952 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . 0.608 ' SD ' ' N ' ' A' ' 417' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.723 0.773 . . . . 0.0 109.012 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 58.0 mp0 -81.11 161.43 24.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.507 -0.746 . . . . 0.0 110.094 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.0 130.84 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.695 0.759 . . . . 0.0 109.051 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.2 ttp -99.36 139.59 34.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.616 0.722 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.79 165.08 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.58 139.4 53.57 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.779 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 165.71 14.71 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.85 -9.74 26.56 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.707 2.271 . . . . 0.0 111.632 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -90.9 -5.32 55.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.115 -0.991 . . . . 0.0 109.492 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 87.47 6.23 77.81 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -83.44 160.75 21.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -1.221 . . . . 0.0 110.318 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 32.0 mm -105.83 128.01 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -127.07 134.41 50.28 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -110.42 136.28 49.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.72 -0.613 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 85.1 mt -135.83 147.97 63.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.91 154.2 71.32 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.284 1.989 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.765 ' H ' ' NE2' ' A' ' 433' ' ' GLN . 0.0 OUTLIER -55.1 147.42 16.09 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.723 0.773 . . . . 0.0 110.991 -179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.2 81.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.33 157.45 35.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.522 -0.987 . . . . 0.0 110.17 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 58.1 p -126.54 167.63 15.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.859 0.838 . . . . 0.0 109.928 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.35 68.28 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.522 0.677 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.01 -43.59 98.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.587 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.45 -42.87 99.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.669 0.747 . . . . 0.0 109.656 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 474' ' ' VAL . 83.2 t80 -61.77 -44.79 96.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.502 -0.749 . . . . 0.0 110.157 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.15 84.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.75 -36.28 83.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.76 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 444' ' ' LEU . 39.1 t -63.49 -36.6 84.31 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 443' ' ' SER . 96.3 mt -52.59 -105.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.23 -2.24 37.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 1.4 t 70.81 -55.8 0.63 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.597 0.713 . . . . 0.0 109.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 65.1 t0 -65.46 -38.79 90.85 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 448' ' ' LEU . 7.3 tt -62.8 -41.6 99.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.692 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -49.19 -9.4 0.12 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 451' ' ' HIS . 8.2 p-10 -91.28 -22.68 20.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.046 -1.267 . . . . 0.0 109.434 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.578 ' N ' ' OD1' ' A' ' 450' ' ' ASP . 40.2 m80 -100.91 -1.18 35.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.361 -0.837 . . . . 0.0 109.053 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 452' ' ' CYS . 26.1 p -61.98 118.1 6.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 41.1 pt -105.84 -5.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.806 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -173.33 176.44 46.01 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.11 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -146.0 151.96 38.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -1.162 . . . . 0.0 109.515 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -132.5 123.8 27.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.551 -0.718 . . . . 0.0 109.194 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -123.1 133.25 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.724 0.773 . . . . 0.0 109.812 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . 0.615 HD21 ' CB ' ' A' ' 472' ' ' ASP . 12.3 m120 55.69 40.89 30.9 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.516 0.675 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m80 56.21 13.01 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.426 0.631 . . . . 0.0 109.364 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.13 135.35 54.01 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.743 0.783 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.9 tp -66.74 134.98 53.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 0.0 109.813 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.32 150.68 49.07 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.357 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.37 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.505 2.136 . . . . 0.0 112.444 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.5 mp -63.55 -37.09 86.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.554 -0.716 . . . . 0.0 109.511 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.7 m -75.02 3.92 7.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 109.33 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -62.87 135.46 57.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.368 -0.832 . . . . 0.0 110.426 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.31 130.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.625 0.726 . . . . 0.0 109.982 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.89 147.52 38.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.61 -0.681 . . . . 0.0 110.494 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -124.26 148.06 47.65 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.862 0.839 . . . . 0.0 109.815 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 41.6 t -64.19 140.01 58.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.913 0.863 . . . . 0.0 111.123 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.15 -31.16 6.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . 0.615 ' CB ' HD21 ' A' ' 458' ' ' ASN . 98.8 m-20 -73.2 147.7 44.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -1.101 . . . . 0.0 111.026 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -95.53 141.93 28.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.72 . . . . 0.0 109.786 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.437 HG11 ' CD2' ' A' ' 440' ' ' PHE . 64.5 t -116.2 132.22 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.647 0.737 . . . . 0.0 109.787 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -138.12 113.58 9.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 109.046 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.0 134.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.77 96.19 8.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.452 -0.78 . . . . 0.0 109.208 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 96.0 p -85.29 166.37 16.54 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.739 0.781 . . . . 0.0 110.381 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.2 m -87.6 -4.61 58.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.077 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.83 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 5.0 m -76.43 101.7 5.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.68 -1.09 47.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.9 96.57 7.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.397 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -95.13 -14.65 23.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -101.81 13.42 34.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.228 -0.92 . . . . 0.0 109.096 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 75.7 m80 54.89 -92.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.675 -0.64 . . . . 0.0 110.023 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.52 141.23 46.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -152.12 164.12 37.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.635 -0.666 . . . . 0.0 109.383 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.893 -1.051 . . . . 0.0 108.914 179.875 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 418' ' ' GLU . 56.6 mp0 -110.64 167.07 10.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.547 -0.721 . . . . 0.0 109.534 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.2 m -112.52 131.4 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 57.3 ttm -98.36 136.09 39.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . 0.437 HG12 ' OD1' ' A' ' 472' ' ' ASP . 33.2 m -131.19 164.61 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.92 140.74 49.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.103 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 176.66 1.89 Allowed Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.09 -34.22 97.29 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 111.912 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -81.43 -3.87 54.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 109.143 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.57 82.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -71.82 153.11 42.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.317 . . . . 0.0 110.371 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -90.25 127.17 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -129.15 113.71 15.42 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.69 127.62 45.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 42.9 mt -131.83 156.12 80.52 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.07 144.79 56.27 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.904 1.736 . . . . 0.0 112.677 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -62.4 141.08 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.577 -0.702 . . . . 0.0 110.545 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.48 84.41 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -66.05 179.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -1.071 . . . . 0.0 110.136 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.0 p -127.67 169.5 13.72 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.96 -26.33 64.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.03 -43.01 99.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.353 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.73 -40.16 96.34 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.845 . . . . 0.0 109.116 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.471 ' CD2' ' CG1' ' A' ' 474' ' ' VAL . 83.1 t80 -61.46 -43.93 97.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.603 -0.686 . . . . 0.0 109.365 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.51 87.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.81 -33.85 76.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.355 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 7.1 t -59.92 -44.2 94.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.798 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.564 ' O ' ' CG ' ' A' ' 445' ' ' HIS . 70.1 mt -65.16 -55.87 16.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.179 -0.95 . . . . 0.0 109.847 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 444' ' ' LEU . 98.8 m-70 -160.02 -167.34 1.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.546 -0.721 . . . . 0.0 109.776 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 69.6 m -110.37 -62.42 1.52 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.613 -0.68 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.46 -48.44 79.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.506 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -64.11 -43.66 94.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.486 -0.759 . . . . 0.0 109.032 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.37 -43.19 95.43 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 59.9 t0 -73.64 -10.34 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.386 -1.067 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -100.94 22.75 11.67 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 84.4 m -81.95 130.74 35.16 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.479 -0.763 . . . . 0.0 109.81 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.47 -4.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.9 45.59 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -150.38 152.17 33.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -1.176 . . . . 0.0 109.123 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -133.15 127.11 33.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 109.191 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.89 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 459' ' ' HIS . 14.8 m120 53.0 57.56 6.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.787 -0.571 . . . . 0.0 110.342 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 458' ' ' ASN . 35.1 p80 41.67 30.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.233 0.54 . . . . 0.0 110.182 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.75 135.48 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 109.325 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.89 134.46 52.1 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.522 -0.736 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.76 150.57 63.36 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.67 160.43 49.49 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.393 2.062 . . . . 0.0 112.256 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.4 mp -63.07 -39.0 93.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.484 -0.76 . . . . 0.0 109.229 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 94.8 p -74.98 10.3 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.244 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -67.02 133.34 49.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.101 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.96 131.02 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.732 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.86 145.75 42.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.801 . . . . 0.0 110.129 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -121.83 134.63 54.89 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.533 0.682 . . . . 0.0 109.427 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -55.68 135.9 51.04 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 96.31 -12.53 66.55 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . 0.437 ' OD1' HG12 ' A' ' 421' ' ' VAL . 36.4 p-10 -83.69 171.35 13.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -1.163 . . . . 0.0 110.47 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -122.19 114.26 20.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 440' ' ' PHE . 18.9 t -93.16 131.79 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -133.0 113.84 13.28 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 5.9 m -83.73 136.38 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 82.3 mt -99.97 131.95 45.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.514 -0.741 . . . . 0.0 109.038 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 45.2 t -136.37 145.91 45.91 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.698 . . . . 0.0 109.752 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 480' ' ' LYS . 94.9 p -85.53 -4.04 59.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.76 . . . . 0.0 108.959 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 479' ' ' SER . 99.0 mttt 52.66 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.725 0.774 . . . . 0.0 110.618 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 11.4 p -64.22 -36.94 85.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.466 -0.771 . . . . 0.0 109.495 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 79.5 mt 56.37 42.27 27.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.628 -0.67 . . . . 0.0 109.895 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.05 71.69 1.23 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.519 -0.738 . . . . 0.0 109.137 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -66.79 -39.21 87.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 109.529 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -59.42 131.4 50.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.299 -0.875 . . . . 0.0 109.694 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -111.05 143.59 41.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.612 -0.68 . . . . 0.0 109.835 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 487' ' ' HIS . 86.3 t60 -141.7 44.96 1.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -152.26 164.07 38.14 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.411 -0.806 . . . . 0.0 109.653 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.933 179.898 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 39.9 tpp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.2 149.07 41.0 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.617 -0.677 . . . . 0.0 109.292 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 7.6 m -112.29 130.53 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.4 ttm -97.11 135.98 38.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 109.765 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.53 165.24 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.564 -0.71 . . . . 0.0 109.238 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' A' ' 428' ' ' ILE . 78.8 m-85 -111.07 141.44 44.56 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.995 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . 0.459 ' OG1' ' N ' ' A' ' 427' ' ' GLU . 82.1 p -96.39 151.44 38.07 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.7 -17.68 51.05 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.563 1.509 . . . . 0.0 110.685 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.431 -0.793 . . . . 0.0 109.176 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.77 1.17 65.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 23.2 mp0 -88.19 155.81 19.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.034 -1.274 . . . . 0.0 109.177 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' A' ' 422' ' ' PHE . 2.7 tp -106.91 140.26 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.46 132.77 53.49 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -103.81 133.45 48.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.275 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 38.8 mt -132.83 148.05 67.93 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.49 157.8 59.6 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.214 1.943 . . . . 0.0 112.157 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.81 148.66 12.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.391 -0.818 . . . . 0.0 110.085 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.9 81.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.84 41.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -127.21 174.44 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.509 -0.744 . . . . 0.0 109.663 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.77 71.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.951 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.97 -42.18 98.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.029 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.96 -43.27 95.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.925 . . . . 0.0 109.703 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 444' ' ' LEU . 85.0 t80 -60.44 -45.06 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.06 85.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.983 . . . . 0.0 109.801 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -63.93 -36.94 85.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.02 . . . . 0.0 109.643 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.6 m -58.02 -41.84 83.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.887 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.459 HD11 ' CE2' ' A' ' 440' ' ' PHE . 70.2 mt -65.92 -75.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -141.89 -178.46 5.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 109.589 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 78.2 p -101.29 -54.01 2.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 109.098 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.407 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 99.1 m-20 -62.33 -45.95 90.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.302 -0.874 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.55 -43.49 96.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.003 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -66.44 -38.81 93.83 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.91 -11.8 61.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 109.202 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -105.01 13.43 30.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 452' ' ' CYS . 30.3 p -74.75 120.8 20.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.935 . . . . 0.0 109.816 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.9 pt -101.81 -3.1 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.276 -0.89 . . . . 0.0 109.439 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.54 45.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -153.05 150.3 29.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.265 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -135.5 133.03 38.06 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.419 -0.801 . . . . 0.0 109.391 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.33 131.24 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 56.47 44.55 24.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.317 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 54.21 15.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.75 . . . . 0.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -113.85 137.1 52.12 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.471 -0.768 . . . . 0.0 109.241 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.25 135.25 53.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.859 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.13 151.28 33.92 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.918 . . . . 0.0 108.984 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.31 162.08 42.0 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.473 2.115 . . . . 0.0 112.615 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -61.88 -40.35 95.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.739 . . . . 0.0 109.546 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 92.7 p -75.29 10.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.653 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -67.23 135.66 53.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.684 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 72.7 t -78.46 132.58 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -0.872 . . . . 0.0 109.681 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -74.97 148.97 39.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 109.77 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -123.19 145.59 48.5 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 36.9 t -65.37 144.22 57.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.55 -40.67 3.03 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.37 145.4 51.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -1.107 . . . . 0.0 109.799 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -87.62 149.95 23.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.153 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 58.4 t -117.91 131.29 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -131.66 138.76 48.88 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.87 130.12 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 109.384 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.72 136.18 33.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.841 . . . . 0.0 109.434 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 58.6 m -129.68 156.9 43.51 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.601 -0.687 . . . . 0.0 109.426 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 93.9 p -78.48 -2.41 38.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 482' ' ' LEU . 45.7 mmtm -76.26 144.96 40.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.308 -0.87 . . . . 0.0 109.956 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 71.0 m -64.03 71.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.673 -0.642 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 480' ' ' LYS . 2.3 pp -89.66 -1.88 58.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.233 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.27 -5.03 59.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 0.0 109.586 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -108.35 117.91 35.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.469 -0.769 . . . . 0.0 109.703 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.455 ' O ' ' N ' ' A' ' 487' ' ' HIS . 98.8 m-70 -58.38 -77.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 488' ' ' HIS . 73.2 m80 47.0 18.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 485' ' ' HIS . 69.4 t60 59.64 -70.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.439 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.555 ' N ' ' O ' ' A' ' 486' ' ' HIS . 75.0 m80 -70.62 136.44 49.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 109.981 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.447 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -90.14 162.11 15.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.599 0.714 . . . . 0.0 110.086 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.89 130.46 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.834 0.825 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 62.0 ttp -99.97 136.34 40.03 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.736 0.779 . . . . 0.0 110.043 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.79 164.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.329 0.585 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.26 138.58 54.45 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.07 0.938 . . . . 0.0 110.229 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.04 164.96 15.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.69 -13.55 40.36 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.487 2.125 . . . . 0.0 111.671 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.78 -5.52 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 109.376 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.35 8.13 83.88 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -84.69 159.45 20.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.624 -0.927 . . . . 0.0 110.566 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.6 mm -105.43 128.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.739 0.78 . . . . 0.0 109.493 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -127.88 144.88 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.525 0.679 . . . . 0.0 109.636 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -124.71 136.0 53.51 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.694 . . . . 0.0 110.072 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 35.6 mt -127.47 147.81 63.89 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.88 158.27 58.55 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.429 2.086 . . . . 0.0 112.593 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.31 141.42 24.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.973 0.892 . . . . 0.0 110.661 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.4 84.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -70.28 150.78 46.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.686 -0.89 . . . . 0.0 110.278 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.1 p -127.24 173.5 9.69 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.929 0.871 . . . . 0.0 110.227 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.29 -27.64 62.32 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.519 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.92 -45.88 90.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.589 -0.695 . . . . 0.0 109.363 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.499 ' CE2' HD11 ' A' ' 444' ' ' LEU . 85.1 t80 -60.76 -44.35 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.765 -0.584 . . . . 0.0 109.8 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.43 90.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . 0.417 ' CE1' ' CD1' ' A' ' 438' ' ' LEU . 5.5 m-85 -68.37 -36.73 79.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 70.3 p -60.27 -38.28 83.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.72 -0.612 . . . . 0.0 109.478 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.499 HD11 ' CE2' ' A' ' 440' ' ' PHE . 85.1 mt -71.88 -75.37 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.491 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -140.48 -179.38 5.98 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 13.0 m -102.42 -59.05 1.77 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.469 -0.77 . . . . 0.0 110.293 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 37.8 p-10 -63.21 -44.04 96.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 110.026 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.53 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.96 -45.12 90.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.511 -0.743 . . . . 0.0 109.065 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.33 92.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.08 -36.15 83.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.737 -0.86 . . . . 0.0 109.557 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.22 20.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.794 -0.566 . . . . 0.0 109.673 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 10.4 t -77.73 120.71 23.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.2 -4.94 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -177.46 178.3 48.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -141.49 148.19 39.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.977 . . . . 0.0 109.958 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -129.54 121.41 27.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.65 0.738 . . . . 0.0 109.694 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.13 132.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.776 0.798 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 54.84 43.9 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.599 0.714 . . . . 0.0 109.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.86 15.07 2.09 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 109.796 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -118.2 134.58 54.89 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.829 0.823 . . . . 0.0 109.815 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 48.8 tp -68.27 134.37 50.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.673 0.749 . . . . 0.0 110.061 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.06 150.35 41.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.725 -0.609 . . . . 0.0 109.787 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.62 163.17 33.91 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.598 2.199 . . . . 0.0 112.826 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -62.73 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.149 0.5 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 5.6 t -75.53 8.15 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.645 -0.659 . . . . 0.0 109.668 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -68.22 134.37 50.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 109.676 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 86.7 t -79.12 130.21 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.777 0.798 . . . . 0.0 109.922 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.9 mt -75.97 144.24 41.08 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.564 0.697 . . . . 0.0 110.243 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -115.24 145.55 42.32 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.892 0.853 . . . . 0.0 110.118 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 39.4 t -66.01 139.99 58.25 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.461 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 92.44 -32.78 5.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -74.73 145.32 43.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.895 . . . . 0.0 110.904 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -86.85 144.76 26.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.519 0.676 . . . . 0.0 109.268 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.69 132.53 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.937 0.875 . . . . 0.0 110.127 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -135.74 141.51 44.86 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.455 0.645 . . . . 0.0 109.305 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.93 131.73 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.859 0.838 . . . . 0.0 110.005 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 76.4 mt -99.12 131.21 45.32 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.469 0.652 . . . . 0.0 109.668 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 46.9 t -133.45 131.82 40.36 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.628 0.728 . . . . 0.0 109.507 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 6.4 t -94.46 -0.32 54.82 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 481' ' ' SER . 68.6 mttm 56.19 44.55 24.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 480' ' ' LYS . 13.5 m -59.04 -151.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.693 0.759 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 482' ' ' LEU . 8.1 mp 47.78 84.22 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.947 0.879 . . . . 0.0 109.366 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 483' ' ' GLU . 58.0 mp0 -82.12 137.48 34.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.772 0.796 . . . . 0.0 110.387 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -88.41 153.01 21.52 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.51 0.671 . . . . 0.0 110.341 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.488 ' O ' ' CG ' ' A' ' 486' ' ' HIS . 2.8 m170 69.38 -48.67 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' A' ' 485' ' ' HIS . 10.6 p80 40.2 40.33 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.707 0.765 . . . . 0.0 109.753 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 486' ' ' HIS . 78.0 m80 45.86 -176.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.496 0.665 . . . . 0.0 111.053 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -67.12 -40.09 86.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.535 -0.728 . . . . 0.0 109.276 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.392 179.619 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.513 0.673 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -76.49 163.76 26.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.739 . . . . 0.0 110.119 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.1 130.75 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 51.1 ttm -95.53 133.77 39.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.646 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.76 163.52 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.53 140.48 52.96 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.615 0.722 . . . . 0.0 109.613 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.1 175.82 2.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.4 -30.04 90.15 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.372 2.048 . . . . 0.0 111.561 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -81.22 -4.09 54.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 109.204 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 81.69 9.18 85.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -69.77 151.88 45.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -1.078 . . . . 0.0 110.414 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.77 122.67 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.462 -0.774 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -128.05 131.36 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -108.04 134.82 50.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.656 -0.653 . . . . 0.0 109.36 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.99 157.43 69.42 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.697 -0.627 . . . . 0.0 109.393 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.94 150.25 79.24 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.208 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -54.34 137.26 42.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -0.838 . . . . 0.0 110.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.09 13.3 74.73 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -65.45 159.35 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -1.08 . . . . 0.0 110.057 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.3 p -126.93 171.97 10.84 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.691 0.758 . . . . 0.0 110.014 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.6 62.88 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.664 -0.647 . . . . 0.0 109.953 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 438' ' ' LEU . 0.2 OUTLIER -62.57 -46.59 87.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.091 -1.006 . . . . 0.0 109.383 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.47 -39.24 93.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.421 -0.799 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.419 ' CE2' HD11 ' A' ' 444' ' ' LEU . 88.0 t80 -60.83 -44.96 96.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.58 92.99 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . 0.431 ' CE1' HD11 ' A' ' 438' ' ' LEU . 4.8 m-85 -67.59 -36.35 80.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 11.7 t -59.82 -43.6 94.46 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.775 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 440' ' ' PHE . 79.5 mt -64.21 -74.91 0.09 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -135.7 -179.73 5.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.467 -0.77 . . . . 0.0 109.673 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 447' ' ' ASP . 29.9 p -103.09 -56.11 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.694 -0.629 . . . . 0.0 109.356 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 448' ' ' LEU . 36.9 p-10 -66.85 -41.66 86.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 447' ' ' ASP . 0.2 OUTLIER -64.37 -44.54 91.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.329 -0.857 . . . . 0.0 109.025 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.32 93.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -70.9 -11.31 60.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -1.095 . . . . 0.0 109.176 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 32.5 m170 -104.55 14.87 29.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 454' ' ' GLY . 11.2 t -77.7 123.53 26.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 109.756 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.64 -4.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . 0.469 ' O ' ' SG ' ' A' ' 452' ' ' CYS . . . -174.42 176.46 46.75 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.537 -1.315 . . . . 0.0 109.898 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -137.16 147.05 45.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -1.056 . . . . 0.0 109.049 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -133.01 121.49 22.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.82 133.78 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.425 0.631 . . . . 0.0 109.543 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 57.28 44.1 22.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.495 0.664 . . . . 0.0 109.708 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 55.77 17.56 2.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.028 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -122.02 142.21 50.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.489 -0.757 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.51 132.81 45.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.69 -0.631 . . . . 0.0 109.896 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.43 150.22 50.55 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.079 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.63 162.05 40.96 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.567 2.178 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.7 mp -63.35 -38.5 91.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 69.9 m -75.02 8.8 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.125 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -67.58 134.21 50.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.01 132.04 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.852 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.88 148.09 40.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.634 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -123.8 145.09 49.3 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.545 0.688 . . . . 0.0 109.454 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.8 m -66.45 144.72 56.33 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.589 0.709 . . . . 0.0 111.224 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 89.12 -30.32 5.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -74.9 153.47 38.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -1.09 . . . . 0.0 110.783 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -98.17 128.97 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.34 131.34 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.97 144.39 45.37 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 11.2 m -109.88 132.18 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.556 0.693 . . . . 0.0 109.722 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.18 129.63 42.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.47 -0.769 . . . . 0.0 109.212 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.3 m -133.8 126.81 31.36 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.593 -0.692 . . . . 0.0 109.528 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 78.1 p -66.26 -34.23 77.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.697 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -72.15 133.72 45.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 18.7 m -159.24 -36.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.267 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 482' ' ' LEU . 0.5 OUTLIER -107.55 1.39 23.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 485' ' ' HIS . 79.7 mm-40 54.54 -120.91 1.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.647 -0.658 . . . . 0.0 110.326 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 484' ' ' HIS . 37.0 t-80 48.45 12.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.367 -0.833 . . . . 0.0 109.37 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 483' ' ' GLU . 51.9 p-80 -67.93 -39.01 83.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.384 -0.823 . . . . 0.0 109.491 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . 0.402 ' N ' ' CG ' ' A' ' 485' ' ' HIS . 59.8 t-80 50.29 86.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . 0.689 ' CD2' ' H ' ' A' ' 489' ' ' HIS . 82.2 t60 -72.37 149.79 44.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.0 110.387 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -60.92 -41.78 96.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.416 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . 0.689 ' H ' ' CD2' ' A' ' 487' ' ' HIS . 80.8 t60 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.87 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.519 0.676 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.96 158.48 25.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 0.0 110.047 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.4 131.31 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.485 0.66 . . . . 0.0 109.449 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 12.3 ptm -97.3 147.51 24.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.646 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.51 161.78 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.03 120.59 42.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.55 0.69 . . . . 0.0 109.646 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.6 p -88.48 154.13 50.96 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.18 -13.13 14.89 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.279 1.986 . . . . 0.0 111.284 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -85.02 -3.68 58.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 84.28 3.67 88.59 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.88 159.49 19.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.959 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.2 mm -113.1 129.6 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.478 -0.763 . . . . 0.0 109.542 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -121.87 137.57 54.73 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -105.01 131.19 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 109.91 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.95 147.43 46.29 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.06 154.44 74.06 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.86 137.96 37.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.581 0.705 . . . . 0.0 110.573 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 84.0 13.24 75.12 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -68.94 155.58 40.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -1.047 . . . . 0.0 110.207 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.4 p -127.09 175.33 8.2 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.664 0.745 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -57.2 -33.36 67.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.693 -0.629 . . . . 0.0 110.125 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 82.2 mt -63.03 -41.97 99.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.117 -0.989 . . . . 0.0 109.794 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -60.44 -43.31 96.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.33 -0.856 . . . . 0.0 109.814 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.449 ' CE2' HD11 ' A' ' 444' ' ' LEU . 70.3 t80 -61.52 -43.45 98.83 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.429 -0.795 . . . . 0.0 109.98 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -56.45 -44.6 80.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.89 -36.34 84.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.627 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.7 p -58.98 -34.36 71.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.449 HD11 ' CE2' ' A' ' 440' ' ' PHE . 86.8 mt -73.78 -76.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.686 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -143.49 -173.8 4.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.265 -0.897 . . . . 0.0 110.101 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' SER . . . . . . . . . . . . . 29.7 t -104.17 -55.22 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.412 0.625 . . . . 0.0 109.512 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.485 ' O ' ' ND1' ' A' ' 451' ' ' HIS . 25.7 p-10 -63.01 -48.83 77.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.817 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 448' ' ' LEU . 0.2 OUTLIER -63.97 -43.15 96.63 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.471 -0.768 . . . . 0.0 109.198 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . -64.35 -41.13 98.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 450' ' ' ASP . 66.3 t0 -69.42 -27.41 65.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -1.066 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.485 ' ND1' ' O ' ' A' ' 447' ' ' ASP . 34.5 m80 -87.72 18.11 4.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.277 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' CYS . . . . . . . . . . . . . 42.6 m -80.23 117.04 20.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -0.875 . . . . 0.0 109.663 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.94 -2.54 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.751 . . . . 0.0 109.377 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -171.16 178.03 43.78 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.402 -1.38 . . . . 0.0 110.288 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -152.89 150.5 29.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -1.024 . . . . 0.0 109.067 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' LYS . . . . . 0.525 ' HZ2' ' HB2' ' A' ' 456' ' ' LYS . 3.2 ttmp? -135.79 131.9 36.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.571 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.47 130.83 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.567 0.699 . . . . 0.0 109.538 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 55.84 43.35 27.76 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.45 0.643 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 459' ' ' HIS . 59.0 t-80 57.9 12.98 1.91 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 109.965 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -113.83 135.34 54.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 47.8 tp -66.68 135.08 53.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 110.109 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.04 151.2 37.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.099 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.17 161.89 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.483 2.122 . . . . 0.0 112.344 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 464' ' ' LEU . 10.6 mp -63.05 -38.31 90.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.646 -0.659 . . . . 0.0 109.504 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.5 p -75.07 9.43 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.977 . . . . 0.0 109.3 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -68.88 135.26 50.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.404 -0.81 . . . . 0.0 110.206 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.35 130.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 110.306 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.63 147.51 37.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 110.174 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -125.46 146.61 49.56 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.607 -0.683 . . . . 0.0 109.909 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 68.2 m -70.49 141.43 51.98 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.565 0.698 . . . . 0.0 110.865 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' GLY . . . . . . . . . . . . . . . 97.48 -22.72 39.31 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.32 171.04 13.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.198 -1.178 . . . . 0.0 110.529 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.69 127.38 56.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 440' ' ' PHE . 60.2 t -102.82 131.7 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.371 -0.831 . . . . 0.0 109.911 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.54 116.05 14.6 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 476' ' ' VAL . 3.6 m -85.05 130.93 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.35 143.67 26.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.558 -0.714 . . . . 0.0 109.652 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 480' ' ' LYS . 70.2 m -123.64 154.96 38.6 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 85.3 p -70.55 37.84 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.474 -0.766 . . . . 0.0 109.87 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 478' ' ' SER . 44.4 mmtm -87.36 -7.86 57.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.461 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 482' ' ' LEU . 19.2 p -171.42 -131.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.956 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.551 ' N ' ' OG ' ' A' ' 481' ' ' SER . 32.8 mt 60.46 49.45 6.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -42.52 137.42 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -73.33 140.94 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.591 -0.693 . . . . 0.0 109.955 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 486' ' ' HIS . 59.1 t-80 -108.46 142.95 38.08 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 487' ' ' HIS . 34.2 p80 -65.51 141.48 58.46 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 486' ' ' HIS . 61.1 t-80 59.43 135.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.501 0.667 . . . . 0.0 110.21 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -103.33 129.75 50.44 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.688 0.756 . . . . 0.0 109.687 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.932 -179.83 . . . . . . . . 0 0 . 1 stop_ save_